data_2kvi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kvi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.479 0.638 0 CA-C-O 119.174 -0.427 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 144.43 38.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 165.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 167.06 28.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.89 2.476 . . . . 0.0 109.877 -171.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -136.79 127.64 27.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.555 1.142 . . . . 0.0 112.142 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.4 tt -118.83 129.05 55.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.655 1.982 . . . . 0.0 109.755 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -111.89 139.58 47.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 110.944 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.62 139.88 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.823 1.249 . . . . 0.0 110.738 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.78 155.89 16.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.999 1.761 . . . . 0.0 111.877 163.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.8 -17.29 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -83.59 -47.57 0.76 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.36 1.464 . . . . 0.0 114.12 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.48 35.43 0.58 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.916 3.077 . . . . 0.0 114.088 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.22 -32.21 15.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.659 1.584 . . . . 0.0 111.544 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -65.12 148.73 51.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.248 1.019 . . . . 0.0 109.634 162.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -50.37 133.93 23.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.365 1.066 . . . . 0.0 112.782 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -145.39 140.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.128 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.4 m -135.78 172.71 12.62 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.973 1.709 . . . . 0.0 108.772 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.54 -39.54 61.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -69.12 -33.5 73.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.18 -53.66 49.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.822 0.737 . . . . 0.0 111.105 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.02 -33.01 74.62 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.71 0.404 . . . . 0.0 111.676 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.38 -48.08 81.3 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -75.94 -35.1 59.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.784 1.174 . . . . 0.0 113.209 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.13 -26.37 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.81 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -99.67 -16.28 18.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -46.07 -48.23 42.65 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 120.836 1.653 . . . . 0.0 115.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -17.71 18.19 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 121.874 1.705 . . . . 0.0 113.758 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -87.38 -34.33 18.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 112.666 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.99 173.1 36.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.443 1.024 . . . . 0.0 115.54 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -94.59 -13.55 25.84 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER 57.43 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 128.458 2.703 . . . . 0.0 116.912 165.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mmt -136.05 -71.08 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.944 -1.723 . . . . 0.0 113.716 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.97 158.4 40.58 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.05 0.94 . . . . 0.0 111.36 -168.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -107.48 153.99 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -155.81 93.03 1.42 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.526 1.13 . . . . 0.0 111.609 164.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.45 135.74 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 120.626 -1.296 . . . . 0.0 112.164 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.41 146.79 13.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.448 1.899 . . . . 0.0 110.844 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 39' ' ' PHE . 35.7 t-20 63.73 -164.05 0.26 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.577 1.951 . . . . 0.0 112.458 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.39 30.13 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.843 1.657 . . . . 0.0 113.938 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 37' ' ' ASN . 96.9 m-85 -145.68 174.37 11.25 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.277 2.631 . . . . 0.0 109.68 -175.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.01 143.01 8.14 Favored Glycine 0 CA--C 1.52 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 111.817 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.38 140.48 49.77 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.21 1.004 . . . . 0.0 108.801 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.4 123.83 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -81.83 143.38 31.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.41 1.1 . . . . 0.0 109.893 168.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.61 164.91 20.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.381 1.472 . . . . 0.0 111.59 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.5 137.65 32.57 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 157.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.85 124.71 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 128.041 2.536 . . . . 0.0 116.651 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.79 -24.31 13.41 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.378 2.718 . . . . 0.0 114.042 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -64.29 -38.42 90.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.682 1.128 . . . . 0.0 110.362 170.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -35.2 80.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.627 1.571 . . . . 0.0 112.071 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.64 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.316 -0.865 . . . . 0.0 112.162 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.296 6.4 ppt_? -69.24 -34.08 74.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.837 0.744 . . . . 0.0 112.924 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -68.31 -33.22 73.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.442 1.019 . . . . 0.0 112.741 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.67 -68.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.259 1.3 pp -72.58 -27.87 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.403 1.456 . . . . 0.0 114.682 -176.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -80.22 -19.34 47.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.3 1.864 . . . . 0.0 114.026 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.1 t -107.41 -30.13 8.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 119.662 1.119 . . . . 0.0 112.134 171.752 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.6 163.91 33.33 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 110.626 171.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -152.21 140.35 20.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.181 0.592 . . . . 0.0 111.848 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -93.07 137.74 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.857 1.263 . . . . 0.0 109.909 163.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.465 0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 111.977 178.431 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 CA-C-O 119.745 -0.19 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -87.77 147.92 24.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.85 163.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.18 154.91 30.03 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.175 1.39 . . . . 0.0 109.23 -172.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -142.03 123.75 15.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.542 1.064 . . . . 0.0 112.883 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 tt -113.87 105.79 13.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.854 2.462 . . . . 0.0 108.904 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -94.75 142.38 27.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.186 0.994 . . . . 0.0 111.162 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 mt -138.51 131.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.386 1.074 . . . . 0.0 110.839 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.38 150.91 18.61 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.904 0.764 . . . . 0.0 112.531 167.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 61.34 27.21 16.9 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.554 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -134.99 -45.97 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.04 1.736 . . . . 0.0 113.386 172.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.554 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 71.7 Cg_endo -73.14 21.27 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.654 2.236 . . . . 0.0 114.864 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.12 -21.92 49.63 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.063 2.145 . . . . 0.0 110.948 169.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.87 162.86 25.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.695 1.598 . . . . 0.0 111.194 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -84.98 106.33 16.4 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.967 0.907 . . . . 0.0 109.257 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.48 137.69 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.788 1.235 . . . . 0.0 111.63 -170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -123.19 172.32 8.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.83 1.652 . . . . 0.0 111.736 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -48.49 -53.0 19.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.072 1.349 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -62.29 -31.16 71.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.77 -49.28 13.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.837 0.744 . . . . 0.0 112.263 -174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.91 -29.24 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -67.99 -53.2 27.85 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.42 0.688 . . . . 0.0 111.991 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -67.39 -32.34 73.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.138 1.336 . . . . 0.0 112.797 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.54 -45.64 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.51 -3.73 57.42 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -48.37 40.2 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.15 -14.35 16.73 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.874 1.716 . . . . 0.0 113.496 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -91.34 -24.12 19.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.553 . . . . 0.0 113.582 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.91 169.54 42.23 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.97 -18.26 56.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -166.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.33 148.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 128.271 2.628 . . . . 0.0 116.224 173.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.7 mmt -131.99 -96.88 0.32 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.196 1.799 . . . . 0.0 110.427 167.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.401 ' H ' ' HB2' ' A' ' 43' ' ' GLN . 81.9 mt-30 -120.78 173.07 7.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.972 2.109 . . . . 0.0 112.314 -168.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 pt -124.92 145.32 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.315 -0.866 . . . . 0.0 112.798 -172.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -154.15 70.41 0.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.158 0.98 . . . . 0.0 113.121 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.73 117.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 108.434 170.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -150.51 150.34 31.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.793 2.437 . . . . 0.0 109.051 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 56.29 -170.37 0.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 113.218 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.82 1.79 3.06 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 120.267 -1.521 . . . . 0.0 113.623 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -144.04 59.62 1.36 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.768 2.427 . . . . 0.0 110.815 -159.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 173.89 42.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.948 1.261 . . . . 0.0 113.217 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -143.82 165.49 27.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.008 1.385 . . . . 0.0 113.966 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.9 mt -129.68 134.5 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 126.017 1.727 . . . . 0.0 107.16 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.401 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 71.8 mt-30 -85.54 141.46 29.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 169.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.86 164.08 21.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 111.59 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.85 141.14 31.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 160.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 62.26 148.84 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 127.706 2.403 . . . . 0.0 115.689 -166.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.48 -33.24 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.632 2.888 . . . . 0.0 112.496 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -60.45 -38.48 84.28 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.761 -0.587 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.0 m -53.59 -43.76 68.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.088 1.355 . . . . 0.0 113.645 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.3 -51.45 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.437 0.695 . . . . 0.0 109.8 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.94 -38.45 66.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.36 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 -31.59 72.82 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.923 1.238 . . . . 0.0 112.505 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.74 -64.05 1.03 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.498 0.719 . . . . 0.0 112.744 173.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.83 -24.15 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.69 -13.66 62.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.915 1.689 . . . . 0.0 111.579 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.5 t -105.12 -37.21 7.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.165 1.386 . . . . 0.0 112.906 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.473 0.696 0 O-C-N 120.93 -1.106 . . . . 0.0 113.161 -179.512 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.6 pt . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.834 0.349 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.05 165.39 30.06 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.783 0.833 . . . . 0.0 112.566 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -141.17 135.74 31.13 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.11 -0.369 . . . . 0.0 111.299 160.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.06 135.51 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.885 1.274 . . . . 0.0 110.676 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.466 0.363 0 C-N-CA 124.505 1.122 . . . . 0.0 111.981 -175.448 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.478 0.568 0 N-CA-C 112.677 0.222 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -120.17 124.04 44.76 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.941 0.897 . . . . 0.0 111.181 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -138.44 161.69 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.054 1.742 . . . . 0.0 112.126 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -134.75 125.56 27.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.119 -0.988 . . . . 0.0 111.658 -172.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -111.37 125.12 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.205 2.602 . . . . 0.0 109.022 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.81 128.58 53.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.406 0.682 . . . . 0.0 110.568 165.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.84 134.69 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.25 -158.96 0.43 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.457 0.551 . . . . 0.0 112.787 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -70.65 73.64 0.55 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.293 1.037 . . . . 0.0 113.256 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.3 tp -129.02 -35.68 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.261 1.825 . . . . 0.0 112.772 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.23 42.7 0.14 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.621 3.547 . . . . 0.0 115.896 168.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -15.23 63.45 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.261 -1.524 . . . . 0.0 113.102 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -95.97 166.32 11.83 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.652 1.581 . . . . 0.0 111.423 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -60.8 126.27 26.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.884 0.874 . . . . 0.0 111.068 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.42 121.96 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.456 1.503 . . . . 0.0 107.972 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -101.19 170.25 8.37 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.867 0.867 . . . . 0.0 111.668 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -54.39 -39.59 67.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.635 . . . . 0.0 112.41 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -71.51 -30.39 65.89 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.87 -54.32 16.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.923 1.238 . . . . 0.0 111.086 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.36 -32.79 73.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.178 -0.326 . . . . 0.0 111.782 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.62 -50.83 61.72 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.522 -0.736 . . . . 0.0 111.447 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -66.88 -38.67 86.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.207 1.367 . . . . 0.0 112.643 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.38 -28.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.291 0.951 . . . . 0.0 112.774 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.33 -2.12 31.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -49.66 -51.95 55.12 Favored Pre-proline 0 N--CA 1.48 1.053 0 CA-C-N 120.107 1.321 . . . . 0.0 114.359 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.77 -19.72 16.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.424 1.544 . . . . 0.0 113.983 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -87.22 -19.94 27.64 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.293 -0.88 . . . . 0.0 112.379 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.32 39.21 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -108.35 -7.46 15.88 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.245 1.942 . . . . 0.0 116.245 -170.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.0 155.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 127.952 2.501 . . . . 0.0 117.278 164.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mmt -139.76 -65.09 0.47 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.296 1.438 . . . . 0.0 112.79 165.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -152.56 159.86 43.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.112 0.965 . . . . 0.0 112.293 -163.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.69 143.4 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.741 1.216 . . . . 0.0 111.327 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -156.26 97.57 1.78 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.994 0.917 . . . . 0.0 112.283 161.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.48 133.83 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.978 -1.076 . . . . 0.0 111.639 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -153.3 162.92 40.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.218 2.607 . . . . 0.0 109.478 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.12 -159.64 0.27 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.409 1.084 . . . . 0.0 112.623 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.14 60.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.962 1.305 . . . . 0.0 113.985 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -103.8 -172.05 2.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.27 1.828 . . . . 0.0 111.885 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.07 145.79 11.21 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 120.525 -1.359 . . . . 0.0 114.219 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.09 138.14 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.29 1.036 . . . . 0.0 110.693 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.5 mt -139.88 133.07 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.91 150.67 20.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.493 -1.379 . . . . 0.0 110.072 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.79 156.72 47.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.857 1.663 . . . . 0.0 112.414 -165.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -94.09 141.22 28.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 58.51 128.92 0.02 OUTLIER Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 128.86 2.864 . . . . 0.0 116.259 -167.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.58 -27.45 38.96 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.274 1.983 . . . . 0.0 114.349 172.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -68.44 -29.8 68.54 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.313 -1.492 . . . . 0.0 112.309 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -62.81 -33.98 76.34 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.71 -54.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.456 0.571 . . . . 0.0 110.897 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.422 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.5 -18.1 62.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.6 -61.41 1.78 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.102 0.865 . . . . 0.0 110.752 166.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.31 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.288 -0.882 . . . . 0.0 111.914 -171.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 -5.33 50.67 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.81 1.244 . . . . 0.0 112.91 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 t -115.03 -31.98 5.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.538 1.063 . . . . 0.0 113.327 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 178.15 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.454 0.645 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.05 174.94 12.59 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.077 1.751 . . . . 0.0 111.842 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -148.62 119.48 7.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.966 0.506 . . . . 0.0 111.53 171.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.08 126.84 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.264 1.425 . . . . 0.0 109.158 166.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 124.358 1.063 . . . . 0.0 112.403 -168.073 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 CA--C 1.539 0.766 0 N-CA-C 112.363 0.101 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -128.12 147.8 50.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.133 1.373 . . . . 0.0 111.304 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.63 155.53 34.85 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.355 2.262 . . . . 0.0 107.865 -171.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -117.07 135.2 53.91 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.044 -1.035 . . . . 0.0 112.218 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -121.69 100.9 7.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.493 2.717 . . . . 0.0 108.173 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -101.82 134.87 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.024 -0.423 . . . . 0.0 110.988 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.24 136.23 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.079 1.352 . . . . 0.0 107.566 165.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.91 -151.24 0.27 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.034 0.826 . . . . 0.0 113.556 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -73.82 87.2 1.74 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.25 1.02 . . . . 0.0 111.097 -170.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -146.97 -52.91 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.839 2.056 . . . . 0.0 111.99 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.36 72.66 4.16 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.859 2.373 . . . . 0.0 110.805 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.04 -37.63 54.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.923 1.289 . . . . 0.0 111.514 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -73.53 162.3 29.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.084 1.354 . . . . 0.0 112.611 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -63.11 131.73 49.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.794 0.838 . . . . 0.0 110.508 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.56 152.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.918 1.687 . . . . 0.0 109.266 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -133.53 166.96 21.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.509 1.123 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -51.46 -43.11 62.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.763 1.225 . . . . 0.0 112.496 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.09 -30.89 71.05 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -73.74 -49.61 24.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.784 1.174 . . . . 0.0 111.981 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.19 -33.0 74.97 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.315 -0.865 . . . . 0.0 111.645 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -66.75 -47.9 70.78 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.986 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -70.44 -28.4 65.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.721 1.146 . . . . 0.0 112.82 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.02 -39.2 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.237 0.926 . . . . 0.0 112.949 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -90.26 -7.3 53.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 m -49.12 -44.37 72.28 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 120.778 1.626 . . . . 0.0 115.34 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.33 -14.71 18.25 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 CA-C-N 122.341 1.872 . . . . 0.0 113.808 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -87.06 -37.01 17.83 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.555 -1.341 . . . . 0.0 112.957 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.28 -178.44 36.15 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.646 1.818 . . . . 0.0 117.646 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -92.75 -14.46 27.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -160.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 61.18 154.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 127.67 2.388 . . . . 0.0 116.71 173.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -145.43 -59.7 0.34 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.415 1.486 . . . . 0.0 113.098 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -162.04 171.81 16.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.006 1.722 . . . . 0.0 110.377 -170.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.5 152.81 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.171 -1.58 . . . . 0.0 113.037 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -152.15 136.19 16.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.114 1.765 . . . . 0.0 107.922 161.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.75 135.55 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.942 1.297 . . . . 0.0 108.561 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -145.79 143.13 29.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.877 0.871 . . . . 0.0 111.277 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 44.44 -124.04 0.96 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 124.803 1.241 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.59 2.84 46.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.132 1.773 . . . . 0.0 115.22 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -134.44 158.44 43.88 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.17 136.25 11.49 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.153 0.883 . . . . 0.0 112.355 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -131.31 64.72 1.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 0.0 110.04 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.25 157.88 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.513 1.525 . . . . 0.0 109.867 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -118.58 132.33 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.122 1.369 . . . . 0.0 109.169 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -123.7 156.25 36.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.891 1.276 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -77.64 149.12 34.76 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 157.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 56.38 124.27 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 127.987 2.515 . . . . 0.0 116.669 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.8 -28.45 30.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.745 2.297 . . . . 0.0 113.332 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.11 -32.41 69.8 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.609 0.64 . . . . 0.0 112.095 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -30.55 36.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.43 -59.78 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.746 0.818 . . . . 0.0 110.563 165.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -36.61 82.43 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.513 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.716 1.144 . . . . 0.0 112.181 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -55.31 23.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.757 1.162 . . . . 0.0 112.583 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 mt -68.86 -49.83 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.567 0.621 . . . . 0.0 110.946 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -75.52 -30.99 59.97 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.957 0.799 . . . . 0.0 113.074 -168.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -80.44 -38.76 29.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.835 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 N--CA 1.476 0.843 0 CA-C-N 120.284 1.402 . . . . 0.0 113.467 -179.516 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 120.687 0.28 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 175.25 12.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.109 0.964 . . . . 0.0 113.222 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -145.22 123.36 12.16 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.178 161.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.5 129.21 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 109.61 166.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.327 172.564 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.482 0.841 0 CA-C-O 118.839 -0.567 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.78 137.32 58.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.364 0.529 . . . . 0.0 109.985 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -145.91 168.06 21.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.793 2.037 . . . . 0.0 109.331 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -147.2 124.62 11.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.942 1.247 . . . . 0.0 114.012 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tt -113.6 125.28 53.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.735 2.414 . . . . 0.0 110.156 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -118.77 142.05 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.258 0.623 . . . . 0.0 111.409 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.92 139.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.15 1.38 . . . . 0.0 108.788 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.46 143.24 14.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.461 0.553 . . . . 0.0 113.999 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 52.8 34.98 17.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.928 1.291 . . . . 0.0 112.972 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.43 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.7 tt -128.51 -51.56 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.664 2.385 . . . . 0.0 109.804 171.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 91.7 Cg_endo -78.75 88.94 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.449 2.1 . . . . 0.0 110.845 170.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.9 -12.7 17.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.416 1.886 . . . . 0.0 112.533 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -96.41 171.82 8.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.825 1.65 . . . . 0.0 111.684 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -68.47 139.66 55.71 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.34 138.15 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.183 1.793 . . . . 0.0 108.273 -175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -112.04 171.3 7.59 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.877 0.871 . . . . 0.0 111.992 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -55.07 -36.63 65.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.597 1.159 . . . . 0.0 112.772 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -69.28 -30.83 69.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.03 -56.95 7.05 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.996 0.817 . . . . 0.0 110.907 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.89 -35.02 79.28 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.905 -0.497 . . . . 0.0 111.623 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.75 -48.58 68.67 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.582 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -69.58 -35.3 75.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.632 1.56 . . . . 0.0 112.72 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.02 -31.72 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.13 -13.13 28.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.23 -47.56 66.59 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.509 1.504 . . . . 0.0 114.934 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -0.5 9.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 CA-C-N 121.673 1.633 . . . . 0.0 113.83 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -115.25 -20.09 10.5 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.125 1.77 . . . . 0.0 114.287 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.44 163.32 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -83.84 -21.04 32.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -161.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 64.27 154.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 126.582 1.953 . . . . 0.0 115.756 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.8 mmt -134.62 -65.7 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.73 -1.231 . . . . 0.0 113.179 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.38 160.51 41.71 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.489 1.116 . . . . 0.0 111.137 -165.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.11 153.01 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -149.41 136.95 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.9 2.08 . . . . 0.0 107.392 158.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt -140.49 121.75 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 108.291 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -149.29 153.41 37.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.972 1.309 . . . . 0.0 111.258 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 55.84 -140.19 0.91 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.996 0.918 . . . . 0.0 111.332 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 21.81 2.34 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.288 1.435 . . . . 0.0 113.418 170.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -131.02 169.95 15.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.127 1.371 . . . . 0.0 112.468 -163.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.39 140.73 10.5 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.445 1.497 . . . . 0.0 111.64 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -130.76 67.07 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.024 2.13 . . . . 0.0 109.834 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.5 120.91 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 120.834 -1.166 . . . . 0.0 110.058 -165.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -83.78 135.98 34.33 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.557 -0.714 . . . . 0.0 109.561 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -122.23 164.77 17.26 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.642 1.577 . . . . 0.0 112.106 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -98.14 139.51 33.82 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 156.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 67.47 145.17 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 128.439 2.696 . . . . 0.0 116.647 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.55 -43.44 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.353 2.702 . . . . 0.0 112.265 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -62.07 -30.1 70.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.907 0.883 . . . . 0.0 111.854 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -73.93 -19.92 60.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 114.923 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.28 -51.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.068 0.849 . . . . 0.0 110.266 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -43.37 98.98 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.559 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.36 -24.47 63.9 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.316 1.417 . . . . 0.0 112.961 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.45 -66.79 0.52 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.294 0.952 . . . . 0.0 111.44 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.19 -23.94 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.165 -1.584 . . . . 0.0 114.769 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -91.85 -0.19 57.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.665 1.575 . . . . 0.0 113.373 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 t -133.8 -29.43 1.32 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.127 1.331 . . . . 0.0 114.009 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 . . . . . 0 N--CA 1.471 0.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.64 169.483 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.77 165.82 24.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.915 0.886 . . . . 0.0 112.857 171.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -152.33 135.08 15.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.278 1.031 . . . . 0.0 110.769 170.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.44 133.29 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.075 1.35 . . . . 0.0 110.365 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 124.408 1.083 . . . . 0.0 111.524 -175.385 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 N--CA 1.482 0.847 0 CA-C-O 119.207 -0.414 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.0 153.59 43.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 112.885 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.71 163.77 36.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 108.152 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -136.84 126.4 25.26 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.152 1.342 . . . . 0.0 113.68 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.76 130.26 39.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.541 2.736 . . . . 0.0 108.501 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.65 134.9 49.63 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.288 0.635 . . . . 0.0 110.439 164.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.31 135.3 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.769 1.228 . . . . 0.0 108.347 169.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.88 -156.63 2.06 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.151 0.881 . . . . 0.0 112.315 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -63.92 90.46 0.06 Allowed 'General case' 0 CA--C 1.551 0.986 0 O-C-N 121.429 -1.042 . . . . 0.0 112.617 -173.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.436 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 66.0 tp -153.24 -48.69 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.23 1.812 . . . . 0.0 113.872 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.436 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 67.7 Cg_endo -77.07 56.7 5.52 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.362 2.708 . . . . 0.0 112.444 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.92 -4.06 35.82 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.275 1.43 . . . . 0.0 112.78 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -85.23 170.63 12.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.678 1.991 . . . . 0.0 111.602 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -69.48 129.09 38.75 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.654 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.03 127.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.729 0.776 . . . . 0.0 112.723 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -127.22 -179.92 5.12 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.597 1.559 . . . . 0.0 110.548 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -45.78 -48.93 15.48 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.541 1.936 . . . . 0.0 112.912 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -66.31 -36.3 82.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.44 0.564 . . . . 0.0 112.377 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.32 -56.6 7.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.6 -29.54 70.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.903 -0.498 . . . . 0.0 112.056 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.86 -52.08 27.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.06 -0.972 . . . . 0.0 111.586 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -64.29 -38.59 91.59 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.59 1.541 . . . . 0.0 111.799 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -74.67 -26.75 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.03 -11.31 20.69 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 m -45.4 -47.89 35.19 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.82 -7.47 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.255 1.841 . . . . 0.0 113.872 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -109.36 -41.15 4.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.939 1.295 . . . . 0.0 112.771 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.23 168.58 27.71 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -170.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -92.3 -15.54 27.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -163.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 0.2 OUTLIER 60.06 155.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 127.905 2.482 . . . . 0.0 115.704 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.5 mmt -137.86 -65.02 0.53 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.831 1.653 . . . . 0.0 112.077 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -158.64 165.51 34.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.004 1.322 . . . . 0.0 111.969 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 pt -128.74 147.51 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -165.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.33 92.03 1.3 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.382 1.473 . . . . 0.0 111.933 162.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.79 136.98 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.88 -1.137 . . . . 0.0 110.244 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -157.76 146.8 19.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.486 1.915 . . . . 0.0 109.052 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.09 -160.06 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.099 0.96 . . . . 0.0 111.786 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.17 -9.89 57.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.655 1.582 . . . . 0.0 114.456 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -111.95 -178.18 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.206 2.203 . . . . 0.0 111.029 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.66 146.43 10.63 Favored Glycine 0 N--CA 1.466 0.638 0 O-C-N 120.264 -1.523 . . . . 0.0 114.899 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.45 133.5 51.03 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 109.255 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.4 mt -138.0 119.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -73.1 137.0 44.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -121.91 163.91 18.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.309 1.843 . . . . 0.0 109.985 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.29 136.53 32.94 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 160.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.332 6.5 p30 54.24 139.22 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 130.158 3.383 . . . . 0.0 118.368 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.04 -27.63 13.8 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.368 2.712 . . . . 0.0 113.988 -170.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -65.67 -35.6 81.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.65 -0.656 . . . . 0.0 110.911 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -37.1 82.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.966 1.706 . . . . 0.0 112.182 172.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.25 -59.9 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.8 0.727 . . . . 0.0 111.245 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -36.2 79.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.612 -169.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.49 -37.68 88.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.47 80.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 111.8 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.7 mt -71.01 -51.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.348 -0.845 . . . . 0.0 111.023 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -66.18 -33.9 76.81 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.437 -0.79 . . . . 0.0 111.22 -171.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t -102.0 -15.19 16.87 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 120.823 1.647 . . . . 0.0 113.986 176.324 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.2 mt . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.57 172.53 18.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.116 0.966 . . . . 0.0 113.599 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -147.51 122.72 10.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 112.249 163.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.58 145.67 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.236 0.36 0 C-N-CA 123.914 0.885 . . . . 0.0 112.477 171.886 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 111.624 -0.183 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.64 148.52 34.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 122.24 1.019 . . . . 0.0 113.308 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -159.88 164.27 33.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 109.428 -172.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -143.17 127.14 17.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.849 1.66 . . . . 0.0 111.941 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.98 120.7 38.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.421 2.688 . . . . 0.0 109.737 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.86 124.3 52.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.191 0.597 . . . . 0.0 110.856 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 mm -81.94 141.12 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.913 0.885 . . . . 0.0 108.777 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.26 -163.56 1.42 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.643 0.64 . . . . 0.0 113.076 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -74.38 41.02 0.14 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.0 mt -97.18 -46.72 0.24 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.365 1.866 . . . . 0.0 114.146 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.68 73.44 5.81 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.426 2.75 . . . . 0.0 111.748 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.56 -13.97 59.57 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.514 165.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -83.49 150.12 26.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.151 1.78 . . . . 0.0 112.107 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -59.0 152.09 20.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.804 0.842 . . . . 0.0 111.587 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.44 160.46 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.173 0.989 . . . . 0.0 111.65 -171.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -125.18 167.75 14.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.758 1.223 . . . . 0.0 112.574 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -52.67 -33.15 45.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.434 0.694 . . . . 0.0 112.704 166.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.68 -35.52 74.64 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -78.39 -51.12 10.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.63 -36.53 81.04 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.919 -0.488 . . . . 0.0 111.303 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -71.5 -42.57 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.286 -0.884 . . . . 0.0 111.75 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -64.27 -44.78 90.66 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.214 1.37 . . . . 0.0 111.592 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -78.14 -30.46 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 117.875 -1.059 . . . . 0.0 113.175 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -93.12 -14.32 27.38 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.1 m -45.68 -48.67 37.98 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-N 120.738 1.608 . . . . 0.0 115.305 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.5 -3.35 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.963 1.379 . . . . 0.0 114.068 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.71 -26.64 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.206 1.402 . . . . 0.0 113.119 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.31 176.3 39.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 122.553 1.085 . . . . 0.0 115.506 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -96.75 -17.95 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -166.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.309 0.1 OUTLIER 58.66 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 127.458 2.303 . . . . 0.0 115.634 175.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.7 mmt -139.94 -63.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.703 1.601 . . . . 0.0 112.069 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -153.22 169.59 22.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.368 1.467 . . . . 0.0 111.224 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.3 149.94 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 120.877 -1.139 . . . . 0.0 112.686 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -156.35 131.26 9.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.861 1.264 . . . . 0.0 108.73 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.7 mt -143.05 120.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.03 159.92 43.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.163 1.785 . . . . 0.0 110.319 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 52.36 -137.7 1.19 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.765 1.226 . . . . 0.0 112.598 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.77 12.08 22.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.839 1.655 . . . . 0.0 113.457 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.75 -172.59 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -162.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.43 135.65 5.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.311 0.958 . . . . 0.0 112.147 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.58 64.92 0.76 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.993 2.117 . . . . 0.0 109.93 -169.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.98 144.82 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.44 1.096 . . . . 0.0 110.078 -167.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -109.22 143.19 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.82 -1.175 . . . . 0.0 110.513 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -134.52 165.77 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.967 1.307 . . . . 0.0 112.586 -169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -100.8 136.46 40.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.403 1.081 . . . . 0.0 109.186 164.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER 59.19 153.19 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 129.189 2.996 . . . . 0.0 116.487 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.75 -29.83 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.231 2.621 . . . . 0.0 113.893 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -66.84 -41.3 87.62 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.854 . . . . 0.0 110.548 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.29 -40.58 35.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.978 2.511 . . . . 0.0 113.595 167.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.56 -58.86 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.332 0.515 . . . . 0.0 111.467 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.81 91.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.011 -172.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.0 -39.37 87.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.615 1.098 . . . . 0.0 112.758 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.57 93.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.475 0.71 . . . . 0.0 111.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.46 -53.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.155 -0.966 . . . . 0.0 111.467 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -62.33 -25.81 68.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.49 1.116 . . . . 0.0 113.015 -169.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.4 t -105.71 -28.22 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.483 1.212 0 CA-C-N 120.81 1.641 . . . . 0.0 114.791 -172.873 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 mm . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.05 177.53 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.539 1.936 . . . . 0.0 110.939 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.03 145.34 32.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.597 0.759 . . . . 0.0 111.943 157.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 p -123.78 127.15 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.086 1.754 . . . . 0.0 109.722 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 124.501 1.121 . . . . 0.0 110.693 173.611 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -98.88 66.42 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.493 1.917 . . . . 0.0 110.222 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.08 157.29 38.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.544 1.138 . . . . 0.0 111.683 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -132.97 134.36 44.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.292 1.037 . . . . 0.0 112.895 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 tt -126.83 111.05 13.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.143 2.177 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -107.73 125.45 51.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.99 0.916 . . . . 0.0 110.136 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mt -114.97 138.78 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.022 0.929 . . . . 0.0 109.491 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.36 -146.38 0.32 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.878 1.228 . . . . 0.0 113.297 166.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -75.1 72.28 2.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.923 1.289 . . . . 0.0 112.48 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.0 tp -131.03 -53.16 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 116.893 -1.527 . . . . 0.0 114.65 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.99 53.14 4.61 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.151 2.567 . . . . 0.0 111.923 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.24 -22.73 51.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.379 1.472 . . . . 0.0 111.972 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.15 165.92 15.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.989 1.715 . . . . 0.0 111.848 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -57.37 131.18 49.31 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.546 0.739 . . . . 0.0 111.253 165.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -144.27 129.18 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.517 1.127 . . . . 0.0 110.301 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.5 p -99.71 170.45 8.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.667 1.187 . . . . 0.0 111.779 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.67 -34.19 64.79 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.295 -0.878 . . . . 0.0 112.627 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.29 -32.47 66.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.47 -36.59 68.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 112.906 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.64 -32.83 58.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.841 0.456 . . . . 0.0 112.128 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -61.8 -46.2 90.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.558 0.743 . . . . 0.0 111.452 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -66.22 -46.01 78.67 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.148 0.885 . . . . 0.0 112.028 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.93 -26.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.416 1.007 . . . . 0.0 113.695 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -99.63 -0.5 40.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -46.49 -53.46 24.13 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.7 -7.76 11.43 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.668 1.579 . . . . 0.0 114.225 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -83.75 -23.57 31.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.133 1.373 . . . . 0.0 112.207 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.62 -173.59 44.86 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -106.32 -10.98 16.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -157.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.04 154.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 127.848 2.459 . . . . 0.0 116.504 170.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -143.99 -64.78 0.37 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.474 1.509 . . . . 0.0 113.127 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -160.65 176.11 11.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.066 1.346 . . . . 0.0 111.994 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.37 157.4 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.553 1.07 . . . . 0.0 112.724 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -156.74 103.96 2.12 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.873 1.269 . . . . 0.0 110.792 166.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -118.21 116.75 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.581 -1.324 . . . . 0.0 110.518 -173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -148.74 149.5 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.385 1.874 . . . . 0.0 111.021 -168.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 t30 58.44 -163.03 0.21 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.149 1.38 . . . . 0.0 112.786 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.02 29.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 O-C-N 119.695 -1.878 . . . . 0.0 114.021 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -144.25 179.22 7.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.321 2.249 . . . . 0.0 109.872 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.8 144.91 9.27 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 121.191 -0.943 . . . . 0.0 112.597 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -131.5 144.85 51.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -138.42 152.82 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.5 141.89 48.12 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.365 1.066 . . . . 0.0 108.953 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -132.41 155.95 47.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.526 1.131 . . . . 0.0 111.287 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -84.17 135.33 34.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 158.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 60.94 139.41 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 128.477 2.711 . . . . 0.0 116.703 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.79 -25.02 24.31 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.307 2.672 . . . . 0.0 112.444 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.07 -34.54 76.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.213 1.005 . . . . 0.0 111.209 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -64.57 -43.56 93.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.418 1.087 . . . . 0.0 112.345 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.14 -49.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 123.554 0.741 . . . . 0.0 110.569 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -61.93 -53.52 54.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.851 0.751 . . . . 0.0 111.322 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -70.99 -24.01 62.3 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.19 5.65 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.319 0.963 . . . . 0.0 111.131 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -75.87 -43.28 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.572 -0.705 . . . . 0.0 111.438 -172.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 -17.41 63.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.972 1.309 . . . . 0.0 112.728 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 t -105.17 4.24 31.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.525 1.13 . . . . 0.0 112.701 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 . . . . . 0 N--CA 1.471 0.583 0 C-N-CA 124.171 0.988 . . . . 0.0 112.46 -175.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.8 35.54 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 112.943 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.59 130.97 25.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 166.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.57 125.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.795 1.638 . . . . 0.0 108.649 165.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 123.954 0.902 . . . . 0.0 111.973 -177.686 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 CA--C 1.545 1.043 0 N-CA-C 114.11 0.773 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -130.98 49.91 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.692 1.997 . . . . 0.0 112.119 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -59.42 161.18 5.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.689 1.595 . . . . 0.0 111.786 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -125.14 125.48 43.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.361 1.065 . . . . 0.0 111.449 -165.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -119.8 123.27 43.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.271 1.828 . . . . 0.0 108.949 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -117.13 146.42 43.18 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.591 1.157 . . . . 0.0 110.929 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.38 139.45 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.814 1.646 . . . . 0.0 110.165 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.98 149.05 18.38 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.746 1.165 . . . . 0.0 113.78 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.05 36.37 27.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.93 -56.22 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.791 1.636 . . . . 0.0 112.179 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.47 99.42 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.27 1.98 . . . . 0.0 111.593 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.37 23.37 3.46 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.986 2.515 . . . . 0.0 111.313 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -137.74 161.64 36.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.806 2.442 . . . . 0.0 108.9 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -56.43 131.92 49.77 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.03 0.832 . . . . 0.0 109.957 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.59 135.05 12.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.291 1.436 . . . . 0.0 109.269 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 167.2 11.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.448 1.499 . . . . 0.0 110.082 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -54.22 -32.0 54.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -65.81 -31.94 73.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.088 1.355 . . . . 0.0 113.93 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.45 -50.8 13.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.816 0.846 . . . . 0.0 110.81 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.43 -30.17 70.47 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.434 -0.791 . . . . 0.0 111.897 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -69.87 -45.29 68.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.871 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -64.66 -39.22 93.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.902 1.228 . . . . 0.0 112.234 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -76.49 -38.39 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.425 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -89.52 -4.39 57.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -48.13 -49.56 59.92 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.41 -19.83 16.65 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 121.84 1.693 . . . . 0.0 113.713 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -77.22 -31.19 55.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.656 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.9 -175.36 46.67 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -18.07 25.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -159.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.04 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.343 2.257 . . . . 0.0 115.474 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.2 mmt -139.35 -72.46 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.529 1.531 . . . . 0.0 112.258 166.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -142.84 171.53 13.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.37 1.868 . . . . 0.0 112.217 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 pt -131.88 150.87 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.579 1.151 . . . . 0.0 113.459 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -151.84 96.46 2.23 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.01 1.724 . . . . 0.0 109.889 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.14 130.99 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.388 -1.445 . . . . 0.0 111.961 -171.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -163.79 141.02 7.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.184 1.394 . . . . 0.0 112.724 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 41.11 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.897 2.479 . . . . 0.0 114.995 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.78 -7.83 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.926 2.49 . . . . 0.0 117.494 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.31 164.88 21.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.838 1.655 . . . . 0.0 110.806 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.74 152.68 24.25 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.79 0.709 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.24 140.73 45.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.506 1.123 . . . . 0.0 109.667 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -134.76 117.57 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -75.97 140.29 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.35 153.94 44.22 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.758 1.623 . . . . 0.0 110.966 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.33 145.74 28.89 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 152.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 58.88 135.66 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.012 2.925 . . . . 0.0 116.883 -171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.13 -31.93 11.44 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.259 1.973 . . . . 0.0 112.808 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.55 -29.31 69.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.719 0.69 . . . . 0.0 111.406 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 m -66.24 -46.76 76.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.796 1.238 . . . . 0.0 113.379 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.94 -51.69 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.78 0.832 . . . . 0.0 111.526 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -47.03 63.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.913 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.56 -13.81 61.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.647 1.112 . . . . 0.0 113.639 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.55 -77.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.405 1.482 . . . . 0.0 112.196 164.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.95 -32.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 O-C-N 120.444 -1.41 . . . . 0.0 114.39 -171.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.58 -12.18 60.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.644 1.111 . . . . 0.0 113.032 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -105.65 -25.03 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.504 1.521 . . . . 0.0 112.653 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.792 1.237 . . . . 0.0 113.55 -174.428 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.71 162.71 34.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -171.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -143.68 128.71 18.57 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.673 -0.642 . . . . 0.0 112.298 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.61 126.67 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.076 2.15 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 174.074 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.989 -0.427 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -60.35 134.61 57.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.251 1.02 . . . . 0.0 112.137 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -145.79 166.07 26.99 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.187 2.195 . . . . 0.0 110.56 -164.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.7 ttp-105 -148.32 130.32 15.33 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.878 -1.139 . . . . 0.0 113.23 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.72 111.55 23.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.22 2.608 . . . . 0.0 109.123 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -109.98 133.57 53.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.816 1.246 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 mt -131.14 141.98 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.553 1.141 . . . . 0.0 110.541 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.07 -137.98 0.3 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.467 1.508 . . . . 0.0 113.626 164.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -78.7 78.82 5.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 0.0 111.667 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.4 tp -139.48 -55.34 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.377 165.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.15 23.56 0.41 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.839 2.359 . . . . 0.0 114.184 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 tt -67.24 -41.83 85.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.722 1.209 . . . . 0.0 113.232 -163.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -144.3 -23.29 0.54 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.45 18.8 13.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.111 1.364 . . . . 0.0 113.614 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.45 125.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 111.067 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 m -111.79 175.85 5.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.043 1.337 . . . . 0.0 110.295 164.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -56.22 -37.82 70.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.91 -28.32 68.85 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.06 -52.14 7.72 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 111.798 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.49 -36.55 78.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.613 0.642 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.04 -48.38 63.02 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.264 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -65.14 -35.51 81.34 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.493 1.497 . . . . 0.0 112.617 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.82 -33.36 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -88.61 -18.33 28.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.048 1.294 . . . . 0.0 114.33 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -43.47 -47.23 17.89 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.63 -13.21 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 CA-C-N 121.948 1.731 . . . . 0.0 113.849 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -105.73 -25.65 12.13 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.766 1.226 . . . . 0.0 113.111 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -149.71 159.0 27.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 118.511 2.165 . . . . 0.0 118.511 -172.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -88.38 -22.12 23.95 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.754 1.622 . . . . 0.0 114.407 -165.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 62.9 156.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.641 2.776 . . . . 0.0 116.768 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.1 mmt -130.97 -71.15 0.58 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.939 1.696 . . . . 0.0 111.325 164.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.19 162.92 39.53 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.446 1.498 . . . . 0.0 111.609 -166.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.66 145.54 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 120.971 -1.081 . . . . 0.0 113.092 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -147.01 137.92 23.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.196 1.398 . . . . 0.0 109.007 159.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.9 mt -139.34 122.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.911 1.284 . . . . 0.0 108.207 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -158.38 155.09 28.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.797 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 58.29 -151.78 0.41 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 111.479 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.44 25.07 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 113.67 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -143.51 170.22 16.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.373 1.469 . . . . 0.0 112.266 -163.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.91 140.99 12.28 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.032 1.301 . . . . 0.0 112.007 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -131.25 72.27 1.5 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.046 1.338 . . . . 0.0 110.539 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.27 129.78 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 120.686 -1.259 . . . . 0.0 110.094 -167.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.98 137.17 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.612 1.165 . . . . 0.0 109.704 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -133.02 169.87 16.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.896 1.278 . . . . 0.0 112.51 -171.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -112.28 146.02 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.42 1.088 . . . . 0.0 109.139 162.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 60.86 122.56 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 127.586 2.354 . . . . 0.0 115.156 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.13 -34.46 16.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.775 2.316 . . . . 0.0 112.815 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -58.91 -24.94 62.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.817 0.847 . . . . 0.0 112.546 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -38.65 23.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 111.949 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.53 -55.25 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.99 0.916 . . . . 0.0 111.62 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.75 99.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.82 -40.0 95.57 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.006 1.275 . . . . 0.0 112.237 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.35 85.06 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.719 0.69 . . . . 0.0 112.026 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.0 mt -71.46 -52.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.41 -19.43 61.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.266 -0.896 . . . . 0.0 113.08 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.6 t -115.27 -8.82 12.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.083 1.353 . . . . 0.0 114.311 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 176.038 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.7 mm . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 166.49 32.63 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.045 0.938 . . . . 0.0 113.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -148.44 133.89 18.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.39 0.676 . . . . 0.0 111.865 163.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.59 133.21 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.152 1.381 . . . . 0.0 109.941 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 CA--C 1.54 0.813 0 N-CA-C 112.937 0.322 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -124.41 133.55 53.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.951 1.7 . . . . 0.0 111.863 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.37 172.86 12.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.8 2.04 . . . . 0.0 109.817 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -144.74 137.75 26.71 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.811 -1.181 . . . . 0.0 111.048 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tt -136.15 126.32 26.31 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.5 1.92 . . . . 0.0 109.684 -173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -117.33 143.86 45.5 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.439 1.096 . . . . 0.0 111.817 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.63 113.92 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.579 1.152 . . . . 0.0 109.083 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.78 50.8 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.009 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -150.25 79.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.282 1.041 . . . . 0.0 111.639 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.0 -48.04 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.669 1.187 . . . . 0.0 112.168 169.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.35 43.91 1.59 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 113.572 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.84 -23.22 67.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.083 1.353 . . . . 0.0 112.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -72.49 0.24 10.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.29 1.836 . . . . 0.0 113.637 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 51.71 56.72 7.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.018 1.327 . . . . 0.0 112.176 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.07 141.47 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.983 1.313 . . . . 0.0 111.736 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -79.13 174.35 11.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.98 -46.54 61.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.559 1.544 . . . . 0.0 112.45 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -74.57 -24.14 58.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.781 0.832 . . . . 0.0 112.846 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.82 -39.88 29.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.698 1.136 . . . . 0.0 112.251 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.85 -34.75 69.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.801 -0.562 . . . . 0.0 111.083 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -74.69 -37.43 62.64 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.686 -1.259 . . . . 0.0 113.088 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -66.08 -26.67 67.59 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.087 1.767 . . . . 0.0 113.166 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.04 -37.65 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.081 0.952 . . . . 0.0 112.026 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -86.96 -14.88 40.48 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.529 1.513 . . . . 0.0 114.964 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 m -47.59 -50.41 50.8 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.93 6.14 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.945 1.764 . . . . 0.0 114.916 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.4 -22.06 5.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.917 1.287 . . . . 0.0 114.1 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.49 -169.13 21.62 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 119.265 0.939 . . . . 0.0 114.997 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -112.12 -17.22 12.87 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 59.39 156.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 127.277 2.231 . . . . 0.0 116.878 171.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.417 ' H ' HD13 ' A' ' 30' ' ' ILE . 9.3 mmt -138.53 -67.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.417 1.487 . . . . 0.0 112.66 167.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -155.37 172.59 17.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.391 1.476 . . . . 0.0 111.978 -163.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.35 160.42 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.555 -1.34 . . . . 0.0 112.983 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -158.04 114.78 2.87 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.108 1.363 . . . . 0.0 109.959 157.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -128.18 115.54 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.588 -1.32 . . . . 0.0 108.871 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -154.5 160.48 41.58 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.633 1.573 . . . . 0.0 110.927 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 50.33 -147.54 0.36 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.745 1.218 . . . . 0.0 110.912 -174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.92 7.9 11.8 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 120.046 -1.659 . . . . 0.0 114.99 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.02 -175.02 3.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.882 1.273 . . . . 0.0 112.764 -171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.41 147.13 18.04 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.006 0.812 . . . . 0.0 112.543 166.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -132.9 144.12 49.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.287 1.435 . . . . 0.0 110.356 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 mt -142.68 124.18 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.406 1.082 . . . . 0.0 108.158 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -85.28 139.13 31.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.349 1.071 . . . . 0.0 108.692 168.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.12 169.48 12.15 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.828 -168.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -104.09 144.16 31.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 155.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.52 127.61 0.01 OUTLIER Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 129.115 2.966 . . . . 0.0 117.807 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -29.8 10.12 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.731 2.287 . . . . 0.0 114.82 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -65.52 -35.95 82.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.087 1.312 . . . . 0.0 110.84 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -40.52 89.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.564 1.946 . . . . 0.0 112.728 168.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.36 -51.68 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.387 0.994 . . . . 0.0 112.195 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -24.76 63.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -75.57 -39.03 58.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.436 -0.79 . . . . 0.0 111.706 169.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.0 -62.93 1.37 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.61 0.764 . . . . 0.0 111.996 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.266 1.1 pp -73.1 -44.65 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.91 1.232 . . . . 0.0 114.054 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.15 -30.75 69.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.369 1.895 . . . . 0.0 112.752 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -104.91 -29.14 10.68 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 . . . . . 0 N--CA 1.476 0.835 0 CA-C-N 120.169 1.35 . . . . 0.0 110.904 168.546 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.899 0.856 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.85 166.56 14.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 109.826 165.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -133.71 120.66 20.88 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.189 0.45 . . . . 0.0 111.377 163.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.05 135.22 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.381 1.072 . . . . 0.0 109.82 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 122.172 0.987 . . . . 0.0 112.797 178.553 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -92.96 142.99 26.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.144 0.883 . . . . 0.0 112.864 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.77 167.6 29.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.703 2.001 . . . . 0.0 110.984 -173.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -138.71 130.99 28.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.206 1.402 . . . . 0.0 111.419 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.73 135.01 51.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.343 2.657 . . . . 0.0 109.167 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -132.16 132.85 43.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.969 0.908 . . . . 0.0 111.025 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.61 112.35 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.235 1.014 . . . . 0.0 110.266 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.18 0.36 75.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.886 172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -64.72 5.98 0.26 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.895 1.678 . . . . 0.0 114.545 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 mt 51.44 54.94 15.5 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.819 2.048 . . . . 0.0 114.641 -172.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -60.72 115.66 2.83 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.876 1.717 . . . . 0.0 110.401 165.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.1 mt -136.44 -7.69 1.97 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.551 1.54 . . . . 0.0 113.879 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -88.1 164.48 15.7 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.658 1.183 . . . . 0.0 111.031 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -59.16 128.65 38.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.22 1.008 . . . . 0.0 112.294 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 m -150.38 151.3 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.647 1.979 . . . . 0.0 109.642 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 t -117.21 168.98 9.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.894 0.854 . . . . 0.0 112.576 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -53.91 -29.08 40.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.451 1.5 . . . . 0.0 114.268 173.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -75.37 -29.26 59.83 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.136 0.88 . . . . 0.0 113.344 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.37 -59.58 3.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.715 1.143 . . . . 0.0 110.996 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.96 -32.89 71.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.779 0.832 . . . . 0.0 111.885 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.36 -44.42 65.05 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.904 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -66.65 -40.91 88.87 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.989 1.722 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.06 -17.76 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -107.81 -8.32 16.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -47.38 -49.51 53.33 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-N 120.911 1.687 . . . . 0.0 114.692 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.1 -8.31 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.041 1.827 . . . . 0.0 114.066 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -97.62 -33.01 11.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.793 1.237 . . . . 0.0 112.765 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.56 -179.71 39.98 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 116.626 1.41 . . . . 0.0 116.626 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -93.27 -18.79 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.2 152.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 127.057 2.143 . . . . 0.0 116.174 174.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.2 mmt -134.05 -68.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.368 1.467 . . . . 0.0 112.202 166.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -151.54 170.58 19.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 111.049 -166.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.34 137.49 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.514 -1.366 . . . . 0.0 111.373 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -140.56 71.36 1.37 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.426 1.49 . . . . 0.0 110.986 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.43 107.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.445 -1.409 . . . . 0.0 108.675 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.2 138.2 50.46 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.738 2.015 . . . . 0.0 109.687 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 53.05 -149.57 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.85 1.26 . . . . 0.0 112.628 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.95 -36.08 28.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.254 0.934 . . . . 0.0 112.046 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -83.01 64.28 7.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.557 1.143 . . . . 0.0 111.559 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 144.98 47.61 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.345 0.497 . . . . 0.0 112.301 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -133.9 155.62 49.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.959 1.361 . . . . 0.0 112.426 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.28 126.71 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.374 1.47 . . . . 0.0 107.452 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -77.37 137.62 38.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.56 0.744 . . . . 0.0 109.457 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.58 164.84 24.03 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.823 0.849 . . . . 0.0 112.684 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -102.63 145.48 29.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.587 1.155 . . . . 0.0 109.131 162.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 53.32 124.21 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 128.905 2.882 . . . . 0.0 116.321 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.91 -29.81 17.85 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.217 . . . . 0.0 112.782 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.98 -30.65 71.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.607 0.763 . . . . 0.0 111.651 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -33.94 38.03 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.751 1.621 . . . . 0.0 112.403 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.35 -58.33 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.23 0.468 . . . . 0.0 110.332 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.278 6.6 ppt_? -64.44 -44.85 89.84 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.336 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -62.69 -29.2 70.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.085 1.766 . . . . 0.0 114.072 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.5 -60.92 2.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.361 0.982 . . . . 0.0 112.055 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.91 -17.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.08 -22.88 36.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.728 1.604 . . . . 0.0 112.953 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.8 t -96.7 -21.24 17.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.649 0.78 . . . . 0.0 112.506 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 120.042 1.292 . . . . 0.0 112.125 172.695 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.79 161.47 26.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.914 1.286 . . . . 0.0 112.322 175.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.29 143.01 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.885 161.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.48 137.46 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.075 2.15 . . . . 0.0 108.404 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.466 0.35 0 C-N-CA 124.597 1.159 . . . . 0.0 109.229 175.538 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 CA--C 1.539 0.768 0 CA-C-O 119.972 -0.095 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -136.06 145.15 45.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.429 1.492 . . . . 0.0 110.386 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.16 167.6 19.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.082 0.953 . . . . 0.0 111.891 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -150.82 125.63 9.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.149 -0.969 . . . . 0.0 112.59 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.9 tt -106.56 142.71 35.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.572 2.749 . . . . 0.0 109.551 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -136.51 144.05 44.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 167.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.97 119.87 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.923 1.289 . . . . 0.0 109.378 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.81 -8.78 66.95 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.309 0.884 . . . . 0.0 115.309 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -163.46 91.54 0.69 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.236 1.518 . . . . 0.0 111.029 167.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.1 tp -156.51 -48.08 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.16 -1.4 . . . . 0.0 112.82 165.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -83.35 66.7 7.59 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.523 2.148 . . . . 0.0 112.225 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.6 mt -84.06 -6.04 59.34 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 0.0 113.805 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.64 11.58 19.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.632 1.573 . . . . 0.0 112.501 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 58.89 138.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.171 2.589 . . . . 0.0 113.694 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.94 136.07 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.33 1.052 . . . . 0.0 109.627 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -89.01 157.05 18.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.625 0.77 . . . . 0.0 112.35 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -47.59 -48.46 28.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.001 1.72 . . . . 0.0 112.891 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -70.11 -26.41 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.1 -44.78 16.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.612 1.165 . . . . 0.0 112.539 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.64 -34.55 77.18 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.553 -0.717 . . . . 0.0 110.988 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -63.97 -48.65 75.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.074 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -65.07 -42.86 93.79 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.452 1.478 . . . . 0.0 112.657 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -26.98 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.726 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -96.28 -5.4 40.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -48.52 -42.92 58.9 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.46 -16.64 4.68 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.124 1.883 . . . . 0.0 113.346 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -79.29 -24.2 43.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.448 1.099 . . . . 0.0 112.23 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.75 41.36 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.61 -17.15 22.59 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -163.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.56 154.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 127.098 2.159 . . . . 0.0 116.759 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -139.38 -65.81 0.47 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.022 1.329 . . . . 0.0 113.22 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -159.99 174.95 13.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.381 1.072 . . . . 0.0 112.086 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.09 155.01 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.469 -1.394 . . . . 0.0 114.559 -171.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.63 120.12 5.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.998 1.319 . . . . 0.0 110.779 162.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.6 mt -132.15 126.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 120.991 -1.068 . . . . 0.0 112.205 -168.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -156.2 147.65 22.62 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.422 1.489 . . . . 0.0 112.058 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 53.55 -152.21 0.31 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.535 1.534 . . . . 0.0 112.561 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.09 -4.21 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.037 1.335 . . . . 0.0 114.245 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.67 -175.61 2.76 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 110.681 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.29 149.66 15.33 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.365 -0.834 . . . . 0.0 113.017 165.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.87 135.87 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.364 1.465 . . . . 0.0 109.971 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.25 114.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -73.71 139.22 45.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.799 0.809 . . . . 0.0 108.844 170.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.52 157.48 42.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.097 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.25 146.17 23.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 60.89 138.09 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 129.156 2.983 . . . . 0.0 117.033 -172.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.57 -35.53 2.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.03 2.486 . . . . 0.0 112.754 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.48 -34.22 75.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.549 0.613 . . . . 0.0 111.269 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -64.14 -43.81 94.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.068 1.347 . . . . 0.0 112.751 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.6 -52.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.745 0.702 . . . . 0.0 111.344 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -40.44 79.59 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.779 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.48 -28.2 66.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.194 1.361 . . . . 0.0 112.655 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.94 -63.6 1.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.892 0.769 . . . . 0.0 111.814 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 pp -78.77 -27.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.89 -26.92 67.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.192 1.36 . . . . 0.0 112.182 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.27 -15.35 16.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.629 1.171 . . . . 0.0 113.624 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 . . . . . 0 N--CA 1.477 0.925 0 O-C-N 120.67 -1.269 . . . . 0.0 113.938 178.159 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.28 166.43 24.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.236 1.415 . . . . 0.0 111.327 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.9 140.07 31.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.63 0.772 . . . . 0.0 112.948 171.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.25 140.4 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.514 1.925 . . . . 0.0 110.103 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.268 1.427 . . . . 0.0 110.039 178.805 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -120.57 152.26 38.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.504 1.922 . . . . 0.0 110.641 168.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 t -163.52 165.21 23.89 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.066 1.746 . . . . 0.0 109.76 -173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -136.91 121.98 19.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.283 1.433 . . . . 0.0 111.721 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.3 tt -108.53 134.21 51.61 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.924 2.49 . . . . 0.0 110.048 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -127.22 137.59 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.257 0.623 . . . . 0.0 111.903 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.19 132.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.27 1.428 . . . . 0.0 108.174 167.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.16 -152.12 0.99 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.483 1.039 . . . . 0.0 113.492 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.35 85.72 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.868 1.667 . . . . 0.0 113.074 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.6 tm? -153.47 -58.56 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.412 1.485 . . . . 0.0 112.753 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 74.8 Cg_endo -71.36 -35.66 8.02 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.855 1.698 . . . . 0.0 112.195 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 14' ' ' ASN . 9.5 mp 55.91 178.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.452 1.501 . . . . 0.0 112.884 -173.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -70.24 17.66 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.078 1.351 . . . . 0.0 113.721 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 12' ' ' LEU . 20.5 t-20 -95.65 -11.52 27.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.08 1.752 . . . . 0.0 112.906 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.5 t -94.55 126.79 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -109.37 171.13 7.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.333 1.453 . . . . 0.0 110.964 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -61.7 -24.37 66.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -74.52 -33.38 62.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.514 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -80.08 -51.37 9.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.047 1.339 . . . . 0.0 111.947 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.17 -32.55 71.16 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.445 -0.784 . . . . 0.0 111.444 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -67.91 -53.64 24.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.494 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -65.0 -31.12 72.2 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.421 1.464 . . . . 0.0 113.925 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.2 -35.85 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.513 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -89.28 -12.4 40.75 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.9 m -46.27 -46.55 44.96 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.13 -4.35 15.24 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 122.723 2.008 . . . . 0.0 113.541 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.05 -21.13 10.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.802 1.241 . . . . 0.0 113.587 -173.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.94 177.03 37.49 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.136 -0.977 . . . . 0.0 115.445 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.24 -16.77 23.32 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.87 157.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 126.523 1.929 . . . . 0.0 115.943 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.0 mmt -136.1 -79.61 0.41 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.206 1.403 . . . . 0.0 112.315 165.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -149.82 170.45 18.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.295 1.438 . . . . 0.0 112.064 -162.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.51 146.43 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -160.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -149.21 132.9 16.86 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.987 2.115 . . . . 0.0 108.524 164.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.91 135.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.41 1.484 . . . . 0.0 108.756 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -150.47 146.96 26.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.524 1.129 . . . . 0.0 110.929 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 51.89 -95.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.678 1.591 . . . . 0.0 113.396 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.54 3.13 6.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.606 1.563 . . . . 0.0 113.565 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -119.51 161.93 19.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.216 1.806 . . . . 0.0 112.557 -164.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.49 135.99 11.22 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.42 1.01 . . . . 0.0 113.027 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.76 95.1 4.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.211 1.804 . . . . 0.0 108.168 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.2 mt -115.52 129.24 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 120.641 -1.287 . . . . 0.0 109.467 -167.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -83.31 142.01 31.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.956 0.902 . . . . 0.0 109.906 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.57 173.85 11.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.539 1.536 . . . . 0.0 112.704 -170.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -118.79 127.1 53.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.627 1.571 . . . . 0.0 108.845 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 67.65 151.13 0.12 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.306 2.642 . . . . 0.0 114.978 -166.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.19 -30.75 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.064 2.509 . . . . 0.0 112.208 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.16 -37.8 86.58 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.664 0.786 . . . . 0.0 110.456 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.0 m -59.04 -27.61 65.65 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.65 -51.65 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.669 0.788 . . . . 0.0 110.769 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -58.43 -51.75 68.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.399 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.17 -40.25 80.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.451 1.023 . . . . 0.0 112.315 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.22 -59.01 5.97 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.216 0.462 . . . . 0.0 111.784 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -41.82 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.957 0.798 . . . . 0.0 111.138 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.63 -33.87 74.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 112.426 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.3 t -101.55 -33.04 10.09 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 . . . . . 0 N--CA 1.474 0.739 0 CA-C-N 119.909 1.231 . . . . 0.0 112.357 173.566 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 171.67 13.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.316 1.046 . . . . 0.0 112.365 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -144.44 144.43 31.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.329 0.585 . . . . 0.0 111.273 164.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.42 131.45 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.818 1.647 . . . . 0.0 109.064 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.467 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 110.134 178.216 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.481 0.772 0 CA-C-O 119.631 -0.237 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -57.01 136.36 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.253 1.021 . . . . 0.0 110.668 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 157.03 43.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.279 1.432 . . . . 0.0 110.811 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -136.94 118.95 15.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.155 0.982 . . . . 0.0 111.488 -168.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.61 101.2 9.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.581 2.352 . . . . 0.0 109.204 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -102.43 137.72 40.31 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.52 121.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.609 1.164 . . . . 0.0 110.304 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.53 -22.81 35.75 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -149.47 26.57 0.84 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 116.272 1.952 . . . . 0.0 116.272 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.8 tp -125.29 -34.59 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-O 116.677 -1.63 . . . . 0.0 114.782 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -72.07 46.49 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.019 3.146 . . . . 0.0 115.015 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.06 -5.71 57.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.593 1.957 . . . . 0.0 113.032 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -123.35 171.1 9.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.878 2.071 . . . . 0.0 111.099 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -67.32 142.97 56.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -144.33 134.13 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.908 1.283 . . . . 0.0 110.684 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -102.16 165.19 11.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.586 1.955 . . . . 0.0 112.005 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -53.49 -38.48 63.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.421 1.088 . . . . 0.0 113.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -79.68 -31.52 41.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 -52.17 64.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.75 0.82 . . . . 0.0 111.74 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.33 -34.86 76.87 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.801 -0.562 . . . . 0.0 111.534 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -67.32 -44.13 79.88 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.327 -0.858 . . . . 0.0 111.865 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -70.87 -40.11 72.46 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.778 1.172 . . . . 0.0 111.912 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.91 -27.02 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.584 1.084 . . . . 0.0 113.056 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.52 -5.59 39.05 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -44.26 86.97 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.54 1.6 9.16 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 121.965 1.777 . . . . 0.0 114.034 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.0 -27.57 8.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.59 174.75 42.67 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 116.82 1.488 . . . . 0.0 116.82 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -88.5 -17.45 30.28 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -162.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 62.14 152.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 126.943 2.097 . . . . 0.0 116.155 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.9 mmt -135.98 -72.25 0.46 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.473 1.509 . . . . 0.0 111.436 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -146.72 169.18 19.58 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 111.201 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.43 142.13 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.828 -1.17 . . . . 0.0 112.705 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -153.1 125.91 8.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.605 1.162 . . . . 0.0 109.261 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -143.36 132.1 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.335 1.454 . . . . 0.0 108.691 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -143.45 127.81 17.81 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.045 0.938 . . . . 0.0 111.56 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.2 t30 53.58 -71.13 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.047 2.539 . . . . 0.0 116.795 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.12 7.73 1.6 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.324 2.25 . . . . 0.0 113.12 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -135.91 140.35 43.99 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.05 -169.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.59 123.03 6.11 Favored Glycine 0 N--CA 1.466 0.666 0 CA-C-O 119.078 -0.845 . . . . 0.0 111.608 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.55 58.28 0.73 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.768 2.427 . . . . 0.0 108.936 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -83.0 139.81 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 120.129 -1.607 . . . . 0.0 109.456 -169.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.92 137.24 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.406 1.082 . . . . 0.0 110.874 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.59 164.15 23.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.466 1.107 . . . . 0.0 112.759 -168.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.63 146.79 26.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.542 156.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 63.38 144.35 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 129.455 3.102 . . . . 0.0 116.32 -172.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.38 -40.88 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.409 2.739 . . . . 0.0 111.612 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -62.75 -41.68 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.709 0.804 . . . . 0.0 111.148 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.7 m -54.23 -34.42 60.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 170.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -72.62 -58.74 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.898 0.772 . . . . 0.0 110.154 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.254 5.4 ppt_? -67.79 -25.98 65.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.423 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -74.46 -37.77 63.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.769 1.168 . . . . 0.0 112.006 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.28 90.83 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.02 -1.05 . . . . 0.0 112.617 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -74.1 -54.16 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.637 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.92 -11.69 60.01 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -168.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.3 t -109.85 -31.36 7.45 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.481 1.107 0 CA-C-N 120.343 1.429 . . . . 0.0 113.733 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 165.83 28.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -143.03 126.03 16.28 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.377 0.671 . . . . 0.0 111.781 164.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -99.11 127.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 109.993 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 124.806 1.242 . . . . 0.0 111.426 171.497 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.537 0.658 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -99.56 64.73 1.32 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.356 2.262 . . . . 0.0 111.032 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 158.11 25.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.919 0.888 . . . . 0.0 112.273 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.85 119.02 10.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 -164.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tt -110.15 125.61 53.21 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.319 2.648 . . . . 0.0 108.892 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -117.87 141.22 48.67 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 111.94 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -132.55 139.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.317 1.447 . . . . 0.0 109.984 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.63 166.55 12.96 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.144 0.878 . . . . 0.0 112.541 163.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.0 t30 57.43 12.87 1.59 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.515 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 10.1 tt -131.8 -45.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.57 1.948 . . . . 0.0 113.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 75.9 Cg_endo -74.27 26.66 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.227 2.618 . . . . 0.0 113.849 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.8 mt -68.09 -20.97 64.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.452 1.501 . . . . 0.0 112.346 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -99.1 12.5 35.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.456 1.903 . . . . 0.0 112.906 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 54.51 163.65 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.208 2.603 . . . . 0.0 114.04 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 t -140.87 129.48 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.241 -1.537 . . . . 0.0 110.06 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -66.2 152.61 44.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.755 0.822 . . . . 0.0 112.386 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -43.43 -34.79 1.38 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 113.835 164.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -89.95 -37.96 13.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.152 0.981 . . . . 0.0 112.307 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -61.47 -50.58 72.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.457 0.571 . . . . 0.0 110.793 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.76 -39.5 87.9 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.694 -0.628 . . . . 0.0 111.938 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.49 -42.38 98.53 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.835 -0.541 . . . . 0.0 110.918 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -77.76 -45.79 23.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.939 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -67.55 -25.5 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 120.313 1.415 . . . . 0.0 112.412 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -100.27 8.74 43.54 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -56.12 -55.88 37.03 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 120.553 1.524 . . . . 0.0 112.655 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.89 -16.99 29.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.043 1.829 . . . . 0.0 113.98 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -80.63 -13.06 59.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.377 1.071 . . . . 0.0 113.35 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.81 -156.5 17.96 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 121.186 -0.946 . . . . 0.0 113.596 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -119.65 -11.65 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.32 0.0 OUTLIER 53.01 163.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 129.414 3.086 . . . . 0.0 116.46 172.401 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.8 mmt -143.04 -69.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.882 -1.761 . . . . 0.0 112.868 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.61 178.01 8.28 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.542 1.537 . . . . 0.0 111.549 -169.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.44 151.51 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.562 1.073 . . . . 0.0 112.714 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.31 111.26 1.88 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.365 158.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.83 123.54 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.861 -1.149 . . . . 0.0 110.325 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -162.18 150.15 14.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.103 1.761 . . . . 0.0 109.876 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 39' ' ' PHE . 40.2 t30 60.01 -162.88 0.25 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.734 1.613 . . . . 0.0 112.426 -175.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.3 17.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.343 1.857 . . . . 0.0 114.636 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 37' ' ' ASN . 47.0 m-85 -141.35 173.75 11.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.233 2.213 . . . . 0.0 110.912 -167.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.4 150.72 22.08 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 121.308 -0.87 . . . . 0.0 112.18 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -120.12 139.41 52.63 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.362 1.065 . . . . 0.0 110.513 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -130.39 131.2 65.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 170.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -94.4 146.36 24.12 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.064 -1.023 . . . . 0.0 108.881 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.82 153.48 47.09 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.566 1.146 . . . . 0.0 112.952 -162.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.96 138.34 34.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.349 0.66 . . . . 0.0 110.229 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 56.25 132.37 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 129.127 2.971 . . . . 0.0 115.683 -162.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.67 -27.22 38.65 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.911 2.407 . . . . 0.0 112.503 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -59.68 -35.72 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.631 -0.668 . . . . 0.0 111.803 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.5 m -61.82 -34.96 76.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 113.128 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 -56.07 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.589 0.756 . . . . 0.0 110.134 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.26 94.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.923 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.69 -26.31 66.12 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.39 -57.14 4.72 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.992 0.814 . . . . 0.0 112.01 168.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.93 -36.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.146 -0.971 . . . . 0.0 112.746 -169.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.05 -37.08 69.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.939 0.79 . . . . 0.0 110.323 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.4 t -86.03 -32.49 21.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.666 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 pt . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.661 0.743 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.51 176.13 12.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.621 1.168 . . . . 0.0 113.382 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.22 145.94 28.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.673 0.789 . . . . 0.0 110.984 159.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -112.63 119.31 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.98 1.712 . . . . 0.0 109.212 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.353 1.061 . . . . 0.0 112.206 -171.046 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 112.821 0.277 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.07 125.72 53.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.604 1.562 . . . . 0.0 111.162 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.45 155.0 45.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.187 1.395 . . . . 0.0 112.685 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -129.52 133.71 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.596 1.558 . . . . 0.0 111.274 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -115.32 104.23 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.137 2.975 . . . . 0.0 107.981 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -96.51 126.26 41.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.202 0.601 . . . . 0.0 110.095 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 mt -115.17 139.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.472 1.109 . . . . 0.0 108.754 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.22 -151.35 0.31 Allowed Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.88 1.267 . . . . 0.0 113.07 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.79 68.31 4.73 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 121.123 -1.222 . . . . 0.0 113.604 -167.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.4 tp -129.19 -53.67 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 116.798 -1.572 . . . . 0.0 114.461 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.7 95.62 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.993 2.462 . . . . 0.0 110.85 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.68 -38.05 6.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.674 1.19 . . . . 0.0 113.3 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -148.03 168.41 22.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.582 1.153 . . . . 0.0 112.902 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t30 51.5 46.16 26.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.965 1.306 . . . . 0.0 112.637 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.16 139.12 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.85 1.26 . . . . 0.0 111.174 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 t -154.19 173.59 15.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.95 2.1 . . . . 0.0 108.196 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -55.58 -40.84 72.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.198 0.908 . . . . 0.0 113.086 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -73.19 -34.13 65.81 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.194 0.598 . . . . 0.0 112.576 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -71.17 -43.79 66.78 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.791 -0.568 . . . . 0.0 111.765 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.75 -34.17 73.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.705 0.684 . . . . 0.0 111.969 171.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.98 -48.48 81.52 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.654 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -72.62 -33.49 66.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.51 1.05 . . . . 0.0 113.189 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.258 1.8 pp -79.88 -26.0 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.642 1.11 . . . . 0.0 113.573 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -101.29 -4.52 26.91 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.571 1.078 . . . . 0.0 113.899 171.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.98 -53.85 19.6 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 114.098 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.14 0.69 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.185 1.923 . . . . 0.0 114.218 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.42 -13.9 14.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.383 1.473 . . . . 0.0 113.429 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.93 -174.79 46.86 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -101.13 -10.45 20.43 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -162.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.89 152.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 168.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.4 mmt -138.11 -73.38 0.41 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 111.99 165.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -153.89 -175.8 5.54 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.811 1.644 . . . . 0.0 111.918 -170.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 pt -131.68 157.03 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.579 1.536 . . . . 0.0 113.45 -165.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -147.8 101.08 3.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.897 1.279 . . . . 0.0 110.0 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.39 110.62 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.29 -1.506 . . . . 0.0 110.737 -174.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -146.61 152.82 39.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.495 1.518 . . . . 0.0 111.319 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.406 ' CG ' ' H ' ' A' ' 38' ' ' ALA . 49.3 t30 55.14 -159.4 0.19 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.26 1.424 . . . . 0.0 112.466 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' H ' ' CG ' ' A' ' 37' ' ' ASN . . . -71.56 30.82 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.995 2.118 . . . . 0.0 114.213 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.75 175.36 10.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.808 2.043 . . . . 0.0 111.059 -170.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.19 135.97 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.326 -0.859 . . . . 0.0 111.947 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.39 157.36 45.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 110.046 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.58 153.54 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.086 -1.009 . . . . 0.0 108.776 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.13 144.62 42.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.679 1.191 . . . . 0.0 109.953 168.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.96 155.5 50.63 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.847 1.259 . . . . 0.0 112.33 -163.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.77 140.11 31.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.045 155.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 60.35 139.17 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.188 2.595 . . . . 0.0 116.418 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.97 -30.33 7.33 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.52 2.147 . . . . 0.0 112.986 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.88 -34.22 77.46 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.56 -0.712 . . . . 0.0 111.494 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -60.47 -42.4 96.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.241 1.416 . . . . 0.0 113.216 167.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.9 -55.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.318 0.647 . . . . 0.0 110.921 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -45.53 94.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.493 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -63.8 -34.58 78.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.754 1.161 . . . . 0.0 112.507 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.5 -54.26 39.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.684 1.129 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mt -72.4 -36.18 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.094 -1.004 . . . . 0.0 111.708 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -83.73 -10.94 57.79 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.847 -1.158 . . . . 0.0 113.331 -173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.38 -40.71 2.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 112.576 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 CA-C-N 118.962 0.801 . . . . 0.0 110.955 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.15 0.5 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.86 167.54 21.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.939 1.296 . . . . 0.0 112.19 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -149.9 122.75 8.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -82.43 133.42 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.735 1.214 . . . . 0.0 109.834 166.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.468 0.431 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 177.905 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 CA-C-O 119.028 -0.488 . . . . 0.0 113.014 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -88.76 59.66 5.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 112.363 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 160.42 31.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.487 0.715 . . . . 0.0 111.091 173.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -140.47 145.37 36.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.72 125.37 37.81 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.801 2.44 . . . . 0.0 108.953 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -127.19 139.88 52.63 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.869 0.868 . . . . 0.0 110.18 173.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -121.18 141.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.046 1.338 . . . . 0.0 107.656 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.02 -151.94 0.03 OUTLIER Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.17 1.843 . . . . 0.0 113.81 171.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -76.18 41.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.759 -1.436 . . . . 0.0 114.718 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.34 -51.87 0.12 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.697 1.999 . . . . 0.0 114.256 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.41 -31.86 2.54 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.897 1.731 . . . . 0.0 112.539 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.43 177.56 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.134 1.774 . . . . 0.0 112.513 -168.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -75.06 2.03 11.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.417 -1.427 . . . . 0.0 112.312 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -79.21 38.32 0.35 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.923 2.089 . . . . 0.0 113.001 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.44 138.26 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.926 2.09 . . . . 0.0 108.139 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.3 t -122.85 179.97 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.572 1.549 . . . . 0.0 111.821 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -59.39 -35.61 74.26 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -79.68 -38.63 33.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.256 0.622 . . . . 0.0 111.291 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.8 -42.5 99.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.83 -38.74 57.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.222 0.609 . . . . 0.0 112.052 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -68.34 -43.66 77.03 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 121.386 -0.821 . . . . 0.0 110.97 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -66.04 -41.62 90.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.206 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.78 -34.21 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.849 0.749 . . . . 0.0 112.077 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -87.52 -19.0 28.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 m -44.05 -51.96 16.93 Favored Pre-proline 0 N--CA 1.48 1.067 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.3 -6.19 18.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.683 1.588 . . . . 0.0 114.063 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -105.6 -24.17 12.62 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.439 1.496 . . . . 0.0 113.772 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.35 165.69 38.41 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -81.16 -19.06 44.23 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 63.58 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.337 1.855 . . . . 0.0 114.938 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -141.75 -68.02 0.39 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.563 -1.336 . . . . 0.0 112.717 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -146.27 179.99 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.574 1.95 . . . . 0.0 110.053 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 pt -134.62 155.57 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.834 -1.166 . . . . 0.0 113.296 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.05 146.03 17.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.242 1.817 . . . . 0.0 108.262 157.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.7 mt -142.53 138.61 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.064 1.746 . . . . 0.0 108.367 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -151.22 150.69 30.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.08 0.952 . . . . 0.0 110.836 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 58.74 -90.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.499 1.52 . . . . 0.0 114.212 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.82 10.41 2.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.133 2.173 . . . . 0.0 112.558 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.42 147.65 50.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.011 1.725 . . . . 0.0 111.948 -164.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 140.38 15.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.97 0.795 . . . . 0.0 112.6 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.2 55.3 1.91 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.529 1.931 . . . . 0.0 110.176 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.5 150.46 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.217 1.407 . . . . 0.0 109.85 -164.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -112.3 140.41 47.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.777 -1.202 . . . . 0.0 110.218 -176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -133.79 144.66 49.16 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 112.272 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.25 135.15 38.44 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 155.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 61.54 133.36 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 129.93 3.292 . . . . 0.0 117.561 -174.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.0 -26.54 15.06 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.092 2.528 . . . . 0.0 113.991 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.29 -32.75 72.11 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.736 -1.227 . . . . 0.0 111.542 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.1 m -68.89 -25.24 64.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.496 1.519 . . . . 0.0 113.185 168.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.7 t -71.21 -58.6 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.558 1.072 . . . . 0.0 110.945 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -46.72 88.36 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.822 -174.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.66 -27.62 69.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.809 1.186 . . . . 0.0 113.455 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.26 -50.74 51.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.647 0.658 . . . . 0.0 112.128 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 mt -70.77 -46.66 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.191 -0.943 . . . . 0.0 111.289 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.35 -22.14 61.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.121 0.968 . . . . 0.0 112.293 -169.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.9 t -118.38 -19.42 8.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.473 0.686 0 CA-C-N 120.201 1.364 . . . . 0.0 111.314 167.871 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 121.028 0.442 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.69 172.05 14.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.684 1.194 . . . . 0.0 112.292 168.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.78 116.13 8.52 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.603 -0.686 . . . . 0.0 112.758 167.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.5 p -87.16 125.78 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 109.648 165.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 C--O 1.235 0.297 0 C-N-CA 124.598 1.159 . . . . 0.0 111.863 -179.014 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 CA-C-O 118.519 -0.701 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -75.65 67.13 2.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.235 1.814 . . . . 0.0 112.317 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.89 167.01 5.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.85 2.46 . . . . 0.0 112.953 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -141.47 133.54 27.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.798 -1.189 . . . . 0.0 112.526 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tt -122.18 129.08 51.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.401 2.28 . . . . 0.0 109.762 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -125.99 133.13 51.87 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.557 0.743 . . . . 0.0 111.393 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.01 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.904 0.882 . . . . 0.0 109.262 167.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.93 -17.11 76.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.012 0.815 . . . . 0.0 113.863 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -148.99 88.62 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.123 1.369 . . . . 0.0 111.661 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.61 -58.0 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.338 162.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.67 85.75 1.58 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.419 2.079 . . . . 0.0 110.531 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.78 -33.84 27.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.901 0.88 . . . . 0.0 112.539 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -160.73 -24.63 0.06 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 172.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.12 61.68 1.44 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.316 1.446 . . . . 0.0 112.085 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.23 128.21 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 109.915 164.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 m -126.08 175.36 7.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.692 1.997 . . . . 0.0 110.693 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -45.45 -49.28 13.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.085 1.754 . . . . 0.0 113.883 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -79.45 -11.6 59.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.827 0.851 . . . . 0.0 113.073 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -83.48 -55.96 4.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.581 1.152 . . . . 0.0 109.803 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.34 -34.54 77.93 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.686 -0.634 . . . . 0.0 111.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -69.48 -45.34 69.23 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.073 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -67.2 -40.01 86.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.41 1.459 . . . . 0.0 112.246 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -27.92 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.831 0.741 . . . . 0.0 112.878 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -97.69 -10.67 24.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.63 -52.14 47.09 Favored Pre-proline 0 N--CA 1.478 0.965 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.94 10.35 2.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.291 1.994 . . . . 0.0 113.697 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -120.15 -29.32 4.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.476 1.51 . . . . 0.0 113.384 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.81 37.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -86.36 -20.44 28.27 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.309 1.444 . . . . 0.0 114.716 -165.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.88 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 127.037 2.135 . . . . 0.0 115.748 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mmt -141.93 -73.48 0.31 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.578 1.551 . . . . 0.0 113.386 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -138.78 171.83 13.76 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.675 1.59 . . . . 0.0 111.894 -169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -130.34 151.53 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -160.55 131.26 5.45 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.275 2.23 . . . . 0.0 109.712 163.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.3 mt -137.37 134.22 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.33 -1.481 . . . . 0.0 109.721 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.41 150.7 23.72 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 112.489 -173.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 59.34 -93.83 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.018 1.727 . . . . 0.0 113.321 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.81 9.2 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.076 1.75 . . . . 0.0 112.621 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.21 169.98 15.21 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 111.299 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.16 138.92 10.44 Favored Glycine 0 N--CA 1.466 0.637 0 C-N-CA 123.93 0.776 . . . . 0.0 112.345 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -122.37 100.53 6.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.858 1.663 . . . . 0.0 108.528 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.04 131.37 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -94.98 142.87 26.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.746 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -128.57 162.39 27.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.209 1.403 . . . . 0.0 110.981 -168.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -92.32 145.65 24.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.712 153.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 62.61 126.02 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.55 2.34 . . . . 0.0 116.792 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 -34.76 14.72 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.447 2.764 . . . . 0.0 114.393 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.27 -35.98 80.66 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.576 -0.702 . . . . 0.0 110.873 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -35.15 79.78 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.871 2.068 . . . . 0.0 112.408 175.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.82 -59.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.619 -0.676 . . . . 0.0 111.432 168.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -34.35 77.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.404 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.75 -39.36 84.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.476 1.035 . . . . 0.0 111.977 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 112.706 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -68.51 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 120.958 -1.089 . . . . 0.0 109.914 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.59 -29.1 63.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.01 -25.02 16.09 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 121.595 0.712 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.72 169.46 19.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.132 1.773 . . . . 0.0 112.468 -168.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -146.33 131.79 18.68 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 110.856 162.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.08 124.38 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 108.796 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 124.128 0.971 . . . . 0.0 112.702 -170.482 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 N-CA-C 111.717 -0.147 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.16 130.63 47.24 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.061 -1.024 . . . . 0.0 111.811 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.51 162.04 36.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 112.46 -172.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -128.96 139.47 52.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 111.181 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -127.81 111.1 13.26 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.169 2.588 . . . . 0.0 109.021 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -113.99 130.6 56.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.533 -0.729 . . . . 0.0 111.293 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.45 134.37 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 108.608 166.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.66 -141.12 0.4 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.7 0.667 . . . . 0.0 112.558 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.53 82.4 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.152 1.781 . . . . 0.0 112.532 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.22 -58.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.571 1.548 . . . . 0.0 111.253 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.49 101.65 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.972 2.448 . . . . 0.0 110.538 169.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.63 -18.27 13.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.397 1.079 . . . . 0.0 112.52 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.99 165.06 12.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.896 1.678 . . . . 0.0 110.425 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.04 144.31 55.16 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.742 -0.599 . . . . 0.0 111.723 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.81 137.95 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.671 1.188 . . . . 0.0 110.074 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 t -84.84 152.45 23.6 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.767 1.227 . . . . 0.0 112.721 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -51.04 -24.28 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.715 1.206 . . . . 0.0 113.291 163.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -86.86 -37.8 17.38 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.622 1.169 . . . . 0.0 111.772 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -61.92 -51.32 68.61 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 110.41 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.08 -35.49 78.27 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.428 -0.795 . . . . 0.0 112.414 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.837 0.744 . . . . 0.0 111.977 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -74.72 -34.61 62.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.175 0.898 . . . . 0.0 112.666 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.01 -35.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.728 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -91.27 -3.33 56.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 m -46.73 -49.97 44.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 120.729 1.604 . . . . 0.0 113.973 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.56 -9.94 18.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.8 1.667 . . . . 0.0 113.91 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.41 -28.57 18.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.183 1.393 . . . . 0.0 111.63 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.66 -176.24 47.06 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 118.966 2.346 . . . . 0.0 118.966 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -162.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.415 HD12 ' H ' ' A' ' 31' ' ' MET 0.261 0.3 OUTLIER 61.86 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 128.908 2.883 . . . . 0.0 116.227 178.298 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.415 ' H ' HD12 ' A' ' 30' ' ' ILE . 5.8 mmt -139.81 -61.96 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.762 1.625 . . . . 0.0 113.268 169.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -156.56 172.76 17.99 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.774 1.17 . . . . 0.0 111.604 -168.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.84 152.95 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.166 1.348 . . . . 0.0 114.198 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.72 125.08 8.81 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.381 2.272 . . . . 0.0 108.465 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -138.62 127.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 120.694 -1.254 . . . . 0.0 110.03 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -149.3 156.85 42.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.32 1.448 . . . . 0.0 111.715 178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 52.97 -109.73 0.49 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.601 1.56 . . . . 0.0 113.105 165.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.71 14.31 13.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.958 1.303 . . . . 0.0 113.684 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -127.12 167.73 15.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.535 1.134 . . . . 0.0 112.111 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.67 127.95 4.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.49 88.07 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.21 1.404 . . . . 0.0 109.241 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -87.41 151.72 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.132 0.968 . . . . 0.0 108.425 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.77 141.38 51.26 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 120.305 -1.497 . . . . 0.0 108.373 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -131.96 165.05 24.79 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.891 1.277 . . . . 0.0 112.176 -165.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.42 140.25 36.95 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 156.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.322 2.1 p30 60.07 144.45 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.723 3.209 . . . . 0.0 115.981 -169.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.0 -23.09 8.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.669 2.246 . . . . 0.0 112.576 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -64.67 -35.79 82.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.903 0.881 . . . . 0.0 110.849 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -57.51 -47.05 82.98 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.599 1.56 . . . . 0.0 112.582 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.37 -55.61 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.335 0.654 . . . . 0.0 110.506 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -36.78 79.51 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.978 -1.01 . . . . 0.0 112.328 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.87 -41.25 83.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.614 1.552 . . . . 0.0 112.088 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -55.86 29.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.097 0.862 . . . . 0.0 111.222 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.3 mt -72.67 -48.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 O-C-N 121.81 -0.556 . . . . 0.0 111.357 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.61 -13.55 62.37 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.086 -0.959 . . . . 0.0 113.43 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.5 t -107.81 -24.76 11.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.094 1.357 . . . . 0.0 114.383 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 . . . . . 0 N--CA 1.48 1.051 0 CA-C-N 120.875 1.67 . . . . 0.0 111.993 173.581 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 42.8 pt . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 122.516 1.15 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 166.34 26.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.791 1.637 . . . . 0.0 111.884 -168.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.15 126.9 29.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 110.49 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.79 140.25 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.608 1.563 . . . . 0.0 109.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.238 0.492 0 C-N-CA 123.723 0.809 . . . . 0.0 112.026 179.42 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.479 0.638 0 CA-C-O 119.174 -0.427 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 144.43 38.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 165.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 167.06 28.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.89 2.476 . . . . 0.0 109.877 -171.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -136.79 127.64 27.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.555 1.142 . . . . 0.0 112.142 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.4 tt -118.83 129.05 55.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.655 1.982 . . . . 0.0 109.755 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -111.89 139.58 47.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 110.944 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.62 139.88 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.823 1.249 . . . . 0.0 110.738 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.78 155.89 16.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.999 1.761 . . . . 0.0 111.877 163.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.8 -17.29 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -83.59 -47.57 0.76 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.36 1.464 . . . . 0.0 114.12 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.48 35.43 0.58 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.916 3.077 . . . . 0.0 114.088 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.22 -32.21 15.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.659 1.584 . . . . 0.0 111.544 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -65.12 148.73 51.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.248 1.019 . . . . 0.0 109.634 162.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -50.37 133.93 23.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.365 1.066 . . . . 0.0 112.782 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -145.39 140.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.128 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.4 m -135.78 172.71 12.62 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.973 1.709 . . . . 0.0 108.772 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.54 -39.54 61.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -69.12 -33.5 73.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.18 -53.66 49.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.822 0.737 . . . . 0.0 111.105 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.02 -33.01 74.62 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.71 0.404 . . . . 0.0 111.676 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.38 -48.08 81.3 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -75.94 -35.1 59.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.784 1.174 . . . . 0.0 113.209 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.13 -26.37 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.81 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -99.67 -16.28 18.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -46.07 -48.23 42.65 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 120.836 1.653 . . . . 0.0 115.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -17.71 18.19 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 121.874 1.705 . . . . 0.0 113.758 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -87.38 -34.33 18.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 112.666 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.99 173.1 36.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.443 1.024 . . . . 0.0 115.54 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -94.59 -13.55 25.84 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER 57.43 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 128.458 2.703 . . . . 0.0 116.912 165.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mmt -136.05 -71.08 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.944 -1.723 . . . . 0.0 113.716 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.97 158.4 40.58 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.05 0.94 . . . . 0.0 111.36 -168.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -107.48 153.99 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -155.81 93.03 1.42 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.526 1.13 . . . . 0.0 111.609 164.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.45 135.74 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 120.626 -1.296 . . . . 0.0 112.164 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.41 146.79 13.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.448 1.899 . . . . 0.0 110.844 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.405 ' C ' ' H ' ' A' ' 39' ' ' PHE . 35.7 t-20 63.73 -164.05 0.26 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.577 1.951 . . . . 0.0 112.458 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.39 30.13 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.843 1.657 . . . . 0.0 113.938 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.405 ' H ' ' C ' ' A' ' 37' ' ' ASN . 96.9 m-85 -145.68 174.37 11.25 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.277 2.631 . . . . 0.0 109.68 -175.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.01 143.01 8.14 Favored Glycine 0 CA--C 1.52 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 111.817 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.38 140.48 49.77 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.21 1.004 . . . . 0.0 108.801 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.4 123.83 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -81.83 143.38 31.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.41 1.1 . . . . 0.0 109.893 168.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.61 164.91 20.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.381 1.472 . . . . 0.0 111.59 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.5 137.65 32.57 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 157.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.85 124.71 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 128.041 2.536 . . . . 0.0 116.651 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.79 -24.31 13.41 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.378 2.718 . . . . 0.0 114.042 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -64.29 -38.42 90.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.682 1.128 . . . . 0.0 110.362 170.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -35.2 80.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.627 1.571 . . . . 0.0 112.071 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.64 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.316 -0.865 . . . . 0.0 112.162 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.296 6.4 ppt_? -69.24 -34.08 74.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.837 0.744 . . . . 0.0 112.924 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -68.31 -33.22 73.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.442 1.019 . . . . 0.0 112.741 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.67 -68.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.259 1.3 pp -72.58 -27.87 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.403 1.456 . . . . 0.0 114.682 -176.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -80.22 -19.34 47.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.3 1.864 . . . . 0.0 114.026 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.1 t -107.41 -30.13 8.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -84.36 -46.45 11.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.662 1.119 . . . . 0.0 112.134 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 t -92.38 -83.2 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.413 1.006 . . . . 0.0 111.556 -174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -163.59 149.77 11.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.269 1.427 . . . . 0.0 110.033 168.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.85 2.11 21.11 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.0 ttt -147.24 144.44 28.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.018 1.327 . . . . 0.0 110.545 170.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -76.41 157.9 31.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.701 1.201 . . . . 0.0 113.04 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.0 125.8 17.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.26 1.424 . . . . 0.0 110.581 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.17 134.44 48.32 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.173 0.892 . . . . 0.0 113.027 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 46.4 28.45 0.73 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.671 1.588 . . . . 0.0 114.993 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -140.32 -47.72 0.43 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.982 -1.074 . . . . 0.0 113.307 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.8 tp -154.05 118.99 5.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.465 0.706 . . . . 0.0 110.463 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 mp -120.04 136.7 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.79 0.836 . . . . 0.0 108.918 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.6 163.91 33.33 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 110.626 171.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -152.21 140.35 20.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.181 0.592 . . . . 0.0 111.848 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -93.07 137.74 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.857 1.263 . . . . 0.0 109.909 163.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -148.18 139.01 23.08 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 111.977 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -115.39 177.56 4.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.314 1.446 . . . . 0.0 111.317 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.9 p -150.61 161.11 43.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.782 1.633 . . . . 0.0 110.154 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.13 139.64 57.5 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.304 -0.247 . . . . 0.0 111.37 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.66 156.33 39.12 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.463 0.705 . . . . 0.0 111.716 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.382 1.873 . . . . 0.0 113.392 -177.224 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 CA-C-O 119.745 -0.19 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -87.77 147.92 24.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.85 163.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.18 154.91 30.03 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.175 1.39 . . . . 0.0 109.23 -172.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -142.03 123.75 15.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.542 1.064 . . . . 0.0 112.883 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 tt -113.87 105.79 13.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.854 2.462 . . . . 0.0 108.904 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -94.75 142.38 27.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.186 0.994 . . . . 0.0 111.162 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 mt -138.51 131.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.386 1.074 . . . . 0.0 110.839 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.38 150.91 18.61 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.904 0.764 . . . . 0.0 112.531 167.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 61.34 27.21 16.9 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.554 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -134.99 -45.97 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.04 1.736 . . . . 0.0 113.386 172.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.554 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 71.7 Cg_endo -73.14 21.27 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.654 2.236 . . . . 0.0 114.864 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.12 -21.92 49.63 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.063 2.145 . . . . 0.0 110.948 169.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.87 162.86 25.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.695 1.598 . . . . 0.0 111.194 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -84.98 106.33 16.4 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.967 0.907 . . . . 0.0 109.257 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.48 137.69 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.788 1.235 . . . . 0.0 111.63 -170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -123.19 172.32 8.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.83 1.652 . . . . 0.0 111.736 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -48.49 -53.0 19.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.072 1.349 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -62.29 -31.16 71.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.77 -49.28 13.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.837 0.744 . . . . 0.0 112.263 -174.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.91 -29.24 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -67.99 -53.2 27.85 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.42 0.688 . . . . 0.0 111.991 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -67.39 -32.34 73.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.138 1.336 . . . . 0.0 112.797 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.54 -45.64 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.51 -3.73 57.42 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -48.37 40.2 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.15 -14.35 16.73 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.874 1.716 . . . . 0.0 113.496 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -91.34 -24.12 19.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.553 . . . . 0.0 113.582 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.91 169.54 42.23 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.97 -18.26 56.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -166.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.33 148.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 128.271 2.628 . . . . 0.0 116.224 173.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.7 mmt -131.99 -96.88 0.32 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.196 1.799 . . . . 0.0 110.427 167.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.401 ' H ' ' HB2' ' A' ' 43' ' ' GLN . 81.9 mt-30 -120.78 173.07 7.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.972 2.109 . . . . 0.0 112.314 -168.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 pt -124.92 145.32 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.315 -0.866 . . . . 0.0 112.798 -172.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -154.15 70.41 0.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.158 0.98 . . . . 0.0 113.121 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.73 117.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 108.434 170.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -150.51 150.34 31.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.793 2.437 . . . . 0.0 109.051 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 56.29 -170.37 0.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 113.218 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.82 1.79 3.06 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 120.267 -1.521 . . . . 0.0 113.623 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -144.04 59.62 1.36 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.768 2.427 . . . . 0.0 110.815 -159.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 173.89 42.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.948 1.261 . . . . 0.0 113.217 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -143.82 165.49 27.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.008 1.385 . . . . 0.0 113.966 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.9 mt -129.68 134.5 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 126.017 1.727 . . . . 0.0 107.16 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.401 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 71.8 mt-30 -85.54 141.46 29.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 169.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.86 164.08 21.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 111.59 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.85 141.14 31.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 160.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 62.26 148.84 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 127.706 2.403 . . . . 0.0 115.689 -166.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.48 -33.24 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.632 2.888 . . . . 0.0 112.496 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -60.45 -38.48 84.28 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.761 -0.587 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.0 m -53.59 -43.76 68.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.088 1.355 . . . . 0.0 113.645 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.3 -51.45 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.437 0.695 . . . . 0.0 109.8 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.94 -38.45 66.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.36 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 -31.59 72.82 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.923 1.238 . . . . 0.0 112.505 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.74 -64.05 1.03 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.498 0.719 . . . . 0.0 112.744 173.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.83 -24.15 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.69 -13.66 62.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.915 1.689 . . . . 0.0 111.579 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.5 t -105.12 -37.21 7.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.165 1.386 . . . . 0.0 112.906 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -86.73 -42.52 13.29 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.93 -1.106 . . . . 0.0 113.161 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -102.23 34.48 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.585 1.954 . . . . 0.0 110.967 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -53.28 137.75 33.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.472 1.909 . . . . 0.0 113.778 -169.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -63.16 146.33 53.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.692 0.797 . . . . 0.0 111.702 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.8 mtm 59.23 23.34 11.69 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.854 1.262 . . . . 0.0 113.934 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -147.98 -46.75 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.781 1.232 . . . . 0.0 112.637 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.72 -15.85 1.55 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.215 2.206 . . . . 0.0 113.129 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.8 -15.83 55.46 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.663 -1.273 . . . . 0.0 115.206 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.27 -24.04 64.84 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.256 1.528 . . . . 0.0 113.214 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -125.78 -20.03 4.75 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.72 150.23 21.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 110.846 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.6 pt -126.94 155.86 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.295 0.638 . . . . 0.0 110.963 168.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.05 165.39 30.06 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.783 0.833 . . . . 0.0 112.566 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -141.17 135.74 31.13 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.11 -0.369 . . . . 0.0 111.299 160.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.06 135.51 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.885 1.274 . . . . 0.0 110.676 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.8 t -160.39 166.94 28.41 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.505 1.122 . . . . 0.0 111.981 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -148.58 0.38 0.57 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.6 p -159.38 170.59 21.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.347 1.859 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.26 150.4 28.57 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.723 -1.236 . . . . 0.0 110.439 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.2 -11.89 20.03 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 C-N-CA 125.257 1.423 . . . . 0.0 112.555 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.478 0.568 0 N-CA-C 112.677 0.222 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -120.17 124.04 44.76 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.941 0.897 . . . . 0.0 111.181 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -138.44 161.69 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.054 1.742 . . . . 0.0 112.126 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -134.75 125.56 27.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.119 -0.988 . . . . 0.0 111.658 -172.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -111.37 125.12 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.205 2.602 . . . . 0.0 109.022 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.81 128.58 53.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.406 0.682 . . . . 0.0 110.568 165.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.84 134.69 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.25 -158.96 0.43 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.457 0.551 . . . . 0.0 112.787 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -70.65 73.64 0.55 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.293 1.037 . . . . 0.0 113.256 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.3 tp -129.02 -35.68 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.261 1.825 . . . . 0.0 112.772 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.23 42.7 0.14 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.621 3.547 . . . . 0.0 115.896 168.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -15.23 63.45 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.261 -1.524 . . . . 0.0 113.102 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -95.97 166.32 11.83 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.652 1.581 . . . . 0.0 111.423 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -60.8 126.27 26.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.884 0.874 . . . . 0.0 111.068 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.42 121.96 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.456 1.503 . . . . 0.0 107.972 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -101.19 170.25 8.37 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.867 0.867 . . . . 0.0 111.668 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -54.39 -39.59 67.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.635 . . . . 0.0 112.41 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -71.51 -30.39 65.89 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.87 -54.32 16.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.923 1.238 . . . . 0.0 111.086 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.36 -32.79 73.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.178 -0.326 . . . . 0.0 111.782 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.62 -50.83 61.72 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.522 -0.736 . . . . 0.0 111.447 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -66.88 -38.67 86.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.207 1.367 . . . . 0.0 112.643 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.38 -28.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.291 0.951 . . . . 0.0 112.774 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.33 -2.12 31.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -49.66 -51.95 55.12 Favored Pre-proline 0 N--CA 1.48 1.053 0 CA-C-N 120.107 1.321 . . . . 0.0 114.359 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.77 -19.72 16.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.424 1.544 . . . . 0.0 113.983 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -87.22 -19.94 27.64 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.293 -0.88 . . . . 0.0 112.379 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.32 39.21 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -108.35 -7.46 15.88 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.245 1.942 . . . . 0.0 116.245 -170.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.0 155.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 127.952 2.501 . . . . 0.0 117.278 164.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mmt -139.76 -65.09 0.47 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.296 1.438 . . . . 0.0 112.79 165.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -152.56 159.86 43.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.112 0.965 . . . . 0.0 112.293 -163.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.69 143.4 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.741 1.216 . . . . 0.0 111.327 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -156.26 97.57 1.78 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.994 0.917 . . . . 0.0 112.283 161.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.48 133.83 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.978 -1.076 . . . . 0.0 111.639 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -153.3 162.92 40.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.218 2.607 . . . . 0.0 109.478 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.12 -159.64 0.27 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.409 1.084 . . . . 0.0 112.623 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.14 60.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.962 1.305 . . . . 0.0 113.985 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -103.8 -172.05 2.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.27 1.828 . . . . 0.0 111.885 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.07 145.79 11.21 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 120.525 -1.359 . . . . 0.0 114.219 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.09 138.14 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.29 1.036 . . . . 0.0 110.693 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.5 mt -139.88 133.07 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.91 150.67 20.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.493 -1.379 . . . . 0.0 110.072 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.79 156.72 47.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.857 1.663 . . . . 0.0 112.414 -165.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -94.09 141.22 28.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 58.51 128.92 0.02 OUTLIER Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 128.86 2.864 . . . . 0.0 116.259 -167.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.58 -27.45 38.96 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.274 1.983 . . . . 0.0 114.349 172.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -68.44 -29.8 68.54 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.313 -1.492 . . . . 0.0 112.309 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -62.81 -33.98 76.34 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.71 -54.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.456 0.571 . . . . 0.0 110.897 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.422 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.5 -18.1 62.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.6 -61.41 1.78 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.102 0.865 . . . . 0.0 110.752 166.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.31 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.288 -0.882 . . . . 0.0 111.914 -171.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 -5.33 50.67 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.81 1.244 . . . . 0.0 112.91 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 t -115.03 -31.98 5.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.538 1.063 . . . . 0.0 113.327 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -115.69 -25.07 7.96 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -110.55 21.16 16.93 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.123 -0.986 . . . . 0.0 112.687 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -75.09 158.49 33.03 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.768 0.794 . . . . 0.0 112.596 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -133.12 131.07 40.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.753 1.621 . . . . 0.0 109.33 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 tpt -145.09 4.76 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.059 0.944 . . . . 0.0 113.067 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -88.04 -29.12 20.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.855 1.262 . . . . 0.0 111.536 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -129.89 -17.6 3.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.396 1.878 . . . . 0.0 112.507 166.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.43 -5.76 49.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.444 1.974 . . . . 0.0 115.232 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -143.17 1.69 1.26 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.697 1.999 . . . . 0.0 114.391 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.64 -18.54 54.3 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.01 1.324 . . . . 0.0 112.705 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.52 160.41 23.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.522 1.529 . . . . 0.0 111.807 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.5 tp -142.41 165.78 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.319 1.448 . . . . 0.0 111.278 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.05 174.94 12.59 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.077 1.751 . . . . 0.0 111.842 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -148.62 119.48 7.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.966 0.506 . . . . 0.0 111.53 171.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.08 126.84 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.264 1.425 . . . . 0.0 109.158 166.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 t -152.01 -173.62 4.6 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.358 1.063 . . . . 0.0 112.403 -168.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -117.98 151.83 36.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.524 1.13 . . . . 0.0 112.279 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -64.06 -8.66 12.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.024 1.33 . . . . 0.0 114.525 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.48 -12.07 59.42 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.292 1.437 . . . . 0.0 113.157 172.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.2 144.65 27.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.687 1.195 . . . . 0.0 111.874 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? . . . . . 0 C--O 1.256 1.403 0 C-N-CA 126.314 1.846 . . . . 0.0 111.334 176.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 CA--C 1.539 0.766 0 N-CA-C 112.363 0.101 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -128.12 147.8 50.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.133 1.373 . . . . 0.0 111.304 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.63 155.53 34.85 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.355 2.262 . . . . 0.0 107.865 -171.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -117.07 135.2 53.91 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.044 -1.035 . . . . 0.0 112.218 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -121.69 100.9 7.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.493 2.717 . . . . 0.0 108.173 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -101.82 134.87 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.024 -0.423 . . . . 0.0 110.988 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.24 136.23 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.079 1.352 . . . . 0.0 107.566 165.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.91 -151.24 0.27 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.034 0.826 . . . . 0.0 113.556 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -73.82 87.2 1.74 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.25 1.02 . . . . 0.0 111.097 -170.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -146.97 -52.91 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.839 2.056 . . . . 0.0 111.99 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.36 72.66 4.16 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.859 2.373 . . . . 0.0 110.805 169.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.04 -37.63 54.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.923 1.289 . . . . 0.0 111.514 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -73.53 162.3 29.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.084 1.354 . . . . 0.0 112.611 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -63.11 131.73 49.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.794 0.838 . . . . 0.0 110.508 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.56 152.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.918 1.687 . . . . 0.0 109.266 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -133.53 166.96 21.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.509 1.123 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -51.46 -43.11 62.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.763 1.225 . . . . 0.0 112.496 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.09 -30.89 71.05 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -73.74 -49.61 24.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.784 1.174 . . . . 0.0 111.981 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.19 -33.0 74.97 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.315 -0.865 . . . . 0.0 111.645 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -66.75 -47.9 70.78 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.986 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -70.44 -28.4 65.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.721 1.146 . . . . 0.0 112.82 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.02 -39.2 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.237 0.926 . . . . 0.0 112.949 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -90.26 -7.3 53.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 m -49.12 -44.37 72.28 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 120.778 1.626 . . . . 0.0 115.34 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.33 -14.71 18.25 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 CA-C-N 122.341 1.872 . . . . 0.0 113.808 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -87.06 -37.01 17.83 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.555 -1.341 . . . . 0.0 112.957 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.28 -178.44 36.15 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.646 1.818 . . . . 0.0 117.646 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -92.75 -14.46 27.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -160.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 61.18 154.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 127.67 2.388 . . . . 0.0 116.71 173.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -145.43 -59.7 0.34 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.415 1.486 . . . . 0.0 113.098 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -162.04 171.81 16.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.006 1.722 . . . . 0.0 110.377 -170.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.5 152.81 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.171 -1.58 . . . . 0.0 113.037 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -152.15 136.19 16.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.114 1.765 . . . . 0.0 107.922 161.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.75 135.55 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.942 1.297 . . . . 0.0 108.561 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -145.79 143.13 29.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.877 0.871 . . . . 0.0 111.277 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 44.44 -124.04 0.96 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 124.803 1.241 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.59 2.84 46.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.132 1.773 . . . . 0.0 115.22 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -134.44 158.44 43.88 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.17 136.25 11.49 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.153 0.883 . . . . 0.0 112.355 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -131.31 64.72 1.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 0.0 110.04 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.25 157.88 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.513 1.525 . . . . 0.0 109.867 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -118.58 132.33 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.122 1.369 . . . . 0.0 109.169 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -123.7 156.25 36.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.891 1.276 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -77.64 149.12 34.76 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 157.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 56.38 124.27 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 127.987 2.515 . . . . 0.0 116.669 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.8 -28.45 30.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.745 2.297 . . . . 0.0 113.332 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.11 -32.41 69.8 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.609 0.64 . . . . 0.0 112.095 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -30.55 36.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.43 -59.78 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.746 0.818 . . . . 0.0 110.563 165.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -36.61 82.43 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.513 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.716 1.144 . . . . 0.0 112.181 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -55.31 23.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.757 1.162 . . . . 0.0 112.583 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 mt -68.86 -49.83 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.567 0.621 . . . . 0.0 110.946 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -75.52 -30.99 59.97 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.957 0.799 . . . . 0.0 113.074 -168.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -80.44 -38.76 29.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.835 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.63 -62.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.284 1.402 . . . . 0.0 113.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 m -78.88 -67.81 0.71 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.28 1.032 . . . . 0.0 113.209 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -162.93 129.06 3.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.462 1.505 . . . . 0.0 112.645 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -75.81 137.67 40.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.781 1.232 . . . . 0.0 111.788 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -71.57 -46.94 57.94 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -168.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -76.8 -26.43 54.43 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -165.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -120.91 14.06 11.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.31 143.85 35.02 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.23 0.919 . . . . 0.0 113.108 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -146.92 -4.38 0.56 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.097 1.759 . . . . 0.0 114.981 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -129.58 -1.57 4.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.817 2.047 . . . . 0.0 113.069 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.5 mt -148.54 157.89 43.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.28 2.232 . . . . 0.0 110.0 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.1 pt -132.71 158.92 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.353 1.461 . . . . 0.0 111.481 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 175.25 12.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.109 0.964 . . . . 0.0 113.222 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -145.22 123.36 12.16 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.178 161.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.5 129.21 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 109.61 166.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -134.72 137.41 43.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.327 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.5 m -86.68 -165.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.869 1.667 . . . . 0.0 112.86 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.2 m -55.15 118.63 4.52 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.748 -0.595 . . . . 0.0 110.275 172.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -157.64 160.21 37.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.913 1.285 . . . . 0.0 110.528 177.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.34 154.83 15.83 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.4 0.545 . . . . 0.0 111.671 168.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 127.03 2.132 . . . . 0.0 113.837 -178.368 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.482 0.841 0 CA-C-O 118.839 -0.567 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.78 137.32 58.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.364 0.529 . . . . 0.0 109.985 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -145.91 168.06 21.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.793 2.037 . . . . 0.0 109.331 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -147.2 124.62 11.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.942 1.247 . . . . 0.0 114.012 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tt -113.6 125.28 53.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.735 2.414 . . . . 0.0 110.156 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -118.77 142.05 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.258 0.623 . . . . 0.0 111.409 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.92 139.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.15 1.38 . . . . 0.0 108.788 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.46 143.24 14.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.461 0.553 . . . . 0.0 113.999 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 52.8 34.98 17.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.928 1.291 . . . . 0.0 112.972 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.7 tt -128.51 -51.56 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.664 2.385 . . . . 0.0 109.804 171.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 91.7 Cg_endo -78.75 88.94 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.449 2.1 . . . . 0.0 110.845 170.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.9 -12.7 17.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.416 1.886 . . . . 0.0 112.533 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -96.41 171.82 8.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.825 1.65 . . . . 0.0 111.684 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -68.47 139.66 55.71 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.34 138.15 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.183 1.793 . . . . 0.0 108.273 -175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -112.04 171.3 7.59 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.877 0.871 . . . . 0.0 111.992 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -55.07 -36.63 65.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.597 1.159 . . . . 0.0 112.772 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -69.28 -30.83 69.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.03 -56.95 7.05 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.996 0.817 . . . . 0.0 110.907 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.89 -35.02 79.28 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.905 -0.497 . . . . 0.0 111.623 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.75 -48.58 68.67 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.582 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -69.58 -35.3 75.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.632 1.56 . . . . 0.0 112.72 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.02 -31.72 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.13 -13.13 28.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.23 -47.56 66.59 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.509 1.504 . . . . 0.0 114.934 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -0.5 9.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 CA-C-N 121.673 1.633 . . . . 0.0 113.83 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -115.25 -20.09 10.5 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.125 1.77 . . . . 0.0 114.287 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.44 163.32 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -83.84 -21.04 32.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -161.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 64.27 154.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 126.582 1.953 . . . . 0.0 115.756 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.8 mmt -134.62 -65.7 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.73 -1.231 . . . . 0.0 113.179 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.38 160.51 41.71 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.489 1.116 . . . . 0.0 111.137 -165.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.11 153.01 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -149.41 136.95 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.9 2.08 . . . . 0.0 107.392 158.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt -140.49 121.75 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 108.291 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -149.29 153.41 37.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.972 1.309 . . . . 0.0 111.258 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 55.84 -140.19 0.91 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.996 0.918 . . . . 0.0 111.332 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 21.81 2.34 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.288 1.435 . . . . 0.0 113.418 170.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -131.02 169.95 15.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.127 1.371 . . . . 0.0 112.468 -163.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.39 140.73 10.5 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.445 1.497 . . . . 0.0 111.64 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -130.76 67.07 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.024 2.13 . . . . 0.0 109.834 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.5 120.91 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 120.834 -1.166 . . . . 0.0 110.058 -165.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -83.78 135.98 34.33 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.557 -0.714 . . . . 0.0 109.561 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -122.23 164.77 17.26 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.642 1.577 . . . . 0.0 112.106 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -98.14 139.51 33.82 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 156.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 67.47 145.17 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 128.439 2.696 . . . . 0.0 116.647 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.55 -43.44 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.353 2.702 . . . . 0.0 112.265 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -62.07 -30.1 70.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.907 0.883 . . . . 0.0 111.854 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -73.93 -19.92 60.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 114.923 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.28 -51.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.068 0.849 . . . . 0.0 110.266 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -43.37 98.98 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.559 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.36 -24.47 63.9 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.316 1.417 . . . . 0.0 112.961 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.45 -66.79 0.52 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.294 0.952 . . . . 0.0 111.44 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.19 -23.94 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.165 -1.584 . . . . 0.0 114.769 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -91.85 -0.19 57.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.665 1.575 . . . . 0.0 113.373 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 t -133.8 -29.43 1.32 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.127 1.331 . . . . 0.0 114.009 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -84.78 -50.12 7.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.64 169.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.6 m -114.94 37.48 3.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 113.503 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.3 139.92 56.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -167.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.38 125.21 26.81 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.125 0.97 . . . . 0.0 111.901 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.2 mmt -123.91 -18.43 5.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 111.791 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.603 1.561 . . . . 0.0 111.017 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -133.29 0.51 3.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.65 -150.27 3.4 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.915 0.769 . . . . 0.0 112.898 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -91.8 -11.76 35.67 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -87.13 158.41 19.17 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.135 1.334 . . . . 0.0 112.316 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.5 mt 55.24 52.99 10.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.399 1.08 . . . . 0.0 112.801 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.22 143.63 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.521 1.529 . . . . 0.0 109.601 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.77 165.82 24.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.915 0.886 . . . . 0.0 112.857 171.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -152.33 135.08 15.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.278 1.031 . . . . 0.0 110.769 170.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.44 133.29 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.075 1.35 . . . . 0.0 110.365 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 159.89 42.88 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.408 1.083 . . . . 0.0 111.524 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.0 p -86.49 -155.69 0.27 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.688 1.995 . . . . 0.0 112.852 -169.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -68.07 38.81 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.659 1.984 . . . . 0.0 113.723 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -70.82 162.98 28.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.959 2.104 . . . . 0.0 113.126 -171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.01 174.64 5.8 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.044 1.738 . . . . 0.0 113.92 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? . . . . . 0 C--O 1.252 1.214 0 C-N-CA 127.516 2.326 . . . . 0.0 110.932 -164.106 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 N--CA 1.482 0.847 0 CA-C-O 119.207 -0.414 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.0 153.59 43.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 112.885 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.71 163.77 36.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 108.152 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -136.84 126.4 25.26 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.152 1.342 . . . . 0.0 113.68 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.76 130.26 39.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.541 2.736 . . . . 0.0 108.501 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.65 134.9 49.63 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.288 0.635 . . . . 0.0 110.439 164.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.31 135.3 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.769 1.228 . . . . 0.0 108.347 169.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.88 -156.63 2.06 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.151 0.881 . . . . 0.0 112.315 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -63.92 90.46 0.06 Allowed 'General case' 0 CA--C 1.551 0.986 0 O-C-N 121.429 -1.042 . . . . 0.0 112.617 -173.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 66.0 tp -153.24 -48.69 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.23 1.812 . . . . 0.0 113.872 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.436 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 67.7 Cg_endo -77.07 56.7 5.52 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.362 2.708 . . . . 0.0 112.444 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.92 -4.06 35.82 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.275 1.43 . . . . 0.0 112.78 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -85.23 170.63 12.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.678 1.991 . . . . 0.0 111.602 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -69.48 129.09 38.75 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.654 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.03 127.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.729 0.776 . . . . 0.0 112.723 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -127.22 -179.92 5.12 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.597 1.559 . . . . 0.0 110.548 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -45.78 -48.93 15.48 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.541 1.936 . . . . 0.0 112.912 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -66.31 -36.3 82.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.44 0.564 . . . . 0.0 112.377 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.32 -56.6 7.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.6 -29.54 70.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.903 -0.498 . . . . 0.0 112.056 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.86 -52.08 27.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.06 -0.972 . . . . 0.0 111.586 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -64.29 -38.59 91.59 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.59 1.541 . . . . 0.0 111.799 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -74.67 -26.75 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.03 -11.31 20.69 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 m -45.4 -47.89 35.19 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.82 -7.47 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.255 1.841 . . . . 0.0 113.872 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -109.36 -41.15 4.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.939 1.295 . . . . 0.0 112.771 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.23 168.58 27.71 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -170.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -92.3 -15.54 27.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -163.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 0.2 OUTLIER 60.06 155.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 127.905 2.482 . . . . 0.0 115.704 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.5 mmt -137.86 -65.02 0.53 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.831 1.653 . . . . 0.0 112.077 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -158.64 165.51 34.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.004 1.322 . . . . 0.0 111.969 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 pt -128.74 147.51 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -165.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.33 92.03 1.3 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.382 1.473 . . . . 0.0 111.933 162.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.79 136.98 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.88 -1.137 . . . . 0.0 110.244 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -157.76 146.8 19.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.486 1.915 . . . . 0.0 109.052 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.09 -160.06 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.099 0.96 . . . . 0.0 111.786 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.17 -9.89 57.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.655 1.582 . . . . 0.0 114.456 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -111.95 -178.18 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.206 2.203 . . . . 0.0 111.029 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.66 146.43 10.63 Favored Glycine 0 N--CA 1.466 0.638 0 O-C-N 120.264 -1.523 . . . . 0.0 114.899 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.45 133.5 51.03 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 109.255 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.4 mt -138.0 119.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -73.1 137.0 44.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -121.91 163.91 18.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.309 1.843 . . . . 0.0 109.985 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.29 136.53 32.94 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 160.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.332 6.5 p30 54.24 139.22 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 130.158 3.383 . . . . 0.0 118.368 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.04 -27.63 13.8 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.368 2.712 . . . . 0.0 113.988 -170.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -65.67 -35.6 81.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.65 -0.656 . . . . 0.0 110.911 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -37.1 82.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.966 1.706 . . . . 0.0 112.182 172.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.25 -59.9 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.8 0.727 . . . . 0.0 111.245 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -36.2 79.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.612 -169.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.49 -37.68 88.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.47 80.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 111.8 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.7 mt -71.01 -51.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.348 -0.845 . . . . 0.0 111.023 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -66.18 -33.9 76.81 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.437 -0.79 . . . . 0.0 111.22 -171.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t -102.0 -15.19 16.87 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -124.03 -41.03 2.24 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.823 1.647 . . . . 0.0 113.986 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 m -71.02 -28.86 64.7 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.732 -1.23 . . . . 0.0 112.195 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.87 -7.6 13.18 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 56.44 13.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.5 mtp -123.36 -29.82 3.76 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.425 -1.422 . . . . 0.0 114.178 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 54.95 23.68 5.26 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.605 1.562 . . . . 0.0 114.387 -167.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.97 153.13 20.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.783 1.633 . . . . 0.0 110.979 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.99 -175.52 38.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.338 0.971 . . . . 0.0 114.34 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 69' ' ' LEU . 18.1 tptm -136.95 122.3 19.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.322 1.449 . . . . 0.0 110.01 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -144.71 -39.24 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.61 1.564 . . . . 0.0 112.219 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.18 155.45 19.41 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.576 1.15 . . . . 0.0 110.614 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.76 130.12 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.923 0.889 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' CD1' ' HE3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.57 172.53 18.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.116 0.966 . . . . 0.0 113.599 -175.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -147.51 122.72 10.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 112.249 163.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.58 145.67 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -151.49 138.6 19.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.914 0.885 . . . . 0.0 112.477 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -92.89 -166.18 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.153 2.181 . . . . 0.0 112.399 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 m -69.72 6.22 1.22 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.614 1.566 . . . . 0.0 114.925 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 -1.98 55.21 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.671 1.588 . . . . 0.0 113.612 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.59 -176.46 5.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.716 1.606 . . . . 0.0 111.978 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.58 1.552 . . . . 0.0 111.013 163.573 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 111.624 -0.183 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.64 148.52 34.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 122.24 1.019 . . . . 0.0 113.308 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -159.88 164.27 33.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 109.428 -172.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -143.17 127.14 17.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.849 1.66 . . . . 0.0 111.941 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tt -117.98 120.7 38.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.421 2.688 . . . . 0.0 109.737 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.86 124.3 52.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.191 0.597 . . . . 0.0 110.856 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 mm -81.94 141.12 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.913 0.885 . . . . 0.0 108.777 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.26 -163.56 1.42 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.643 0.64 . . . . 0.0 113.076 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -74.38 41.02 0.14 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.0 mt -97.18 -46.72 0.24 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.365 1.866 . . . . 0.0 114.146 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.68 73.44 5.81 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.426 2.75 . . . . 0.0 111.748 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.56 -13.97 59.57 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.514 165.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -83.49 150.12 26.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.151 1.78 . . . . 0.0 112.107 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -59.0 152.09 20.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.804 0.842 . . . . 0.0 111.587 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.44 160.46 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.173 0.989 . . . . 0.0 111.65 -171.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -125.18 167.75 14.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.758 1.223 . . . . 0.0 112.574 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -52.67 -33.15 45.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.434 0.694 . . . . 0.0 112.704 166.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.68 -35.52 74.64 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -78.39 -51.12 10.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.63 -36.53 81.04 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.919 -0.488 . . . . 0.0 111.303 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -71.5 -42.57 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.286 -0.884 . . . . 0.0 111.75 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -64.27 -44.78 90.66 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.214 1.37 . . . . 0.0 111.592 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -78.14 -30.46 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 117.875 -1.059 . . . . 0.0 113.175 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -93.12 -14.32 27.38 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.1 m -45.68 -48.67 37.98 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-N 120.738 1.608 . . . . 0.0 115.305 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.5 -3.35 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.963 1.379 . . . . 0.0 114.068 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.71 -26.64 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.206 1.402 . . . . 0.0 113.119 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.31 176.3 39.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 122.553 1.085 . . . . 0.0 115.506 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -96.75 -17.95 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -166.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.309 0.1 OUTLIER 58.66 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 127.458 2.303 . . . . 0.0 115.634 175.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.7 mmt -139.94 -63.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.703 1.601 . . . . 0.0 112.069 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -153.22 169.59 22.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.368 1.467 . . . . 0.0 111.224 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.3 149.94 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 120.877 -1.139 . . . . 0.0 112.686 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -156.35 131.26 9.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.861 1.264 . . . . 0.0 108.73 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.7 mt -143.05 120.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.03 159.92 43.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.163 1.785 . . . . 0.0 110.319 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 52.36 -137.7 1.19 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.765 1.226 . . . . 0.0 112.598 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.77 12.08 22.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.839 1.655 . . . . 0.0 113.457 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.75 -172.59 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -162.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.43 135.65 5.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.311 0.958 . . . . 0.0 112.147 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.58 64.92 0.76 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.993 2.117 . . . . 0.0 109.93 -169.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.98 144.82 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.44 1.096 . . . . 0.0 110.078 -167.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -109.22 143.19 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.82 -1.175 . . . . 0.0 110.513 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -134.52 165.77 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.967 1.307 . . . . 0.0 112.586 -169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -100.8 136.46 40.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.403 1.081 . . . . 0.0 109.186 164.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER 59.19 153.19 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 129.189 2.996 . . . . 0.0 116.487 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.75 -29.83 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.231 2.621 . . . . 0.0 113.893 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -66.84 -41.3 87.62 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.854 . . . . 0.0 110.548 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.29 -40.58 35.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.978 2.511 . . . . 0.0 113.595 167.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.56 -58.86 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.332 0.515 . . . . 0.0 111.467 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.81 91.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.011 -172.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.0 -39.37 87.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.615 1.098 . . . . 0.0 112.758 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.57 93.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.475 0.71 . . . . 0.0 111.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.46 -53.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.155 -0.966 . . . . 0.0 111.467 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -62.33 -25.81 68.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.49 1.116 . . . . 0.0 113.015 -169.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.4 t -105.71 -28.22 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.04 -19.11 7.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 120.81 1.641 . . . . 0.0 114.791 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.9 m -124.42 30.18 6.1 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.204 1.401 . . . . 0.0 112.639 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -150.2 148.67 29.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.791 2.037 . . . . 0.0 109.486 170.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -77.0 52.13 0.85 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.805 1.242 . . . . 0.0 111.864 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 55.35 -167.78 0.09 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.863 1.665 . . . . 0.0 113.232 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -62.04 -9.62 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 120.689 -1.257 . . . . 0.0 114.11 170.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.17 -16.24 61.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.0 141.33 47.25 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.256 0.931 . . . . 0.0 114.48 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -129.01 -16.68 4.04 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.51 1.924 . . . . 0.0 113.991 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -130.02 -12.18 4.18 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.78 152.46 42.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.169 0.895 . . . . 0.0 111.2 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 mm -122.82 154.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.461 1.504 . . . . 0.0 109.74 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.05 177.53 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.539 1.936 . . . . 0.0 110.939 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.03 145.34 32.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.597 0.759 . . . . 0.0 111.943 157.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 p -123.78 127.15 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.086 1.754 . . . . 0.0 109.722 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.2 m -142.35 147.59 36.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.501 1.121 . . . . 0.0 110.693 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -79.19 -167.46 1.18 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.105 0.962 . . . . 0.0 111.706 167.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 t -56.11 138.47 49.57 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.859 -1.15 . . . . 0.0 112.488 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -150.42 171.95 16.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.874 0.869 . . . . 0.0 111.266 164.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.4 168.64 9.47 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.807 1.643 . . . . 0.0 111.873 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.732 1.613 . . . . 0.0 112.159 178.312 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -98.88 66.42 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.493 1.917 . . . . 0.0 110.222 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.08 157.29 38.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.544 1.138 . . . . 0.0 111.683 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -132.97 134.36 44.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.292 1.037 . . . . 0.0 112.895 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 tt -126.83 111.05 13.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.143 2.177 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -107.73 125.45 51.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.99 0.916 . . . . 0.0 110.136 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mt -114.97 138.78 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.022 0.929 . . . . 0.0 109.491 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.36 -146.38 0.32 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.878 1.228 . . . . 0.0 113.297 166.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -75.1 72.28 2.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.923 1.289 . . . . 0.0 112.48 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.517 ' CD2' ' HG ' ' A' ' 58' ' ' SER . 64.0 tp -131.03 -53.16 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 116.893 -1.527 . . . . 0.0 114.65 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -79.99 53.14 4.61 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.151 2.567 . . . . 0.0 111.923 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.24 -22.73 51.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.379 1.472 . . . . 0.0 111.972 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.15 165.92 15.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.989 1.715 . . . . 0.0 111.848 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -57.37 131.18 49.31 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.546 0.739 . . . . 0.0 111.253 165.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -144.27 129.18 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.517 1.127 . . . . 0.0 110.301 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.5 p -99.71 170.45 8.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.667 1.187 . . . . 0.0 111.779 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.67 -34.19 64.79 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.295 -0.878 . . . . 0.0 112.627 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.29 -32.47 66.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.47 -36.59 68.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 112.906 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.64 -32.83 58.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.841 0.456 . . . . 0.0 112.128 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -61.8 -46.2 90.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.558 0.743 . . . . 0.0 111.452 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -66.22 -46.01 78.67 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.148 0.885 . . . . 0.0 112.028 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.93 -26.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.416 1.007 . . . . 0.0 113.695 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -99.63 -0.5 40.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -46.49 -53.46 24.13 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.7 -7.76 11.43 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.668 1.579 . . . . 0.0 114.225 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -83.75 -23.57 31.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.133 1.373 . . . . 0.0 112.207 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.62 -173.59 44.86 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -106.32 -10.98 16.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -157.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.04 154.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 127.848 2.459 . . . . 0.0 116.504 170.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -143.99 -64.78 0.37 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.474 1.509 . . . . 0.0 113.127 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -160.65 176.11 11.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.066 1.346 . . . . 0.0 111.994 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.37 157.4 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.553 1.07 . . . . 0.0 112.724 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -156.74 103.96 2.12 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.873 1.269 . . . . 0.0 110.792 166.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -118.21 116.75 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.581 -1.324 . . . . 0.0 110.518 -173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -148.74 149.5 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.385 1.874 . . . . 0.0 111.021 -168.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 t30 58.44 -163.03 0.21 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.149 1.38 . . . . 0.0 112.786 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.02 29.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 O-C-N 119.695 -1.878 . . . . 0.0 114.021 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -144.25 179.22 7.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.321 2.249 . . . . 0.0 109.872 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.8 144.91 9.27 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 121.191 -0.943 . . . . 0.0 112.597 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -131.5 144.85 51.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -138.42 152.82 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.5 141.89 48.12 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.365 1.066 . . . . 0.0 108.953 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -132.41 155.95 47.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.526 1.131 . . . . 0.0 111.287 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -84.17 135.33 34.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 158.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 60.94 139.41 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 128.477 2.711 . . . . 0.0 116.703 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.79 -25.02 24.31 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.307 2.672 . . . . 0.0 112.444 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.07 -34.54 76.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.213 1.005 . . . . 0.0 111.209 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -64.57 -43.56 93.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.418 1.087 . . . . 0.0 112.345 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.14 -49.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 123.554 0.741 . . . . 0.0 110.569 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -61.93 -53.52 54.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.851 0.751 . . . . 0.0 111.322 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -70.99 -24.01 62.3 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.19 5.65 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.319 0.963 . . . . 0.0 111.131 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -75.87 -43.28 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.572 -0.705 . . . . 0.0 111.438 -172.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 -17.41 63.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.972 1.309 . . . . 0.0 112.728 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 t -105.17 4.24 31.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.525 1.13 . . . . 0.0 112.701 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -130.82 -63.2 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.171 0.988 . . . . 0.0 112.46 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.517 ' HG ' ' CD2' ' A' ' 10' ' ' LEU . 19.8 m -66.49 -37.65 85.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.667 0.787 . . . . 0.0 111.78 175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.55 -1.29 57.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.16 0.984 . . . . 0.0 112.907 170.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 54.05 -125.69 2.31 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.993 1.717 . . . . 0.0 112.494 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.2 mtt -105.87 14.13 28.51 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.452 -1.405 . . . . 0.0 112.655 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.4 173.64 11.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.065 1.346 . . . . 0.0 111.376 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -106.14 5.9 30.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.11 158.83 51.34 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.148 0.885 . . . . 0.0 113.177 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -81.2 132.44 35.35 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.444 0.698 . . . . 0.0 111.231 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -131.01 -27.94 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.495 2.318 . . . . 0.0 111.712 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 mt -147.06 177.03 9.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.775 2.43 . . . . 0.0 111.505 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.42 141.95 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.946 1.298 . . . . 0.0 109.525 171.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.8 35.54 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 112.943 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.59 130.97 25.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 166.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.57 125.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.795 1.638 . . . . 0.0 108.649 165.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -146.23 171.58 14.74 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.954 0.902 . . . . 0.0 111.973 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.7 p -142.78 150.6 40.23 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.293 1.437 . . . . 0.0 110.984 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 p -148.45 171.03 16.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -121.87 -34.47 3.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.277 1.431 . . . . 0.0 112.714 174.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.58 -6.67 0.61 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.759 1.624 . . . . 0.0 114.306 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.699 -1.62 . . . . 0.0 113.378 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 CA--C 1.545 1.043 0 N-CA-C 114.11 0.773 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -130.98 49.91 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.692 1.997 . . . . 0.0 112.119 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -59.42 161.18 5.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.689 1.595 . . . . 0.0 111.786 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -125.14 125.48 43.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.361 1.065 . . . . 0.0 111.449 -165.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -119.8 123.27 43.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.271 1.828 . . . . 0.0 108.949 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -117.13 146.42 43.18 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.591 1.157 . . . . 0.0 110.929 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.38 139.45 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.814 1.646 . . . . 0.0 110.165 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.98 149.05 18.38 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.746 1.165 . . . . 0.0 113.78 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.05 36.37 27.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.6 tt -134.93 -56.22 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.791 1.636 . . . . 0.0 112.179 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.47 99.42 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.27 1.98 . . . . 0.0 111.593 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.37 23.37 3.46 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.986 2.515 . . . . 0.0 111.313 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -137.74 161.64 36.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.806 2.442 . . . . 0.0 108.9 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -56.43 131.92 49.77 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.03 0.832 . . . . 0.0 109.957 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.59 135.05 12.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.291 1.436 . . . . 0.0 109.269 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 167.2 11.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.448 1.499 . . . . 0.0 110.082 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -54.22 -32.0 54.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -65.81 -31.94 73.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.088 1.355 . . . . 0.0 113.93 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.45 -50.8 13.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.816 0.846 . . . . 0.0 110.81 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.43 -30.17 70.47 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.434 -0.791 . . . . 0.0 111.897 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -69.87 -45.29 68.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.871 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -64.66 -39.22 93.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.902 1.228 . . . . 0.0 112.234 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -76.49 -38.39 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.425 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -89.52 -4.39 57.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -48.13 -49.56 59.92 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.41 -19.83 16.65 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 121.84 1.693 . . . . 0.0 113.713 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -77.22 -31.19 55.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.656 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.9 -175.36 46.67 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -18.07 25.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -159.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.04 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.343 2.257 . . . . 0.0 115.474 174.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 6.2 mmt -139.35 -72.46 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.529 1.531 . . . . 0.0 112.258 166.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -142.84 171.53 13.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.37 1.868 . . . . 0.0 112.217 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 pt -131.88 150.87 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.579 1.151 . . . . 0.0 113.459 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -151.84 96.46 2.23 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.01 1.724 . . . . 0.0 109.889 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.14 130.99 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.388 -1.445 . . . . 0.0 111.961 -171.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -163.79 141.02 7.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.184 1.394 . . . . 0.0 112.724 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 41.11 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.897 2.479 . . . . 0.0 114.995 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.78 -7.83 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.926 2.49 . . . . 0.0 117.494 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.31 164.88 21.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.838 1.655 . . . . 0.0 110.806 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.74 152.68 24.25 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.79 0.709 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.24 140.73 45.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.506 1.123 . . . . 0.0 109.667 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -134.76 117.57 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -75.97 140.29 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.35 153.94 44.22 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.758 1.623 . . . . 0.0 110.966 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.33 145.74 28.89 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 152.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 58.88 135.66 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.012 2.925 . . . . 0.0 116.883 -171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.13 -31.93 11.44 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.259 1.973 . . . . 0.0 112.808 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.55 -29.31 69.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.719 0.69 . . . . 0.0 111.406 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 m -66.24 -46.76 76.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.796 1.238 . . . . 0.0 113.379 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.94 -51.69 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.78 0.832 . . . . 0.0 111.526 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -47.03 63.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.913 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.56 -13.81 61.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.647 1.112 . . . . 0.0 113.639 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.55 -77.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.405 1.482 . . . . 0.0 112.196 164.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.95 -32.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 O-C-N 120.444 -1.41 . . . . 0.0 114.39 -171.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.58 -12.18 60.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.644 1.111 . . . . 0.0 113.032 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -105.65 -25.03 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.504 1.521 . . . . 0.0 112.653 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -98.94 -59.68 1.68 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.792 1.237 . . . . 0.0 113.55 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.5 m -67.84 -51.38 49.14 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 54.83 22.03 3.97 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.645 1.578 . . . . 0.0 112.899 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -100.72 162.53 12.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.969 2.108 . . . . 0.0 110.002 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.5 mtm -120.11 169.72 9.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.416 1.086 . . . . 0.0 111.962 -172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -51.89 156.96 1.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.422 1.089 . . . . 0.0 113.053 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 57.75 18.05 4.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.742 1.217 . . . . 0.0 113.926 -171.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.4 149.82 39.33 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.67 1.129 . . . . 0.0 113.326 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -72.19 -35.78 69.05 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.233 0.613 . . . . 0.0 112.135 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -142.91 166.44 24.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.896 1.279 . . . . 0.0 113.442 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mt 57.36 20.84 6.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.715 2.006 . . . . 0.0 115.295 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.0 pt -63.07 156.77 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.806 1.243 . . . . 0.0 112.624 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.71 162.71 34.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -171.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -143.68 128.71 18.57 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.673 -0.642 . . . . 0.0 112.298 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.61 126.67 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.076 2.15 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 t -141.04 132.43 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 95.9 p -85.07 18.6 2.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.5 m -55.36 155.52 5.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.966 1.307 . . . . 0.0 114.461 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -101.42 1.19 38.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.241 1.416 . . . . 0.0 113.354 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.24 163.24 37.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.436 1.094 . . . . 0.0 112.268 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.654 1.581 . . . . 0.0 113.055 177.702 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.989 -0.427 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -60.35 134.61 57.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.251 1.02 . . . . 0.0 112.137 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -145.79 166.07 26.99 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.187 2.195 . . . . 0.0 110.56 -164.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.7 ttp-105 -148.32 130.32 15.33 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.878 -1.139 . . . . 0.0 113.23 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.72 111.55 23.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.22 2.608 . . . . 0.0 109.123 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -109.98 133.57 53.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.816 1.246 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 mt -131.14 141.98 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.553 1.141 . . . . 0.0 110.541 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.07 -137.98 0.3 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.467 1.508 . . . . 0.0 113.626 164.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -78.7 78.82 5.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 0.0 111.667 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.4 tp -139.48 -55.34 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.377 165.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.15 23.56 0.41 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.839 2.359 . . . . 0.0 114.184 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 tt -67.24 -41.83 85.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.722 1.209 . . . . 0.0 113.232 -163.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -144.3 -23.29 0.54 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.45 18.8 13.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.111 1.364 . . . . 0.0 113.614 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.45 125.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 111.067 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 m -111.79 175.85 5.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.043 1.337 . . . . 0.0 110.295 164.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -56.22 -37.82 70.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.91 -28.32 68.85 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.06 -52.14 7.72 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 111.798 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.49 -36.55 78.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.613 0.642 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.04 -48.38 63.02 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.264 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -65.14 -35.51 81.34 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.493 1.497 . . . . 0.0 112.617 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.82 -33.36 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -88.61 -18.33 28.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.048 1.294 . . . . 0.0 114.33 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -43.47 -47.23 17.89 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.63 -13.21 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 CA-C-N 121.948 1.731 . . . . 0.0 113.849 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -105.73 -25.65 12.13 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.766 1.226 . . . . 0.0 113.111 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -149.71 159.0 27.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 118.511 2.165 . . . . 0.0 118.511 -172.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -88.38 -22.12 23.95 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.754 1.622 . . . . 0.0 114.407 -165.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 62.9 156.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.641 2.776 . . . . 0.0 116.768 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.1 mmt -130.97 -71.15 0.58 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.939 1.696 . . . . 0.0 111.325 164.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.19 162.92 39.53 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.446 1.498 . . . . 0.0 111.609 -166.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.66 145.54 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 120.971 -1.081 . . . . 0.0 113.092 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -147.01 137.92 23.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.196 1.398 . . . . 0.0 109.007 159.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.9 mt -139.34 122.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.911 1.284 . . . . 0.0 108.207 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -158.38 155.09 28.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.797 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 58.29 -151.78 0.41 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 111.479 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.44 25.07 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 113.67 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -143.51 170.22 16.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.373 1.469 . . . . 0.0 112.266 -163.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.91 140.99 12.28 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.032 1.301 . . . . 0.0 112.007 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -131.25 72.27 1.5 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.046 1.338 . . . . 0.0 110.539 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.27 129.78 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 120.686 -1.259 . . . . 0.0 110.094 -167.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.98 137.17 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.612 1.165 . . . . 0.0 109.704 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -133.02 169.87 16.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.896 1.278 . . . . 0.0 112.51 -171.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -112.28 146.02 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.42 1.088 . . . . 0.0 109.139 162.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 60.86 122.56 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 127.586 2.354 . . . . 0.0 115.156 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.13 -34.46 16.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.775 2.316 . . . . 0.0 112.815 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -58.91 -24.94 62.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.817 0.847 . . . . 0.0 112.546 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.53 -38.65 23.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 111.949 177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.53 -55.25 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.99 0.916 . . . . 0.0 111.62 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.75 99.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.82 -40.0 95.57 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.006 1.275 . . . . 0.0 112.237 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.35 85.06 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.719 0.69 . . . . 0.0 112.026 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.0 mt -71.46 -52.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.41 -19.43 61.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.266 -0.896 . . . . 0.0 113.08 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.6 t -115.27 -8.82 12.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.083 1.353 . . . . 0.0 114.311 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.11 -15.31 1.12 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -97.27 1.41 49.57 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.739 -1.851 . . . . 0.0 112.167 156.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 53.74 33.07 15.99 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.749 2.419 . . . . 0.0 115.332 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.05 125.48 26.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.577 -0.702 . . . . 0.0 111.345 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.5 mtm -94.7 11.93 29.56 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.995 1.718 . . . . 0.0 113.884 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 60.43 30.72 20.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.44 1.096 . . . . 0.0 112.337 -170.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.65 -12.95 0.67 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.994 2.118 . . . . 0.0 112.506 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.12 -172.01 32.57 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.813 1.673 . . . . 0.0 111.291 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -129.03 24.63 5.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 0.0 113.263 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -93.59 -23.65 18.22 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.472 -0.767 . . . . 0.0 113.068 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 tp -150.31 169.84 20.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.122 0.569 . . . . 0.0 112.134 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.7 mm -113.27 140.65 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 109.222 167.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 166.49 32.63 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.045 0.938 . . . . 0.0 113.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -148.44 133.89 18.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.39 0.676 . . . . 0.0 111.865 163.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.59 133.21 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.152 1.381 . . . . 0.0 109.941 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -150.08 167.4 26.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 m -123.86 151.43 43.47 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.829 1.651 . . . . 0.0 111.208 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -134.81 158.26 44.64 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -84.81 145.9 27.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.268 0.627 . . . . 0.0 112.021 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.33 1.56 18.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.965 1.706 . . . . 0.0 113.106 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.463 1.505 . . . . 0.0 112.717 171.047 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 CA--C 1.54 0.813 0 N-CA-C 112.937 0.322 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -124.41 133.55 53.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.951 1.7 . . . . 0.0 111.863 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.37 172.86 12.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.8 2.04 . . . . 0.0 109.817 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -144.74 137.75 26.71 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.811 -1.181 . . . . 0.0 111.048 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tt -136.15 126.32 26.31 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.5 1.92 . . . . 0.0 109.684 -173.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -117.33 143.86 45.5 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.439 1.096 . . . . 0.0 111.817 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.63 113.92 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.579 1.152 . . . . 0.0 109.083 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.78 50.8 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.009 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -150.25 79.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.282 1.041 . . . . 0.0 111.639 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -153.0 -48.04 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.669 1.187 . . . . 0.0 112.168 169.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.35 43.91 1.59 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 113.572 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.84 -23.22 67.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.083 1.353 . . . . 0.0 112.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -72.49 0.24 10.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.29 1.836 . . . . 0.0 113.637 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 51.71 56.72 7.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.018 1.327 . . . . 0.0 112.176 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.07 141.47 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.983 1.313 . . . . 0.0 111.736 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -79.13 174.35 11.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.98 -46.54 61.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.559 1.544 . . . . 0.0 112.45 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -74.57 -24.14 58.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.781 0.832 . . . . 0.0 112.846 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.82 -39.88 29.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.698 1.136 . . . . 0.0 112.251 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.85 -34.75 69.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.801 -0.562 . . . . 0.0 111.083 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -74.69 -37.43 62.64 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.686 -1.259 . . . . 0.0 113.088 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -66.08 -26.67 67.59 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.087 1.767 . . . . 0.0 113.166 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.04 -37.65 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.081 0.952 . . . . 0.0 112.026 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -86.96 -14.88 40.48 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.529 1.513 . . . . 0.0 114.964 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 m -47.59 -50.41 50.8 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.93 6.14 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.945 1.764 . . . . 0.0 114.916 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.4 -22.06 5.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.917 1.287 . . . . 0.0 114.1 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.49 -169.13 21.62 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 119.265 0.939 . . . . 0.0 114.997 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -112.12 -17.22 12.87 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 59.39 156.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 127.277 2.231 . . . . 0.0 116.878 171.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.417 ' H ' HD13 ' A' ' 30' ' ' ILE . 9.3 mmt -138.53 -67.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.417 1.487 . . . . 0.0 112.66 167.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -155.37 172.59 17.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.391 1.476 . . . . 0.0 111.978 -163.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.35 160.42 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.555 -1.34 . . . . 0.0 112.983 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -158.04 114.78 2.87 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.108 1.363 . . . . 0.0 109.959 157.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -128.18 115.54 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.588 -1.32 . . . . 0.0 108.871 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -154.5 160.48 41.58 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.633 1.573 . . . . 0.0 110.927 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 50.33 -147.54 0.36 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.745 1.218 . . . . 0.0 110.912 -174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.92 7.9 11.8 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 120.046 -1.659 . . . . 0.0 114.99 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.02 -175.02 3.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.882 1.273 . . . . 0.0 112.764 -171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.41 147.13 18.04 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.006 0.812 . . . . 0.0 112.543 166.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -132.9 144.12 49.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.287 1.435 . . . . 0.0 110.356 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 mt -142.68 124.18 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.406 1.082 . . . . 0.0 108.158 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -85.28 139.13 31.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.349 1.071 . . . . 0.0 108.692 168.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.12 169.48 12.15 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.828 -168.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -104.09 144.16 31.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 155.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.52 127.61 0.01 OUTLIER Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 129.115 2.966 . . . . 0.0 117.807 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -29.8 10.12 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.731 2.287 . . . . 0.0 114.82 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -65.52 -35.95 82.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.087 1.312 . . . . 0.0 110.84 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -40.52 89.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.564 1.946 . . . . 0.0 112.728 168.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.36 -51.68 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.387 0.994 . . . . 0.0 112.195 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -24.76 63.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -75.57 -39.03 58.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.436 -0.79 . . . . 0.0 111.706 169.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.0 -62.93 1.37 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.61 0.764 . . . . 0.0 111.996 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.266 1.1 pp -73.1 -44.65 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.91 1.232 . . . . 0.0 114.054 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.15 -30.75 69.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.369 1.895 . . . . 0.0 112.752 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -104.91 -29.14 10.68 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.72 -51.93 6.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.169 1.35 . . . . 0.0 110.904 168.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.6 m -100.05 -98.67 0.24 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.577 1.551 . . . . 0.0 112.116 -167.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -149.2 151.08 33.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.166 1.386 . . . . 0.0 111.972 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.93 176.88 9.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.067 1.347 . . . . 0.0 112.266 170.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.41 -26.63 66.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.413 -1.429 . . . . 0.0 113.312 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.71 -146.84 0.18 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.244 2.218 . . . . 0.0 113.72 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.755 1.622 . . . . 0.0 113.339 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.93 13.61 69.63 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.3 1.428 . . . . 0.0 115.124 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -77.01 -33.13 57.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.791 1.636 . . . . 0.0 114.115 -171.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.07 -48.72 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 111.361 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.22 152.04 36.52 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -171.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.52 166.36 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.972 1.309 . . . . 0.0 112.038 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.85 166.56 14.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 109.826 165.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -133.71 120.66 20.88 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.189 0.45 . . . . 0.0 111.377 163.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.05 135.22 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.381 1.072 . . . . 0.0 109.82 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.4 t -154.36 166.42 33.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.172 0.987 . . . . 0.0 112.797 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 p -128.05 -160.1 0.99 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.95 1.7 . . . . 0.0 112.103 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -70.4 10.81 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 171.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -51.79 150.64 3.9 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.647 -1.283 . . . . 0.0 112.509 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.16 -9.95 13.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.348 1.459 . . . . 0.0 114.892 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 125.968 1.707 . . . . 0.0 112.433 175.135 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -92.96 142.99 26.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.144 0.883 . . . . 0.0 112.864 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.77 167.6 29.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.703 2.001 . . . . 0.0 110.984 -173.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -138.71 130.99 28.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.206 1.402 . . . . 0.0 111.419 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.73 135.01 51.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.343 2.657 . . . . 0.0 109.167 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -132.16 132.85 43.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.969 0.908 . . . . 0.0 111.025 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.61 112.35 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.235 1.014 . . . . 0.0 110.266 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.18 0.36 75.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.886 172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -64.72 5.98 0.26 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.895 1.678 . . . . 0.0 114.545 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 mt 51.44 54.94 15.5 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.819 2.048 . . . . 0.0 114.641 -172.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -60.72 115.66 2.83 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.876 1.717 . . . . 0.0 110.401 165.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.1 mt -136.44 -7.69 1.97 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.551 1.54 . . . . 0.0 113.879 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -88.1 164.48 15.7 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.658 1.183 . . . . 0.0 111.031 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -59.16 128.65 38.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.22 1.008 . . . . 0.0 112.294 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 m -150.38 151.3 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.647 1.979 . . . . 0.0 109.642 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 t -117.21 168.98 9.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.894 0.854 . . . . 0.0 112.576 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -53.91 -29.08 40.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.451 1.5 . . . . 0.0 114.268 173.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -75.37 -29.26 59.83 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.136 0.88 . . . . 0.0 113.344 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.37 -59.58 3.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.715 1.143 . . . . 0.0 110.996 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.96 -32.89 71.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.779 0.832 . . . . 0.0 111.885 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.36 -44.42 65.05 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.904 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -66.65 -40.91 88.87 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.989 1.722 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.06 -17.76 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -107.81 -8.32 16.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -47.38 -49.51 53.33 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-N 120.911 1.687 . . . . 0.0 114.692 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.1 -8.31 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.041 1.827 . . . . 0.0 114.066 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -97.62 -33.01 11.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.793 1.237 . . . . 0.0 112.765 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.56 -179.71 39.98 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 116.626 1.41 . . . . 0.0 116.626 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -93.27 -18.79 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.2 152.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 127.057 2.143 . . . . 0.0 116.174 174.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.2 mmt -134.05 -68.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.368 1.467 . . . . 0.0 112.202 166.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -151.54 170.58 19.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 111.049 -166.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.34 137.49 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.514 -1.366 . . . . 0.0 111.373 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -140.56 71.36 1.37 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.426 1.49 . . . . 0.0 110.986 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.43 107.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.445 -1.409 . . . . 0.0 108.675 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.2 138.2 50.46 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.738 2.015 . . . . 0.0 109.687 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 53.05 -149.57 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.85 1.26 . . . . 0.0 112.628 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.95 -36.08 28.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.254 0.934 . . . . 0.0 112.046 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -83.01 64.28 7.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.557 1.143 . . . . 0.0 111.559 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 144.98 47.61 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.345 0.497 . . . . 0.0 112.301 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -133.9 155.62 49.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.959 1.361 . . . . 0.0 112.426 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.28 126.71 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.374 1.47 . . . . 0.0 107.452 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -77.37 137.62 38.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.56 0.744 . . . . 0.0 109.457 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.58 164.84 24.03 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.823 0.849 . . . . 0.0 112.684 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -102.63 145.48 29.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.587 1.155 . . . . 0.0 109.131 162.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 53.32 124.21 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 128.905 2.882 . . . . 0.0 116.321 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.91 -29.81 17.85 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.217 . . . . 0.0 112.782 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.98 -30.65 71.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.607 0.763 . . . . 0.0 111.651 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -33.94 38.03 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.751 1.621 . . . . 0.0 112.403 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.35 -58.33 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.23 0.468 . . . . 0.0 110.332 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.278 6.6 ppt_? -64.44 -44.85 89.84 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.336 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -62.69 -29.2 70.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.085 1.766 . . . . 0.0 114.072 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.5 -60.92 2.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.361 0.982 . . . . 0.0 112.055 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.91 -17.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.08 -22.88 36.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.728 1.604 . . . . 0.0 112.953 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.8 t -96.7 -21.24 17.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.649 0.78 . . . . 0.0 112.506 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -87.75 -56.92 3.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.042 1.292 . . . . 0.0 112.125 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.1 m -84.61 39.33 0.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.101 1.36 . . . . 0.0 112.02 167.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -66.29 -43.79 85.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.312 1.445 . . . . 0.0 111.867 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -151.95 -54.83 0.13 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 112.159 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.2 mtm 36.66 52.85 1.03 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.007 1.723 . . . . 0.0 114.46 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -56.36 101.99 0.07 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.904 1.282 . . . . 0.0 112.523 -166.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -162.43 -35.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.423 1.089 . . . . 0.0 112.325 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.31 167.18 37.63 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.66 1.6 . . . . 0.0 111.592 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -83.62 20.56 1.38 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.768 1.627 . . . . 0.0 113.0 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -65.84 -36.54 83.75 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.343 1.857 . . . . 0.0 112.863 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.42 144.93 55.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.0 tp -167.14 153.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.711 2.004 . . . . 0.0 108.302 164.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.79 161.47 26.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.914 1.286 . . . . 0.0 112.322 175.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.29 143.01 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.885 161.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.48 137.46 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.075 2.15 . . . . 0.0 108.404 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -138.29 113.64 9.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.597 1.159 . . . . 0.0 109.229 175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -77.33 25.8 0.17 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.3 t -159.04 177.71 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.359 1.464 . . . . 0.0 111.366 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -148.64 156.96 43.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.03 1.332 . . . . 0.0 111.805 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.87 172.31 0.12 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.639 1.976 . . . . 0.0 114.729 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.358 1.463 . . . . 0.0 112.574 -178.191 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 CA--C 1.539 0.768 0 CA-C-O 119.972 -0.095 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -136.06 145.15 45.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.429 1.492 . . . . 0.0 110.386 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.16 167.6 19.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.082 0.953 . . . . 0.0 111.891 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -150.82 125.63 9.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.149 -0.969 . . . . 0.0 112.59 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.9 tt -106.56 142.71 35.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.572 2.749 . . . . 0.0 109.551 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -136.51 144.05 44.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 167.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.97 119.87 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.923 1.289 . . . . 0.0 109.378 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.81 -8.78 66.95 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.309 0.884 . . . . 0.0 115.309 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -163.46 91.54 0.69 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.236 1.518 . . . . 0.0 111.029 167.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.1 tp -156.51 -48.08 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.16 -1.4 . . . . 0.0 112.82 165.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -83.35 66.7 7.59 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.523 2.148 . . . . 0.0 112.225 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.6 mt -84.06 -6.04 59.34 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 0.0 113.805 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.64 11.58 19.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.632 1.573 . . . . 0.0 112.501 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 58.89 138.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.171 2.589 . . . . 0.0 113.694 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.94 136.07 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.33 1.052 . . . . 0.0 109.627 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -89.01 157.05 18.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.625 0.77 . . . . 0.0 112.35 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -47.59 -48.46 28.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.001 1.72 . . . . 0.0 112.891 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -70.11 -26.41 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.1 -44.78 16.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.612 1.165 . . . . 0.0 112.539 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.64 -34.55 77.18 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.553 -0.717 . . . . 0.0 110.988 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -63.97 -48.65 75.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.074 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -65.07 -42.86 93.79 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.452 1.478 . . . . 0.0 112.657 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -26.98 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.726 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -96.28 -5.4 40.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -48.52 -42.92 58.9 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.46 -16.64 4.68 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.124 1.883 . . . . 0.0 113.346 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -79.29 -24.2 43.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.448 1.099 . . . . 0.0 112.23 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.75 41.36 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.61 -17.15 22.59 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -163.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.56 154.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 127.098 2.159 . . . . 0.0 116.759 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -139.38 -65.81 0.47 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.022 1.329 . . . . 0.0 113.22 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -159.99 174.95 13.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.381 1.072 . . . . 0.0 112.086 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.09 155.01 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.469 -1.394 . . . . 0.0 114.559 -171.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.63 120.12 5.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.998 1.319 . . . . 0.0 110.779 162.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.6 mt -132.15 126.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 120.991 -1.068 . . . . 0.0 112.205 -168.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -156.2 147.65 22.62 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.422 1.489 . . . . 0.0 112.058 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 53.55 -152.21 0.31 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.535 1.534 . . . . 0.0 112.561 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.09 -4.21 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.037 1.335 . . . . 0.0 114.245 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.67 -175.61 2.76 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 110.681 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.29 149.66 15.33 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.365 -0.834 . . . . 0.0 113.017 165.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.87 135.87 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.364 1.465 . . . . 0.0 109.971 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.25 114.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -73.71 139.22 45.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.799 0.809 . . . . 0.0 108.844 170.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.52 157.48 42.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.097 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.25 146.17 23.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 60.89 138.09 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 129.156 2.983 . . . . 0.0 117.033 -172.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.57 -35.53 2.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.03 2.486 . . . . 0.0 112.754 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.48 -34.22 75.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.549 0.613 . . . . 0.0 111.269 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -64.14 -43.81 94.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.068 1.347 . . . . 0.0 112.751 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.6 -52.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.745 0.702 . . . . 0.0 111.344 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -40.44 79.59 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.779 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.48 -28.2 66.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.194 1.361 . . . . 0.0 112.655 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.94 -63.6 1.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.892 0.769 . . . . 0.0 111.814 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 pp -78.77 -27.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.89 -26.92 67.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.192 1.36 . . . . 0.0 112.182 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.27 -15.35 16.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.629 1.171 . . . . 0.0 113.624 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -107.39 -46.12 3.93 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.67 -1.269 . . . . 0.0 113.938 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.4 m -83.82 -39.9 19.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.792 0.724 . . . . 0.0 111.003 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 56.23 -173.34 0.07 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.854 1.661 . . . . 0.0 114.267 171.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 57.93 16.23 3.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.021 1.729 . . . . 0.0 114.91 165.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -58.54 -33.9 70.4 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.318 -1.489 . . . . 0.0 110.79 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.97 6.61 41.41 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.194 1.797 . . . . 0.0 113.363 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -130.09 -11.87 4.17 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.424 1.49 . . . . 0.0 114.621 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.13 -177.78 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.777 -1.202 . . . . 0.0 112.926 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -144.91 23.27 1.55 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.0 1.32 . . . . 0.0 114.096 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.8 -30.57 63.82 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.115 0.966 . . . . 0.0 111.317 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.16 167.81 18.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.895 1.278 . . . . 0.0 112.84 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.99 153.32 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.052 1.741 . . . . 0.0 109.378 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.28 166.43 24.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.236 1.415 . . . . 0.0 111.327 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.9 140.07 31.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.63 0.772 . . . . 0.0 112.948 171.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.25 140.4 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.514 1.925 . . . . 0.0 110.103 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m -153.69 146.35 24.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.268 1.427 . . . . 0.0 110.039 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.0 p -99.37 0.03 41.98 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.3 t -146.19 167.34 23.7 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.123 1.769 . . . . 0.0 111.12 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -97.29 -12.63 22.67 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.464 1.106 . . . . 0.0 112.876 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.94 -38.82 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ttm-85 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.809 0.844 . . . . 0.0 112.923 -175.014 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -120.57 152.26 38.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.504 1.922 . . . . 0.0 110.641 168.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 t -163.52 165.21 23.89 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.066 1.746 . . . . 0.0 109.76 -173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -136.91 121.98 19.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.283 1.433 . . . . 0.0 111.721 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.3 tt -108.53 134.21 51.61 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.924 2.49 . . . . 0.0 110.048 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -127.22 137.59 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.257 0.623 . . . . 0.0 111.903 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.19 132.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.27 1.428 . . . . 0.0 108.174 167.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.16 -152.12 0.99 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.483 1.039 . . . . 0.0 113.492 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.35 85.72 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.868 1.667 . . . . 0.0 113.074 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.6 tm? -153.47 -58.56 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.412 1.485 . . . . 0.0 112.753 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 74.8 Cg_endo -71.36 -35.66 8.02 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.855 1.698 . . . . 0.0 112.195 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 14' ' ' ASN . 9.5 mp 55.91 178.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.452 1.501 . . . . 0.0 112.884 -173.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -70.24 17.66 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.078 1.351 . . . . 0.0 113.721 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 12' ' ' LEU . 20.5 t-20 -95.65 -11.52 27.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.08 1.752 . . . . 0.0 112.906 172.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.5 t -94.55 126.79 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -109.37 171.13 7.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.333 1.453 . . . . 0.0 110.964 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -61.7 -24.37 66.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -74.52 -33.38 62.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.514 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -80.08 -51.37 9.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.047 1.339 . . . . 0.0 111.947 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.17 -32.55 71.16 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.445 -0.784 . . . . 0.0 111.444 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -67.91 -53.64 24.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.494 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -65.0 -31.12 72.2 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.421 1.464 . . . . 0.0 113.925 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.2 -35.85 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.513 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -89.28 -12.4 40.75 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.9 m -46.27 -46.55 44.96 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.13 -4.35 15.24 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 122.723 2.008 . . . . 0.0 113.541 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.05 -21.13 10.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.802 1.241 . . . . 0.0 113.587 -173.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.94 177.03 37.49 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.136 -0.977 . . . . 0.0 115.445 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.24 -16.77 23.32 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.87 157.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 126.523 1.929 . . . . 0.0 115.943 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.0 mmt -136.1 -79.61 0.41 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.206 1.403 . . . . 0.0 112.315 165.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -149.82 170.45 18.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.295 1.438 . . . . 0.0 112.064 -162.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.51 146.43 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -160.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -149.21 132.9 16.86 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.987 2.115 . . . . 0.0 108.524 164.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.91 135.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.41 1.484 . . . . 0.0 108.756 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -150.47 146.96 26.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.524 1.129 . . . . 0.0 110.929 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 51.89 -95.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.678 1.591 . . . . 0.0 113.396 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.54 3.13 6.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.606 1.563 . . . . 0.0 113.565 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -119.51 161.93 19.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.216 1.806 . . . . 0.0 112.557 -164.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.49 135.99 11.22 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.42 1.01 . . . . 0.0 113.027 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.76 95.1 4.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.211 1.804 . . . . 0.0 108.168 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.2 mt -115.52 129.24 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 120.641 -1.287 . . . . 0.0 109.467 -167.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -83.31 142.01 31.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.956 0.902 . . . . 0.0 109.906 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.57 173.85 11.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.539 1.536 . . . . 0.0 112.704 -170.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -118.79 127.1 53.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.627 1.571 . . . . 0.0 108.845 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 67.65 151.13 0.12 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.306 2.642 . . . . 0.0 114.978 -166.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.19 -30.75 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.064 2.509 . . . . 0.0 112.208 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.16 -37.8 86.58 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.664 0.786 . . . . 0.0 110.456 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.0 m -59.04 -27.61 65.65 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.65 -51.65 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.669 0.788 . . . . 0.0 110.769 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -58.43 -51.75 68.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.399 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.17 -40.25 80.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.451 1.023 . . . . 0.0 112.315 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.22 -59.01 5.97 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.216 0.462 . . . . 0.0 111.784 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -41.82 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.957 0.798 . . . . 0.0 111.138 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.63 -33.87 74.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 112.426 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.3 t -101.55 -33.04 10.09 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -87.66 -50.64 6.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.909 1.231 . . . . 0.0 112.357 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -88.91 -49.45 6.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.246 0.93 . . . . 0.0 112.385 -173.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 51.68 -144.79 0.57 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.823 1.649 . . . . 0.0 111.485 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 54.57 16.67 1.4 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.0 ttt -75.97 -29.96 58.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.041 -1.037 . . . . 0.0 110.869 165.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -110.21 167.42 10.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 t80 50.6 35.46 11.59 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.708 1.603 . . . . 0.0 113.998 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.12 -10.88 0.33 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.309 0.956 . . . . 0.0 115.467 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 pttp 42.61 34.47 0.56 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.109 2.164 . . . . 0.0 116.322 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -62.01 -34.42 76.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.285 1.034 . . . . 0.0 111.756 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.97 166.71 23.97 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.453 1.101 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.3 mt -114.55 151.0 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.884 1.674 . . . . 0.0 108.486 166.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 171.67 13.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.316 1.046 . . . . 0.0 112.365 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -144.44 144.43 31.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.329 0.585 . . . . 0.0 111.273 164.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.42 131.45 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.818 1.647 . . . . 0.0 109.064 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.4 t -142.96 131.1 21.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 110.134 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -75.61 12.36 1.05 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.0 m 48.84 29.99 2.51 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.183 1.393 . . . . 0.0 113.483 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -103.39 26.91 7.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.422 1.889 . . . . 0.0 111.761 -170.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 172.1 13.24 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.778 2.031 . . . . 0.0 110.389 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.899 -170.137 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.481 0.772 0 CA-C-O 119.631 -0.237 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -57.01 136.36 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.253 1.021 . . . . 0.0 110.668 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 157.03 43.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.279 1.432 . . . . 0.0 110.811 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -136.94 118.95 15.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.155 0.982 . . . . 0.0 111.488 -168.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.61 101.2 9.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.581 2.352 . . . . 0.0 109.204 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -102.43 137.72 40.31 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.52 121.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.609 1.164 . . . . 0.0 110.304 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.53 -22.81 35.75 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -149.47 26.57 0.84 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 116.272 1.952 . . . . 0.0 116.272 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.8 tp -125.29 -34.59 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-O 116.677 -1.63 . . . . 0.0 114.782 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -72.07 46.49 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.019 3.146 . . . . 0.0 115.015 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.06 -5.71 57.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.593 1.957 . . . . 0.0 113.032 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -123.35 171.1 9.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.878 2.071 . . . . 0.0 111.099 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -67.32 142.97 56.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -144.33 134.13 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.908 1.283 . . . . 0.0 110.684 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -102.16 165.19 11.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.586 1.955 . . . . 0.0 112.005 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -53.49 -38.48 63.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.421 1.088 . . . . 0.0 113.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -79.68 -31.52 41.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 -52.17 64.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.75 0.82 . . . . 0.0 111.74 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.33 -34.86 76.87 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.801 -0.562 . . . . 0.0 111.534 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -67.32 -44.13 79.88 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.327 -0.858 . . . . 0.0 111.865 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -70.87 -40.11 72.46 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.778 1.172 . . . . 0.0 111.912 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.91 -27.02 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.584 1.084 . . . . 0.0 113.056 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.52 -5.59 39.05 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -44.26 86.97 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.54 1.6 9.16 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 121.965 1.777 . . . . 0.0 114.034 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.0 -27.57 8.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.59 174.75 42.67 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 116.82 1.488 . . . . 0.0 116.82 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -88.5 -17.45 30.28 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -162.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 62.14 152.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 126.943 2.097 . . . . 0.0 116.155 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.9 mmt -135.98 -72.25 0.46 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.473 1.509 . . . . 0.0 111.436 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -146.72 169.18 19.58 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 111.201 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.43 142.13 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.828 -1.17 . . . . 0.0 112.705 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -153.1 125.91 8.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.605 1.162 . . . . 0.0 109.261 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -143.36 132.1 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.335 1.454 . . . . 0.0 108.691 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -143.45 127.81 17.81 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.045 0.938 . . . . 0.0 111.56 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.2 t30 53.58 -71.13 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.047 2.539 . . . . 0.0 116.795 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.12 7.73 1.6 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.324 2.25 . . . . 0.0 113.12 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -135.91 140.35 43.99 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.05 -169.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.59 123.03 6.11 Favored Glycine 0 N--CA 1.466 0.666 0 CA-C-O 119.078 -0.845 . . . . 0.0 111.608 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.55 58.28 0.73 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.768 2.427 . . . . 0.0 108.936 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -83.0 139.81 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 120.129 -1.607 . . . . 0.0 109.456 -169.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.92 137.24 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.406 1.082 . . . . 0.0 110.874 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.59 164.15 23.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.466 1.107 . . . . 0.0 112.759 -168.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.63 146.79 26.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.542 156.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 63.38 144.35 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 129.455 3.102 . . . . 0.0 116.32 -172.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.38 -40.88 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.409 2.739 . . . . 0.0 111.612 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -62.75 -41.68 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.709 0.804 . . . . 0.0 111.148 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.7 m -54.23 -34.42 60.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 170.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -72.62 -58.74 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.898 0.772 . . . . 0.0 110.154 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.254 5.4 ppt_? -67.79 -25.98 65.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.423 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -74.46 -37.77 63.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.769 1.168 . . . . 0.0 112.006 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.28 90.83 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.02 -1.05 . . . . 0.0 112.617 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -74.1 -54.16 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.637 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.92 -11.69 60.01 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -168.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.3 t -109.85 -31.36 7.45 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -108.86 -32.41 7.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.343 1.429 . . . . 0.0 113.733 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -87.37 59.15 5.37 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.521 -1.362 . . . . 0.0 111.868 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 54.79 5.16 0.08 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -88.79 -4.69 58.44 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.697 1.599 . . . . 0.0 113.304 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 tpt -78.6 39.19 0.34 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.889 2.076 . . . . 0.0 112.352 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -138.14 153.34 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.371 1.869 . . . . 0.0 110.257 -170.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -72.43 -32.03 65.97 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.692 0.797 . . . . 0.0 111.322 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.04 178.17 34.02 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.113 0.863 . . . . 0.0 113.027 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 143.99 49.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.988 1.315 . . . . 0.0 111.604 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -155.87 -39.48 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 112.345 167.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.88 134.35 34.52 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.3 135.83 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.691 1.596 . . . . 0.0 109.193 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 165.83 28.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -143.03 126.03 16.28 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.377 0.671 . . . . 0.0 111.781 164.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -99.11 127.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 109.993 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.8 p -142.62 161.74 37.29 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.806 1.242 . . . . 0.0 111.426 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -116.34 -162.86 0.87 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.166 0.987 . . . . 0.0 112.236 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.9 p -61.17 -0.12 0.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -62.47 -23.7 67.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.978 1.311 . . . . 0.0 112.934 167.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.8 176.29 8.82 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 112.613 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.234 2.214 . . . . 0.0 111.179 173.547 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.537 0.658 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -99.56 64.73 1.32 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.356 2.262 . . . . 0.0 111.032 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 158.11 25.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.919 0.888 . . . . 0.0 112.273 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.85 119.02 10.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 -164.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tt -110.15 125.61 53.21 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.319 2.648 . . . . 0.0 108.892 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -117.87 141.22 48.67 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 111.94 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -132.55 139.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.317 1.447 . . . . 0.0 109.984 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.63 166.55 12.96 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.144 0.878 . . . . 0.0 112.541 163.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.0 t30 57.43 12.87 1.59 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.515 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 10.1 tt -131.8 -45.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.57 1.948 . . . . 0.0 113.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 75.9 Cg_endo -74.27 26.66 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.227 2.618 . . . . 0.0 113.849 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.8 mt -68.09 -20.97 64.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.452 1.501 . . . . 0.0 112.346 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -99.1 12.5 35.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.456 1.903 . . . . 0.0 112.906 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 54.51 163.65 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.208 2.603 . . . . 0.0 114.04 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 t -140.87 129.48 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.241 -1.537 . . . . 0.0 110.06 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -66.2 152.61 44.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.755 0.822 . . . . 0.0 112.386 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -43.43 -34.79 1.38 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 113.835 164.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -89.95 -37.96 13.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.152 0.981 . . . . 0.0 112.307 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -61.47 -50.58 72.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.457 0.571 . . . . 0.0 110.793 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.76 -39.5 87.9 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.694 -0.628 . . . . 0.0 111.938 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.49 -42.38 98.53 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.835 -0.541 . . . . 0.0 110.918 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -77.76 -45.79 23.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.939 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -67.55 -25.5 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 120.313 1.415 . . . . 0.0 112.412 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -100.27 8.74 43.54 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -56.12 -55.88 37.03 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 120.553 1.524 . . . . 0.0 112.655 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.89 -16.99 29.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.043 1.829 . . . . 0.0 113.98 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -80.63 -13.06 59.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.377 1.071 . . . . 0.0 113.35 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.81 -156.5 17.96 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 121.186 -0.946 . . . . 0.0 113.596 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -119.65 -11.65 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.32 0.0 OUTLIER 53.01 163.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 129.414 3.086 . . . . 0.0 116.46 172.401 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.8 mmt -143.04 -69.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.882 -1.761 . . . . 0.0 112.868 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.61 178.01 8.28 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.542 1.537 . . . . 0.0 111.549 -169.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.44 151.51 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.562 1.073 . . . . 0.0 112.714 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.31 111.26 1.88 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.365 158.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.83 123.54 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.861 -1.149 . . . . 0.0 110.325 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -162.18 150.15 14.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.103 1.761 . . . . 0.0 109.876 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 39' ' ' PHE . 40.2 t30 60.01 -162.88 0.25 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.734 1.613 . . . . 0.0 112.426 -175.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.3 17.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.343 1.857 . . . . 0.0 114.636 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 37' ' ' ASN . 47.0 m-85 -141.35 173.75 11.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.233 2.213 . . . . 0.0 110.912 -167.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.4 150.72 22.08 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 121.308 -0.87 . . . . 0.0 112.18 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -120.12 139.41 52.63 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.362 1.065 . . . . 0.0 110.513 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -130.39 131.2 65.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 170.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -94.4 146.36 24.12 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.064 -1.023 . . . . 0.0 108.881 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.82 153.48 47.09 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.566 1.146 . . . . 0.0 112.952 -162.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.96 138.34 34.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.349 0.66 . . . . 0.0 110.229 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 56.25 132.37 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 129.127 2.971 . . . . 0.0 115.683 -162.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.67 -27.22 38.65 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.911 2.407 . . . . 0.0 112.503 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -59.68 -35.72 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.631 -0.668 . . . . 0.0 111.803 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.5 m -61.82 -34.96 76.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 113.128 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 -56.07 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.589 0.756 . . . . 0.0 110.134 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.26 94.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.923 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.69 -26.31 66.12 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.39 -57.14 4.72 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.992 0.814 . . . . 0.0 112.01 168.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.93 -36.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.146 -0.971 . . . . 0.0 112.746 -169.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.05 -37.08 69.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.939 0.79 . . . . 0.0 110.323 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.4 t -86.03 -32.49 21.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -113.39 -46.18 3.09 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 m -79.44 -8.57 59.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -139.06 168.3 20.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.404 2.281 . . . . 0.0 110.104 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.47 -26.2 7.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.612 1.165 . . . . 0.0 113.483 -172.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.1 tpp -150.92 133.28 15.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.954 0.902 . . . . 0.0 112.749 -175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -63.8 -3.31 2.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.764 1.626 . . . . 0.0 114.882 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -132.22 11.05 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.687 1.995 . . . . 0.0 112.904 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.03 134.55 7.69 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.721 1.153 . . . . 0.0 113.327 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -76.92 128.63 34.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.532 1.133 . . . . 0.0 111.052 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -140.43 -34.16 0.54 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.919 1.687 . . . . 0.0 112.111 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tp -150.42 156.11 40.85 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.978 1.311 . . . . 0.0 113.334 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 pt -90.8 143.93 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.623 1.169 . . . . 0.0 112.548 167.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.51 176.13 12.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.621 1.168 . . . . 0.0 113.382 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.22 145.94 28.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.673 0.789 . . . . 0.0 110.984 159.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -112.63 119.31 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.98 1.712 . . . . 0.0 109.212 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 t -142.22 163.43 32.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.353 1.061 . . . . 0.0 112.206 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.6 p -132.49 15.07 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.925 1.29 . . . . 0.0 113.05 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 95.6 p -148.78 -6.76 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -173.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.04 164.32 15.56 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 120.334 1.425 . . . . 0.0 112.033 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.88 158.18 22.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.278 1.031 . . . . 0.0 112.902 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.515 1.126 . . . . 0.0 111.698 175.432 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 112.821 0.277 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.07 125.72 53.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.604 1.562 . . . . 0.0 111.162 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -141.45 155.0 45.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.187 1.395 . . . . 0.0 112.685 -178.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -129.52 133.71 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.596 1.558 . . . . 0.0 111.274 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -115.32 104.23 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.137 2.975 . . . . 0.0 107.981 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -96.51 126.26 41.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.202 0.601 . . . . 0.0 110.095 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 mt -115.17 139.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.472 1.109 . . . . 0.0 108.754 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.22 -151.35 0.31 Allowed Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.88 1.267 . . . . 0.0 113.07 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.79 68.31 4.73 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 121.123 -1.222 . . . . 0.0 113.604 -167.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.4 tp -129.19 -53.67 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 116.798 -1.572 . . . . 0.0 114.461 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.7 95.62 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.993 2.462 . . . . 0.0 110.85 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.68 -38.05 6.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.674 1.19 . . . . 0.0 113.3 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -148.03 168.41 22.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.582 1.153 . . . . 0.0 112.902 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t30 51.5 46.16 26.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.965 1.306 . . . . 0.0 112.637 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.16 139.12 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.85 1.26 . . . . 0.0 111.174 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 t -154.19 173.59 15.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.95 2.1 . . . . 0.0 108.196 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -55.58 -40.84 72.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.198 0.908 . . . . 0.0 113.086 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -73.19 -34.13 65.81 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.194 0.598 . . . . 0.0 112.576 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -71.17 -43.79 66.78 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.791 -0.568 . . . . 0.0 111.765 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.75 -34.17 73.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.705 0.684 . . . . 0.0 111.969 171.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.98 -48.48 81.52 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.654 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -72.62 -33.49 66.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.51 1.05 . . . . 0.0 113.189 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.258 1.8 pp -79.88 -26.0 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.642 1.11 . . . . 0.0 113.573 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -101.29 -4.52 26.91 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.571 1.078 . . . . 0.0 113.899 171.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.98 -53.85 19.6 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 114.098 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.14 0.69 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.185 1.923 . . . . 0.0 114.218 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.42 -13.9 14.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.383 1.473 . . . . 0.0 113.429 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.93 -174.79 46.86 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -101.13 -10.45 20.43 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -162.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.89 152.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 168.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.4 mmt -138.11 -73.38 0.41 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 111.99 165.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -153.89 -175.8 5.54 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.811 1.644 . . . . 0.0 111.918 -170.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 pt -131.68 157.03 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.579 1.536 . . . . 0.0 113.45 -165.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -147.8 101.08 3.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.897 1.279 . . . . 0.0 110.0 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.39 110.62 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.29 -1.506 . . . . 0.0 110.737 -174.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -146.61 152.82 39.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.495 1.518 . . . . 0.0 111.319 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.406 ' CG ' ' H ' ' A' ' 38' ' ' ALA . 49.3 t30 55.14 -159.4 0.19 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.26 1.424 . . . . 0.0 112.466 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' H ' ' CG ' ' A' ' 37' ' ' ASN . . . -71.56 30.82 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.995 2.118 . . . . 0.0 114.213 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.75 175.36 10.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.808 2.043 . . . . 0.0 111.059 -170.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.19 135.97 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.326 -0.859 . . . . 0.0 111.947 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.39 157.36 45.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 110.046 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.58 153.54 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.086 -1.009 . . . . 0.0 108.776 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.13 144.62 42.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.679 1.191 . . . . 0.0 109.953 168.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.96 155.5 50.63 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.847 1.259 . . . . 0.0 112.33 -163.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.77 140.11 31.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.045 155.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 60.35 139.17 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.188 2.595 . . . . 0.0 116.418 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.97 -30.33 7.33 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.52 2.147 . . . . 0.0 112.986 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.88 -34.22 77.46 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.56 -0.712 . . . . 0.0 111.494 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -60.47 -42.4 96.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.241 1.416 . . . . 0.0 113.216 167.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.9 -55.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.318 0.647 . . . . 0.0 110.921 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -45.53 94.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.493 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -63.8 -34.58 78.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.754 1.161 . . . . 0.0 112.507 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.5 -54.26 39.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.684 1.129 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mt -72.4 -36.18 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.094 -1.004 . . . . 0.0 111.708 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -83.73 -10.94 57.79 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.847 -1.158 . . . . 0.0 113.331 -173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.38 -40.71 2.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 112.576 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -50.16 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.962 0.801 . . . . 0.0 110.955 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 m -85.36 18.72 2.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.249 1.02 . . . . 0.0 113.669 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 61' ' ' MET . 52.1 tt0 -54.88 139.04 41.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.446 1.498 . . . . 0.0 111.771 -177.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -98.39 -0.3 43.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.503 1.521 . . . . 0.0 114.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.401 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 19.1 ttt 70.92 148.95 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.03 2.532 . . . . 0.0 113.823 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.24 35.32 0.11 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.666 1.586 . . . . 0.0 114.249 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -142.03 -11.11 0.87 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.428 1.491 . . . . 0.0 114.275 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.1 165.36 38.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 119.824 1.193 . . . . 0.0 113.283 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -155.54 128.5 8.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.659 1.184 . . . . 0.0 110.157 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -127.67 -0.72 6.11 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.1 172.53 12.53 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.574 1.95 . . . . 0.0 110.866 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.34 166.39 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.367 1.067 . . . . 0.0 112.154 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.86 167.54 21.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.939 1.296 . . . . 0.0 112.19 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -149.9 122.75 8.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -82.43 133.42 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.735 1.214 . . . . 0.0 109.834 166.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.9 t -147.58 160.87 42.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 66.7 p -157.77 -176.05 5.72 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.2 t -55.6 -25.26 37.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.833 0.853 . . . . 0.0 113.267 166.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.84 -20.68 56.05 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.5 1.045 . . . . 0.0 113.604 171.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.45 -1.85 56.31 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.071 0.948 . . . . 0.0 113.066 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 117.686 -1.149 . . . . 0.0 110.333 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 CA-C-O 119.028 -0.488 . . . . 0.0 113.014 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -88.76 59.66 5.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 112.363 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 160.42 31.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.487 0.715 . . . . 0.0 111.091 173.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -140.47 145.37 36.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.72 125.37 37.81 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.801 2.44 . . . . 0.0 108.953 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -127.19 139.88 52.63 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.869 0.868 . . . . 0.0 110.18 173.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -121.18 141.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.046 1.338 . . . . 0.0 107.656 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.02 -151.94 0.03 OUTLIER Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.17 1.843 . . . . 0.0 113.81 171.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -76.18 41.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.759 -1.436 . . . . 0.0 114.718 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.34 -51.87 0.12 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.697 1.999 . . . . 0.0 114.256 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.41 -31.86 2.54 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.897 1.731 . . . . 0.0 112.539 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.43 177.56 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.134 1.774 . . . . 0.0 112.513 -168.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -75.06 2.03 11.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.417 -1.427 . . . . 0.0 112.312 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -79.21 38.32 0.35 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.923 2.089 . . . . 0.0 113.001 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.44 138.26 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.926 2.09 . . . . 0.0 108.139 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.3 t -122.85 179.97 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.572 1.549 . . . . 0.0 111.821 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -59.39 -35.61 74.26 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -79.68 -38.63 33.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.256 0.622 . . . . 0.0 111.291 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.8 -42.5 99.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.83 -38.74 57.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.222 0.609 . . . . 0.0 112.052 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -68.34 -43.66 77.03 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 121.386 -0.821 . . . . 0.0 110.97 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -66.04 -41.62 90.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.206 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.78 -34.21 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.849 0.749 . . . . 0.0 112.077 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -87.52 -19.0 28.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 m -44.05 -51.96 16.93 Favored Pre-proline 0 N--CA 1.48 1.067 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.3 -6.19 18.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.683 1.588 . . . . 0.0 114.063 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -105.6 -24.17 12.62 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.439 1.496 . . . . 0.0 113.772 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.35 165.69 38.41 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -81.16 -19.06 44.23 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 63.58 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.337 1.855 . . . . 0.0 114.938 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -141.75 -68.02 0.39 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.563 -1.336 . . . . 0.0 112.717 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -146.27 179.99 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.574 1.95 . . . . 0.0 110.053 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 pt -134.62 155.57 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.834 -1.166 . . . . 0.0 113.296 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.05 146.03 17.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.242 1.817 . . . . 0.0 108.262 157.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.7 mt -142.53 138.61 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.064 1.746 . . . . 0.0 108.367 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -151.22 150.69 30.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.08 0.952 . . . . 0.0 110.836 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 58.74 -90.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.499 1.52 . . . . 0.0 114.212 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.82 10.41 2.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.133 2.173 . . . . 0.0 112.558 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.42 147.65 50.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.011 1.725 . . . . 0.0 111.948 -164.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 140.38 15.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.97 0.795 . . . . 0.0 112.6 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.2 55.3 1.91 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.529 1.931 . . . . 0.0 110.176 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.5 150.46 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.217 1.407 . . . . 0.0 109.85 -164.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -112.3 140.41 47.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.777 -1.202 . . . . 0.0 110.218 -176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -133.79 144.66 49.16 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 112.272 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.25 135.15 38.44 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 155.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 61.54 133.36 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 129.93 3.292 . . . . 0.0 117.561 -174.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.0 -26.54 15.06 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.092 2.528 . . . . 0.0 113.991 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.29 -32.75 72.11 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.736 -1.227 . . . . 0.0 111.542 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.1 m -68.89 -25.24 64.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.496 1.519 . . . . 0.0 113.185 168.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.7 t -71.21 -58.6 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.558 1.072 . . . . 0.0 110.945 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -46.72 88.36 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.822 -174.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.66 -27.62 69.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.809 1.186 . . . . 0.0 113.455 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.26 -50.74 51.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.647 0.658 . . . . 0.0 112.128 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 mt -70.77 -46.66 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.191 -0.943 . . . . 0.0 111.289 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.35 -22.14 61.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.121 0.968 . . . . 0.0 112.293 -169.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.9 t -118.38 -19.42 8.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.85 -54.05 2.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.201 1.364 . . . . 0.0 111.314 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 m -77.0 -56.18 4.81 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -162.08 133.4 5.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.918 0.887 . . . . 0.0 112.735 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -100.14 154.11 18.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.363 1.065 . . . . 0.0 112.659 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.7 tpt 55.74 49.29 16.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.534 1.533 . . . . 0.0 113.017 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -55.36 -17.28 4.57 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -55.76 -12.38 1.27 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.11 34.56 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 53.2 36.77 23.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.535 1.934 . . . . 0.0 114.961 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -126.42 -11.42 6.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.695 1.998 . . . . 0.0 113.659 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -138.04 148.09 44.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.26 2.624 . . . . 0.0 110.053 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt -124.48 148.31 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.898 0.879 . . . . 0.0 111.22 -172.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.69 172.05 14.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.684 1.194 . . . . 0.0 112.292 168.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.78 116.13 8.52 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.603 -0.686 . . . . 0.0 112.758 167.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.5 p -87.16 125.78 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 109.648 165.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.0 m -131.18 145.33 51.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.598 1.159 . . . . 0.0 111.863 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.3 m -101.19 -20.65 15.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.358 1.863 . . . . 0.0 112.089 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.7 t -161.15 161.76 31.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.543 2.337 . . . . 0.0 109.573 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -112.26 3.49 17.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.054 1.342 . . . . 0.0 113.562 166.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.23 -171.07 3.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.604 1.961 . . . . 0.0 110.286 -168.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.3 ttm105 . . . . . 0 C--O 1.257 1.451 0 C-N-CA 125.638 1.575 . . . . 0.0 113.052 176.294 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 CA-C-O 118.519 -0.701 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -75.65 67.13 2.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.235 1.814 . . . . 0.0 112.317 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.89 167.01 5.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.85 2.46 . . . . 0.0 112.953 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -141.47 133.54 27.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.798 -1.189 . . . . 0.0 112.526 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tt -122.18 129.08 51.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.401 2.28 . . . . 0.0 109.762 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -125.99 133.13 51.87 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.557 0.743 . . . . 0.0 111.393 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.01 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.904 0.882 . . . . 0.0 109.262 167.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.93 -17.11 76.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.012 0.815 . . . . 0.0 113.863 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -148.99 88.62 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.123 1.369 . . . . 0.0 111.661 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.61 -58.0 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.338 162.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.67 85.75 1.58 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.419 2.079 . . . . 0.0 110.531 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.78 -33.84 27.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.901 0.88 . . . . 0.0 112.539 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -160.73 -24.63 0.06 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 172.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.12 61.68 1.44 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.316 1.446 . . . . 0.0 112.085 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.23 128.21 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 109.915 164.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 m -126.08 175.36 7.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.692 1.997 . . . . 0.0 110.693 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -45.45 -49.28 13.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.085 1.754 . . . . 0.0 113.883 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -79.45 -11.6 59.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.827 0.851 . . . . 0.0 113.073 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -83.48 -55.96 4.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.581 1.152 . . . . 0.0 109.803 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.34 -34.54 77.93 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.686 -0.634 . . . . 0.0 111.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -69.48 -45.34 69.23 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.073 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -67.2 -40.01 86.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.41 1.459 . . . . 0.0 112.246 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -27.92 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.831 0.741 . . . . 0.0 112.878 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -97.69 -10.67 24.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.63 -52.14 47.09 Favored Pre-proline 0 N--CA 1.478 0.965 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.94 10.35 2.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.291 1.994 . . . . 0.0 113.697 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -120.15 -29.32 4.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.476 1.51 . . . . 0.0 113.384 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.81 37.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -86.36 -20.44 28.27 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.309 1.444 . . . . 0.0 114.716 -165.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.88 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 127.037 2.135 . . . . 0.0 115.748 176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mmt -141.93 -73.48 0.31 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.578 1.551 . . . . 0.0 113.386 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -138.78 171.83 13.76 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.675 1.59 . . . . 0.0 111.894 -169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -130.34 151.53 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -160.55 131.26 5.45 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.275 2.23 . . . . 0.0 109.712 163.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.3 mt -137.37 134.22 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.33 -1.481 . . . . 0.0 109.721 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.41 150.7 23.72 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 112.489 -173.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 59.34 -93.83 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.018 1.727 . . . . 0.0 113.321 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.81 9.2 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.076 1.75 . . . . 0.0 112.621 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.21 169.98 15.21 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 111.299 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.16 138.92 10.44 Favored Glycine 0 N--CA 1.466 0.637 0 C-N-CA 123.93 0.776 . . . . 0.0 112.345 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -122.37 100.53 6.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.858 1.663 . . . . 0.0 108.528 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.04 131.37 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -94.98 142.87 26.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.746 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -128.57 162.39 27.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.209 1.403 . . . . 0.0 110.981 -168.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -92.32 145.65 24.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.712 153.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 62.61 126.02 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.55 2.34 . . . . 0.0 116.792 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 -34.76 14.72 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.447 2.764 . . . . 0.0 114.393 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.27 -35.98 80.66 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.576 -0.702 . . . . 0.0 110.873 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -35.15 79.78 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.871 2.068 . . . . 0.0 112.408 175.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.82 -59.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.619 -0.676 . . . . 0.0 111.432 168.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -34.35 77.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.404 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.75 -39.36 84.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.476 1.035 . . . . 0.0 111.977 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 112.706 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -68.51 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 120.958 -1.089 . . . . 0.0 109.914 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.59 -29.1 63.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.01 -25.02 16.09 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.69 -41.18 3.09 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 m -82.75 -19.77 37.24 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.26 -0.9 . . . . 0.0 112.962 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -120.42 145.99 46.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.562 1.945 . . . . 0.0 110.547 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -122.14 -11.13 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.7 ttt -144.23 154.3 42.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.575 1.55 . . . . 0.0 111.326 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -71.32 123.36 22.12 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.102 -0.999 . . . . 0.0 111.409 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 54.84 36.23 26.06 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.248 1.019 . . . . 0.0 112.277 -168.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.76 158.32 24.36 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.405 1.479 . . . . 0.0 113.901 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -96.56 157.76 15.75 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.318 -1.107 . . . . 0.0 113.072 -165.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt 57.72 14.6 2.51 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.152 2.181 . . . . 0.0 114.571 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.22 107.17 8.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.056 1.342 . . . . 0.0 109.925 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -113.66 150.2 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.688 1.195 . . . . 0.0 109.42 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.72 169.46 19.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.132 1.773 . . . . 0.0 112.468 -168.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -146.33 131.79 18.68 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 110.856 162.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.08 124.38 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 108.796 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -138.66 168.94 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.128 0.971 . . . . 0.0 112.702 -170.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -114.73 -172.51 2.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.446 1.099 . . . . 0.0 112.996 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 p -66.2 -3.85 6.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -66.68 165.61 14.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.42 1.088 . . . . 0.0 111.032 168.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.19 -1.39 23.04 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.26 1.424 . . . . 0.0 114.758 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 . . . . . 0 C--O 1.253 1.246 0 CA-C-O 116.379 -1.772 . . . . 0.0 111.446 -175.186 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 N-CA-C 111.717 -0.147 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.16 130.63 47.24 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.061 -1.024 . . . . 0.0 111.811 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.51 162.04 36.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 112.46 -172.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -128.96 139.47 52.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 111.181 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -127.81 111.1 13.26 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.169 2.588 . . . . 0.0 109.021 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -113.99 130.6 56.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.533 -0.729 . . . . 0.0 111.293 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.45 134.37 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 108.608 166.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.66 -141.12 0.4 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.7 0.667 . . . . 0.0 112.558 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.53 82.4 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.152 1.781 . . . . 0.0 112.532 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.22 -58.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.571 1.548 . . . . 0.0 111.253 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.49 101.65 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.972 2.448 . . . . 0.0 110.538 169.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.63 -18.27 13.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.397 1.079 . . . . 0.0 112.52 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.99 165.06 12.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.896 1.678 . . . . 0.0 110.425 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.04 144.31 55.16 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.742 -0.599 . . . . 0.0 111.723 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.81 137.95 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.671 1.188 . . . . 0.0 110.074 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 t -84.84 152.45 23.6 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.767 1.227 . . . . 0.0 112.721 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -51.04 -24.28 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.715 1.206 . . . . 0.0 113.291 163.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -86.86 -37.8 17.38 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.622 1.169 . . . . 0.0 111.772 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -61.92 -51.32 68.61 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 110.41 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.08 -35.49 78.27 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.428 -0.795 . . . . 0.0 112.414 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.837 0.744 . . . . 0.0 111.977 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -74.72 -34.61 62.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.175 0.898 . . . . 0.0 112.666 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.01 -35.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.728 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -91.27 -3.33 56.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 m -46.73 -49.97 44.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 120.729 1.604 . . . . 0.0 113.973 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.56 -9.94 18.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.8 1.667 . . . . 0.0 113.91 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.41 -28.57 18.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.183 1.393 . . . . 0.0 111.63 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.66 -176.24 47.06 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 118.966 2.346 . . . . 0.0 118.966 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -162.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 HD12 ' H ' ' A' ' 31' ' ' MET 0.261 0.3 OUTLIER 61.86 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 128.908 2.883 . . . . 0.0 116.227 178.298 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.415 ' H ' HD12 ' A' ' 30' ' ' ILE . 5.8 mmt -139.81 -61.96 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.762 1.625 . . . . 0.0 113.268 169.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -156.56 172.76 17.99 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.774 1.17 . . . . 0.0 111.604 -168.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.84 152.95 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.166 1.348 . . . . 0.0 114.198 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.72 125.08 8.81 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.381 2.272 . . . . 0.0 108.465 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -138.62 127.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 120.694 -1.254 . . . . 0.0 110.03 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -149.3 156.85 42.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.32 1.448 . . . . 0.0 111.715 178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 52.97 -109.73 0.49 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.601 1.56 . . . . 0.0 113.105 165.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.71 14.31 13.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.958 1.303 . . . . 0.0 113.684 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -127.12 167.73 15.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.535 1.134 . . . . 0.0 112.111 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.67 127.95 4.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.49 88.07 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.21 1.404 . . . . 0.0 109.241 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -87.41 151.72 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.132 0.968 . . . . 0.0 108.425 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.77 141.38 51.26 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 120.305 -1.497 . . . . 0.0 108.373 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -131.96 165.05 24.79 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.891 1.277 . . . . 0.0 112.176 -165.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.42 140.25 36.95 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 156.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.322 2.1 p30 60.07 144.45 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.723 3.209 . . . . 0.0 115.981 -169.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.0 -23.09 8.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.669 2.246 . . . . 0.0 112.576 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -64.67 -35.79 82.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.903 0.881 . . . . 0.0 110.849 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.4 m -57.51 -47.05 82.98 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.599 1.56 . . . . 0.0 112.582 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.37 -55.61 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.335 0.654 . . . . 0.0 110.506 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -36.78 79.51 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.978 -1.01 . . . . 0.0 112.328 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.87 -41.25 83.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.614 1.552 . . . . 0.0 112.088 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -55.86 29.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.097 0.862 . . . . 0.0 111.222 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.3 mt -72.67 -48.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 O-C-N 121.81 -0.556 . . . . 0.0 111.357 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.61 -13.55 62.37 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.086 -0.959 . . . . 0.0 113.43 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.5 t -107.81 -24.76 11.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.094 1.357 . . . . 0.0 114.383 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -96.95 -62.56 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.875 1.67 . . . . 0.0 111.993 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -68.27 -33.99 75.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.637 -0.664 . . . . 0.0 111.182 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 55.07 -158.44 0.2 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 112.565 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -121.96 140.2 52.74 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.69 1.196 . . . . 0.0 109.425 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.97 159.51 15.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.381 1.472 . . . . 0.0 111.249 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -76.63 32.39 0.13 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.244 1.418 . . . . 0.0 114.085 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.28 136.77 31.95 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.153 1.781 . . . . 0.0 109.827 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.76 150.52 48.07 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm 48.53 42.24 18.48 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.678 1.239 . . . . 0.0 113.03 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -141.54 134.49 28.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.574 1.55 . . . . 0.0 110.021 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.93 40.98 30.42 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.832 1.253 . . . . 0.0 112.009 -175.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 42.8 pt -84.38 161.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.648 1.179 . . . . 0.0 113.142 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 166.34 26.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.791 1.637 . . . . 0.0 111.884 -168.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.15 126.9 29.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 110.49 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.79 140.25 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.608 1.563 . . . . 0.0 109.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m -140.53 131.93 26.81 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.723 0.809 . . . . 0.0 112.026 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -81.46 -2.66 50.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.942 2.097 . . . . 0.0 112.998 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 m -131.35 151.8 51.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.011 2.125 . . . . 0.0 110.603 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -120.88 145.49 47.59 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.97 . . . . 0.0 113.315 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.27 28.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 110.982 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.523 1.929 . . . . 0.0 113.614 -171.688 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.479 0.638 0 CA-C-O 119.174 -0.427 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 144.43 38.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 165.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 167.06 28.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.89 2.476 . . . . 0.0 109.877 -171.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -136.79 127.64 27.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.555 1.142 . . . . 0.0 112.142 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.4 tt -118.83 129.05 55.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.655 1.982 . . . . 0.0 109.755 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -111.89 139.58 47.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 110.944 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.62 139.88 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.823 1.249 . . . . 0.0 110.738 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.78 155.89 16.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.999 1.761 . . . . 0.0 111.877 163.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.8 -17.29 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -83.59 -47.57 0.76 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.36 1.464 . . . . 0.0 114.12 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.48 35.43 0.58 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.916 3.077 . . . . 0.0 114.088 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.22 -32.21 15.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.659 1.584 . . . . 0.0 111.544 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -65.12 148.73 51.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.248 1.019 . . . . 0.0 109.634 162.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -50.37 133.93 23.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.365 1.066 . . . . 0.0 112.782 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -145.39 140.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.128 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.4 m -135.78 172.71 12.62 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.973 1.709 . . . . 0.0 108.772 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.54 -39.54 61.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -69.12 -33.5 73.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.18 -53.66 49.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.822 0.737 . . . . 0.0 111.105 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.02 -33.01 74.62 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.71 0.404 . . . . 0.0 111.676 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.38 -48.08 81.3 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -75.94 -35.1 59.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.784 1.174 . . . . 0.0 113.209 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.13 -26.37 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.81 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -99.67 -16.28 18.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -46.07 -48.23 42.65 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 120.836 1.653 . . . . 0.0 115.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -17.71 18.19 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 121.874 1.705 . . . . 0.0 113.758 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -87.38 -34.33 18.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 112.666 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.99 173.1 36.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.443 1.024 . . . . 0.0 115.54 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -94.59 -13.55 25.84 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER 57.43 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 128.458 2.703 . . . . 0.0 116.912 165.266 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mmt -136.05 -71.08 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.944 -1.723 . . . . 0.0 113.716 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.97 158.4 40.58 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.05 0.94 . . . . 0.0 111.36 -168.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -107.48 153.99 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -155.81 93.03 1.42 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.526 1.13 . . . . 0.0 111.609 164.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.45 135.74 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 120.626 -1.296 . . . . 0.0 112.164 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.41 146.79 13.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.448 1.899 . . . . 0.0 110.844 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 63.73 -164.05 0.26 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.577 1.951 . . . . 0.0 112.458 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.39 30.13 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.843 1.657 . . . . 0.0 113.938 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.68 174.37 11.25 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.277 2.631 . . . . 0.0 109.68 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.01 143.01 8.14 Favored Glycine 0 CA--C 1.52 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 111.817 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.38 140.48 49.77 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.21 1.004 . . . . 0.0 108.801 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.4 123.83 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -81.83 143.38 31.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.41 1.1 . . . . 0.0 109.893 168.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.61 164.91 20.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.381 1.472 . . . . 0.0 111.59 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.5 137.65 32.57 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 157.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.85 124.71 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 128.041 2.536 . . . . 0.0 116.651 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.79 -24.31 13.41 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.378 2.718 . . . . 0.0 114.042 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -64.29 -38.42 90.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.682 1.128 . . . . 0.0 110.362 170.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -35.2 80.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.627 1.571 . . . . 0.0 112.071 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.64 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.316 -0.865 . . . . 0.0 112.162 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.296 6.4 ppt_? -69.24 -34.08 74.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.837 0.744 . . . . 0.0 112.924 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -68.31 -33.22 73.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.442 1.019 . . . . 0.0 112.741 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.67 -68.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 69' ' ' LEU 0.259 1.3 pp -72.58 -27.87 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.403 1.456 . . . . 0.0 114.682 -176.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -80.22 -19.34 47.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.3 1.864 . . . . 0.0 114.026 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.1 t -107.41 -30.13 8.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 119.662 1.119 . . . . 0.0 112.134 171.752 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.6 163.91 33.33 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 110.626 171.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -152.21 140.35 20.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.181 0.592 . . . . 0.0 111.848 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -93.07 137.74 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.857 1.263 . . . . 0.0 109.909 163.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.465 0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 111.977 178.431 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 CA-C-O 119.745 -0.19 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -87.77 147.92 24.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.85 163.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.18 154.91 30.03 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.175 1.39 . . . . 0.0 109.23 -172.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -142.03 123.75 15.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.542 1.064 . . . . 0.0 112.883 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 tt -113.87 105.79 13.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.854 2.462 . . . . 0.0 108.904 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -94.75 142.38 27.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.186 0.994 . . . . 0.0 111.162 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 mt -138.51 131.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.386 1.074 . . . . 0.0 110.839 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.38 150.91 18.61 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.904 0.764 . . . . 0.0 112.531 167.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 61.34 27.21 16.9 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.66 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -134.99 -45.97 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.04 1.736 . . . . 0.0 113.386 172.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.66 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 71.7 Cg_endo -73.14 21.27 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.654 2.236 . . . . 0.0 114.864 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.12 -21.92 49.63 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.063 2.145 . . . . 0.0 110.948 169.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.87 162.86 25.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.695 1.598 . . . . 0.0 111.194 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -84.98 106.33 16.4 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.967 0.907 . . . . 0.0 109.257 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.48 137.69 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.788 1.235 . . . . 0.0 111.63 -170.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -123.19 172.32 8.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.83 1.652 . . . . 0.0 111.736 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -48.49 -53.0 19.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.072 1.349 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -62.29 -31.16 71.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.77 -49.28 13.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.837 0.744 . . . . 0.0 112.263 -174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 33' ' ' ILE . 4.3 pp -65.91 -29.24 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -67.99 -53.2 27.85 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.42 0.688 . . . . 0.0 111.991 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -67.39 -32.34 73.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.138 1.336 . . . . 0.0 112.797 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.54 -45.64 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.51 -3.73 57.42 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -48.37 40.2 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.15 -14.35 16.73 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.874 1.716 . . . . 0.0 113.496 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -91.34 -24.12 19.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.553 . . . . 0.0 113.582 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.91 169.54 42.23 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.97 -18.26 56.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -166.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.33 148.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 128.271 2.628 . . . . 0.0 116.224 173.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.7 mmt -131.99 -96.88 0.32 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.196 1.799 . . . . 0.0 110.427 167.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' H ' ' HB2' ' A' ' 43' ' ' GLN . 81.9 mt-30 -120.78 173.07 7.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.972 2.109 . . . . 0.0 112.314 -168.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 20' ' ' LEU . 10.5 pt -124.92 145.32 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.315 -0.866 . . . . 0.0 112.798 -172.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -154.15 70.41 0.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.158 0.98 . . . . 0.0 113.121 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.73 117.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 108.434 170.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -150.51 150.34 31.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.793 2.437 . . . . 0.0 109.051 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 56.29 -170.37 0.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 113.218 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.82 1.79 3.06 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 120.267 -1.521 . . . . 0.0 113.623 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -144.04 59.62 1.36 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.768 2.427 . . . . 0.0 110.815 -159.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 173.89 42.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.948 1.261 . . . . 0.0 113.217 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -143.82 165.49 27.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.008 1.385 . . . . 0.0 113.966 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.9 mt -129.68 134.5 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 126.017 1.727 . . . . 0.0 107.16 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.466 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 71.8 mt-30 -85.54 141.46 29.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 169.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.86 164.08 21.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 111.59 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.85 141.14 31.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 160.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 62.26 148.84 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 127.706 2.403 . . . . 0.0 115.689 -166.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.48 -33.24 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.632 2.888 . . . . 0.0 112.496 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -60.45 -38.48 84.28 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.761 -0.587 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.0 m -53.59 -43.76 68.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.088 1.355 . . . . 0.0 113.645 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.3 -51.45 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.437 0.695 . . . . 0.0 109.8 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.94 -38.45 66.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.36 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 -31.59 72.82 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.923 1.238 . . . . 0.0 112.505 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.74 -64.05 1.03 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.498 0.719 . . . . 0.0 112.744 173.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.83 -24.15 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.69 -13.66 62.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.915 1.689 . . . . 0.0 111.579 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.5 t -105.12 -37.21 7.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.165 1.386 . . . . 0.0 112.906 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.473 0.696 0 O-C-N 120.93 -1.106 . . . . 0.0 113.161 -179.512 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.6 pt . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.834 0.349 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.05 165.39 30.06 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.783 0.833 . . . . 0.0 112.566 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -141.17 135.74 31.13 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.11 -0.369 . . . . 0.0 111.299 160.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.06 135.51 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.885 1.274 . . . . 0.0 110.676 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.466 0.363 0 C-N-CA 124.505 1.122 . . . . 0.0 111.981 -175.448 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.478 0.568 0 N-CA-C 112.677 0.222 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -120.17 124.04 44.76 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.941 0.897 . . . . 0.0 111.181 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -138.44 161.69 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.054 1.742 . . . . 0.0 112.126 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -134.75 125.56 27.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.119 -0.988 . . . . 0.0 111.658 -172.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -111.37 125.12 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.205 2.602 . . . . 0.0 109.022 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.81 128.58 53.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.406 0.682 . . . . 0.0 110.568 165.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.84 134.69 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.25 -158.96 0.43 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.457 0.551 . . . . 0.0 112.787 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -70.65 73.64 0.55 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.293 1.037 . . . . 0.0 113.256 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.3 tp -129.02 -35.68 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.261 1.825 . . . . 0.0 112.772 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.23 42.7 0.14 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.621 3.547 . . . . 0.0 115.896 168.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -15.23 63.45 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.261 -1.524 . . . . 0.0 113.102 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -95.97 166.32 11.83 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.652 1.581 . . . . 0.0 111.423 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -60.8 126.27 26.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.884 0.874 . . . . 0.0 111.068 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.42 121.96 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.456 1.503 . . . . 0.0 107.972 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -101.19 170.25 8.37 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.867 0.867 . . . . 0.0 111.668 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -54.39 -39.59 67.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.635 . . . . 0.0 112.41 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -71.51 -30.39 65.89 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.87 -54.32 16.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.923 1.238 . . . . 0.0 111.086 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.36 -32.79 73.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.178 -0.326 . . . . 0.0 111.782 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.62 -50.83 61.72 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.522 -0.736 . . . . 0.0 111.447 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -66.88 -38.67 86.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.207 1.367 . . . . 0.0 112.643 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.38 -28.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.291 0.951 . . . . 0.0 112.774 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.33 -2.12 31.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -49.66 -51.95 55.12 Favored Pre-proline 0 N--CA 1.48 1.053 0 CA-C-N 120.107 1.321 . . . . 0.0 114.359 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.77 -19.72 16.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.424 1.544 . . . . 0.0 113.983 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -87.22 -19.94 27.64 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.293 -0.88 . . . . 0.0 112.379 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.32 39.21 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -108.35 -7.46 15.88 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.245 1.942 . . . . 0.0 116.245 -170.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.0 155.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 127.952 2.501 . . . . 0.0 117.278 164.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mmt -139.76 -65.09 0.47 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.296 1.438 . . . . 0.0 112.79 165.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -152.56 159.86 43.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.112 0.965 . . . . 0.0 112.293 -163.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.69 143.4 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.741 1.216 . . . . 0.0 111.327 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -156.26 97.57 1.78 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.994 0.917 . . . . 0.0 112.283 161.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.48 133.83 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.978 -1.076 . . . . 0.0 111.639 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -153.3 162.92 40.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.218 2.607 . . . . 0.0 109.478 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.12 -159.64 0.27 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.409 1.084 . . . . 0.0 112.623 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.14 60.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.962 1.305 . . . . 0.0 113.985 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -103.8 -172.05 2.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.27 1.828 . . . . 0.0 111.885 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.07 145.79 11.21 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 120.525 -1.359 . . . . 0.0 114.219 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.09 138.14 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.29 1.036 . . . . 0.0 110.693 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.5 mt -139.88 133.07 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.91 150.67 20.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.493 -1.379 . . . . 0.0 110.072 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.79 156.72 47.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.857 1.663 . . . . 0.0 112.414 -165.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -94.09 141.22 28.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 58.51 128.92 0.02 OUTLIER Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 128.86 2.864 . . . . 0.0 116.259 -167.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.58 -27.45 38.96 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.274 1.983 . . . . 0.0 114.349 172.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -68.44 -29.8 68.54 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.313 -1.492 . . . . 0.0 112.309 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -62.81 -33.98 76.34 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.71 -54.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.456 0.571 . . . . 0.0 110.897 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.422 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.5 -18.1 62.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.6 -61.41 1.78 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.102 0.865 . . . . 0.0 110.752 166.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.31 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.288 -0.882 . . . . 0.0 111.914 -171.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 -5.33 50.67 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.81 1.244 . . . . 0.0 112.91 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 t -115.03 -31.98 5.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.538 1.063 . . . . 0.0 113.327 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 178.15 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.454 0.645 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.05 174.94 12.59 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.077 1.751 . . . . 0.0 111.842 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -148.62 119.48 7.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.966 0.506 . . . . 0.0 111.53 171.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.08 126.84 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.264 1.425 . . . . 0.0 109.158 166.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 124.358 1.063 . . . . 0.0 112.403 -168.073 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 CA--C 1.539 0.766 0 N-CA-C 112.363 0.101 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -128.12 147.8 50.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.133 1.373 . . . . 0.0 111.304 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.63 155.53 34.85 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.355 2.262 . . . . 0.0 107.865 -171.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -117.07 135.2 53.91 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.044 -1.035 . . . . 0.0 112.218 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -121.69 100.9 7.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.493 2.717 . . . . 0.0 108.173 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -101.82 134.87 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.024 -0.423 . . . . 0.0 110.988 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.24 136.23 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.079 1.352 . . . . 0.0 107.566 165.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.91 -151.24 0.27 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.034 0.826 . . . . 0.0 113.556 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -73.82 87.2 1.74 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.25 1.02 . . . . 0.0 111.097 -170.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.428 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 3.2 tm? -146.97 -52.91 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.839 2.056 . . . . 0.0 111.99 -169.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 93.7 Cg_endo -74.36 72.66 4.16 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.859 2.373 . . . . 0.0 110.805 169.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.04 -37.63 54.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.923 1.289 . . . . 0.0 111.514 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -73.53 162.3 29.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.084 1.354 . . . . 0.0 112.611 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -63.11 131.73 49.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.794 0.838 . . . . 0.0 110.508 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.56 152.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.918 1.687 . . . . 0.0 109.266 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -133.53 166.96 21.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.509 1.123 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -51.46 -43.11 62.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.763 1.225 . . . . 0.0 112.496 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.09 -30.89 71.05 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -73.74 -49.61 24.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.784 1.174 . . . . 0.0 111.981 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.19 -33.0 74.97 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.315 -0.865 . . . . 0.0 111.645 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -66.75 -47.9 70.78 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.986 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -70.44 -28.4 65.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.721 1.146 . . . . 0.0 112.82 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.02 -39.2 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.237 0.926 . . . . 0.0 112.949 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -90.26 -7.3 53.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 m -49.12 -44.37 72.28 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 120.778 1.626 . . . . 0.0 115.34 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.33 -14.71 18.25 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 CA-C-N 122.341 1.872 . . . . 0.0 113.808 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -87.06 -37.01 17.83 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.555 -1.341 . . . . 0.0 112.957 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.28 -178.44 36.15 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.646 1.818 . . . . 0.0 117.646 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -92.75 -14.46 27.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -160.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 61.18 154.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 127.67 2.388 . . . . 0.0 116.71 173.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -145.43 -59.7 0.34 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.415 1.486 . . . . 0.0 113.098 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -162.04 171.81 16.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.006 1.722 . . . . 0.0 110.377 -170.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.5 152.81 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.171 -1.58 . . . . 0.0 113.037 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -152.15 136.19 16.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.114 1.765 . . . . 0.0 107.922 161.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.75 135.55 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.942 1.297 . . . . 0.0 108.561 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -145.79 143.13 29.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.877 0.871 . . . . 0.0 111.277 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 44.44 -124.04 0.96 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 124.803 1.241 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.59 2.84 46.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.132 1.773 . . . . 0.0 115.22 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -134.44 158.44 43.88 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.17 136.25 11.49 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.153 0.883 . . . . 0.0 112.355 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -131.31 64.72 1.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 0.0 110.04 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.25 157.88 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.513 1.525 . . . . 0.0 109.867 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -118.58 132.33 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.122 1.369 . . . . 0.0 109.169 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -123.7 156.25 36.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.891 1.276 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -77.64 149.12 34.76 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 157.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m120 56.38 124.27 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 127.987 2.515 . . . . 0.0 116.669 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.8 -28.45 30.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.745 2.297 . . . . 0.0 113.332 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.11 -32.41 69.8 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.609 0.64 . . . . 0.0 112.095 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -30.55 36.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.43 -59.78 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.746 0.818 . . . . 0.0 110.563 165.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -36.61 82.43 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.513 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.716 1.144 . . . . 0.0 112.181 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -55.31 23.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.757 1.162 . . . . 0.0 112.583 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 mt -68.86 -49.83 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.567 0.621 . . . . 0.0 110.946 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -75.52 -30.99 59.97 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.957 0.799 . . . . 0.0 113.074 -168.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -80.44 -38.76 29.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.835 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 N--CA 1.476 0.843 0 CA-C-N 120.284 1.402 . . . . 0.0 113.467 -179.516 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 120.687 0.28 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 175.25 12.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.109 0.964 . . . . 0.0 113.222 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -145.22 123.36 12.16 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.178 161.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.5 129.21 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 109.61 166.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.327 172.564 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.482 0.841 0 CA-C-O 118.839 -0.567 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.78 137.32 58.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.364 0.529 . . . . 0.0 109.985 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -145.91 168.06 21.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.793 2.037 . . . . 0.0 109.331 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -147.2 124.62 11.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.942 1.247 . . . . 0.0 114.012 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tt -113.6 125.28 53.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.735 2.414 . . . . 0.0 110.156 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -118.77 142.05 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.258 0.623 . . . . 0.0 111.409 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.92 139.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.15 1.38 . . . . 0.0 108.788 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.46 143.24 14.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.461 0.553 . . . . 0.0 113.999 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 52.8 34.98 17.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.928 1.291 . . . . 0.0 112.972 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.542 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.7 tt -128.51 -51.56 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.664 2.385 . . . . 0.0 109.804 171.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 91.7 Cg_endo -78.75 88.94 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.449 2.1 . . . . 0.0 110.845 170.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.9 -12.7 17.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.416 1.886 . . . . 0.0 112.533 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -96.41 171.82 8.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.825 1.65 . . . . 0.0 111.684 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -68.47 139.66 55.71 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.34 138.15 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.183 1.793 . . . . 0.0 108.273 -175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -112.04 171.3 7.59 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.877 0.871 . . . . 0.0 111.992 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -55.07 -36.63 65.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.597 1.159 . . . . 0.0 112.772 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -69.28 -30.83 69.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.03 -56.95 7.05 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.996 0.817 . . . . 0.0 110.907 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.89 -35.02 79.28 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.905 -0.497 . . . . 0.0 111.623 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.75 -48.58 68.67 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.582 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -69.58 -35.3 75.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.632 1.56 . . . . 0.0 112.72 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.02 -31.72 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.13 -13.13 28.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.23 -47.56 66.59 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.509 1.504 . . . . 0.0 114.934 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -0.5 9.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 CA-C-N 121.673 1.633 . . . . 0.0 113.83 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -115.25 -20.09 10.5 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.125 1.77 . . . . 0.0 114.287 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.44 163.32 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -83.84 -21.04 32.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -161.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 64.27 154.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 126.582 1.953 . . . . 0.0 115.756 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.8 mmt -134.62 -65.7 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.73 -1.231 . . . . 0.0 113.179 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.38 160.51 41.71 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.489 1.116 . . . . 0.0 111.137 -165.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.11 153.01 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -149.41 136.95 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.9 2.08 . . . . 0.0 107.392 158.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt -140.49 121.75 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 108.291 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -149.29 153.41 37.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.972 1.309 . . . . 0.0 111.258 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 55.84 -140.19 0.91 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.996 0.918 . . . . 0.0 111.332 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 21.81 2.34 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.288 1.435 . . . . 0.0 113.418 170.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -131.02 169.95 15.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.127 1.371 . . . . 0.0 112.468 -163.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.39 140.73 10.5 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.445 1.497 . . . . 0.0 111.64 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -130.76 67.07 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.024 2.13 . . . . 0.0 109.834 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.5 120.91 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 120.834 -1.166 . . . . 0.0 110.058 -165.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -83.78 135.98 34.33 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.557 -0.714 . . . . 0.0 109.561 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -122.23 164.77 17.26 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.642 1.577 . . . . 0.0 112.106 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -98.14 139.51 33.82 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 156.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 67.47 145.17 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 128.439 2.696 . . . . 0.0 116.647 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.55 -43.44 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.353 2.702 . . . . 0.0 112.265 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -62.07 -30.1 70.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.907 0.883 . . . . 0.0 111.854 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -73.93 -19.92 60.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 114.923 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.28 -51.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.068 0.849 . . . . 0.0 110.266 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -43.37 98.98 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.559 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.36 -24.47 63.9 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.316 1.417 . . . . 0.0 112.961 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.45 -66.79 0.52 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.294 0.952 . . . . 0.0 111.44 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.19 -23.94 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.165 -1.584 . . . . 0.0 114.769 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -91.85 -0.19 57.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.665 1.575 . . . . 0.0 113.373 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 t -133.8 -29.43 1.32 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.127 1.331 . . . . 0.0 114.009 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 . . . . . 0 N--CA 1.471 0.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.64 169.483 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.77 165.82 24.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.915 0.886 . . . . 0.0 112.857 171.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -152.33 135.08 15.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.278 1.031 . . . . 0.0 110.769 170.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.44 133.29 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.075 1.35 . . . . 0.0 110.365 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 124.408 1.083 . . . . 0.0 111.524 -175.385 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 N--CA 1.482 0.847 0 CA-C-O 119.207 -0.414 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.0 153.59 43.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 112.885 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.71 163.77 36.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 108.152 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -136.84 126.4 25.26 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.152 1.342 . . . . 0.0 113.68 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.76 130.26 39.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.541 2.736 . . . . 0.0 108.501 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.65 134.9 49.63 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.288 0.635 . . . . 0.0 110.439 164.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.31 135.3 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.769 1.228 . . . . 0.0 108.347 169.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.88 -156.63 2.06 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.151 0.881 . . . . 0.0 112.315 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -63.92 90.46 0.06 Allowed 'General case' 0 CA--C 1.551 0.986 0 O-C-N 121.429 -1.042 . . . . 0.0 112.617 -173.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 66.0 tp -153.24 -48.69 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.23 1.812 . . . . 0.0 113.872 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 67.7 Cg_endo -77.07 56.7 5.52 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.362 2.708 . . . . 0.0 112.444 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.92 -4.06 35.82 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.275 1.43 . . . . 0.0 112.78 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -85.23 170.63 12.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.678 1.991 . . . . 0.0 111.602 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -69.48 129.09 38.75 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.654 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.03 127.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.729 0.776 . . . . 0.0 112.723 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -127.22 -179.92 5.12 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.597 1.559 . . . . 0.0 110.548 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -45.78 -48.93 15.48 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.541 1.936 . . . . 0.0 112.912 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -66.31 -36.3 82.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.44 0.564 . . . . 0.0 112.377 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.32 -56.6 7.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.6 -29.54 70.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.903 -0.498 . . . . 0.0 112.056 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.86 -52.08 27.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.06 -0.972 . . . . 0.0 111.586 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -64.29 -38.59 91.59 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.59 1.541 . . . . 0.0 111.799 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -74.67 -26.75 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.03 -11.31 20.69 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 m -45.4 -47.89 35.19 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.82 -7.47 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.255 1.841 . . . . 0.0 113.872 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -109.36 -41.15 4.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.939 1.295 . . . . 0.0 112.771 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.23 168.58 27.71 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -170.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -92.3 -15.54 27.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -163.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 0.2 OUTLIER 60.06 155.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 127.905 2.482 . . . . 0.0 115.704 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.5 mmt -137.86 -65.02 0.53 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.831 1.653 . . . . 0.0 112.077 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -158.64 165.51 34.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.004 1.322 . . . . 0.0 111.969 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 pt -128.74 147.51 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -165.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.33 92.03 1.3 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.382 1.473 . . . . 0.0 111.933 162.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.79 136.98 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.88 -1.137 . . . . 0.0 110.244 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -157.76 146.8 19.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.486 1.915 . . . . 0.0 109.052 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.09 -160.06 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.099 0.96 . . . . 0.0 111.786 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.17 -9.89 57.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.655 1.582 . . . . 0.0 114.456 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -111.95 -178.18 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.206 2.203 . . . . 0.0 111.029 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.66 146.43 10.63 Favored Glycine 0 N--CA 1.466 0.638 0 O-C-N 120.264 -1.523 . . . . 0.0 114.899 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.45 133.5 51.03 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 109.255 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.4 mt -138.0 119.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -73.1 137.0 44.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -121.91 163.91 18.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.309 1.843 . . . . 0.0 109.985 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.29 136.53 32.94 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 160.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.332 6.5 p30 54.24 139.22 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 130.158 3.383 . . . . 0.0 118.368 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.04 -27.63 13.8 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.368 2.712 . . . . 0.0 113.988 -170.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -65.67 -35.6 81.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.65 -0.656 . . . . 0.0 110.911 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -37.1 82.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.966 1.706 . . . . 0.0 112.182 172.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.25 -59.9 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.8 0.727 . . . . 0.0 111.245 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -36.2 79.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.612 -169.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.49 -37.68 88.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.47 80.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 111.8 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.7 mt -71.01 -51.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.348 -0.845 . . . . 0.0 111.023 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -66.18 -33.9 76.81 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.437 -0.79 . . . . 0.0 111.22 -171.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t -102.0 -15.19 16.87 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 120.823 1.647 . . . . 0.0 113.986 176.324 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.2 mt . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.57 172.53 18.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.116 0.966 . . . . 0.0 113.599 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -147.51 122.72 10.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 112.249 163.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.58 145.67 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.236 0.36 0 C-N-CA 123.914 0.885 . . . . 0.0 112.477 171.886 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 111.624 -0.183 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.64 148.52 34.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 122.24 1.019 . . . . 0.0 113.308 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -159.88 164.27 33.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 109.428 -172.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -143.17 127.14 17.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.849 1.66 . . . . 0.0 111.941 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.515 HD13 ' CE1' ' A' ' 44' ' ' PHE . 7.5 tt -117.98 120.7 38.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.421 2.688 . . . . 0.0 109.737 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.86 124.3 52.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.191 0.597 . . . . 0.0 110.856 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 mm -81.94 141.12 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.913 0.885 . . . . 0.0 108.777 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.26 -163.56 1.42 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.643 0.64 . . . . 0.0 113.076 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -74.38 41.02 0.14 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.0 mt -97.18 -46.72 0.24 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.365 1.866 . . . . 0.0 114.146 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.68 73.44 5.81 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.426 2.75 . . . . 0.0 111.748 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.56 -13.97 59.57 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.514 165.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -83.49 150.12 26.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.151 1.78 . . . . 0.0 112.107 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -59.0 152.09 20.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.804 0.842 . . . . 0.0 111.587 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.44 160.46 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.173 0.989 . . . . 0.0 111.65 -171.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -125.18 167.75 14.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.758 1.223 . . . . 0.0 112.574 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -52.67 -33.15 45.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.434 0.694 . . . . 0.0 112.704 166.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.68 -35.52 74.64 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -78.39 -51.12 10.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.63 -36.53 81.04 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.919 -0.488 . . . . 0.0 111.303 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -71.5 -42.57 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.286 -0.884 . . . . 0.0 111.75 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -64.27 -44.78 90.66 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.214 1.37 . . . . 0.0 111.592 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -78.14 -30.46 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 117.875 -1.059 . . . . 0.0 113.175 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -93.12 -14.32 27.38 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.1 m -45.68 -48.67 37.98 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-N 120.738 1.608 . . . . 0.0 115.305 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.5 -3.35 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.963 1.379 . . . . 0.0 114.068 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.71 -26.64 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.206 1.402 . . . . 0.0 113.119 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.31 176.3 39.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 122.553 1.085 . . . . 0.0 115.506 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -96.75 -17.95 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -166.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 44' ' ' PHE 0.309 0.1 OUTLIER 58.66 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 127.458 2.303 . . . . 0.0 115.634 175.686 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.7 mmt -139.94 -63.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.703 1.601 . . . . 0.0 112.069 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -153.22 169.59 22.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.368 1.467 . . . . 0.0 111.224 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.3 149.94 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 120.877 -1.139 . . . . 0.0 112.686 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -156.35 131.26 9.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.861 1.264 . . . . 0.0 108.73 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.7 mt -143.05 120.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.03 159.92 43.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.163 1.785 . . . . 0.0 110.319 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 52.36 -137.7 1.19 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.765 1.226 . . . . 0.0 112.598 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.77 12.08 22.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.839 1.655 . . . . 0.0 113.457 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.75 -172.59 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -162.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.43 135.65 5.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.311 0.958 . . . . 0.0 112.147 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.58 64.92 0.76 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.993 2.117 . . . . 0.0 109.93 -169.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.98 144.82 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.44 1.096 . . . . 0.0 110.078 -167.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -109.22 143.19 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.82 -1.175 . . . . 0.0 110.513 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 5' ' ' LEU . 11.4 m-85 -134.52 165.77 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.967 1.307 . . . . 0.0 112.586 -169.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -100.8 136.46 40.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.403 1.081 . . . . 0.0 109.186 164.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER 59.19 153.19 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 129.189 2.996 . . . . 0.0 116.487 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.75 -29.83 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.231 2.621 . . . . 0.0 113.893 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -66.84 -41.3 87.62 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.854 . . . . 0.0 110.548 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.29 -40.58 35.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.978 2.511 . . . . 0.0 113.595 167.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.56 -58.86 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.332 0.515 . . . . 0.0 111.467 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.81 91.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.011 -172.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.0 -39.37 87.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.615 1.098 . . . . 0.0 112.758 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.57 93.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.475 0.71 . . . . 0.0 111.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.46 -53.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.155 -0.966 . . . . 0.0 111.467 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -62.33 -25.81 68.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.49 1.116 . . . . 0.0 113.015 -169.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.4 t -105.71 -28.22 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.483 1.212 0 CA-C-N 120.81 1.641 . . . . 0.0 114.791 -172.873 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 mm . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.05 177.53 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.539 1.936 . . . . 0.0 110.939 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.03 145.34 32.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.597 0.759 . . . . 0.0 111.943 157.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 p -123.78 127.15 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.086 1.754 . . . . 0.0 109.722 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 124.501 1.121 . . . . 0.0 110.693 173.611 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -98.88 66.42 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.493 1.917 . . . . 0.0 110.222 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.08 157.29 38.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.544 1.138 . . . . 0.0 111.683 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -132.97 134.36 44.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.292 1.037 . . . . 0.0 112.895 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 tt -126.83 111.05 13.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.143 2.177 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -107.73 125.45 51.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.99 0.916 . . . . 0.0 110.136 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mt -114.97 138.78 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.022 0.929 . . . . 0.0 109.491 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.36 -146.38 0.32 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.878 1.228 . . . . 0.0 113.297 166.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -75.1 72.28 2.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.923 1.289 . . . . 0.0 112.48 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.434 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 64.0 tp -131.03 -53.16 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 116.893 -1.527 . . . . 0.0 114.65 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 45.7 Cg_endo -79.99 53.14 4.61 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.151 2.567 . . . . 0.0 111.923 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.24 -22.73 51.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.379 1.472 . . . . 0.0 111.972 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.15 165.92 15.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.989 1.715 . . . . 0.0 111.848 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -57.37 131.18 49.31 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.546 0.739 . . . . 0.0 111.253 165.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -144.27 129.18 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.517 1.127 . . . . 0.0 110.301 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.5 p -99.71 170.45 8.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.667 1.187 . . . . 0.0 111.779 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.67 -34.19 64.79 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.295 -0.878 . . . . 0.0 112.627 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.29 -32.47 66.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.47 -36.59 68.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 112.906 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.64 -32.83 58.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.841 0.456 . . . . 0.0 112.128 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -61.8 -46.2 90.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.558 0.743 . . . . 0.0 111.452 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -66.22 -46.01 78.67 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.148 0.885 . . . . 0.0 112.028 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.93 -26.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.416 1.007 . . . . 0.0 113.695 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -99.63 -0.5 40.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -46.49 -53.46 24.13 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.7 -7.76 11.43 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.668 1.579 . . . . 0.0 114.225 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -83.75 -23.57 31.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.133 1.373 . . . . 0.0 112.207 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.62 -173.59 44.86 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -106.32 -10.98 16.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -157.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 62.04 154.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 127.848 2.459 . . . . 0.0 116.504 170.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.446 ' H ' HD13 ' A' ' 30' ' ' ILE . 8.0 mmt -143.99 -64.78 0.37 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.474 1.509 . . . . 0.0 113.127 169.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -160.65 176.11 11.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.066 1.346 . . . . 0.0 111.994 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.37 157.4 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.553 1.07 . . . . 0.0 112.724 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -156.74 103.96 2.12 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.873 1.269 . . . . 0.0 110.792 166.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -118.21 116.75 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.581 -1.324 . . . . 0.0 110.518 -173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -148.74 149.5 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.385 1.874 . . . . 0.0 111.021 -168.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 t30 58.44 -163.03 0.21 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.149 1.38 . . . . 0.0 112.786 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.02 29.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 O-C-N 119.695 -1.878 . . . . 0.0 114.021 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -144.25 179.22 7.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.321 2.249 . . . . 0.0 109.872 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.8 144.91 9.27 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 121.191 -0.943 . . . . 0.0 112.597 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -131.5 144.85 51.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -138.42 152.82 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.5 141.89 48.12 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.365 1.066 . . . . 0.0 108.953 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -132.41 155.95 47.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.526 1.131 . . . . 0.0 111.287 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -84.17 135.33 34.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 158.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 60.94 139.41 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 128.477 2.711 . . . . 0.0 116.703 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.79 -25.02 24.31 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.307 2.672 . . . . 0.0 112.444 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.07 -34.54 76.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.213 1.005 . . . . 0.0 111.209 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -64.57 -43.56 93.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.418 1.087 . . . . 0.0 112.345 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.14 -49.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 123.554 0.741 . . . . 0.0 110.569 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -61.93 -53.52 54.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.851 0.751 . . . . 0.0 111.322 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -70.99 -24.01 62.3 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.19 5.65 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.319 0.963 . . . . 0.0 111.131 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -75.87 -43.28 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.572 -0.705 . . . . 0.0 111.438 -172.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 -17.41 63.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.972 1.309 . . . . 0.0 112.728 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 t -105.17 4.24 31.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.525 1.13 . . . . 0.0 112.701 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 . . . . . 0 N--CA 1.471 0.583 0 C-N-CA 124.171 0.988 . . . . 0.0 112.46 -175.999 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.8 35.54 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 112.943 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.59 130.97 25.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 166.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.57 125.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.795 1.638 . . . . 0.0 108.649 165.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 123.954 0.902 . . . . 0.0 111.973 -177.686 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 CA--C 1.545 1.043 0 N-CA-C 114.11 0.773 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -130.98 49.91 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.692 1.997 . . . . 0.0 112.119 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -59.42 161.18 5.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.689 1.595 . . . . 0.0 111.786 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -125.14 125.48 43.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.361 1.065 . . . . 0.0 111.449 -165.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -119.8 123.27 43.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.271 1.828 . . . . 0.0 108.949 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -117.13 146.42 43.18 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.591 1.157 . . . . 0.0 110.929 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.38 139.45 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.814 1.646 . . . . 0.0 110.165 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.98 149.05 18.38 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.746 1.165 . . . . 0.0 113.78 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.05 36.37 27.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.6 tt -134.93 -56.22 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.791 1.636 . . . . 0.0 112.179 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 72.0 Cg_endo -74.47 99.42 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.27 1.98 . . . . 0.0 111.593 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.37 23.37 3.46 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.986 2.515 . . . . 0.0 111.313 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -137.74 161.64 36.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.806 2.442 . . . . 0.0 108.9 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -56.43 131.92 49.77 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.03 0.832 . . . . 0.0 109.957 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.59 135.05 12.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.291 1.436 . . . . 0.0 109.269 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 167.2 11.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.448 1.499 . . . . 0.0 110.082 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -54.22 -32.0 54.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -65.81 -31.94 73.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.088 1.355 . . . . 0.0 113.93 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.45 -50.8 13.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.816 0.846 . . . . 0.0 110.81 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.43 -30.17 70.47 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.434 -0.791 . . . . 0.0 111.897 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -69.87 -45.29 68.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.871 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -64.66 -39.22 93.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.902 1.228 . . . . 0.0 112.234 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -76.49 -38.39 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.425 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -89.52 -4.39 57.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -48.13 -49.56 59.92 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.41 -19.83 16.65 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 121.84 1.693 . . . . 0.0 113.713 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -77.22 -31.19 55.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.656 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.9 -175.36 46.67 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -18.07 25.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -159.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 62.04 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.343 2.257 . . . . 0.0 115.474 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.427 ' H ' HD13 ' A' ' 30' ' ' ILE . 6.2 mmt -139.35 -72.46 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.529 1.531 . . . . 0.0 112.258 166.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -142.84 171.53 13.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.37 1.868 . . . . 0.0 112.217 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 pt -131.88 150.87 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.579 1.151 . . . . 0.0 113.459 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -151.84 96.46 2.23 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.01 1.724 . . . . 0.0 109.889 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.14 130.99 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.388 -1.445 . . . . 0.0 111.961 -171.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -163.79 141.02 7.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.184 1.394 . . . . 0.0 112.724 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 41.11 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.897 2.479 . . . . 0.0 114.995 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.78 -7.83 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.926 2.49 . . . . 0.0 117.494 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.31 164.88 21.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.838 1.655 . . . . 0.0 110.806 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.74 152.68 24.25 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.79 0.709 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.24 140.73 45.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.506 1.123 . . . . 0.0 109.667 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -134.76 117.57 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -75.97 140.29 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.35 153.94 44.22 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.758 1.623 . . . . 0.0 110.966 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.33 145.74 28.89 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 152.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 58.88 135.66 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.012 2.925 . . . . 0.0 116.883 -171.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.13 -31.93 11.44 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.259 1.973 . . . . 0.0 112.808 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.55 -29.31 69.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.719 0.69 . . . . 0.0 111.406 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 m -66.24 -46.76 76.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.796 1.238 . . . . 0.0 113.379 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.94 -51.69 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.78 0.832 . . . . 0.0 111.526 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -47.03 63.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.913 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.56 -13.81 61.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.647 1.112 . . . . 0.0 113.639 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.55 -77.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.405 1.482 . . . . 0.0 112.196 164.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.95 -32.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 O-C-N 120.444 -1.41 . . . . 0.0 114.39 -171.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.58 -12.18 60.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.644 1.111 . . . . 0.0 113.032 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -105.65 -25.03 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.504 1.521 . . . . 0.0 112.653 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.792 1.237 . . . . 0.0 113.55 -174.428 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.71 162.71 34.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -171.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -143.68 128.71 18.57 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.673 -0.642 . . . . 0.0 112.298 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.61 126.67 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.076 2.15 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 174.074 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.989 -0.427 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -60.35 134.61 57.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.251 1.02 . . . . 0.0 112.137 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -145.79 166.07 26.99 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.187 2.195 . . . . 0.0 110.56 -164.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.7 ttp-105 -148.32 130.32 15.33 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.878 -1.139 . . . . 0.0 113.23 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.72 111.55 23.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.22 2.608 . . . . 0.0 109.123 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -109.98 133.57 53.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.816 1.246 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 mt -131.14 141.98 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.553 1.141 . . . . 0.0 110.541 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.07 -137.98 0.3 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.467 1.508 . . . . 0.0 113.626 164.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -78.7 78.82 5.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 0.0 111.667 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 58.4 tp -139.48 -55.34 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.377 165.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 60.6 Cg_endo -75.15 23.56 0.41 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.839 2.359 . . . . 0.0 114.184 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 tt -67.24 -41.83 85.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.722 1.209 . . . . 0.0 113.232 -163.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -144.3 -23.29 0.54 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.45 18.8 13.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.111 1.364 . . . . 0.0 113.614 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.45 125.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 111.067 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 m -111.79 175.85 5.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.043 1.337 . . . . 0.0 110.295 164.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -56.22 -37.82 70.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.91 -28.32 68.85 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.06 -52.14 7.72 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 111.798 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.49 -36.55 78.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.613 0.642 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.04 -48.38 63.02 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.264 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -65.14 -35.51 81.34 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.493 1.497 . . . . 0.0 112.617 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.82 -33.36 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -88.61 -18.33 28.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.048 1.294 . . . . 0.0 114.33 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -43.47 -47.23 17.89 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.63 -13.21 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 CA-C-N 121.948 1.731 . . . . 0.0 113.849 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -105.73 -25.65 12.13 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.766 1.226 . . . . 0.0 113.111 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . -149.71 159.0 27.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 118.511 2.165 . . . . 0.0 118.511 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -88.38 -22.12 23.95 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.754 1.622 . . . . 0.0 114.407 -165.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 62.9 156.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.641 2.776 . . . . 0.0 116.768 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.1 mmt -130.97 -71.15 0.58 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.939 1.696 . . . . 0.0 111.325 164.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.19 162.92 39.53 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.446 1.498 . . . . 0.0 111.609 -166.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.66 145.54 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 120.971 -1.081 . . . . 0.0 113.092 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -147.01 137.92 23.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.196 1.398 . . . . 0.0 109.007 159.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.9 mt -139.34 122.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.911 1.284 . . . . 0.0 108.207 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -158.38 155.09 28.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.797 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 58.29 -151.78 0.41 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 111.479 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.44 25.07 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 113.67 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -143.51 170.22 16.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.373 1.469 . . . . 0.0 112.266 -163.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.91 140.99 12.28 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.032 1.301 . . . . 0.0 112.007 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -131.25 72.27 1.5 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.046 1.338 . . . . 0.0 110.539 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.27 129.78 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 120.686 -1.259 . . . . 0.0 110.094 -167.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.98 137.17 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.612 1.165 . . . . 0.0 109.704 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -133.02 169.87 16.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.896 1.278 . . . . 0.0 112.51 -171.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -112.28 146.02 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.42 1.088 . . . . 0.0 109.139 162.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 60.86 122.56 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 127.586 2.354 . . . . 0.0 115.156 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.13 -34.46 16.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.775 2.316 . . . . 0.0 112.815 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -58.91 -24.94 62.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.817 0.847 . . . . 0.0 112.546 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -82.53 -38.65 23.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 111.949 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.53 -55.25 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.99 0.916 . . . . 0.0 111.62 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.75 99.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.82 -40.0 95.57 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.006 1.275 . . . . 0.0 112.237 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.35 85.06 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.719 0.69 . . . . 0.0 112.026 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.0 mt -71.46 -52.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.41 -19.43 61.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.266 -0.896 . . . . 0.0 113.08 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.6 t -115.27 -8.82 12.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.083 1.353 . . . . 0.0 114.311 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 176.038 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.7 mm . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 166.49 32.63 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.045 0.938 . . . . 0.0 113.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -148.44 133.89 18.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.39 0.676 . . . . 0.0 111.865 163.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.59 133.21 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.152 1.381 . . . . 0.0 109.941 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.91 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 CA--C 1.54 0.813 0 N-CA-C 112.937 0.322 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -124.41 133.55 53.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.951 1.7 . . . . 0.0 111.863 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.37 172.86 12.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.8 2.04 . . . . 0.0 109.817 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -144.74 137.75 26.71 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.811 -1.181 . . . . 0.0 111.048 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 5' ' ' LEU . 6.1 tt -136.15 126.32 26.31 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.5 1.92 . . . . 0.0 109.684 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -117.33 143.86 45.5 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.439 1.096 . . . . 0.0 111.817 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.63 113.92 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.579 1.152 . . . . 0.0 109.083 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.78 50.8 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.009 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -150.25 79.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.282 1.041 . . . . 0.0 111.639 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.562 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 1.2 tt -153.0 -48.04 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.669 1.187 . . . . 0.0 112.168 169.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 52.3 Cg_endo -82.35 43.91 1.59 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 113.572 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.84 -23.22 67.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.083 1.353 . . . . 0.0 112.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -72.49 0.24 10.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.29 1.836 . . . . 0.0 113.637 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 51.71 56.72 7.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.018 1.327 . . . . 0.0 112.176 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.07 141.47 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.983 1.313 . . . . 0.0 111.736 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -79.13 174.35 11.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.98 -46.54 61.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.559 1.544 . . . . 0.0 112.45 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -74.57 -24.14 58.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.781 0.832 . . . . 0.0 112.846 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.82 -39.88 29.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.698 1.136 . . . . 0.0 112.251 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.85 -34.75 69.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.801 -0.562 . . . . 0.0 111.083 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -74.69 -37.43 62.64 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.686 -1.259 . . . . 0.0 113.088 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -66.08 -26.67 67.59 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.087 1.767 . . . . 0.0 113.166 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.04 -37.65 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.081 0.952 . . . . 0.0 112.026 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -86.96 -14.88 40.48 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.529 1.513 . . . . 0.0 114.964 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 m -47.59 -50.41 50.8 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.93 6.14 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.945 1.764 . . . . 0.0 114.916 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.4 -22.06 5.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.917 1.287 . . . . 0.0 114.1 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.49 -169.13 21.62 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 119.265 0.939 . . . . 0.0 114.997 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -112.12 -17.22 12.87 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 59.39 156.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 127.277 2.231 . . . . 0.0 116.878 171.441 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.51 ' H ' HD13 ' A' ' 30' ' ' ILE . 9.3 mmt -138.53 -67.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.417 1.487 . . . . 0.0 112.66 167.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -155.37 172.59 17.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.391 1.476 . . . . 0.0 111.978 -163.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.35 160.42 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.555 -1.34 . . . . 0.0 112.983 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -158.04 114.78 2.87 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.108 1.363 . . . . 0.0 109.959 157.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -128.18 115.54 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.588 -1.32 . . . . 0.0 108.871 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -154.5 160.48 41.58 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.633 1.573 . . . . 0.0 110.927 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 50.33 -147.54 0.36 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.745 1.218 . . . . 0.0 110.912 -174.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.92 7.9 11.8 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 120.046 -1.659 . . . . 0.0 114.99 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.02 -175.02 3.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.882 1.273 . . . . 0.0 112.764 -171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.41 147.13 18.04 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.006 0.812 . . . . 0.0 112.543 166.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -132.9 144.12 49.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.287 1.435 . . . . 0.0 110.356 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 mt -142.68 124.18 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.406 1.082 . . . . 0.0 108.158 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -85.28 139.13 31.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.349 1.071 . . . . 0.0 108.692 168.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.12 169.48 12.15 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.828 -168.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -104.09 144.16 31.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 155.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.52 127.61 0.01 OUTLIER Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 129.115 2.966 . . . . 0.0 117.807 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -29.8 10.12 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.731 2.287 . . . . 0.0 114.82 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -65.52 -35.95 82.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.087 1.312 . . . . 0.0 110.84 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -40.52 89.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.564 1.946 . . . . 0.0 112.728 168.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.36 -51.68 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.387 0.994 . . . . 0.0 112.195 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -24.76 63.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -75.57 -39.03 58.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.436 -0.79 . . . . 0.0 111.706 169.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.0 -62.93 1.37 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.61 0.764 . . . . 0.0 111.996 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.266 1.1 pp -73.1 -44.65 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.91 1.232 . . . . 0.0 114.054 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.15 -30.75 69.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.369 1.895 . . . . 0.0 112.752 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -104.91 -29.14 10.68 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 . . . . . 0 N--CA 1.476 0.835 0 CA-C-N 120.169 1.35 . . . . 0.0 110.904 168.546 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.899 0.856 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.85 166.56 14.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 109.826 165.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -133.71 120.66 20.88 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.189 0.45 . . . . 0.0 111.377 163.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.05 135.22 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.381 1.072 . . . . 0.0 109.82 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 122.172 0.987 . . . . 0.0 112.797 178.553 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -92.96 142.99 26.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.144 0.883 . . . . 0.0 112.864 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.77 167.6 29.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.703 2.001 . . . . 0.0 110.984 -173.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -138.71 130.99 28.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.206 1.402 . . . . 0.0 111.419 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.73 135.01 51.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.343 2.657 . . . . 0.0 109.167 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -132.16 132.85 43.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.969 0.908 . . . . 0.0 111.025 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.61 112.35 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.235 1.014 . . . . 0.0 110.266 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 68' ' ' ILE . . . -91.18 0.36 75.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.886 172.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -64.72 5.98 0.26 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.895 1.678 . . . . 0.0 114.545 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 mt 51.44 54.94 15.5 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.819 2.048 . . . . 0.0 114.641 -172.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -60.72 115.66 2.83 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.876 1.717 . . . . 0.0 110.401 165.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.1 mt -136.44 -7.69 1.97 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.551 1.54 . . . . 0.0 113.879 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -88.1 164.48 15.7 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.658 1.183 . . . . 0.0 111.031 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -59.16 128.65 38.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.22 1.008 . . . . 0.0 112.294 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 m -150.38 151.3 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.647 1.979 . . . . 0.0 109.642 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 t -117.21 168.98 9.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.894 0.854 . . . . 0.0 112.576 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -53.91 -29.08 40.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.451 1.5 . . . . 0.0 114.268 173.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -75.37 -29.26 59.83 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.136 0.88 . . . . 0.0 113.344 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.37 -59.58 3.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.715 1.143 . . . . 0.0 110.996 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.96 -32.89 71.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.779 0.832 . . . . 0.0 111.885 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.36 -44.42 65.05 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.904 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -66.65 -40.91 88.87 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.989 1.722 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.06 -17.76 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -107.81 -8.32 16.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -47.38 -49.51 53.33 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-N 120.911 1.687 . . . . 0.0 114.692 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.1 -8.31 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.041 1.827 . . . . 0.0 114.066 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -97.62 -33.01 11.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.793 1.237 . . . . 0.0 112.765 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.56 -179.71 39.98 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 116.626 1.41 . . . . 0.0 116.626 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -93.27 -18.79 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.2 152.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 127.057 2.143 . . . . 0.0 116.174 174.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.2 mmt -134.05 -68.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.368 1.467 . . . . 0.0 112.202 166.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -151.54 170.58 19.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 111.049 -166.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.34 137.49 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.514 -1.366 . . . . 0.0 111.373 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -140.56 71.36 1.37 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.426 1.49 . . . . 0.0 110.986 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.43 107.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.445 -1.409 . . . . 0.0 108.675 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.2 138.2 50.46 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.738 2.015 . . . . 0.0 109.687 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 53.05 -149.57 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.85 1.26 . . . . 0.0 112.628 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.95 -36.08 28.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.254 0.934 . . . . 0.0 112.046 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -83.01 64.28 7.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.557 1.143 . . . . 0.0 111.559 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 144.98 47.61 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.345 0.497 . . . . 0.0 112.301 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -133.9 155.62 49.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.959 1.361 . . . . 0.0 112.426 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.28 126.71 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.374 1.47 . . . . 0.0 107.452 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -77.37 137.62 38.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.56 0.744 . . . . 0.0 109.457 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.58 164.84 24.03 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.823 0.849 . . . . 0.0 112.684 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -102.63 145.48 29.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.587 1.155 . . . . 0.0 109.131 162.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 53.32 124.21 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 128.905 2.882 . . . . 0.0 116.321 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.91 -29.81 17.85 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.217 . . . . 0.0 112.782 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.98 -30.65 71.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.607 0.763 . . . . 0.0 111.651 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -33.94 38.03 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.751 1.621 . . . . 0.0 112.403 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.35 -58.33 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.23 0.468 . . . . 0.0 110.332 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.278 6.6 ppt_? -64.44 -44.85 89.84 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.336 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -62.69 -29.2 70.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.085 1.766 . . . . 0.0 114.072 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.5 -60.92 2.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.361 0.982 . . . . 0.0 112.055 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.91 -17.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.08 -22.88 36.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.728 1.604 . . . . 0.0 112.953 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.8 t -96.7 -21.24 17.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.649 0.78 . . . . 0.0 112.506 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 120.042 1.292 . . . . 0.0 112.125 172.695 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.408 HG23 ' HA3' ' A' ' 8' ' ' GLY . 8.0 tp . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' H ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.79 161.47 26.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.914 1.286 . . . . 0.0 112.322 175.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.29 143.01 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.885 161.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.48 137.46 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.075 2.15 . . . . 0.0 108.404 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.466 0.35 0 C-N-CA 124.597 1.159 . . . . 0.0 109.229 175.538 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 CA--C 1.539 0.768 0 CA-C-O 119.972 -0.095 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -136.06 145.15 45.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.429 1.492 . . . . 0.0 110.386 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.16 167.6 19.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.082 0.953 . . . . 0.0 111.891 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -150.82 125.63 9.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.149 -0.969 . . . . 0.0 112.59 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 6' ' ' PHE . 5.9 tt -106.56 142.71 35.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.572 2.749 . . . . 0.0 109.551 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.525 ' N ' HD23 ' A' ' 5' ' ' LEU . 26.5 t80 -136.51 144.05 44.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 167.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.97 119.87 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.923 1.289 . . . . 0.0 109.378 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.81 -8.78 66.95 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.309 0.884 . . . . 0.0 115.309 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -163.46 91.54 0.69 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.236 1.518 . . . . 0.0 111.029 167.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.555 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 29.1 tp -156.51 -48.08 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.16 -1.4 . . . . 0.0 112.82 165.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 54.5 Cg_endo -83.35 66.7 7.59 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.523 2.148 . . . . 0.0 112.225 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.6 mt -84.06 -6.04 59.34 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 0.0 113.805 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.64 11.58 19.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.632 1.573 . . . . 0.0 112.501 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 58.89 138.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.171 2.589 . . . . 0.0 113.694 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.94 136.07 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.33 1.052 . . . . 0.0 109.627 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -89.01 157.05 18.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.625 0.77 . . . . 0.0 112.35 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -47.59 -48.46 28.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.001 1.72 . . . . 0.0 112.891 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -70.11 -26.41 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.1 -44.78 16.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.612 1.165 . . . . 0.0 112.539 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.64 -34.55 77.18 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.553 -0.717 . . . . 0.0 110.988 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -63.97 -48.65 75.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.074 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -65.07 -42.86 93.79 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.452 1.478 . . . . 0.0 112.657 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -26.98 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.726 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -96.28 -5.4 40.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -48.52 -42.92 58.9 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.46 -16.64 4.68 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.124 1.883 . . . . 0.0 113.346 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -79.29 -24.2 43.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.448 1.099 . . . . 0.0 112.23 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.75 41.36 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.61 -17.15 22.59 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -163.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.56 154.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 127.098 2.159 . . . . 0.0 116.759 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -139.38 -65.81 0.47 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.022 1.329 . . . . 0.0 113.22 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -159.99 174.95 13.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.381 1.072 . . . . 0.0 112.086 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.09 155.01 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.469 -1.394 . . . . 0.0 114.559 -171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.63 120.12 5.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.998 1.319 . . . . 0.0 110.779 162.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.6 mt -132.15 126.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 120.991 -1.068 . . . . 0.0 112.205 -168.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -156.2 147.65 22.62 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.422 1.489 . . . . 0.0 112.058 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 53.55 -152.21 0.31 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.535 1.534 . . . . 0.0 112.561 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.09 -4.21 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.037 1.335 . . . . 0.0 114.245 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.67 -175.61 2.76 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 110.681 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.29 149.66 15.33 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.365 -0.834 . . . . 0.0 113.017 165.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.87 135.87 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.364 1.465 . . . . 0.0 109.971 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.25 114.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -73.71 139.22 45.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.799 0.809 . . . . 0.0 108.844 170.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.52 157.48 42.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.097 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.25 146.17 23.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 60.89 138.09 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 129.156 2.983 . . . . 0.0 117.033 -172.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.57 -35.53 2.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.03 2.486 . . . . 0.0 112.754 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.48 -34.22 75.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.549 0.613 . . . . 0.0 111.269 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -64.14 -43.81 94.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.068 1.347 . . . . 0.0 112.751 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.6 -52.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.745 0.702 . . . . 0.0 111.344 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -40.44 79.59 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.779 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.48 -28.2 66.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.194 1.361 . . . . 0.0 112.655 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.94 -63.6 1.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.892 0.769 . . . . 0.0 111.814 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 pp -78.77 -27.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.89 -26.92 67.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.192 1.36 . . . . 0.0 112.182 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.27 -15.35 16.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.629 1.171 . . . . 0.0 113.624 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 . . . . . 0 N--CA 1.477 0.925 0 O-C-N 120.67 -1.269 . . . . 0.0 113.938 178.159 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.28 166.43 24.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.236 1.415 . . . . 0.0 111.327 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.9 140.07 31.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.63 0.772 . . . . 0.0 112.948 171.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.25 140.4 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.514 1.925 . . . . 0.0 110.103 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.268 1.427 . . . . 0.0 110.039 178.805 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -120.57 152.26 38.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.504 1.922 . . . . 0.0 110.641 168.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 t -163.52 165.21 23.89 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.066 1.746 . . . . 0.0 109.76 -173.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -136.91 121.98 19.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.283 1.433 . . . . 0.0 111.721 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 44' ' ' PHE . 8.3 tt -108.53 134.21 51.61 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.924 2.49 . . . . 0.0 110.048 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -127.22 137.59 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.257 0.623 . . . . 0.0 111.903 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.19 132.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.27 1.428 . . . . 0.0 108.174 167.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.16 -152.12 0.99 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.483 1.039 . . . . 0.0 113.492 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.35 85.72 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.868 1.667 . . . . 0.0 113.074 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.6 tm? -153.47 -58.56 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.412 1.485 . . . . 0.0 112.753 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 74.8 Cg_endo -71.36 -35.66 8.02 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.855 1.698 . . . . 0.0 112.195 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp 55.91 178.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.452 1.501 . . . . 0.0 112.884 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -70.24 17.66 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.078 1.351 . . . . 0.0 113.721 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.65 -11.52 27.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.08 1.752 . . . . 0.0 112.906 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.5 t -94.55 126.79 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -109.37 171.13 7.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.333 1.453 . . . . 0.0 110.964 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -61.7 -24.37 66.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -74.52 -33.38 62.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.514 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -80.08 -51.37 9.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.047 1.339 . . . . 0.0 111.947 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.17 -32.55 71.16 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.445 -0.784 . . . . 0.0 111.444 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -67.91 -53.64 24.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.494 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -65.0 -31.12 72.2 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.421 1.464 . . . . 0.0 113.925 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.2 -35.85 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.513 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 27.5 m-85 -89.28 -12.4 40.75 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.9 m -46.27 -46.55 44.96 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.13 -4.35 15.24 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 122.723 2.008 . . . . 0.0 113.541 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.05 -21.13 10.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.802 1.241 . . . . 0.0 113.587 -173.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.94 177.03 37.49 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.136 -0.977 . . . . 0.0 115.445 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.24 -16.77 23.32 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.87 157.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 126.523 1.929 . . . . 0.0 115.943 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.0 mmt -136.1 -79.61 0.41 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.206 1.403 . . . . 0.0 112.315 165.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -149.82 170.45 18.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.295 1.438 . . . . 0.0 112.064 -162.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.51 146.43 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -160.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -149.21 132.9 16.86 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.987 2.115 . . . . 0.0 108.524 164.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.91 135.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.41 1.484 . . . . 0.0 108.756 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -150.47 146.96 26.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.524 1.129 . . . . 0.0 110.929 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 51.89 -95.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.678 1.591 . . . . 0.0 113.396 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.54 3.13 6.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.606 1.563 . . . . 0.0 113.565 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -119.51 161.93 19.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.216 1.806 . . . . 0.0 112.557 -164.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.49 135.99 11.22 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.42 1.01 . . . . 0.0 113.027 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.76 95.1 4.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.211 1.804 . . . . 0.0 108.168 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.2 mt -115.52 129.24 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 120.641 -1.287 . . . . 0.0 109.467 -167.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -83.31 142.01 31.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.956 0.902 . . . . 0.0 109.906 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' CE1' HD13 ' A' ' 5' ' ' LEU . 1.9 m-85 -134.57 173.85 11.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.539 1.536 . . . . 0.0 112.704 -170.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -118.79 127.1 53.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.627 1.571 . . . . 0.0 108.845 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 67.65 151.13 0.12 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.306 2.642 . . . . 0.0 114.978 -166.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.19 -30.75 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.064 2.509 . . . . 0.0 112.208 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.16 -37.8 86.58 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.664 0.786 . . . . 0.0 110.456 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.0 m -59.04 -27.61 65.65 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.65 -51.65 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.669 0.788 . . . . 0.0 110.769 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -58.43 -51.75 68.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.399 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.17 -40.25 80.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.451 1.023 . . . . 0.0 112.315 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -58.22 -59.01 5.97 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.216 0.462 . . . . 0.0 111.784 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -41.82 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.957 0.798 . . . . 0.0 111.138 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.63 -33.87 74.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 112.426 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.3 t -101.55 -33.04 10.09 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 . . . . . 0 N--CA 1.474 0.739 0 CA-C-N 119.909 1.231 . . . . 0.0 112.357 173.566 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 171.67 13.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.316 1.046 . . . . 0.0 112.365 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -144.44 144.43 31.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.329 0.585 . . . . 0.0 111.273 164.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.42 131.45 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.818 1.647 . . . . 0.0 109.064 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.467 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 110.134 178.216 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.481 0.772 0 CA-C-O 119.631 -0.237 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -57.01 136.36 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.253 1.021 . . . . 0.0 110.668 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 157.03 43.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.279 1.432 . . . . 0.0 110.811 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -136.94 118.95 15.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.155 0.982 . . . . 0.0 111.488 -168.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.61 101.2 9.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.581 2.352 . . . . 0.0 109.204 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -102.43 137.72 40.31 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.52 121.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.609 1.164 . . . . 0.0 110.304 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.53 -22.81 35.75 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -149.47 26.57 0.84 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 116.272 1.952 . . . . 0.0 116.272 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.8 tp -125.29 -34.59 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-O 116.677 -1.63 . . . . 0.0 114.782 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -72.07 46.49 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.019 3.146 . . . . 0.0 115.015 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.06 -5.71 57.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.593 1.957 . . . . 0.0 113.032 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -123.35 171.1 9.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.878 2.071 . . . . 0.0 111.099 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -67.32 142.97 56.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -144.33 134.13 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.908 1.283 . . . . 0.0 110.684 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -102.16 165.19 11.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.586 1.955 . . . . 0.0 112.005 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -53.49 -38.48 63.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.421 1.088 . . . . 0.0 113.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -79.68 -31.52 41.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 -52.17 64.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.75 0.82 . . . . 0.0 111.74 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD11 ' CG2' ' A' ' 33' ' ' ILE . 3.9 pp -68.33 -34.86 76.87 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.801 -0.562 . . . . 0.0 111.534 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -67.32 -44.13 79.88 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.327 -0.858 . . . . 0.0 111.865 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -70.87 -40.11 72.46 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.778 1.172 . . . . 0.0 111.912 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.91 -27.02 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.584 1.084 . . . . 0.0 113.056 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.52 -5.59 39.05 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -44.26 86.97 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.54 1.6 9.16 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 121.965 1.777 . . . . 0.0 114.034 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.0 -27.57 8.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.59 174.75 42.67 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 116.82 1.488 . . . . 0.0 116.82 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -88.5 -17.45 30.28 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -162.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 62.14 152.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 126.943 2.097 . . . . 0.0 116.155 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.9 mmt -135.98 -72.25 0.46 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.473 1.509 . . . . 0.0 111.436 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -146.72 169.18 19.58 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 111.201 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.443 ' CG2' HD11 ' A' ' 20' ' ' LEU . 1.6 pp -133.43 142.13 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.828 -1.17 . . . . 0.0 112.705 -170.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -153.1 125.91 8.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.605 1.162 . . . . 0.0 109.261 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -143.36 132.1 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.335 1.454 . . . . 0.0 108.691 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -143.45 127.81 17.81 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.045 0.938 . . . . 0.0 111.56 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.2 t30 53.58 -71.13 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.047 2.539 . . . . 0.0 116.795 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.12 7.73 1.6 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.324 2.25 . . . . 0.0 113.12 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -135.91 140.35 43.99 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.05 -169.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.59 123.03 6.11 Favored Glycine 0 N--CA 1.466 0.666 0 CA-C-O 119.078 -0.845 . . . . 0.0 111.608 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.55 58.28 0.73 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.768 2.427 . . . . 0.0 108.936 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -83.0 139.81 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 120.129 -1.607 . . . . 0.0 109.456 -169.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.92 137.24 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.406 1.082 . . . . 0.0 110.874 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.59 164.15 23.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.466 1.107 . . . . 0.0 112.759 -168.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.63 146.79 26.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.542 156.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 63.38 144.35 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 129.455 3.102 . . . . 0.0 116.32 -172.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.38 -40.88 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.409 2.739 . . . . 0.0 111.612 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -62.75 -41.68 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.709 0.804 . . . . 0.0 111.148 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.7 m -54.23 -34.42 60.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 170.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -72.62 -58.74 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.898 0.772 . . . . 0.0 110.154 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.254 5.4 ppt_? -67.79 -25.98 65.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.423 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -74.46 -37.77 63.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.769 1.168 . . . . 0.0 112.006 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.28 90.83 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.02 -1.05 . . . . 0.0 112.617 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -74.1 -54.16 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.637 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.92 -11.69 60.01 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -168.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.3 t -109.85 -31.36 7.45 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.481 1.107 0 CA-C-N 120.343 1.429 . . . . 0.0 113.733 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 165.83 28.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -143.03 126.03 16.28 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.377 0.671 . . . . 0.0 111.781 164.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -99.11 127.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 109.993 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 124.806 1.242 . . . . 0.0 111.426 171.497 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.537 0.658 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -99.56 64.73 1.32 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.356 2.262 . . . . 0.0 111.032 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 158.11 25.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.919 0.888 . . . . 0.0 112.273 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.85 119.02 10.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 -164.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tt -110.15 125.61 53.21 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.319 2.648 . . . . 0.0 108.892 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -117.87 141.22 48.67 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 111.94 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -132.55 139.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.317 1.447 . . . . 0.0 109.984 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.63 166.55 12.96 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.144 0.878 . . . . 0.0 112.541 163.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.0 t30 57.43 12.87 1.59 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.634 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 10.1 tt -131.8 -45.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.57 1.948 . . . . 0.0 113.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.634 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 75.9 Cg_endo -74.27 26.66 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.227 2.618 . . . . 0.0 113.849 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.8 mt -68.09 -20.97 64.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.452 1.501 . . . . 0.0 112.346 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -99.1 12.5 35.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.456 1.903 . . . . 0.0 112.906 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 54.51 163.65 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.208 2.603 . . . . 0.0 114.04 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 t -140.87 129.48 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.241 -1.537 . . . . 0.0 110.06 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -66.2 152.61 44.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.755 0.822 . . . . 0.0 112.386 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -43.43 -34.79 1.38 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 113.835 164.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -89.95 -37.96 13.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.152 0.981 . . . . 0.0 112.307 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -61.47 -50.58 72.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.457 0.571 . . . . 0.0 110.793 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.76 -39.5 87.9 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.694 -0.628 . . . . 0.0 111.938 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.49 -42.38 98.53 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.835 -0.541 . . . . 0.0 110.918 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -77.76 -45.79 23.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.939 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -67.55 -25.5 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 120.313 1.415 . . . . 0.0 112.412 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -100.27 8.74 43.54 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -56.12 -55.88 37.03 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 120.553 1.524 . . . . 0.0 112.655 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.89 -16.99 29.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.043 1.829 . . . . 0.0 113.98 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -80.63 -13.06 59.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.377 1.071 . . . . 0.0 113.35 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 49' ' ' SER . . . -179.81 -156.5 17.96 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 121.186 -0.946 . . . . 0.0 113.596 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -119.65 -11.65 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.32 0.0 OUTLIER 53.01 163.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 129.414 3.086 . . . . 0.0 116.46 172.401 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.8 mmt -143.04 -69.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.882 -1.761 . . . . 0.0 112.868 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.61 178.01 8.28 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.542 1.537 . . . . 0.0 111.549 -169.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.44 151.51 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.562 1.073 . . . . 0.0 112.714 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.31 111.26 1.88 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.365 158.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.83 123.54 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.861 -1.149 . . . . 0.0 110.325 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -162.18 150.15 14.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.103 1.761 . . . . 0.0 109.876 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.2 t30 60.01 -162.88 0.25 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.734 1.613 . . . . 0.0 112.426 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.3 17.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.343 1.857 . . . . 0.0 114.636 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -141.35 173.75 11.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.233 2.213 . . . . 0.0 110.912 -167.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.4 150.72 22.08 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 121.308 -0.87 . . . . 0.0 112.18 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -120.12 139.41 52.63 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.362 1.065 . . . . 0.0 110.513 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -130.39 131.2 65.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 170.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -94.4 146.36 24.12 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.064 -1.023 . . . . 0.0 108.881 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.82 153.48 47.09 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.566 1.146 . . . . 0.0 112.952 -162.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.96 138.34 34.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.349 0.66 . . . . 0.0 110.229 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 56.25 132.37 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 129.127 2.971 . . . . 0.0 115.683 -162.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.67 -27.22 38.65 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.911 2.407 . . . . 0.0 112.503 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -59.68 -35.72 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.631 -0.668 . . . . 0.0 111.803 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.42 ' HB3' ' HA3' ' A' ' 28' ' ' GLY . 49.5 m -61.82 -34.96 76.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 113.128 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 -56.07 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.589 0.756 . . . . 0.0 110.134 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.26 94.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.923 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.69 -26.31 66.12 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.39 -57.14 4.72 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.992 0.814 . . . . 0.0 112.01 168.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.93 -36.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.146 -0.971 . . . . 0.0 112.746 -169.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.05 -37.08 69.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.939 0.79 . . . . 0.0 110.323 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.4 t -86.03 -32.49 21.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.666 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 pt . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.661 0.743 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.51 176.13 12.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.621 1.168 . . . . 0.0 113.382 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.22 145.94 28.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.673 0.789 . . . . 0.0 110.984 159.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -112.63 119.31 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.98 1.712 . . . . 0.0 109.212 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.353 1.061 . . . . 0.0 112.206 -171.046 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 112.821 0.277 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.07 125.72 53.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.604 1.562 . . . . 0.0 111.162 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.45 155.0 45.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.187 1.395 . . . . 0.0 112.685 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -129.52 133.71 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.596 1.558 . . . . 0.0 111.274 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -115.32 104.23 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.137 2.975 . . . . 0.0 107.981 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -96.51 126.26 41.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.202 0.601 . . . . 0.0 110.095 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 mt -115.17 139.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.472 1.109 . . . . 0.0 108.754 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.22 -151.35 0.31 Allowed Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.88 1.267 . . . . 0.0 113.07 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.79 68.31 4.73 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 121.123 -1.222 . . . . 0.0 113.604 -167.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 58.4 tp -129.19 -53.67 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 116.798 -1.572 . . . . 0.0 114.461 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 96.0 Cg_endo -80.7 95.62 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.993 2.462 . . . . 0.0 110.85 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.68 -38.05 6.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.674 1.19 . . . . 0.0 113.3 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -148.03 168.41 22.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.582 1.153 . . . . 0.0 112.902 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t30 51.5 46.16 26.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.965 1.306 . . . . 0.0 112.637 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.16 139.12 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.85 1.26 . . . . 0.0 111.174 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 t -154.19 173.59 15.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.95 2.1 . . . . 0.0 108.196 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -55.58 -40.84 72.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.198 0.908 . . . . 0.0 113.086 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -73.19 -34.13 65.81 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.194 0.598 . . . . 0.0 112.576 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -71.17 -43.79 66.78 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.791 -0.568 . . . . 0.0 111.765 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.75 -34.17 73.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.705 0.684 . . . . 0.0 111.969 171.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.98 -48.48 81.52 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.654 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -72.62 -33.49 66.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.51 1.05 . . . . 0.0 113.189 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 24' ' ' PHE 0.258 1.8 pp -79.88 -26.0 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.642 1.11 . . . . 0.0 113.573 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' CD1' HD12 ' A' ' 23' ' ' ILE . 15.8 m-30 -101.29 -4.52 26.91 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.571 1.078 . . . . 0.0 113.899 171.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.98 -53.85 19.6 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 114.098 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.14 0.69 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.185 1.923 . . . . 0.0 114.218 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.42 -13.9 14.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.383 1.473 . . . . 0.0 113.429 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.93 -174.79 46.86 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -101.13 -10.45 20.43 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -162.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.89 152.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 168.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.4 mmt -138.11 -73.38 0.41 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 111.99 165.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -153.89 -175.8 5.54 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.811 1.644 . . . . 0.0 111.918 -170.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 pt -131.68 157.03 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.579 1.536 . . . . 0.0 113.45 -165.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -147.8 101.08 3.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.897 1.279 . . . . 0.0 110.0 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.39 110.62 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.29 -1.506 . . . . 0.0 110.737 -174.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -146.61 152.82 39.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.495 1.518 . . . . 0.0 111.319 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t30 55.14 -159.4 0.19 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.26 1.424 . . . . 0.0 112.466 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.56 30.82 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.995 2.118 . . . . 0.0 114.213 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.75 175.36 10.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.808 2.043 . . . . 0.0 111.059 -170.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.19 135.97 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.326 -0.859 . . . . 0.0 111.947 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.39 157.36 45.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 110.046 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.58 153.54 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.086 -1.009 . . . . 0.0 108.776 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.13 144.62 42.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.679 1.191 . . . . 0.0 109.953 168.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.96 155.5 50.63 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.847 1.259 . . . . 0.0 112.33 -163.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.77 140.11 31.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.045 155.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 60.35 139.17 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.188 2.595 . . . . 0.0 116.418 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.97 -30.33 7.33 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.52 2.147 . . . . 0.0 112.986 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.88 -34.22 77.46 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.56 -0.712 . . . . 0.0 111.494 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -60.47 -42.4 96.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.241 1.416 . . . . 0.0 113.216 167.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.9 -55.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.318 0.647 . . . . 0.0 110.921 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -45.53 94.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.493 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -63.8 -34.58 78.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.754 1.161 . . . . 0.0 112.507 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.5 -54.26 39.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.684 1.129 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mt -72.4 -36.18 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.094 -1.004 . . . . 0.0 111.708 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -83.73 -10.94 57.79 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.847 -1.158 . . . . 0.0 113.331 -173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.38 -40.71 2.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 112.576 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 CA-C-N 118.962 0.801 . . . . 0.0 110.955 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.15 0.5 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.86 167.54 21.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.939 1.296 . . . . 0.0 112.19 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -149.9 122.75 8.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -82.43 133.42 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.735 1.214 . . . . 0.0 109.834 166.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.468 0.431 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 177.905 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 CA-C-O 119.028 -0.488 . . . . 0.0 113.014 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -88.76 59.66 5.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 112.363 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 160.42 31.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.487 0.715 . . . . 0.0 111.091 173.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -140.47 145.37 36.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.72 125.37 37.81 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.801 2.44 . . . . 0.0 108.953 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -127.19 139.88 52.63 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.869 0.868 . . . . 0.0 110.18 173.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -121.18 141.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.046 1.338 . . . . 0.0 107.656 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.02 -151.94 0.03 OUTLIER Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.17 1.843 . . . . 0.0 113.81 171.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -76.18 41.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.759 -1.436 . . . . 0.0 114.718 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.34 -51.87 0.12 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.697 1.999 . . . . 0.0 114.256 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.41 -31.86 2.54 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.897 1.731 . . . . 0.0 112.539 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.43 177.56 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.134 1.774 . . . . 0.0 112.513 -168.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -75.06 2.03 11.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.417 -1.427 . . . . 0.0 112.312 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -79.21 38.32 0.35 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.923 2.089 . . . . 0.0 113.001 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.44 138.26 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.926 2.09 . . . . 0.0 108.139 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.3 t -122.85 179.97 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.572 1.549 . . . . 0.0 111.821 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -59.39 -35.61 74.26 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -79.68 -38.63 33.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.256 0.622 . . . . 0.0 111.291 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.8 -42.5 99.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.83 -38.74 57.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.222 0.609 . . . . 0.0 112.052 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -68.34 -43.66 77.03 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 121.386 -0.821 . . . . 0.0 110.97 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -66.04 -41.62 90.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.206 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.78 -34.21 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.849 0.749 . . . . 0.0 112.077 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.419 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 28.4 m-85 -87.52 -19.0 28.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 m -44.05 -51.96 16.93 Favored Pre-proline 0 N--CA 1.48 1.067 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.3 -6.19 18.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.683 1.588 . . . . 0.0 114.063 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -105.6 -24.17 12.62 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.439 1.496 . . . . 0.0 113.772 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.35 165.69 38.41 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -81.16 -19.06 44.23 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 63.58 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.337 1.855 . . . . 0.0 114.938 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -141.75 -68.02 0.39 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.563 -1.336 . . . . 0.0 112.717 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -146.27 179.99 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.574 1.95 . . . . 0.0 110.053 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 pt -134.62 155.57 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.834 -1.166 . . . . 0.0 113.296 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.05 146.03 17.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.242 1.817 . . . . 0.0 108.262 157.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.7 mt -142.53 138.61 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.064 1.746 . . . . 0.0 108.367 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -151.22 150.69 30.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.08 0.952 . . . . 0.0 110.836 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 58.74 -90.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.499 1.52 . . . . 0.0 114.212 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.82 10.41 2.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.133 2.173 . . . . 0.0 112.558 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.42 147.65 50.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.011 1.725 . . . . 0.0 111.948 -164.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 140.38 15.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.97 0.795 . . . . 0.0 112.6 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.2 55.3 1.91 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.529 1.931 . . . . 0.0 110.176 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.5 150.46 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.217 1.407 . . . . 0.0 109.85 -164.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -112.3 140.41 47.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.777 -1.202 . . . . 0.0 110.218 -176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -133.79 144.66 49.16 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 112.272 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.25 135.15 38.44 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 155.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 61.54 133.36 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 129.93 3.292 . . . . 0.0 117.561 -174.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.0 -26.54 15.06 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.092 2.528 . . . . 0.0 113.991 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.29 -32.75 72.11 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.736 -1.227 . . . . 0.0 111.542 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.1 m -68.89 -25.24 64.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.496 1.519 . . . . 0.0 113.185 168.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.7 t -71.21 -58.6 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.558 1.072 . . . . 0.0 110.945 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -46.72 88.36 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.822 -174.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.66 -27.62 69.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.809 1.186 . . . . 0.0 113.455 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -68.26 -50.74 51.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.647 0.658 . . . . 0.0 112.128 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 mt -70.77 -46.66 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.191 -0.943 . . . . 0.0 111.289 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.35 -22.14 61.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.121 0.968 . . . . 0.0 112.293 -169.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.9 t -118.38 -19.42 8.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.473 0.686 0 CA-C-N 120.201 1.364 . . . . 0.0 111.314 167.871 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 121.028 0.442 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.69 172.05 14.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.684 1.194 . . . . 0.0 112.292 168.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.78 116.13 8.52 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.603 -0.686 . . . . 0.0 112.758 167.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.5 p -87.16 125.78 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 109.648 165.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 C--O 1.235 0.297 0 C-N-CA 124.598 1.159 . . . . 0.0 111.863 -179.014 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 CA-C-O 118.519 -0.701 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -75.65 67.13 2.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.235 1.814 . . . . 0.0 112.317 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.89 167.01 5.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.85 2.46 . . . . 0.0 112.953 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -141.47 133.54 27.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.798 -1.189 . . . . 0.0 112.526 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.446 HD13 ' CE1' ' A' ' 44' ' ' PHE . 8.1 tt -122.18 129.08 51.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.401 2.28 . . . . 0.0 109.762 -176.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -125.99 133.13 51.87 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.557 0.743 . . . . 0.0 111.393 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.01 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.904 0.882 . . . . 0.0 109.262 167.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.93 -17.11 76.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.012 0.815 . . . . 0.0 113.863 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -148.99 88.62 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.123 1.369 . . . . 0.0 111.661 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.61 -58.0 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.338 162.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.67 85.75 1.58 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.419 2.079 . . . . 0.0 110.531 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.78 -33.84 27.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.901 0.88 . . . . 0.0 112.539 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -160.73 -24.63 0.06 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 172.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.12 61.68 1.44 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.316 1.446 . . . . 0.0 112.085 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.23 128.21 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 109.915 164.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 m -126.08 175.36 7.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.692 1.997 . . . . 0.0 110.693 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -45.45 -49.28 13.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.085 1.754 . . . . 0.0 113.883 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -79.45 -11.6 59.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.827 0.851 . . . . 0.0 113.073 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -83.48 -55.96 4.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.581 1.152 . . . . 0.0 109.803 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.34 -34.54 77.93 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.686 -0.634 . . . . 0.0 111.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -69.48 -45.34 69.23 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.073 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -67.2 -40.01 86.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.41 1.459 . . . . 0.0 112.246 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -27.92 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.831 0.741 . . . . 0.0 112.878 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -97.69 -10.67 24.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.63 -52.14 47.09 Favored Pre-proline 0 N--CA 1.478 0.965 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.94 10.35 2.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.291 1.994 . . . . 0.0 113.697 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -120.15 -29.32 4.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.476 1.51 . . . . 0.0 113.384 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.81 37.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -86.36 -20.44 28.27 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.309 1.444 . . . . 0.0 114.716 -165.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 61.88 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 127.037 2.135 . . . . 0.0 115.748 176.337 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.413 ' H ' HD13 ' A' ' 30' ' ' ILE . 7.8 mmt -141.93 -73.48 0.31 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.578 1.551 . . . . 0.0 113.386 169.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -138.78 171.83 13.76 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.675 1.59 . . . . 0.0 111.894 -169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -130.34 151.53 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -160.55 131.26 5.45 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.275 2.23 . . . . 0.0 109.712 163.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.3 mt -137.37 134.22 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.33 -1.481 . . . . 0.0 109.721 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.41 150.7 23.72 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 112.489 -173.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 59.34 -93.83 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.018 1.727 . . . . 0.0 113.321 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.81 9.2 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.076 1.75 . . . . 0.0 112.621 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.21 169.98 15.21 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 111.299 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.16 138.92 10.44 Favored Glycine 0 N--CA 1.466 0.637 0 C-N-CA 123.93 0.776 . . . . 0.0 112.345 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -122.37 100.53 6.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.858 1.663 . . . . 0.0 108.528 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.04 131.37 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -94.98 142.87 26.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.746 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CE1' HD13 ' A' ' 5' ' ' LEU . 6.6 m-85 -128.57 162.39 27.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.209 1.403 . . . . 0.0 110.981 -168.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -92.32 145.65 24.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.712 153.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.0 m120 62.61 126.02 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.55 2.34 . . . . 0.0 116.792 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 -34.76 14.72 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.447 2.764 . . . . 0.0 114.393 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.27 -35.98 80.66 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.576 -0.702 . . . . 0.0 110.873 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -35.15 79.78 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.871 2.068 . . . . 0.0 112.408 175.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.82 -59.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.619 -0.676 . . . . 0.0 111.432 168.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -34.35 77.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.404 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.75 -39.36 84.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.476 1.035 . . . . 0.0 111.977 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 112.706 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -68.51 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 120.958 -1.089 . . . . 0.0 109.914 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.59 -29.1 63.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.01 -25.02 16.09 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 121.595 0.712 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.72 169.46 19.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.132 1.773 . . . . 0.0 112.468 -168.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -146.33 131.79 18.68 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 110.856 162.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.08 124.38 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 108.796 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 124.128 0.971 . . . . 0.0 112.702 -170.482 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 N-CA-C 111.717 -0.147 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.16 130.63 47.24 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.061 -1.024 . . . . 0.0 111.811 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.51 162.04 36.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 112.46 -172.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -128.96 139.47 52.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 111.181 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -127.81 111.1 13.26 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.169 2.588 . . . . 0.0 109.021 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -113.99 130.6 56.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.533 -0.729 . . . . 0.0 111.293 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.45 134.37 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 108.608 166.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.66 -141.12 0.4 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.7 0.667 . . . . 0.0 112.558 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.53 82.4 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.152 1.781 . . . . 0.0 112.532 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.22 -58.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.571 1.548 . . . . 0.0 111.253 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.49 101.65 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.972 2.448 . . . . 0.0 110.538 169.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.63 -18.27 13.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.397 1.079 . . . . 0.0 112.52 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.99 165.06 12.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.896 1.678 . . . . 0.0 110.425 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.04 144.31 55.16 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.742 -0.599 . . . . 0.0 111.723 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.81 137.95 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.671 1.188 . . . . 0.0 110.074 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 t -84.84 152.45 23.6 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.767 1.227 . . . . 0.0 112.721 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -51.04 -24.28 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.715 1.206 . . . . 0.0 113.291 163.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -86.86 -37.8 17.38 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.622 1.169 . . . . 0.0 111.772 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -61.92 -51.32 68.61 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 110.41 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.08 -35.49 78.27 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.428 -0.795 . . . . 0.0 112.414 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.837 0.744 . . . . 0.0 111.977 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -74.72 -34.61 62.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.175 0.898 . . . . 0.0 112.666 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.01 -35.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.728 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -91.27 -3.33 56.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 m -46.73 -49.97 44.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 120.729 1.604 . . . . 0.0 113.973 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.56 -9.94 18.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.8 1.667 . . . . 0.0 113.91 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.41 -28.57 18.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.183 1.393 . . . . 0.0 111.63 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.66 -176.24 47.06 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 118.966 2.346 . . . . 0.0 118.966 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -162.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 31' ' ' MET 0.261 0.3 OUTLIER 61.86 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 128.908 2.883 . . . . 0.0 116.227 178.298 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.431 ' H ' HD13 ' A' ' 30' ' ' ILE . 5.8 mmt -139.81 -61.96 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.762 1.625 . . . . 0.0 113.268 169.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -156.56 172.76 17.99 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.774 1.17 . . . . 0.0 111.604 -168.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.84 152.95 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.166 1.348 . . . . 0.0 114.198 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.72 125.08 8.81 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.381 2.272 . . . . 0.0 108.465 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -138.62 127.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 120.694 -1.254 . . . . 0.0 110.03 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -149.3 156.85 42.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.32 1.448 . . . . 0.0 111.715 178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 52.97 -109.73 0.49 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.601 1.56 . . . . 0.0 113.105 165.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.71 14.31 13.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.958 1.303 . . . . 0.0 113.684 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -127.12 167.73 15.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.535 1.134 . . . . 0.0 112.111 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.67 127.95 4.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.49 88.07 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.21 1.404 . . . . 0.0 109.241 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -87.41 151.72 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.132 0.968 . . . . 0.0 108.425 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.77 141.38 51.26 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 120.305 -1.497 . . . . 0.0 108.373 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 49' ' ' SER . 2.4 m-85 -131.96 165.05 24.79 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.891 1.277 . . . . 0.0 112.176 -165.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.42 140.25 36.95 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 156.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.322 2.1 p30 60.07 144.45 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.723 3.209 . . . . 0.0 115.981 -169.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.0 -23.09 8.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.669 2.246 . . . . 0.0 112.576 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -64.67 -35.79 82.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.903 0.881 . . . . 0.0 110.849 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.413 ' HB3' ' CD2' ' A' ' 44' ' ' PHE . 72.4 m -57.51 -47.05 82.98 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.599 1.56 . . . . 0.0 112.582 167.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.37 -55.61 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.335 0.654 . . . . 0.0 110.506 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -36.78 79.51 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.978 -1.01 . . . . 0.0 112.328 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.87 -41.25 83.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.614 1.552 . . . . 0.0 112.088 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -55.86 29.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.097 0.862 . . . . 0.0 111.222 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.3 mt -72.67 -48.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 O-C-N 121.81 -0.556 . . . . 0.0 111.357 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.61 -13.55 62.37 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.086 -0.959 . . . . 0.0 113.43 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.5 t -107.81 -24.76 11.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.094 1.357 . . . . 0.0 114.383 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 . . . . . 0 N--CA 1.48 1.051 0 CA-C-N 120.875 1.67 . . . . 0.0 111.993 173.581 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 42.8 pt . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 122.516 1.15 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 166.34 26.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.791 1.637 . . . . 0.0 111.884 -168.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.15 126.9 29.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 110.49 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.79 140.25 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.608 1.563 . . . . 0.0 109.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.238 0.492 0 C-N-CA 123.723 0.809 . . . . 0.0 112.026 179.42 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.479 0.638 0 CA-C-O 119.174 -0.427 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 144.43 38.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 165.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 167.06 28.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.89 2.476 . . . . 0.0 109.877 -171.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -136.79 127.64 27.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.555 1.142 . . . . 0.0 112.142 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.4 tt -118.83 129.05 55.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.655 1.982 . . . . 0.0 109.755 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -111.89 139.58 47.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 110.944 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.62 139.88 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.823 1.249 . . . . 0.0 110.738 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.78 155.89 16.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.999 1.761 . . . . 0.0 111.877 163.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.8 -17.29 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -83.59 -47.57 0.76 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.36 1.464 . . . . 0.0 114.12 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.48 35.43 0.58 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.916 3.077 . . . . 0.0 114.088 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.22 -32.21 15.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.659 1.584 . . . . 0.0 111.544 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -65.12 148.73 51.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.248 1.019 . . . . 0.0 109.634 162.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -50.37 133.93 23.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.365 1.066 . . . . 0.0 112.782 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -145.39 140.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.128 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.4 m -135.78 172.71 12.62 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.973 1.709 . . . . 0.0 108.772 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.54 -39.54 61.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -69.12 -33.5 73.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.18 -53.66 49.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.822 0.737 . . . . 0.0 111.105 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.02 -33.01 74.62 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.71 0.404 . . . . 0.0 111.676 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.38 -48.08 81.3 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -75.94 -35.1 59.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.784 1.174 . . . . 0.0 113.209 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.13 -26.37 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.81 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -99.67 -16.28 18.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -46.07 -48.23 42.65 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 120.836 1.653 . . . . 0.0 115.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -17.71 18.19 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 121.874 1.705 . . . . 0.0 113.758 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -87.38 -34.33 18.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 112.666 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.99 173.1 36.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.443 1.024 . . . . 0.0 115.54 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -94.59 -13.55 25.84 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER 57.43 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 128.458 2.703 . . . . 0.0 116.912 165.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mmt -136.05 -71.08 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.944 -1.723 . . . . 0.0 113.716 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.97 158.4 40.58 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.05 0.94 . . . . 0.0 111.36 -168.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -107.48 153.99 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -155.81 93.03 1.42 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.526 1.13 . . . . 0.0 111.609 164.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.45 135.74 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 120.626 -1.296 . . . . 0.0 112.164 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.41 146.79 13.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.448 1.899 . . . . 0.0 110.844 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 63.73 -164.05 0.26 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.577 1.951 . . . . 0.0 112.458 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.39 30.13 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.843 1.657 . . . . 0.0 113.938 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.68 174.37 11.25 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.277 2.631 . . . . 0.0 109.68 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.01 143.01 8.14 Favored Glycine 0 CA--C 1.52 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 111.817 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.38 140.48 49.77 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.21 1.004 . . . . 0.0 108.801 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.4 123.83 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -81.83 143.38 31.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.41 1.1 . . . . 0.0 109.893 168.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.61 164.91 20.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.381 1.472 . . . . 0.0 111.59 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.5 137.65 32.57 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 157.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.85 124.71 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 128.041 2.536 . . . . 0.0 116.651 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.79 -24.31 13.41 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.378 2.718 . . . . 0.0 114.042 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -64.29 -38.42 90.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.682 1.128 . . . . 0.0 110.362 170.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -35.2 80.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.627 1.571 . . . . 0.0 112.071 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.64 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.316 -0.865 . . . . 0.0 112.162 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.296 6.4 ppt_? -69.24 -34.08 74.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.837 0.744 . . . . 0.0 112.924 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -68.31 -33.22 73.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.442 1.019 . . . . 0.0 112.741 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.67 -68.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 69' ' ' LEU 0.259 1.3 pp -72.58 -27.87 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.403 1.456 . . . . 0.0 114.682 -176.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -80.22 -19.34 47.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.3 1.864 . . . . 0.0 114.026 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.1 t -107.41 -30.13 8.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -84.36 -46.45 11.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.662 1.119 . . . . 0.0 112.134 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 t -92.38 -83.2 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.413 1.006 . . . . 0.0 111.556 -174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -163.59 149.77 11.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.269 1.427 . . . . 0.0 110.033 168.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.85 2.11 21.11 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.0 ttt -147.24 144.44 28.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.018 1.327 . . . . 0.0 110.545 170.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -76.41 157.9 31.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.701 1.201 . . . . 0.0 113.04 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.0 125.8 17.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.26 1.424 . . . . 0.0 110.581 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.17 134.44 48.32 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.173 0.892 . . . . 0.0 113.027 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 46.4 28.45 0.73 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.671 1.588 . . . . 0.0 114.993 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -140.32 -47.72 0.43 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.982 -1.074 . . . . 0.0 113.307 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.8 tp -154.05 118.99 5.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.465 0.706 . . . . 0.0 110.463 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 mp -120.04 136.7 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.79 0.836 . . . . 0.0 108.918 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.6 163.91 33.33 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 110.626 171.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -152.21 140.35 20.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.181 0.592 . . . . 0.0 111.848 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -93.07 137.74 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.857 1.263 . . . . 0.0 109.909 163.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -148.18 139.01 23.08 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 111.977 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -115.39 177.56 4.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.314 1.446 . . . . 0.0 111.317 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.9 p -150.61 161.11 43.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.782 1.633 . . . . 0.0 110.154 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.13 139.64 57.5 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.304 -0.247 . . . . 0.0 111.37 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.66 156.33 39.12 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.463 0.705 . . . . 0.0 111.716 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.382 1.873 . . . . 0.0 113.392 -177.224 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 CA-C-O 119.745 -0.19 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -87.77 147.92 24.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.85 163.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.18 154.91 30.03 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.175 1.39 . . . . 0.0 109.23 -172.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -142.03 123.75 15.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.542 1.064 . . . . 0.0 112.883 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 tt -113.87 105.79 13.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.854 2.462 . . . . 0.0 108.904 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -94.75 142.38 27.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.186 0.994 . . . . 0.0 111.162 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 mt -138.51 131.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.386 1.074 . . . . 0.0 110.839 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.38 150.91 18.61 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.904 0.764 . . . . 0.0 112.531 167.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 61.34 27.21 16.9 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.66 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -134.99 -45.97 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.04 1.736 . . . . 0.0 113.386 172.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.66 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 71.7 Cg_endo -73.14 21.27 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.654 2.236 . . . . 0.0 114.864 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.12 -21.92 49.63 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.063 2.145 . . . . 0.0 110.948 169.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.87 162.86 25.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.695 1.598 . . . . 0.0 111.194 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -84.98 106.33 16.4 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.967 0.907 . . . . 0.0 109.257 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.48 137.69 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.788 1.235 . . . . 0.0 111.63 -170.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -123.19 172.32 8.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.83 1.652 . . . . 0.0 111.736 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -48.49 -53.0 19.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.072 1.349 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -62.29 -31.16 71.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.77 -49.28 13.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.837 0.744 . . . . 0.0 112.263 -174.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 33' ' ' ILE . 4.3 pp -65.91 -29.24 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -67.99 -53.2 27.85 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.42 0.688 . . . . 0.0 111.991 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -67.39 -32.34 73.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.138 1.336 . . . . 0.0 112.797 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.54 -45.64 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.51 -3.73 57.42 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -48.37 40.2 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.15 -14.35 16.73 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.874 1.716 . . . . 0.0 113.496 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -91.34 -24.12 19.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.553 . . . . 0.0 113.582 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.91 169.54 42.23 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.97 -18.26 56.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -166.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.33 148.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 128.271 2.628 . . . . 0.0 116.224 173.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.7 mmt -131.99 -96.88 0.32 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.196 1.799 . . . . 0.0 110.427 167.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' H ' ' HB2' ' A' ' 43' ' ' GLN . 81.9 mt-30 -120.78 173.07 7.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.972 2.109 . . . . 0.0 112.314 -168.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 20' ' ' LEU . 10.5 pt -124.92 145.32 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.315 -0.866 . . . . 0.0 112.798 -172.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -154.15 70.41 0.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.158 0.98 . . . . 0.0 113.121 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.73 117.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 108.434 170.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -150.51 150.34 31.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.793 2.437 . . . . 0.0 109.051 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 56.29 -170.37 0.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 113.218 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.82 1.79 3.06 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 120.267 -1.521 . . . . 0.0 113.623 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -144.04 59.62 1.36 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.768 2.427 . . . . 0.0 110.815 -159.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 173.89 42.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.948 1.261 . . . . 0.0 113.217 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -143.82 165.49 27.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.008 1.385 . . . . 0.0 113.966 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.9 mt -129.68 134.5 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 126.017 1.727 . . . . 0.0 107.16 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.466 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 71.8 mt-30 -85.54 141.46 29.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 169.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.86 164.08 21.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 111.59 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.85 141.14 31.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 160.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 62.26 148.84 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 127.706 2.403 . . . . 0.0 115.689 -166.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.48 -33.24 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.632 2.888 . . . . 0.0 112.496 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -60.45 -38.48 84.28 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.761 -0.587 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.0 m -53.59 -43.76 68.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.088 1.355 . . . . 0.0 113.645 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.3 -51.45 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.437 0.695 . . . . 0.0 109.8 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.94 -38.45 66.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.36 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 -31.59 72.82 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.923 1.238 . . . . 0.0 112.505 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.74 -64.05 1.03 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.498 0.719 . . . . 0.0 112.744 173.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.83 -24.15 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.69 -13.66 62.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.915 1.689 . . . . 0.0 111.579 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.5 t -105.12 -37.21 7.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.165 1.386 . . . . 0.0 112.906 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -86.73 -42.52 13.29 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.93 -1.106 . . . . 0.0 113.161 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -102.23 34.48 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.585 1.954 . . . . 0.0 110.967 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -53.28 137.75 33.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.472 1.909 . . . . 0.0 113.778 -169.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -63.16 146.33 53.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.692 0.797 . . . . 0.0 111.702 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.8 mtm 59.23 23.34 11.69 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.854 1.262 . . . . 0.0 113.934 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -147.98 -46.75 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.781 1.232 . . . . 0.0 112.637 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.72 -15.85 1.55 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.215 2.206 . . . . 0.0 113.129 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.8 -15.83 55.46 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.663 -1.273 . . . . 0.0 115.206 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.27 -24.04 64.84 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.256 1.528 . . . . 0.0 113.214 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -125.78 -20.03 4.75 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.72 150.23 21.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 110.846 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.6 pt -126.94 155.86 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.295 0.638 . . . . 0.0 110.963 168.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.05 165.39 30.06 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.783 0.833 . . . . 0.0 112.566 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -141.17 135.74 31.13 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.11 -0.369 . . . . 0.0 111.299 160.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.06 135.51 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.885 1.274 . . . . 0.0 110.676 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.8 t -160.39 166.94 28.41 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.505 1.122 . . . . 0.0 111.981 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -148.58 0.38 0.57 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.6 p -159.38 170.59 21.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.347 1.859 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.26 150.4 28.57 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.723 -1.236 . . . . 0.0 110.439 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.2 -11.89 20.03 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 C-N-CA 125.257 1.423 . . . . 0.0 112.555 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.478 0.568 0 N-CA-C 112.677 0.222 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -120.17 124.04 44.76 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.941 0.897 . . . . 0.0 111.181 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -138.44 161.69 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.054 1.742 . . . . 0.0 112.126 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -134.75 125.56 27.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.119 -0.988 . . . . 0.0 111.658 -172.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -111.37 125.12 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.205 2.602 . . . . 0.0 109.022 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.81 128.58 53.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.406 0.682 . . . . 0.0 110.568 165.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.84 134.69 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.25 -158.96 0.43 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.457 0.551 . . . . 0.0 112.787 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -70.65 73.64 0.55 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.293 1.037 . . . . 0.0 113.256 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.3 tp -129.02 -35.68 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.261 1.825 . . . . 0.0 112.772 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.23 42.7 0.14 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.621 3.547 . . . . 0.0 115.896 168.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -15.23 63.45 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.261 -1.524 . . . . 0.0 113.102 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -95.97 166.32 11.83 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.652 1.581 . . . . 0.0 111.423 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -60.8 126.27 26.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.884 0.874 . . . . 0.0 111.068 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.42 121.96 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.456 1.503 . . . . 0.0 107.972 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -101.19 170.25 8.37 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.867 0.867 . . . . 0.0 111.668 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -54.39 -39.59 67.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.635 . . . . 0.0 112.41 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -71.51 -30.39 65.89 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.87 -54.32 16.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.923 1.238 . . . . 0.0 111.086 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.36 -32.79 73.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.178 -0.326 . . . . 0.0 111.782 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.62 -50.83 61.72 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.522 -0.736 . . . . 0.0 111.447 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -66.88 -38.67 86.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.207 1.367 . . . . 0.0 112.643 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.38 -28.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.291 0.951 . . . . 0.0 112.774 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.33 -2.12 31.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -49.66 -51.95 55.12 Favored Pre-proline 0 N--CA 1.48 1.053 0 CA-C-N 120.107 1.321 . . . . 0.0 114.359 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.77 -19.72 16.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.424 1.544 . . . . 0.0 113.983 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -87.22 -19.94 27.64 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.293 -0.88 . . . . 0.0 112.379 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.32 39.21 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -108.35 -7.46 15.88 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.245 1.942 . . . . 0.0 116.245 -170.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.0 155.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 127.952 2.501 . . . . 0.0 117.278 164.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mmt -139.76 -65.09 0.47 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.296 1.438 . . . . 0.0 112.79 165.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -152.56 159.86 43.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.112 0.965 . . . . 0.0 112.293 -163.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.69 143.4 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.741 1.216 . . . . 0.0 111.327 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -156.26 97.57 1.78 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.994 0.917 . . . . 0.0 112.283 161.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.48 133.83 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.978 -1.076 . . . . 0.0 111.639 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -153.3 162.92 40.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.218 2.607 . . . . 0.0 109.478 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.12 -159.64 0.27 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.409 1.084 . . . . 0.0 112.623 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.14 60.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.962 1.305 . . . . 0.0 113.985 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -103.8 -172.05 2.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.27 1.828 . . . . 0.0 111.885 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.07 145.79 11.21 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 120.525 -1.359 . . . . 0.0 114.219 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.09 138.14 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.29 1.036 . . . . 0.0 110.693 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.5 mt -139.88 133.07 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.91 150.67 20.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.493 -1.379 . . . . 0.0 110.072 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.79 156.72 47.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.857 1.663 . . . . 0.0 112.414 -165.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -94.09 141.22 28.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 58.51 128.92 0.02 OUTLIER Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 128.86 2.864 . . . . 0.0 116.259 -167.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.58 -27.45 38.96 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.274 1.983 . . . . 0.0 114.349 172.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -68.44 -29.8 68.54 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.313 -1.492 . . . . 0.0 112.309 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -62.81 -33.98 76.34 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.71 -54.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.456 0.571 . . . . 0.0 110.897 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.422 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.5 -18.1 62.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.6 -61.41 1.78 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.102 0.865 . . . . 0.0 110.752 166.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.31 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.288 -0.882 . . . . 0.0 111.914 -171.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 -5.33 50.67 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.81 1.244 . . . . 0.0 112.91 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 t -115.03 -31.98 5.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.538 1.063 . . . . 0.0 113.327 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -115.69 -25.07 7.96 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -110.55 21.16 16.93 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.123 -0.986 . . . . 0.0 112.687 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -75.09 158.49 33.03 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.768 0.794 . . . . 0.0 112.596 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -133.12 131.07 40.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.753 1.621 . . . . 0.0 109.33 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 tpt -145.09 4.76 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.059 0.944 . . . . 0.0 113.067 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -88.04 -29.12 20.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.855 1.262 . . . . 0.0 111.536 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -129.89 -17.6 3.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.396 1.878 . . . . 0.0 112.507 166.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.43 -5.76 49.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.444 1.974 . . . . 0.0 115.232 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -143.17 1.69 1.26 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.697 1.999 . . . . 0.0 114.391 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.64 -18.54 54.3 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.01 1.324 . . . . 0.0 112.705 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.52 160.41 23.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.522 1.529 . . . . 0.0 111.807 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.5 tp -142.41 165.78 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.319 1.448 . . . . 0.0 111.278 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.05 174.94 12.59 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.077 1.751 . . . . 0.0 111.842 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -148.62 119.48 7.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.966 0.506 . . . . 0.0 111.53 171.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.08 126.84 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.264 1.425 . . . . 0.0 109.158 166.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 t -152.01 -173.62 4.6 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.358 1.063 . . . . 0.0 112.403 -168.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -117.98 151.83 36.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.524 1.13 . . . . 0.0 112.279 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -64.06 -8.66 12.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.024 1.33 . . . . 0.0 114.525 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.48 -12.07 59.42 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.292 1.437 . . . . 0.0 113.157 172.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.2 144.65 27.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.687 1.195 . . . . 0.0 111.874 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? . . . . . 0 C--O 1.256 1.403 0 C-N-CA 126.314 1.846 . . . . 0.0 111.334 176.928 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 CA--C 1.539 0.766 0 N-CA-C 112.363 0.101 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -128.12 147.8 50.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.133 1.373 . . . . 0.0 111.304 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.63 155.53 34.85 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.355 2.262 . . . . 0.0 107.865 -171.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -117.07 135.2 53.91 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.044 -1.035 . . . . 0.0 112.218 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -121.69 100.9 7.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.493 2.717 . . . . 0.0 108.173 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -101.82 134.87 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.024 -0.423 . . . . 0.0 110.988 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.24 136.23 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.079 1.352 . . . . 0.0 107.566 165.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.91 -151.24 0.27 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.034 0.826 . . . . 0.0 113.556 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -73.82 87.2 1.74 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.25 1.02 . . . . 0.0 111.097 -170.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 3.2 tm? -146.97 -52.91 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.839 2.056 . . . . 0.0 111.99 -169.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 93.7 Cg_endo -74.36 72.66 4.16 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.859 2.373 . . . . 0.0 110.805 169.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.04 -37.63 54.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.923 1.289 . . . . 0.0 111.514 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -73.53 162.3 29.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.084 1.354 . . . . 0.0 112.611 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -63.11 131.73 49.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.794 0.838 . . . . 0.0 110.508 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.56 152.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.918 1.687 . . . . 0.0 109.266 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -133.53 166.96 21.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.509 1.123 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -51.46 -43.11 62.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.763 1.225 . . . . 0.0 112.496 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.09 -30.89 71.05 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -73.74 -49.61 24.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.784 1.174 . . . . 0.0 111.981 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.19 -33.0 74.97 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.315 -0.865 . . . . 0.0 111.645 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -66.75 -47.9 70.78 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.986 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -70.44 -28.4 65.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.721 1.146 . . . . 0.0 112.82 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.02 -39.2 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.237 0.926 . . . . 0.0 112.949 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -90.26 -7.3 53.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 m -49.12 -44.37 72.28 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 120.778 1.626 . . . . 0.0 115.34 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.33 -14.71 18.25 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 CA-C-N 122.341 1.872 . . . . 0.0 113.808 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -87.06 -37.01 17.83 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.555 -1.341 . . . . 0.0 112.957 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.28 -178.44 36.15 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.646 1.818 . . . . 0.0 117.646 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -92.75 -14.46 27.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -160.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 61.18 154.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 127.67 2.388 . . . . 0.0 116.71 173.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -145.43 -59.7 0.34 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.415 1.486 . . . . 0.0 113.098 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -162.04 171.81 16.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.006 1.722 . . . . 0.0 110.377 -170.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.5 152.81 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.171 -1.58 . . . . 0.0 113.037 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -152.15 136.19 16.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.114 1.765 . . . . 0.0 107.922 161.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.75 135.55 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.942 1.297 . . . . 0.0 108.561 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -145.79 143.13 29.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.877 0.871 . . . . 0.0 111.277 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 44.44 -124.04 0.96 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 124.803 1.241 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.59 2.84 46.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.132 1.773 . . . . 0.0 115.22 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -134.44 158.44 43.88 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.17 136.25 11.49 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.153 0.883 . . . . 0.0 112.355 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -131.31 64.72 1.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 0.0 110.04 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.25 157.88 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.513 1.525 . . . . 0.0 109.867 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -118.58 132.33 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.122 1.369 . . . . 0.0 109.169 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -123.7 156.25 36.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.891 1.276 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -77.64 149.12 34.76 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 157.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m120 56.38 124.27 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 127.987 2.515 . . . . 0.0 116.669 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.8 -28.45 30.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.745 2.297 . . . . 0.0 113.332 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.11 -32.41 69.8 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.609 0.64 . . . . 0.0 112.095 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -30.55 36.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.43 -59.78 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.746 0.818 . . . . 0.0 110.563 165.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -36.61 82.43 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.513 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.716 1.144 . . . . 0.0 112.181 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -55.31 23.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.757 1.162 . . . . 0.0 112.583 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 mt -68.86 -49.83 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.567 0.621 . . . . 0.0 110.946 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -75.52 -30.99 59.97 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.957 0.799 . . . . 0.0 113.074 -168.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -80.44 -38.76 29.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.835 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.63 -62.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.284 1.402 . . . . 0.0 113.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 m -78.88 -67.81 0.71 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.28 1.032 . . . . 0.0 113.209 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -162.93 129.06 3.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.462 1.505 . . . . 0.0 112.645 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -75.81 137.67 40.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.781 1.232 . . . . 0.0 111.788 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -71.57 -46.94 57.94 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -168.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -76.8 -26.43 54.43 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -165.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -120.91 14.06 11.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.31 143.85 35.02 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.23 0.919 . . . . 0.0 113.108 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -146.92 -4.38 0.56 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.097 1.759 . . . . 0.0 114.981 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -129.58 -1.57 4.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.817 2.047 . . . . 0.0 113.069 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.5 mt -148.54 157.89 43.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.28 2.232 . . . . 0.0 110.0 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.1 pt -132.71 158.92 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.353 1.461 . . . . 0.0 111.481 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 175.25 12.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.109 0.964 . . . . 0.0 113.222 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -145.22 123.36 12.16 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.178 161.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.5 129.21 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 109.61 166.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -134.72 137.41 43.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.327 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.5 m -86.68 -165.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.869 1.667 . . . . 0.0 112.86 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.2 m -55.15 118.63 4.52 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.748 -0.595 . . . . 0.0 110.275 172.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -157.64 160.21 37.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.913 1.285 . . . . 0.0 110.528 177.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.34 154.83 15.83 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.4 0.545 . . . . 0.0 111.671 168.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 127.03 2.132 . . . . 0.0 113.837 -178.368 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.482 0.841 0 CA-C-O 118.839 -0.567 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.78 137.32 58.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.364 0.529 . . . . 0.0 109.985 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -145.91 168.06 21.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.793 2.037 . . . . 0.0 109.331 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -147.2 124.62 11.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.942 1.247 . . . . 0.0 114.012 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tt -113.6 125.28 53.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.735 2.414 . . . . 0.0 110.156 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -118.77 142.05 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.258 0.623 . . . . 0.0 111.409 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.92 139.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.15 1.38 . . . . 0.0 108.788 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.46 143.24 14.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.461 0.553 . . . . 0.0 113.999 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 52.8 34.98 17.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.928 1.291 . . . . 0.0 112.972 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.7 tt -128.51 -51.56 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.664 2.385 . . . . 0.0 109.804 171.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 91.7 Cg_endo -78.75 88.94 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.449 2.1 . . . . 0.0 110.845 170.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.9 -12.7 17.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.416 1.886 . . . . 0.0 112.533 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -96.41 171.82 8.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.825 1.65 . . . . 0.0 111.684 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -68.47 139.66 55.71 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.34 138.15 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.183 1.793 . . . . 0.0 108.273 -175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -112.04 171.3 7.59 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.877 0.871 . . . . 0.0 111.992 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -55.07 -36.63 65.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.597 1.159 . . . . 0.0 112.772 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -69.28 -30.83 69.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.03 -56.95 7.05 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.996 0.817 . . . . 0.0 110.907 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.89 -35.02 79.28 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.905 -0.497 . . . . 0.0 111.623 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.75 -48.58 68.67 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.582 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -69.58 -35.3 75.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.632 1.56 . . . . 0.0 112.72 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.02 -31.72 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.13 -13.13 28.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.23 -47.56 66.59 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.509 1.504 . . . . 0.0 114.934 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -0.5 9.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 CA-C-N 121.673 1.633 . . . . 0.0 113.83 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -115.25 -20.09 10.5 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.125 1.77 . . . . 0.0 114.287 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.44 163.32 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -83.84 -21.04 32.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -161.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 64.27 154.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 126.582 1.953 . . . . 0.0 115.756 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.8 mmt -134.62 -65.7 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.73 -1.231 . . . . 0.0 113.179 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.38 160.51 41.71 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.489 1.116 . . . . 0.0 111.137 -165.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.11 153.01 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -149.41 136.95 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.9 2.08 . . . . 0.0 107.392 158.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt -140.49 121.75 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 108.291 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -149.29 153.41 37.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.972 1.309 . . . . 0.0 111.258 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 55.84 -140.19 0.91 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.996 0.918 . . . . 0.0 111.332 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 21.81 2.34 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.288 1.435 . . . . 0.0 113.418 170.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -131.02 169.95 15.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.127 1.371 . . . . 0.0 112.468 -163.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.39 140.73 10.5 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.445 1.497 . . . . 0.0 111.64 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -130.76 67.07 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.024 2.13 . . . . 0.0 109.834 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.5 120.91 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 120.834 -1.166 . . . . 0.0 110.058 -165.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -83.78 135.98 34.33 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.557 -0.714 . . . . 0.0 109.561 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -122.23 164.77 17.26 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.642 1.577 . . . . 0.0 112.106 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -98.14 139.51 33.82 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 156.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 67.47 145.17 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 128.439 2.696 . . . . 0.0 116.647 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.55 -43.44 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.353 2.702 . . . . 0.0 112.265 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -62.07 -30.1 70.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.907 0.883 . . . . 0.0 111.854 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -73.93 -19.92 60.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 114.923 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.28 -51.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.068 0.849 . . . . 0.0 110.266 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -43.37 98.98 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.559 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.36 -24.47 63.9 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.316 1.417 . . . . 0.0 112.961 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.45 -66.79 0.52 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.294 0.952 . . . . 0.0 111.44 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.19 -23.94 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.165 -1.584 . . . . 0.0 114.769 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -91.85 -0.19 57.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.665 1.575 . . . . 0.0 113.373 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 t -133.8 -29.43 1.32 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.127 1.331 . . . . 0.0 114.009 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -84.78 -50.12 7.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.64 169.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.6 m -114.94 37.48 3.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 113.503 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.3 139.92 56.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -167.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.38 125.21 26.81 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.125 0.97 . . . . 0.0 111.901 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.2 mmt -123.91 -18.43 5.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 111.791 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.603 1.561 . . . . 0.0 111.017 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -133.29 0.51 3.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.65 -150.27 3.4 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.915 0.769 . . . . 0.0 112.898 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -91.8 -11.76 35.67 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -87.13 158.41 19.17 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.135 1.334 . . . . 0.0 112.316 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.5 mt 55.24 52.99 10.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.399 1.08 . . . . 0.0 112.801 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.22 143.63 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.521 1.529 . . . . 0.0 109.601 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.77 165.82 24.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.915 0.886 . . . . 0.0 112.857 171.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -152.33 135.08 15.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.278 1.031 . . . . 0.0 110.769 170.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.44 133.29 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.075 1.35 . . . . 0.0 110.365 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 159.89 42.88 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.408 1.083 . . . . 0.0 111.524 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.0 p -86.49 -155.69 0.27 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.688 1.995 . . . . 0.0 112.852 -169.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -68.07 38.81 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.659 1.984 . . . . 0.0 113.723 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -70.82 162.98 28.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.959 2.104 . . . . 0.0 113.126 -171.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.01 174.64 5.8 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.044 1.738 . . . . 0.0 113.92 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? . . . . . 0 C--O 1.252 1.214 0 C-N-CA 127.516 2.326 . . . . 0.0 110.932 -164.106 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 N--CA 1.482 0.847 0 CA-C-O 119.207 -0.414 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.0 153.59 43.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 112.885 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.71 163.77 36.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 108.152 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -136.84 126.4 25.26 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.152 1.342 . . . . 0.0 113.68 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.76 130.26 39.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.541 2.736 . . . . 0.0 108.501 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.65 134.9 49.63 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.288 0.635 . . . . 0.0 110.439 164.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.31 135.3 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.769 1.228 . . . . 0.0 108.347 169.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.88 -156.63 2.06 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.151 0.881 . . . . 0.0 112.315 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -63.92 90.46 0.06 Allowed 'General case' 0 CA--C 1.551 0.986 0 O-C-N 121.429 -1.042 . . . . 0.0 112.617 -173.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 66.0 tp -153.24 -48.69 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.23 1.812 . . . . 0.0 113.872 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 67.7 Cg_endo -77.07 56.7 5.52 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.362 2.708 . . . . 0.0 112.444 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.92 -4.06 35.82 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.275 1.43 . . . . 0.0 112.78 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -85.23 170.63 12.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.678 1.991 . . . . 0.0 111.602 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -69.48 129.09 38.75 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.654 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.03 127.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.729 0.776 . . . . 0.0 112.723 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -127.22 -179.92 5.12 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.597 1.559 . . . . 0.0 110.548 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -45.78 -48.93 15.48 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.541 1.936 . . . . 0.0 112.912 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -66.31 -36.3 82.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.44 0.564 . . . . 0.0 112.377 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.32 -56.6 7.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.6 -29.54 70.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.903 -0.498 . . . . 0.0 112.056 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.86 -52.08 27.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.06 -0.972 . . . . 0.0 111.586 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -64.29 -38.59 91.59 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.59 1.541 . . . . 0.0 111.799 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -74.67 -26.75 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.03 -11.31 20.69 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 m -45.4 -47.89 35.19 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.82 -7.47 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.255 1.841 . . . . 0.0 113.872 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -109.36 -41.15 4.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.939 1.295 . . . . 0.0 112.771 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.23 168.58 27.71 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -170.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -92.3 -15.54 27.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -163.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 0.2 OUTLIER 60.06 155.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 127.905 2.482 . . . . 0.0 115.704 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.5 mmt -137.86 -65.02 0.53 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.831 1.653 . . . . 0.0 112.077 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -158.64 165.51 34.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.004 1.322 . . . . 0.0 111.969 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 pt -128.74 147.51 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -165.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.33 92.03 1.3 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.382 1.473 . . . . 0.0 111.933 162.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.79 136.98 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.88 -1.137 . . . . 0.0 110.244 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -157.76 146.8 19.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.486 1.915 . . . . 0.0 109.052 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.09 -160.06 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.099 0.96 . . . . 0.0 111.786 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.17 -9.89 57.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.655 1.582 . . . . 0.0 114.456 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -111.95 -178.18 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.206 2.203 . . . . 0.0 111.029 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.66 146.43 10.63 Favored Glycine 0 N--CA 1.466 0.638 0 O-C-N 120.264 -1.523 . . . . 0.0 114.899 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.45 133.5 51.03 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 109.255 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.4 mt -138.0 119.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -73.1 137.0 44.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -121.91 163.91 18.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.309 1.843 . . . . 0.0 109.985 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.29 136.53 32.94 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 160.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.332 6.5 p30 54.24 139.22 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 130.158 3.383 . . . . 0.0 118.368 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.04 -27.63 13.8 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.368 2.712 . . . . 0.0 113.988 -170.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -65.67 -35.6 81.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.65 -0.656 . . . . 0.0 110.911 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -37.1 82.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.966 1.706 . . . . 0.0 112.182 172.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.25 -59.9 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.8 0.727 . . . . 0.0 111.245 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -36.2 79.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.612 -169.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.49 -37.68 88.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.47 80.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 111.8 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.7 mt -71.01 -51.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.348 -0.845 . . . . 0.0 111.023 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -66.18 -33.9 76.81 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.437 -0.79 . . . . 0.0 111.22 -171.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t -102.0 -15.19 16.87 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -124.03 -41.03 2.24 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.823 1.647 . . . . 0.0 113.986 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 m -71.02 -28.86 64.7 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.732 -1.23 . . . . 0.0 112.195 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.87 -7.6 13.18 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 56.44 13.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.5 mtp -123.36 -29.82 3.76 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.425 -1.422 . . . . 0.0 114.178 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 54.95 23.68 5.26 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.605 1.562 . . . . 0.0 114.387 -167.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.97 153.13 20.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.783 1.633 . . . . 0.0 110.979 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.99 -175.52 38.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.338 0.971 . . . . 0.0 114.34 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HE3' ' CD1' ' A' ' 69' ' ' LEU . 18.1 tptm -136.95 122.3 19.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.322 1.449 . . . . 0.0 110.01 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -144.71 -39.24 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.61 1.564 . . . . 0.0 112.219 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.18 155.45 19.41 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.576 1.15 . . . . 0.0 110.614 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.76 130.12 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.923 0.889 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' CD1' ' HE3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.57 172.53 18.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.116 0.966 . . . . 0.0 113.599 -175.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -147.51 122.72 10.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 112.249 163.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.58 145.67 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -151.49 138.6 19.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.914 0.885 . . . . 0.0 112.477 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -92.89 -166.18 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.153 2.181 . . . . 0.0 112.399 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 m -69.72 6.22 1.22 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.614 1.566 . . . . 0.0 114.925 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 -1.98 55.21 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.671 1.588 . . . . 0.0 113.612 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.59 -176.46 5.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.716 1.606 . . . . 0.0 111.978 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.58 1.552 . . . . 0.0 111.013 163.573 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 111.624 -0.183 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.64 148.52 34.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 122.24 1.019 . . . . 0.0 113.308 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -159.88 164.27 33.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 109.428 -172.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -143.17 127.14 17.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.849 1.66 . . . . 0.0 111.941 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.515 HD13 ' CE1' ' A' ' 44' ' ' PHE . 7.5 tt -117.98 120.7 38.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.421 2.688 . . . . 0.0 109.737 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.86 124.3 52.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.191 0.597 . . . . 0.0 110.856 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 mm -81.94 141.12 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.913 0.885 . . . . 0.0 108.777 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.26 -163.56 1.42 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.643 0.64 . . . . 0.0 113.076 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -74.38 41.02 0.14 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.0 mt -97.18 -46.72 0.24 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.365 1.866 . . . . 0.0 114.146 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.68 73.44 5.81 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.426 2.75 . . . . 0.0 111.748 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.56 -13.97 59.57 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.514 165.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -83.49 150.12 26.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.151 1.78 . . . . 0.0 112.107 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -59.0 152.09 20.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.804 0.842 . . . . 0.0 111.587 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.44 160.46 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.173 0.989 . . . . 0.0 111.65 -171.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -125.18 167.75 14.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.758 1.223 . . . . 0.0 112.574 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -52.67 -33.15 45.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.434 0.694 . . . . 0.0 112.704 166.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.68 -35.52 74.64 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -78.39 -51.12 10.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.63 -36.53 81.04 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.919 -0.488 . . . . 0.0 111.303 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -71.5 -42.57 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.286 -0.884 . . . . 0.0 111.75 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -64.27 -44.78 90.66 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.214 1.37 . . . . 0.0 111.592 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -78.14 -30.46 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 117.875 -1.059 . . . . 0.0 113.175 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -93.12 -14.32 27.38 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.1 m -45.68 -48.67 37.98 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-N 120.738 1.608 . . . . 0.0 115.305 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.5 -3.35 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.963 1.379 . . . . 0.0 114.068 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.71 -26.64 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.206 1.402 . . . . 0.0 113.119 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.31 176.3 39.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 122.553 1.085 . . . . 0.0 115.506 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -96.75 -17.95 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -166.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 44' ' ' PHE 0.309 0.1 OUTLIER 58.66 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 127.458 2.303 . . . . 0.0 115.634 175.686 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.7 mmt -139.94 -63.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.703 1.601 . . . . 0.0 112.069 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -153.22 169.59 22.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.368 1.467 . . . . 0.0 111.224 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.3 149.94 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 120.877 -1.139 . . . . 0.0 112.686 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -156.35 131.26 9.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.861 1.264 . . . . 0.0 108.73 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.7 mt -143.05 120.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.03 159.92 43.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.163 1.785 . . . . 0.0 110.319 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 52.36 -137.7 1.19 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.765 1.226 . . . . 0.0 112.598 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.77 12.08 22.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.839 1.655 . . . . 0.0 113.457 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.75 -172.59 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -162.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.43 135.65 5.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.311 0.958 . . . . 0.0 112.147 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.58 64.92 0.76 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.993 2.117 . . . . 0.0 109.93 -169.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.98 144.82 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.44 1.096 . . . . 0.0 110.078 -167.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -109.22 143.19 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.82 -1.175 . . . . 0.0 110.513 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 5' ' ' LEU . 11.4 m-85 -134.52 165.77 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.967 1.307 . . . . 0.0 112.586 -169.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -100.8 136.46 40.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.403 1.081 . . . . 0.0 109.186 164.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER 59.19 153.19 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 129.189 2.996 . . . . 0.0 116.487 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.75 -29.83 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.231 2.621 . . . . 0.0 113.893 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -66.84 -41.3 87.62 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.854 . . . . 0.0 110.548 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.29 -40.58 35.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.978 2.511 . . . . 0.0 113.595 167.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.56 -58.86 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.332 0.515 . . . . 0.0 111.467 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.81 91.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.011 -172.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.0 -39.37 87.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.615 1.098 . . . . 0.0 112.758 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.57 93.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.475 0.71 . . . . 0.0 111.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.46 -53.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.155 -0.966 . . . . 0.0 111.467 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -62.33 -25.81 68.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.49 1.116 . . . . 0.0 113.015 -169.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.4 t -105.71 -28.22 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.04 -19.11 7.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 120.81 1.641 . . . . 0.0 114.791 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.9 m -124.42 30.18 6.1 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.204 1.401 . . . . 0.0 112.639 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -150.2 148.67 29.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.791 2.037 . . . . 0.0 109.486 170.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -77.0 52.13 0.85 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.805 1.242 . . . . 0.0 111.864 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 55.35 -167.78 0.09 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.863 1.665 . . . . 0.0 113.232 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -62.04 -9.62 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 120.689 -1.257 . . . . 0.0 114.11 170.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.17 -16.24 61.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.0 141.33 47.25 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.256 0.931 . . . . 0.0 114.48 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -129.01 -16.68 4.04 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.51 1.924 . . . . 0.0 113.991 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -130.02 -12.18 4.18 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.78 152.46 42.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.169 0.895 . . . . 0.0 111.2 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 mm -122.82 154.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.461 1.504 . . . . 0.0 109.74 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.05 177.53 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.539 1.936 . . . . 0.0 110.939 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.03 145.34 32.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.597 0.759 . . . . 0.0 111.943 157.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 p -123.78 127.15 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.086 1.754 . . . . 0.0 109.722 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.2 m -142.35 147.59 36.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.501 1.121 . . . . 0.0 110.693 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -79.19 -167.46 1.18 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.105 0.962 . . . . 0.0 111.706 167.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 t -56.11 138.47 49.57 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.859 -1.15 . . . . 0.0 112.488 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -150.42 171.95 16.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.874 0.869 . . . . 0.0 111.266 164.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.4 168.64 9.47 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.807 1.643 . . . . 0.0 111.873 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.732 1.613 . . . . 0.0 112.159 178.312 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -98.88 66.42 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.493 1.917 . . . . 0.0 110.222 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.08 157.29 38.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.544 1.138 . . . . 0.0 111.683 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -132.97 134.36 44.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.292 1.037 . . . . 0.0 112.895 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 tt -126.83 111.05 13.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.143 2.177 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -107.73 125.45 51.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.99 0.916 . . . . 0.0 110.136 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mt -114.97 138.78 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.022 0.929 . . . . 0.0 109.491 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.36 -146.38 0.32 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.878 1.228 . . . . 0.0 113.297 166.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -75.1 72.28 2.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.923 1.289 . . . . 0.0 112.48 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 64.0 tp -131.03 -53.16 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 116.893 -1.527 . . . . 0.0 114.65 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 45.7 Cg_endo -79.99 53.14 4.61 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.151 2.567 . . . . 0.0 111.923 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.24 -22.73 51.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.379 1.472 . . . . 0.0 111.972 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.15 165.92 15.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.989 1.715 . . . . 0.0 111.848 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -57.37 131.18 49.31 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.546 0.739 . . . . 0.0 111.253 165.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -144.27 129.18 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.517 1.127 . . . . 0.0 110.301 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.5 p -99.71 170.45 8.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.667 1.187 . . . . 0.0 111.779 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.67 -34.19 64.79 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.295 -0.878 . . . . 0.0 112.627 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.29 -32.47 66.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.47 -36.59 68.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 112.906 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.64 -32.83 58.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.841 0.456 . . . . 0.0 112.128 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -61.8 -46.2 90.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.558 0.743 . . . . 0.0 111.452 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -66.22 -46.01 78.67 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.148 0.885 . . . . 0.0 112.028 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.93 -26.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.416 1.007 . . . . 0.0 113.695 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -99.63 -0.5 40.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -46.49 -53.46 24.13 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.7 -7.76 11.43 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.668 1.579 . . . . 0.0 114.225 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -83.75 -23.57 31.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.133 1.373 . . . . 0.0 112.207 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.62 -173.59 44.86 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -106.32 -10.98 16.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -157.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 62.04 154.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 127.848 2.459 . . . . 0.0 116.504 170.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.446 ' H ' HD13 ' A' ' 30' ' ' ILE . 8.0 mmt -143.99 -64.78 0.37 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.474 1.509 . . . . 0.0 113.127 169.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -160.65 176.11 11.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.066 1.346 . . . . 0.0 111.994 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.37 157.4 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.553 1.07 . . . . 0.0 112.724 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -156.74 103.96 2.12 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.873 1.269 . . . . 0.0 110.792 166.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -118.21 116.75 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.581 -1.324 . . . . 0.0 110.518 -173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -148.74 149.5 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.385 1.874 . . . . 0.0 111.021 -168.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 t30 58.44 -163.03 0.21 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.149 1.38 . . . . 0.0 112.786 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.02 29.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 O-C-N 119.695 -1.878 . . . . 0.0 114.021 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -144.25 179.22 7.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.321 2.249 . . . . 0.0 109.872 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.8 144.91 9.27 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 121.191 -0.943 . . . . 0.0 112.597 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -131.5 144.85 51.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -138.42 152.82 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.5 141.89 48.12 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.365 1.066 . . . . 0.0 108.953 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -132.41 155.95 47.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.526 1.131 . . . . 0.0 111.287 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -84.17 135.33 34.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 158.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 60.94 139.41 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 128.477 2.711 . . . . 0.0 116.703 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.79 -25.02 24.31 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.307 2.672 . . . . 0.0 112.444 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.07 -34.54 76.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.213 1.005 . . . . 0.0 111.209 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -64.57 -43.56 93.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.418 1.087 . . . . 0.0 112.345 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.14 -49.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 123.554 0.741 . . . . 0.0 110.569 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -61.93 -53.52 54.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.851 0.751 . . . . 0.0 111.322 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -70.99 -24.01 62.3 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.19 5.65 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.319 0.963 . . . . 0.0 111.131 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -75.87 -43.28 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.572 -0.705 . . . . 0.0 111.438 -172.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 -17.41 63.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.972 1.309 . . . . 0.0 112.728 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 t -105.17 4.24 31.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.525 1.13 . . . . 0.0 112.701 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -130.82 -63.2 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.171 0.988 . . . . 0.0 112.46 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -66.49 -37.65 85.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.667 0.787 . . . . 0.0 111.78 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.55 -1.29 57.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.16 0.984 . . . . 0.0 112.907 170.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 54.05 -125.69 2.31 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.993 1.717 . . . . 0.0 112.494 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.2 mtt -105.87 14.13 28.51 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.452 -1.405 . . . . 0.0 112.655 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.4 173.64 11.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.065 1.346 . . . . 0.0 111.376 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -106.14 5.9 30.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.11 158.83 51.34 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.148 0.885 . . . . 0.0 113.177 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -81.2 132.44 35.35 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.444 0.698 . . . . 0.0 111.231 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -131.01 -27.94 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.495 2.318 . . . . 0.0 111.712 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 mt -147.06 177.03 9.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.775 2.43 . . . . 0.0 111.505 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.42 141.95 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.946 1.298 . . . . 0.0 109.525 171.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.8 35.54 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 112.943 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.59 130.97 25.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 166.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.57 125.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.795 1.638 . . . . 0.0 108.649 165.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -146.23 171.58 14.74 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.954 0.902 . . . . 0.0 111.973 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.7 p -142.78 150.6 40.23 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.293 1.437 . . . . 0.0 110.984 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 p -148.45 171.03 16.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -121.87 -34.47 3.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.277 1.431 . . . . 0.0 112.714 174.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.58 -6.67 0.61 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.759 1.624 . . . . 0.0 114.306 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.699 -1.62 . . . . 0.0 113.378 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 CA--C 1.545 1.043 0 N-CA-C 114.11 0.773 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -130.98 49.91 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.692 1.997 . . . . 0.0 112.119 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -59.42 161.18 5.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.689 1.595 . . . . 0.0 111.786 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -125.14 125.48 43.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.361 1.065 . . . . 0.0 111.449 -165.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -119.8 123.27 43.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.271 1.828 . . . . 0.0 108.949 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -117.13 146.42 43.18 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.591 1.157 . . . . 0.0 110.929 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.38 139.45 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.814 1.646 . . . . 0.0 110.165 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.98 149.05 18.38 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.746 1.165 . . . . 0.0 113.78 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.05 36.37 27.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.6 tt -134.93 -56.22 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.791 1.636 . . . . 0.0 112.179 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 72.0 Cg_endo -74.47 99.42 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.27 1.98 . . . . 0.0 111.593 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.37 23.37 3.46 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.986 2.515 . . . . 0.0 111.313 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -137.74 161.64 36.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.806 2.442 . . . . 0.0 108.9 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -56.43 131.92 49.77 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.03 0.832 . . . . 0.0 109.957 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.59 135.05 12.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.291 1.436 . . . . 0.0 109.269 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 167.2 11.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.448 1.499 . . . . 0.0 110.082 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -54.22 -32.0 54.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -65.81 -31.94 73.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.088 1.355 . . . . 0.0 113.93 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.45 -50.8 13.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.816 0.846 . . . . 0.0 110.81 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.43 -30.17 70.47 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.434 -0.791 . . . . 0.0 111.897 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -69.87 -45.29 68.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.871 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -64.66 -39.22 93.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.902 1.228 . . . . 0.0 112.234 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -76.49 -38.39 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.425 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -89.52 -4.39 57.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -48.13 -49.56 59.92 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.41 -19.83 16.65 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 121.84 1.693 . . . . 0.0 113.713 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -77.22 -31.19 55.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.656 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.9 -175.36 46.67 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -18.07 25.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -159.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 62.04 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.343 2.257 . . . . 0.0 115.474 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.427 ' H ' HD13 ' A' ' 30' ' ' ILE . 6.2 mmt -139.35 -72.46 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.529 1.531 . . . . 0.0 112.258 166.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -142.84 171.53 13.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.37 1.868 . . . . 0.0 112.217 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 pt -131.88 150.87 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.579 1.151 . . . . 0.0 113.459 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -151.84 96.46 2.23 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.01 1.724 . . . . 0.0 109.889 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.14 130.99 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.388 -1.445 . . . . 0.0 111.961 -171.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -163.79 141.02 7.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.184 1.394 . . . . 0.0 112.724 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 41.11 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.897 2.479 . . . . 0.0 114.995 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.78 -7.83 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.926 2.49 . . . . 0.0 117.494 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.31 164.88 21.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.838 1.655 . . . . 0.0 110.806 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.74 152.68 24.25 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.79 0.709 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.24 140.73 45.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.506 1.123 . . . . 0.0 109.667 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -134.76 117.57 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -75.97 140.29 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.35 153.94 44.22 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.758 1.623 . . . . 0.0 110.966 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.33 145.74 28.89 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 152.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 58.88 135.66 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.012 2.925 . . . . 0.0 116.883 -171.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.13 -31.93 11.44 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.259 1.973 . . . . 0.0 112.808 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.55 -29.31 69.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.719 0.69 . . . . 0.0 111.406 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 m -66.24 -46.76 76.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.796 1.238 . . . . 0.0 113.379 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.94 -51.69 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.78 0.832 . . . . 0.0 111.526 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -47.03 63.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.913 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.56 -13.81 61.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.647 1.112 . . . . 0.0 113.639 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.55 -77.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.405 1.482 . . . . 0.0 112.196 164.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.95 -32.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 O-C-N 120.444 -1.41 . . . . 0.0 114.39 -171.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.58 -12.18 60.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.644 1.111 . . . . 0.0 113.032 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -105.65 -25.03 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.504 1.521 . . . . 0.0 112.653 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -98.94 -59.68 1.68 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.792 1.237 . . . . 0.0 113.55 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.5 m -67.84 -51.38 49.14 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 54.83 22.03 3.97 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.645 1.578 . . . . 0.0 112.899 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -100.72 162.53 12.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.969 2.108 . . . . 0.0 110.002 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.5 mtm -120.11 169.72 9.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.416 1.086 . . . . 0.0 111.962 -172.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -51.89 156.96 1.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.422 1.089 . . . . 0.0 113.053 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 57.75 18.05 4.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.742 1.217 . . . . 0.0 113.926 -171.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.4 149.82 39.33 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.67 1.129 . . . . 0.0 113.326 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -72.19 -35.78 69.05 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.233 0.613 . . . . 0.0 112.135 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -142.91 166.44 24.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.896 1.279 . . . . 0.0 113.442 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mt 57.36 20.84 6.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.715 2.006 . . . . 0.0 115.295 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.0 pt -63.07 156.77 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.806 1.243 . . . . 0.0 112.624 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.71 162.71 34.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -171.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -143.68 128.71 18.57 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.673 -0.642 . . . . 0.0 112.298 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.61 126.67 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.076 2.15 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 t -141.04 132.43 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 95.9 p -85.07 18.6 2.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.5 m -55.36 155.52 5.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.966 1.307 . . . . 0.0 114.461 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -101.42 1.19 38.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.241 1.416 . . . . 0.0 113.354 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.24 163.24 37.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.436 1.094 . . . . 0.0 112.268 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.654 1.581 . . . . 0.0 113.055 177.702 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.989 -0.427 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -60.35 134.61 57.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.251 1.02 . . . . 0.0 112.137 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -145.79 166.07 26.99 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.187 2.195 . . . . 0.0 110.56 -164.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.7 ttp-105 -148.32 130.32 15.33 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.878 -1.139 . . . . 0.0 113.23 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.72 111.55 23.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.22 2.608 . . . . 0.0 109.123 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -109.98 133.57 53.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.816 1.246 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 mt -131.14 141.98 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.553 1.141 . . . . 0.0 110.541 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.07 -137.98 0.3 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.467 1.508 . . . . 0.0 113.626 164.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -78.7 78.82 5.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 0.0 111.667 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 58.4 tp -139.48 -55.34 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.377 165.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 60.6 Cg_endo -75.15 23.56 0.41 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.839 2.359 . . . . 0.0 114.184 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 tt -67.24 -41.83 85.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.722 1.209 . . . . 0.0 113.232 -163.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -144.3 -23.29 0.54 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.45 18.8 13.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.111 1.364 . . . . 0.0 113.614 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.45 125.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 111.067 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 m -111.79 175.85 5.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.043 1.337 . . . . 0.0 110.295 164.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -56.22 -37.82 70.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.91 -28.32 68.85 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.06 -52.14 7.72 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 111.798 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.49 -36.55 78.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.613 0.642 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.04 -48.38 63.02 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.264 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -65.14 -35.51 81.34 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.493 1.497 . . . . 0.0 112.617 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.82 -33.36 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -88.61 -18.33 28.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.048 1.294 . . . . 0.0 114.33 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -43.47 -47.23 17.89 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.63 -13.21 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 CA-C-N 121.948 1.731 . . . . 0.0 113.849 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -105.73 -25.65 12.13 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.766 1.226 . . . . 0.0 113.111 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . -149.71 159.0 27.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 118.511 2.165 . . . . 0.0 118.511 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -88.38 -22.12 23.95 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.754 1.622 . . . . 0.0 114.407 -165.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 62.9 156.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.641 2.776 . . . . 0.0 116.768 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.1 mmt -130.97 -71.15 0.58 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.939 1.696 . . . . 0.0 111.325 164.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.19 162.92 39.53 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.446 1.498 . . . . 0.0 111.609 -166.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.66 145.54 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 120.971 -1.081 . . . . 0.0 113.092 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -147.01 137.92 23.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.196 1.398 . . . . 0.0 109.007 159.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.9 mt -139.34 122.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.911 1.284 . . . . 0.0 108.207 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -158.38 155.09 28.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.797 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 58.29 -151.78 0.41 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 111.479 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.44 25.07 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 113.67 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -143.51 170.22 16.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.373 1.469 . . . . 0.0 112.266 -163.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.91 140.99 12.28 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.032 1.301 . . . . 0.0 112.007 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -131.25 72.27 1.5 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.046 1.338 . . . . 0.0 110.539 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.27 129.78 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 120.686 -1.259 . . . . 0.0 110.094 -167.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.98 137.17 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.612 1.165 . . . . 0.0 109.704 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -133.02 169.87 16.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.896 1.278 . . . . 0.0 112.51 -171.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -112.28 146.02 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.42 1.088 . . . . 0.0 109.139 162.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 60.86 122.56 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 127.586 2.354 . . . . 0.0 115.156 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.13 -34.46 16.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.775 2.316 . . . . 0.0 112.815 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -58.91 -24.94 62.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.817 0.847 . . . . 0.0 112.546 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -82.53 -38.65 23.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 111.949 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.53 -55.25 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.99 0.916 . . . . 0.0 111.62 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.75 99.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.82 -40.0 95.57 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.006 1.275 . . . . 0.0 112.237 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.35 85.06 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.719 0.69 . . . . 0.0 112.026 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.0 mt -71.46 -52.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.41 -19.43 61.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.266 -0.896 . . . . 0.0 113.08 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.6 t -115.27 -8.82 12.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.083 1.353 . . . . 0.0 114.311 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.11 -15.31 1.12 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -97.27 1.41 49.57 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.739 -1.851 . . . . 0.0 112.167 156.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 53.74 33.07 15.99 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.749 2.419 . . . . 0.0 115.332 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.05 125.48 26.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.577 -0.702 . . . . 0.0 111.345 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.5 mtm -94.7 11.93 29.56 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.995 1.718 . . . . 0.0 113.884 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 60.43 30.72 20.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.44 1.096 . . . . 0.0 112.337 -170.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.65 -12.95 0.67 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.994 2.118 . . . . 0.0 112.506 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.12 -172.01 32.57 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.813 1.673 . . . . 0.0 111.291 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -129.03 24.63 5.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 0.0 113.263 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -93.59 -23.65 18.22 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.472 -0.767 . . . . 0.0 113.068 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 tp -150.31 169.84 20.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.122 0.569 . . . . 0.0 112.134 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.7 mm -113.27 140.65 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 109.222 167.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 166.49 32.63 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.045 0.938 . . . . 0.0 113.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -148.44 133.89 18.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.39 0.676 . . . . 0.0 111.865 163.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.59 133.21 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.152 1.381 . . . . 0.0 109.941 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -150.08 167.4 26.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 m -123.86 151.43 43.47 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.829 1.651 . . . . 0.0 111.208 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -134.81 158.26 44.64 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -84.81 145.9 27.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.268 0.627 . . . . 0.0 112.021 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.33 1.56 18.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.965 1.706 . . . . 0.0 113.106 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.463 1.505 . . . . 0.0 112.717 171.047 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 CA--C 1.54 0.813 0 N-CA-C 112.937 0.322 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -124.41 133.55 53.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.951 1.7 . . . . 0.0 111.863 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.37 172.86 12.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.8 2.04 . . . . 0.0 109.817 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -144.74 137.75 26.71 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.811 -1.181 . . . . 0.0 111.048 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 5' ' ' LEU . 6.1 tt -136.15 126.32 26.31 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.5 1.92 . . . . 0.0 109.684 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -117.33 143.86 45.5 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.439 1.096 . . . . 0.0 111.817 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.63 113.92 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.579 1.152 . . . . 0.0 109.083 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.78 50.8 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.009 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -150.25 79.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.282 1.041 . . . . 0.0 111.639 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.562 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 1.2 tt -153.0 -48.04 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.669 1.187 . . . . 0.0 112.168 169.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 52.3 Cg_endo -82.35 43.91 1.59 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 113.572 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.84 -23.22 67.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.083 1.353 . . . . 0.0 112.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -72.49 0.24 10.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.29 1.836 . . . . 0.0 113.637 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 51.71 56.72 7.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.018 1.327 . . . . 0.0 112.176 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.07 141.47 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.983 1.313 . . . . 0.0 111.736 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -79.13 174.35 11.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.98 -46.54 61.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.559 1.544 . . . . 0.0 112.45 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -74.57 -24.14 58.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.781 0.832 . . . . 0.0 112.846 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.82 -39.88 29.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.698 1.136 . . . . 0.0 112.251 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.85 -34.75 69.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.801 -0.562 . . . . 0.0 111.083 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -74.69 -37.43 62.64 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.686 -1.259 . . . . 0.0 113.088 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -66.08 -26.67 67.59 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.087 1.767 . . . . 0.0 113.166 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.04 -37.65 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.081 0.952 . . . . 0.0 112.026 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -86.96 -14.88 40.48 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.529 1.513 . . . . 0.0 114.964 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 m -47.59 -50.41 50.8 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.93 6.14 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.945 1.764 . . . . 0.0 114.916 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.4 -22.06 5.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.917 1.287 . . . . 0.0 114.1 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.49 -169.13 21.62 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 119.265 0.939 . . . . 0.0 114.997 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -112.12 -17.22 12.87 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 59.39 156.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 127.277 2.231 . . . . 0.0 116.878 171.441 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.51 ' H ' HD13 ' A' ' 30' ' ' ILE . 9.3 mmt -138.53 -67.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.417 1.487 . . . . 0.0 112.66 167.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -155.37 172.59 17.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.391 1.476 . . . . 0.0 111.978 -163.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.35 160.42 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.555 -1.34 . . . . 0.0 112.983 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -158.04 114.78 2.87 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.108 1.363 . . . . 0.0 109.959 157.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -128.18 115.54 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.588 -1.32 . . . . 0.0 108.871 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -154.5 160.48 41.58 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.633 1.573 . . . . 0.0 110.927 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 50.33 -147.54 0.36 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.745 1.218 . . . . 0.0 110.912 -174.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.92 7.9 11.8 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 120.046 -1.659 . . . . 0.0 114.99 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.02 -175.02 3.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.882 1.273 . . . . 0.0 112.764 -171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.41 147.13 18.04 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.006 0.812 . . . . 0.0 112.543 166.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -132.9 144.12 49.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.287 1.435 . . . . 0.0 110.356 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 mt -142.68 124.18 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.406 1.082 . . . . 0.0 108.158 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -85.28 139.13 31.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.349 1.071 . . . . 0.0 108.692 168.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.12 169.48 12.15 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.828 -168.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -104.09 144.16 31.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 155.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.52 127.61 0.01 OUTLIER Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 129.115 2.966 . . . . 0.0 117.807 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -29.8 10.12 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.731 2.287 . . . . 0.0 114.82 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -65.52 -35.95 82.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.087 1.312 . . . . 0.0 110.84 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -40.52 89.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.564 1.946 . . . . 0.0 112.728 168.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.36 -51.68 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.387 0.994 . . . . 0.0 112.195 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -24.76 63.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -75.57 -39.03 58.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.436 -0.79 . . . . 0.0 111.706 169.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.0 -62.93 1.37 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.61 0.764 . . . . 0.0 111.996 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.266 1.1 pp -73.1 -44.65 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.91 1.232 . . . . 0.0 114.054 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.15 -30.75 69.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.369 1.895 . . . . 0.0 112.752 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -104.91 -29.14 10.68 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.72 -51.93 6.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.169 1.35 . . . . 0.0 110.904 168.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.6 m -100.05 -98.67 0.24 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.577 1.551 . . . . 0.0 112.116 -167.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -149.2 151.08 33.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.166 1.386 . . . . 0.0 111.972 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.93 176.88 9.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.067 1.347 . . . . 0.0 112.266 170.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.41 -26.63 66.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.413 -1.429 . . . . 0.0 113.312 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.71 -146.84 0.18 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.244 2.218 . . . . 0.0 113.72 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.755 1.622 . . . . 0.0 113.339 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.93 13.61 69.63 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.3 1.428 . . . . 0.0 115.124 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -77.01 -33.13 57.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.791 1.636 . . . . 0.0 114.115 -171.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.07 -48.72 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 111.361 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.22 152.04 36.52 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -171.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.52 166.36 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.972 1.309 . . . . 0.0 112.038 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.85 166.56 14.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 109.826 165.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -133.71 120.66 20.88 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.189 0.45 . . . . 0.0 111.377 163.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.05 135.22 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.381 1.072 . . . . 0.0 109.82 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.4 t -154.36 166.42 33.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.172 0.987 . . . . 0.0 112.797 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 p -128.05 -160.1 0.99 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.95 1.7 . . . . 0.0 112.103 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -70.4 10.81 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 171.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -51.79 150.64 3.9 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.647 -1.283 . . . . 0.0 112.509 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.16 -9.95 13.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.348 1.459 . . . . 0.0 114.892 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 125.968 1.707 . . . . 0.0 112.433 175.135 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -92.96 142.99 26.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.144 0.883 . . . . 0.0 112.864 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.77 167.6 29.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.703 2.001 . . . . 0.0 110.984 -173.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -138.71 130.99 28.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.206 1.402 . . . . 0.0 111.419 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.73 135.01 51.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.343 2.657 . . . . 0.0 109.167 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -132.16 132.85 43.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.969 0.908 . . . . 0.0 111.025 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.61 112.35 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.235 1.014 . . . . 0.0 110.266 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 68' ' ' ILE . . . -91.18 0.36 75.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.886 172.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -64.72 5.98 0.26 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.895 1.678 . . . . 0.0 114.545 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 mt 51.44 54.94 15.5 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.819 2.048 . . . . 0.0 114.641 -172.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -60.72 115.66 2.83 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.876 1.717 . . . . 0.0 110.401 165.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.1 mt -136.44 -7.69 1.97 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.551 1.54 . . . . 0.0 113.879 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -88.1 164.48 15.7 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.658 1.183 . . . . 0.0 111.031 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -59.16 128.65 38.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.22 1.008 . . . . 0.0 112.294 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 m -150.38 151.3 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.647 1.979 . . . . 0.0 109.642 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 t -117.21 168.98 9.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.894 0.854 . . . . 0.0 112.576 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -53.91 -29.08 40.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.451 1.5 . . . . 0.0 114.268 173.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -75.37 -29.26 59.83 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.136 0.88 . . . . 0.0 113.344 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.37 -59.58 3.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.715 1.143 . . . . 0.0 110.996 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.96 -32.89 71.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.779 0.832 . . . . 0.0 111.885 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.36 -44.42 65.05 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.904 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -66.65 -40.91 88.87 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.989 1.722 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.06 -17.76 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -107.81 -8.32 16.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -47.38 -49.51 53.33 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-N 120.911 1.687 . . . . 0.0 114.692 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.1 -8.31 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.041 1.827 . . . . 0.0 114.066 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -97.62 -33.01 11.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.793 1.237 . . . . 0.0 112.765 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.56 -179.71 39.98 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 116.626 1.41 . . . . 0.0 116.626 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -93.27 -18.79 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.2 152.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 127.057 2.143 . . . . 0.0 116.174 174.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.2 mmt -134.05 -68.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.368 1.467 . . . . 0.0 112.202 166.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -151.54 170.58 19.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 111.049 -166.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.34 137.49 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.514 -1.366 . . . . 0.0 111.373 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -140.56 71.36 1.37 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.426 1.49 . . . . 0.0 110.986 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.43 107.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.445 -1.409 . . . . 0.0 108.675 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.2 138.2 50.46 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.738 2.015 . . . . 0.0 109.687 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 53.05 -149.57 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.85 1.26 . . . . 0.0 112.628 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.95 -36.08 28.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.254 0.934 . . . . 0.0 112.046 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -83.01 64.28 7.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.557 1.143 . . . . 0.0 111.559 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 144.98 47.61 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.345 0.497 . . . . 0.0 112.301 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -133.9 155.62 49.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.959 1.361 . . . . 0.0 112.426 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.28 126.71 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.374 1.47 . . . . 0.0 107.452 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -77.37 137.62 38.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.56 0.744 . . . . 0.0 109.457 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.58 164.84 24.03 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.823 0.849 . . . . 0.0 112.684 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -102.63 145.48 29.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.587 1.155 . . . . 0.0 109.131 162.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 53.32 124.21 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 128.905 2.882 . . . . 0.0 116.321 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.91 -29.81 17.85 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.217 . . . . 0.0 112.782 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.98 -30.65 71.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.607 0.763 . . . . 0.0 111.651 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -33.94 38.03 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.751 1.621 . . . . 0.0 112.403 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.35 -58.33 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.23 0.468 . . . . 0.0 110.332 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.278 6.6 ppt_? -64.44 -44.85 89.84 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.336 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -62.69 -29.2 70.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.085 1.766 . . . . 0.0 114.072 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.5 -60.92 2.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.361 0.982 . . . . 0.0 112.055 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.91 -17.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.08 -22.88 36.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.728 1.604 . . . . 0.0 112.953 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.8 t -96.7 -21.24 17.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.649 0.78 . . . . 0.0 112.506 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -87.75 -56.92 3.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.042 1.292 . . . . 0.0 112.125 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.1 m -84.61 39.33 0.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.101 1.36 . . . . 0.0 112.02 167.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -66.29 -43.79 85.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.312 1.445 . . . . 0.0 111.867 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -151.95 -54.83 0.13 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 112.159 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.2 mtm 36.66 52.85 1.03 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.007 1.723 . . . . 0.0 114.46 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -56.36 101.99 0.07 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.904 1.282 . . . . 0.0 112.523 -166.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -162.43 -35.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.423 1.089 . . . . 0.0 112.325 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.31 167.18 37.63 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.66 1.6 . . . . 0.0 111.592 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -83.62 20.56 1.38 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.768 1.627 . . . . 0.0 113.0 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -65.84 -36.54 83.75 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.343 1.857 . . . . 0.0 112.863 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.42 144.93 55.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.408 HG23 ' HA3' ' A' ' 8' ' ' GLY . 8.0 tp -167.14 153.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.711 2.004 . . . . 0.0 108.302 164.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' H ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.79 161.47 26.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.914 1.286 . . . . 0.0 112.322 175.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.29 143.01 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.885 161.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.48 137.46 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.075 2.15 . . . . 0.0 108.404 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -138.29 113.64 9.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.597 1.159 . . . . 0.0 109.229 175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -77.33 25.8 0.17 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.3 t -159.04 177.71 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.359 1.464 . . . . 0.0 111.366 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -148.64 156.96 43.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.03 1.332 . . . . 0.0 111.805 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.87 172.31 0.12 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.639 1.976 . . . . 0.0 114.729 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.358 1.463 . . . . 0.0 112.574 -178.191 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 CA--C 1.539 0.768 0 CA-C-O 119.972 -0.095 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -136.06 145.15 45.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.429 1.492 . . . . 0.0 110.386 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.16 167.6 19.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.082 0.953 . . . . 0.0 111.891 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -150.82 125.63 9.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.149 -0.969 . . . . 0.0 112.59 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 6' ' ' PHE . 5.9 tt -106.56 142.71 35.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.572 2.749 . . . . 0.0 109.551 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.525 ' N ' HD23 ' A' ' 5' ' ' LEU . 26.5 t80 -136.51 144.05 44.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 167.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.97 119.87 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.923 1.289 . . . . 0.0 109.378 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.81 -8.78 66.95 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.309 0.884 . . . . 0.0 115.309 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -163.46 91.54 0.69 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.236 1.518 . . . . 0.0 111.029 167.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.555 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 29.1 tp -156.51 -48.08 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.16 -1.4 . . . . 0.0 112.82 165.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 54.5 Cg_endo -83.35 66.7 7.59 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.523 2.148 . . . . 0.0 112.225 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.6 mt -84.06 -6.04 59.34 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 0.0 113.805 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.64 11.58 19.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.632 1.573 . . . . 0.0 112.501 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 58.89 138.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.171 2.589 . . . . 0.0 113.694 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.94 136.07 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.33 1.052 . . . . 0.0 109.627 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -89.01 157.05 18.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.625 0.77 . . . . 0.0 112.35 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -47.59 -48.46 28.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.001 1.72 . . . . 0.0 112.891 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -70.11 -26.41 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.1 -44.78 16.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.612 1.165 . . . . 0.0 112.539 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.64 -34.55 77.18 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.553 -0.717 . . . . 0.0 110.988 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -63.97 -48.65 75.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.074 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -65.07 -42.86 93.79 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.452 1.478 . . . . 0.0 112.657 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -26.98 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.726 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -96.28 -5.4 40.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -48.52 -42.92 58.9 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.46 -16.64 4.68 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.124 1.883 . . . . 0.0 113.346 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -79.29 -24.2 43.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.448 1.099 . . . . 0.0 112.23 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.75 41.36 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.61 -17.15 22.59 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -163.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.56 154.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 127.098 2.159 . . . . 0.0 116.759 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -139.38 -65.81 0.47 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.022 1.329 . . . . 0.0 113.22 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -159.99 174.95 13.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.381 1.072 . . . . 0.0 112.086 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.09 155.01 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.469 -1.394 . . . . 0.0 114.559 -171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.63 120.12 5.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.998 1.319 . . . . 0.0 110.779 162.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.6 mt -132.15 126.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 120.991 -1.068 . . . . 0.0 112.205 -168.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -156.2 147.65 22.62 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.422 1.489 . . . . 0.0 112.058 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 53.55 -152.21 0.31 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.535 1.534 . . . . 0.0 112.561 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.09 -4.21 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.037 1.335 . . . . 0.0 114.245 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.67 -175.61 2.76 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 110.681 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.29 149.66 15.33 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.365 -0.834 . . . . 0.0 113.017 165.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.87 135.87 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.364 1.465 . . . . 0.0 109.971 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.25 114.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -73.71 139.22 45.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.799 0.809 . . . . 0.0 108.844 170.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.52 157.48 42.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.097 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.25 146.17 23.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 60.89 138.09 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 129.156 2.983 . . . . 0.0 117.033 -172.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.57 -35.53 2.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.03 2.486 . . . . 0.0 112.754 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.48 -34.22 75.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.549 0.613 . . . . 0.0 111.269 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -64.14 -43.81 94.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.068 1.347 . . . . 0.0 112.751 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.6 -52.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.745 0.702 . . . . 0.0 111.344 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -40.44 79.59 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.779 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.48 -28.2 66.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.194 1.361 . . . . 0.0 112.655 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.94 -63.6 1.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.892 0.769 . . . . 0.0 111.814 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 pp -78.77 -27.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.89 -26.92 67.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.192 1.36 . . . . 0.0 112.182 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.27 -15.35 16.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.629 1.171 . . . . 0.0 113.624 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -107.39 -46.12 3.93 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.67 -1.269 . . . . 0.0 113.938 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.4 m -83.82 -39.9 19.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.792 0.724 . . . . 0.0 111.003 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 56.23 -173.34 0.07 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.854 1.661 . . . . 0.0 114.267 171.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 57.93 16.23 3.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.021 1.729 . . . . 0.0 114.91 165.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -58.54 -33.9 70.4 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.318 -1.489 . . . . 0.0 110.79 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.97 6.61 41.41 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.194 1.797 . . . . 0.0 113.363 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -130.09 -11.87 4.17 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.424 1.49 . . . . 0.0 114.621 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.13 -177.78 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.777 -1.202 . . . . 0.0 112.926 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -144.91 23.27 1.55 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.0 1.32 . . . . 0.0 114.096 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.8 -30.57 63.82 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.115 0.966 . . . . 0.0 111.317 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.16 167.81 18.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.895 1.278 . . . . 0.0 112.84 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.99 153.32 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.052 1.741 . . . . 0.0 109.378 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.28 166.43 24.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.236 1.415 . . . . 0.0 111.327 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.9 140.07 31.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.63 0.772 . . . . 0.0 112.948 171.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.25 140.4 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.514 1.925 . . . . 0.0 110.103 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m -153.69 146.35 24.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.268 1.427 . . . . 0.0 110.039 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.0 p -99.37 0.03 41.98 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.3 t -146.19 167.34 23.7 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.123 1.769 . . . . 0.0 111.12 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -97.29 -12.63 22.67 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.464 1.106 . . . . 0.0 112.876 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.94 -38.82 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ttm-85 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.809 0.844 . . . . 0.0 112.923 -175.014 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -120.57 152.26 38.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.504 1.922 . . . . 0.0 110.641 168.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 t -163.52 165.21 23.89 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.066 1.746 . . . . 0.0 109.76 -173.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -136.91 121.98 19.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.283 1.433 . . . . 0.0 111.721 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 44' ' ' PHE . 8.3 tt -108.53 134.21 51.61 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.924 2.49 . . . . 0.0 110.048 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -127.22 137.59 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.257 0.623 . . . . 0.0 111.903 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.19 132.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.27 1.428 . . . . 0.0 108.174 167.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.16 -152.12 0.99 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.483 1.039 . . . . 0.0 113.492 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.35 85.72 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.868 1.667 . . . . 0.0 113.074 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.6 tm? -153.47 -58.56 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.412 1.485 . . . . 0.0 112.753 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 74.8 Cg_endo -71.36 -35.66 8.02 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.855 1.698 . . . . 0.0 112.195 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp 55.91 178.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.452 1.501 . . . . 0.0 112.884 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -70.24 17.66 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.078 1.351 . . . . 0.0 113.721 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.65 -11.52 27.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.08 1.752 . . . . 0.0 112.906 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.5 t -94.55 126.79 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -109.37 171.13 7.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.333 1.453 . . . . 0.0 110.964 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -61.7 -24.37 66.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -74.52 -33.38 62.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.514 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -80.08 -51.37 9.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.047 1.339 . . . . 0.0 111.947 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.17 -32.55 71.16 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.445 -0.784 . . . . 0.0 111.444 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -67.91 -53.64 24.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.494 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -65.0 -31.12 72.2 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.421 1.464 . . . . 0.0 113.925 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.2 -35.85 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.513 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 27.5 m-85 -89.28 -12.4 40.75 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.9 m -46.27 -46.55 44.96 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.13 -4.35 15.24 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 122.723 2.008 . . . . 0.0 113.541 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.05 -21.13 10.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.802 1.241 . . . . 0.0 113.587 -173.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.94 177.03 37.49 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.136 -0.977 . . . . 0.0 115.445 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.24 -16.77 23.32 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.87 157.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 126.523 1.929 . . . . 0.0 115.943 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.0 mmt -136.1 -79.61 0.41 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.206 1.403 . . . . 0.0 112.315 165.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -149.82 170.45 18.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.295 1.438 . . . . 0.0 112.064 -162.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.51 146.43 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -160.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -149.21 132.9 16.86 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.987 2.115 . . . . 0.0 108.524 164.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.91 135.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.41 1.484 . . . . 0.0 108.756 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -150.47 146.96 26.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.524 1.129 . . . . 0.0 110.929 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 51.89 -95.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.678 1.591 . . . . 0.0 113.396 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.54 3.13 6.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.606 1.563 . . . . 0.0 113.565 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -119.51 161.93 19.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.216 1.806 . . . . 0.0 112.557 -164.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.49 135.99 11.22 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.42 1.01 . . . . 0.0 113.027 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.76 95.1 4.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.211 1.804 . . . . 0.0 108.168 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.2 mt -115.52 129.24 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 120.641 -1.287 . . . . 0.0 109.467 -167.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -83.31 142.01 31.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.956 0.902 . . . . 0.0 109.906 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' CE1' HD13 ' A' ' 5' ' ' LEU . 1.9 m-85 -134.57 173.85 11.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.539 1.536 . . . . 0.0 112.704 -170.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -118.79 127.1 53.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.627 1.571 . . . . 0.0 108.845 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 67.65 151.13 0.12 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.306 2.642 . . . . 0.0 114.978 -166.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.19 -30.75 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.064 2.509 . . . . 0.0 112.208 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.16 -37.8 86.58 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.664 0.786 . . . . 0.0 110.456 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.0 m -59.04 -27.61 65.65 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.65 -51.65 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.669 0.788 . . . . 0.0 110.769 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -58.43 -51.75 68.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.399 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.17 -40.25 80.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.451 1.023 . . . . 0.0 112.315 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -58.22 -59.01 5.97 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.216 0.462 . . . . 0.0 111.784 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -41.82 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.957 0.798 . . . . 0.0 111.138 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.63 -33.87 74.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 112.426 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.3 t -101.55 -33.04 10.09 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -87.66 -50.64 6.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.909 1.231 . . . . 0.0 112.357 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -88.91 -49.45 6.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.246 0.93 . . . . 0.0 112.385 -173.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 51.68 -144.79 0.57 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.823 1.649 . . . . 0.0 111.485 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 54.57 16.67 1.4 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.0 ttt -75.97 -29.96 58.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.041 -1.037 . . . . 0.0 110.869 165.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -110.21 167.42 10.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 t80 50.6 35.46 11.59 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.708 1.603 . . . . 0.0 113.998 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.12 -10.88 0.33 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.309 0.956 . . . . 0.0 115.467 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 pttp 42.61 34.47 0.56 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.109 2.164 . . . . 0.0 116.322 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -62.01 -34.42 76.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.285 1.034 . . . . 0.0 111.756 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.97 166.71 23.97 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.453 1.101 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.3 mt -114.55 151.0 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.884 1.674 . . . . 0.0 108.486 166.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 171.67 13.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.316 1.046 . . . . 0.0 112.365 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -144.44 144.43 31.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.329 0.585 . . . . 0.0 111.273 164.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.42 131.45 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.818 1.647 . . . . 0.0 109.064 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.4 t -142.96 131.1 21.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 110.134 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -75.61 12.36 1.05 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.0 m 48.84 29.99 2.51 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.183 1.393 . . . . 0.0 113.483 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -103.39 26.91 7.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.422 1.889 . . . . 0.0 111.761 -170.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 172.1 13.24 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.778 2.031 . . . . 0.0 110.389 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.899 -170.137 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.481 0.772 0 CA-C-O 119.631 -0.237 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -57.01 136.36 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.253 1.021 . . . . 0.0 110.668 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 157.03 43.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.279 1.432 . . . . 0.0 110.811 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -136.94 118.95 15.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.155 0.982 . . . . 0.0 111.488 -168.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.61 101.2 9.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.581 2.352 . . . . 0.0 109.204 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -102.43 137.72 40.31 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.52 121.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.609 1.164 . . . . 0.0 110.304 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.53 -22.81 35.75 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -149.47 26.57 0.84 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 116.272 1.952 . . . . 0.0 116.272 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.8 tp -125.29 -34.59 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-O 116.677 -1.63 . . . . 0.0 114.782 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -72.07 46.49 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.019 3.146 . . . . 0.0 115.015 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.06 -5.71 57.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.593 1.957 . . . . 0.0 113.032 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -123.35 171.1 9.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.878 2.071 . . . . 0.0 111.099 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -67.32 142.97 56.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -144.33 134.13 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.908 1.283 . . . . 0.0 110.684 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -102.16 165.19 11.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.586 1.955 . . . . 0.0 112.005 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -53.49 -38.48 63.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.421 1.088 . . . . 0.0 113.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -79.68 -31.52 41.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 -52.17 64.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.75 0.82 . . . . 0.0 111.74 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD11 ' CG2' ' A' ' 33' ' ' ILE . 3.9 pp -68.33 -34.86 76.87 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.801 -0.562 . . . . 0.0 111.534 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -67.32 -44.13 79.88 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.327 -0.858 . . . . 0.0 111.865 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -70.87 -40.11 72.46 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.778 1.172 . . . . 0.0 111.912 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.91 -27.02 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.584 1.084 . . . . 0.0 113.056 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.52 -5.59 39.05 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -44.26 86.97 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.54 1.6 9.16 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 121.965 1.777 . . . . 0.0 114.034 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.0 -27.57 8.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.59 174.75 42.67 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 116.82 1.488 . . . . 0.0 116.82 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -88.5 -17.45 30.28 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -162.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 62.14 152.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 126.943 2.097 . . . . 0.0 116.155 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.9 mmt -135.98 -72.25 0.46 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.473 1.509 . . . . 0.0 111.436 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -146.72 169.18 19.58 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 111.201 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.443 ' CG2' HD11 ' A' ' 20' ' ' LEU . 1.6 pp -133.43 142.13 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.828 -1.17 . . . . 0.0 112.705 -170.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -153.1 125.91 8.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.605 1.162 . . . . 0.0 109.261 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -143.36 132.1 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.335 1.454 . . . . 0.0 108.691 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -143.45 127.81 17.81 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.045 0.938 . . . . 0.0 111.56 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.2 t30 53.58 -71.13 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.047 2.539 . . . . 0.0 116.795 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.12 7.73 1.6 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.324 2.25 . . . . 0.0 113.12 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -135.91 140.35 43.99 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.05 -169.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.59 123.03 6.11 Favored Glycine 0 N--CA 1.466 0.666 0 CA-C-O 119.078 -0.845 . . . . 0.0 111.608 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.55 58.28 0.73 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.768 2.427 . . . . 0.0 108.936 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -83.0 139.81 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 120.129 -1.607 . . . . 0.0 109.456 -169.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.92 137.24 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.406 1.082 . . . . 0.0 110.874 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.59 164.15 23.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.466 1.107 . . . . 0.0 112.759 -168.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.63 146.79 26.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.542 156.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 63.38 144.35 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 129.455 3.102 . . . . 0.0 116.32 -172.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.38 -40.88 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.409 2.739 . . . . 0.0 111.612 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -62.75 -41.68 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.709 0.804 . . . . 0.0 111.148 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.7 m -54.23 -34.42 60.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 170.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -72.62 -58.74 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.898 0.772 . . . . 0.0 110.154 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.254 5.4 ppt_? -67.79 -25.98 65.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.423 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -74.46 -37.77 63.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.769 1.168 . . . . 0.0 112.006 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.28 90.83 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.02 -1.05 . . . . 0.0 112.617 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -74.1 -54.16 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.637 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.92 -11.69 60.01 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -168.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.3 t -109.85 -31.36 7.45 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -108.86 -32.41 7.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.343 1.429 . . . . 0.0 113.733 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -87.37 59.15 5.37 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.521 -1.362 . . . . 0.0 111.868 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 54.79 5.16 0.08 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -88.79 -4.69 58.44 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.697 1.599 . . . . 0.0 113.304 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 tpt -78.6 39.19 0.34 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.889 2.076 . . . . 0.0 112.352 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -138.14 153.34 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.371 1.869 . . . . 0.0 110.257 -170.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -72.43 -32.03 65.97 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.692 0.797 . . . . 0.0 111.322 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.04 178.17 34.02 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.113 0.863 . . . . 0.0 113.027 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 143.99 49.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.988 1.315 . . . . 0.0 111.604 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -155.87 -39.48 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 112.345 167.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.88 134.35 34.52 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.3 135.83 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.691 1.596 . . . . 0.0 109.193 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 165.83 28.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -143.03 126.03 16.28 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.377 0.671 . . . . 0.0 111.781 164.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -99.11 127.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 109.993 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.8 p -142.62 161.74 37.29 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.806 1.242 . . . . 0.0 111.426 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -116.34 -162.86 0.87 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.166 0.987 . . . . 0.0 112.236 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.9 p -61.17 -0.12 0.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -62.47 -23.7 67.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.978 1.311 . . . . 0.0 112.934 167.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.8 176.29 8.82 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 112.613 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.234 2.214 . . . . 0.0 111.179 173.547 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.537 0.658 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -99.56 64.73 1.32 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.356 2.262 . . . . 0.0 111.032 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 158.11 25.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.919 0.888 . . . . 0.0 112.273 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.85 119.02 10.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 -164.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tt -110.15 125.61 53.21 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.319 2.648 . . . . 0.0 108.892 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -117.87 141.22 48.67 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 111.94 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -132.55 139.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.317 1.447 . . . . 0.0 109.984 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.63 166.55 12.96 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.144 0.878 . . . . 0.0 112.541 163.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.0 t30 57.43 12.87 1.59 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.634 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 10.1 tt -131.8 -45.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.57 1.948 . . . . 0.0 113.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.634 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 75.9 Cg_endo -74.27 26.66 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.227 2.618 . . . . 0.0 113.849 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.8 mt -68.09 -20.97 64.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.452 1.501 . . . . 0.0 112.346 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -99.1 12.5 35.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.456 1.903 . . . . 0.0 112.906 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 54.51 163.65 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.208 2.603 . . . . 0.0 114.04 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 t -140.87 129.48 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.241 -1.537 . . . . 0.0 110.06 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -66.2 152.61 44.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.755 0.822 . . . . 0.0 112.386 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -43.43 -34.79 1.38 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 113.835 164.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -89.95 -37.96 13.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.152 0.981 . . . . 0.0 112.307 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -61.47 -50.58 72.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.457 0.571 . . . . 0.0 110.793 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.76 -39.5 87.9 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.694 -0.628 . . . . 0.0 111.938 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.49 -42.38 98.53 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.835 -0.541 . . . . 0.0 110.918 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -77.76 -45.79 23.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.939 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -67.55 -25.5 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 120.313 1.415 . . . . 0.0 112.412 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -100.27 8.74 43.54 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -56.12 -55.88 37.03 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 120.553 1.524 . . . . 0.0 112.655 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.89 -16.99 29.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.043 1.829 . . . . 0.0 113.98 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -80.63 -13.06 59.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.377 1.071 . . . . 0.0 113.35 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 49' ' ' SER . . . -179.81 -156.5 17.96 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 121.186 -0.946 . . . . 0.0 113.596 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -119.65 -11.65 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.32 0.0 OUTLIER 53.01 163.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 129.414 3.086 . . . . 0.0 116.46 172.401 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.8 mmt -143.04 -69.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.882 -1.761 . . . . 0.0 112.868 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.61 178.01 8.28 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.542 1.537 . . . . 0.0 111.549 -169.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.44 151.51 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.562 1.073 . . . . 0.0 112.714 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.31 111.26 1.88 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.365 158.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.83 123.54 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.861 -1.149 . . . . 0.0 110.325 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -162.18 150.15 14.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.103 1.761 . . . . 0.0 109.876 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.2 t30 60.01 -162.88 0.25 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.734 1.613 . . . . 0.0 112.426 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.3 17.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.343 1.857 . . . . 0.0 114.636 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -141.35 173.75 11.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.233 2.213 . . . . 0.0 110.912 -167.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.4 150.72 22.08 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 121.308 -0.87 . . . . 0.0 112.18 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -120.12 139.41 52.63 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.362 1.065 . . . . 0.0 110.513 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -130.39 131.2 65.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 170.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -94.4 146.36 24.12 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.064 -1.023 . . . . 0.0 108.881 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.82 153.48 47.09 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.566 1.146 . . . . 0.0 112.952 -162.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.96 138.34 34.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.349 0.66 . . . . 0.0 110.229 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 56.25 132.37 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 129.127 2.971 . . . . 0.0 115.683 -162.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.67 -27.22 38.65 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.911 2.407 . . . . 0.0 112.503 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -59.68 -35.72 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.631 -0.668 . . . . 0.0 111.803 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.42 ' HB3' ' HA3' ' A' ' 28' ' ' GLY . 49.5 m -61.82 -34.96 76.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 113.128 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 -56.07 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.589 0.756 . . . . 0.0 110.134 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.26 94.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.923 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.69 -26.31 66.12 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.39 -57.14 4.72 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.992 0.814 . . . . 0.0 112.01 168.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.93 -36.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.146 -0.971 . . . . 0.0 112.746 -169.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.05 -37.08 69.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.939 0.79 . . . . 0.0 110.323 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.4 t -86.03 -32.49 21.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -113.39 -46.18 3.09 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 m -79.44 -8.57 59.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -139.06 168.3 20.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.404 2.281 . . . . 0.0 110.104 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.47 -26.2 7.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.612 1.165 . . . . 0.0 113.483 -172.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.424 ' HG3' ' H ' ' A' ' 63' ' ' PHE . 45.1 tpp -150.92 133.28 15.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.954 0.902 . . . . 0.0 112.749 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -63.8 -3.31 2.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.764 1.626 . . . . 0.0 114.882 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.424 ' H ' ' HG3' ' A' ' 61' ' ' MET . 78.2 m-85 -132.22 11.05 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.687 1.995 . . . . 0.0 112.904 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.03 134.55 7.69 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.721 1.153 . . . . 0.0 113.327 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -76.92 128.63 34.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.532 1.133 . . . . 0.0 111.052 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -140.43 -34.16 0.54 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.919 1.687 . . . . 0.0 112.111 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tp -150.42 156.11 40.85 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.978 1.311 . . . . 0.0 113.334 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 pt -90.8 143.93 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.623 1.169 . . . . 0.0 112.548 167.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.51 176.13 12.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.621 1.168 . . . . 0.0 113.382 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.22 145.94 28.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.673 0.789 . . . . 0.0 110.984 159.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -112.63 119.31 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.98 1.712 . . . . 0.0 109.212 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 t -142.22 163.43 32.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.353 1.061 . . . . 0.0 112.206 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.6 p -132.49 15.07 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.925 1.29 . . . . 0.0 113.05 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 95.6 p -148.78 -6.76 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -173.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.04 164.32 15.56 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 120.334 1.425 . . . . 0.0 112.033 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.88 158.18 22.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.278 1.031 . . . . 0.0 112.902 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.515 1.126 . . . . 0.0 111.698 175.432 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 112.821 0.277 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.07 125.72 53.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.604 1.562 . . . . 0.0 111.162 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -141.45 155.0 45.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.187 1.395 . . . . 0.0 112.685 -178.092 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -129.52 133.71 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.596 1.558 . . . . 0.0 111.274 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -115.32 104.23 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.137 2.975 . . . . 0.0 107.981 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -96.51 126.26 41.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.202 0.601 . . . . 0.0 110.095 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 mt -115.17 139.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.472 1.109 . . . . 0.0 108.754 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.22 -151.35 0.31 Allowed Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.88 1.267 . . . . 0.0 113.07 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.79 68.31 4.73 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 121.123 -1.222 . . . . 0.0 113.604 -167.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 58.4 tp -129.19 -53.67 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 116.798 -1.572 . . . . 0.0 114.461 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 96.0 Cg_endo -80.7 95.62 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.993 2.462 . . . . 0.0 110.85 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.68 -38.05 6.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.674 1.19 . . . . 0.0 113.3 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -148.03 168.41 22.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.582 1.153 . . . . 0.0 112.902 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t30 51.5 46.16 26.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.965 1.306 . . . . 0.0 112.637 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.16 139.12 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.85 1.26 . . . . 0.0 111.174 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 t -154.19 173.59 15.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.95 2.1 . . . . 0.0 108.196 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -55.58 -40.84 72.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.198 0.908 . . . . 0.0 113.086 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -73.19 -34.13 65.81 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.194 0.598 . . . . 0.0 112.576 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -71.17 -43.79 66.78 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.791 -0.568 . . . . 0.0 111.765 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.75 -34.17 73.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.705 0.684 . . . . 0.0 111.969 171.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.98 -48.48 81.52 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.654 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -72.62 -33.49 66.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.51 1.05 . . . . 0.0 113.189 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 24' ' ' PHE 0.258 1.8 pp -79.88 -26.0 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.642 1.11 . . . . 0.0 113.573 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' CD1' HD12 ' A' ' 23' ' ' ILE . 15.8 m-30 -101.29 -4.52 26.91 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.571 1.078 . . . . 0.0 113.899 171.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.98 -53.85 19.6 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 114.098 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.14 0.69 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.185 1.923 . . . . 0.0 114.218 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.42 -13.9 14.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.383 1.473 . . . . 0.0 113.429 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.93 -174.79 46.86 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -101.13 -10.45 20.43 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -162.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.89 152.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 168.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.4 mmt -138.11 -73.38 0.41 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 111.99 165.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -153.89 -175.8 5.54 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.811 1.644 . . . . 0.0 111.918 -170.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 pt -131.68 157.03 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.579 1.536 . . . . 0.0 113.45 -165.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -147.8 101.08 3.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.897 1.279 . . . . 0.0 110.0 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.39 110.62 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.29 -1.506 . . . . 0.0 110.737 -174.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -146.61 152.82 39.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.495 1.518 . . . . 0.0 111.319 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t30 55.14 -159.4 0.19 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.26 1.424 . . . . 0.0 112.466 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.56 30.82 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.995 2.118 . . . . 0.0 114.213 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.75 175.36 10.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.808 2.043 . . . . 0.0 111.059 -170.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.19 135.97 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.326 -0.859 . . . . 0.0 111.947 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.39 157.36 45.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 110.046 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.58 153.54 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.086 -1.009 . . . . 0.0 108.776 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.13 144.62 42.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.679 1.191 . . . . 0.0 109.953 168.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.96 155.5 50.63 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.847 1.259 . . . . 0.0 112.33 -163.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.77 140.11 31.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.045 155.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 60.35 139.17 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.188 2.595 . . . . 0.0 116.418 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.97 -30.33 7.33 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.52 2.147 . . . . 0.0 112.986 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.88 -34.22 77.46 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.56 -0.712 . . . . 0.0 111.494 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -60.47 -42.4 96.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.241 1.416 . . . . 0.0 113.216 167.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.9 -55.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.318 0.647 . . . . 0.0 110.921 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -45.53 94.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.493 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -63.8 -34.58 78.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.754 1.161 . . . . 0.0 112.507 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.5 -54.26 39.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.684 1.129 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mt -72.4 -36.18 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.094 -1.004 . . . . 0.0 111.708 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -83.73 -10.94 57.79 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.847 -1.158 . . . . 0.0 113.331 -173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.38 -40.71 2.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 112.576 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -50.16 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.962 0.801 . . . . 0.0 110.955 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 m -85.36 18.72 2.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.249 1.02 . . . . 0.0 113.669 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' HG2' ' H ' ' A' ' 61' ' ' MET . 52.1 tt0 -54.88 139.04 41.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.446 1.498 . . . . 0.0 111.771 -177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -98.39 -0.3 43.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.503 1.521 . . . . 0.0 114.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.459 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 19.1 ttt 70.92 148.95 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.03 2.532 . . . . 0.0 113.823 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.24 35.32 0.11 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.666 1.586 . . . . 0.0 114.249 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -142.03 -11.11 0.87 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.428 1.491 . . . . 0.0 114.275 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.1 165.36 38.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 119.824 1.193 . . . . 0.0 113.283 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -155.54 128.5 8.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.659 1.184 . . . . 0.0 110.157 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -127.67 -0.72 6.11 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.1 172.53 12.53 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.574 1.95 . . . . 0.0 110.866 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.34 166.39 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.367 1.067 . . . . 0.0 112.154 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.86 167.54 21.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.939 1.296 . . . . 0.0 112.19 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -149.9 122.75 8.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -82.43 133.42 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.735 1.214 . . . . 0.0 109.834 166.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.9 t -147.58 160.87 42.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 66.7 p -157.77 -176.05 5.72 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.2 t -55.6 -25.26 37.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.833 0.853 . . . . 0.0 113.267 166.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.84 -20.68 56.05 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.5 1.045 . . . . 0.0 113.604 171.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.45 -1.85 56.31 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.071 0.948 . . . . 0.0 113.066 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 117.686 -1.149 . . . . 0.0 110.333 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 CA-C-O 119.028 -0.488 . . . . 0.0 113.014 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -88.76 59.66 5.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 112.363 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 160.42 31.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.487 0.715 . . . . 0.0 111.091 173.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -140.47 145.37 36.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.72 125.37 37.81 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.801 2.44 . . . . 0.0 108.953 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -127.19 139.88 52.63 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.869 0.868 . . . . 0.0 110.18 173.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -121.18 141.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.046 1.338 . . . . 0.0 107.656 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.02 -151.94 0.03 OUTLIER Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.17 1.843 . . . . 0.0 113.81 171.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -76.18 41.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.759 -1.436 . . . . 0.0 114.718 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.34 -51.87 0.12 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.697 1.999 . . . . 0.0 114.256 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.41 -31.86 2.54 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.897 1.731 . . . . 0.0 112.539 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.43 177.56 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.134 1.774 . . . . 0.0 112.513 -168.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -75.06 2.03 11.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.417 -1.427 . . . . 0.0 112.312 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -79.21 38.32 0.35 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.923 2.089 . . . . 0.0 113.001 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.44 138.26 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.926 2.09 . . . . 0.0 108.139 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.3 t -122.85 179.97 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.572 1.549 . . . . 0.0 111.821 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -59.39 -35.61 74.26 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -79.68 -38.63 33.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.256 0.622 . . . . 0.0 111.291 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.8 -42.5 99.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.83 -38.74 57.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.222 0.609 . . . . 0.0 112.052 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -68.34 -43.66 77.03 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 121.386 -0.821 . . . . 0.0 110.97 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -66.04 -41.62 90.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.206 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.78 -34.21 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.849 0.749 . . . . 0.0 112.077 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.419 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 28.4 m-85 -87.52 -19.0 28.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 m -44.05 -51.96 16.93 Favored Pre-proline 0 N--CA 1.48 1.067 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.3 -6.19 18.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.683 1.588 . . . . 0.0 114.063 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -105.6 -24.17 12.62 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.439 1.496 . . . . 0.0 113.772 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.35 165.69 38.41 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -81.16 -19.06 44.23 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 63.58 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.337 1.855 . . . . 0.0 114.938 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -141.75 -68.02 0.39 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.563 -1.336 . . . . 0.0 112.717 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -146.27 179.99 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.574 1.95 . . . . 0.0 110.053 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 pt -134.62 155.57 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.834 -1.166 . . . . 0.0 113.296 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.05 146.03 17.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.242 1.817 . . . . 0.0 108.262 157.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.7 mt -142.53 138.61 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.064 1.746 . . . . 0.0 108.367 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -151.22 150.69 30.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.08 0.952 . . . . 0.0 110.836 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 58.74 -90.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.499 1.52 . . . . 0.0 114.212 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.82 10.41 2.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.133 2.173 . . . . 0.0 112.558 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.42 147.65 50.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.011 1.725 . . . . 0.0 111.948 -164.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 140.38 15.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.97 0.795 . . . . 0.0 112.6 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.2 55.3 1.91 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.529 1.931 . . . . 0.0 110.176 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.5 150.46 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.217 1.407 . . . . 0.0 109.85 -164.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -112.3 140.41 47.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.777 -1.202 . . . . 0.0 110.218 -176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -133.79 144.66 49.16 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 112.272 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.25 135.15 38.44 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 155.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 61.54 133.36 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 129.93 3.292 . . . . 0.0 117.561 -174.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.0 -26.54 15.06 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.092 2.528 . . . . 0.0 113.991 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.29 -32.75 72.11 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.736 -1.227 . . . . 0.0 111.542 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.1 m -68.89 -25.24 64.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.496 1.519 . . . . 0.0 113.185 168.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.7 t -71.21 -58.6 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.558 1.072 . . . . 0.0 110.945 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -46.72 88.36 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.822 -174.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.66 -27.62 69.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.809 1.186 . . . . 0.0 113.455 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -68.26 -50.74 51.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.647 0.658 . . . . 0.0 112.128 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 mt -70.77 -46.66 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.191 -0.943 . . . . 0.0 111.289 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.35 -22.14 61.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.121 0.968 . . . . 0.0 112.293 -169.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.9 t -118.38 -19.42 8.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.85 -54.05 2.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.201 1.364 . . . . 0.0 111.314 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 m -77.0 -56.18 4.81 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -162.08 133.4 5.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.918 0.887 . . . . 0.0 112.735 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -100.14 154.11 18.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.363 1.065 . . . . 0.0 112.659 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.7 tpt 55.74 49.29 16.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.534 1.533 . . . . 0.0 113.017 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -55.36 -17.28 4.57 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -55.76 -12.38 1.27 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.11 34.56 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 53.2 36.77 23.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.535 1.934 . . . . 0.0 114.961 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -126.42 -11.42 6.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.695 1.998 . . . . 0.0 113.659 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -138.04 148.09 44.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.26 2.624 . . . . 0.0 110.053 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt -124.48 148.31 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.898 0.879 . . . . 0.0 111.22 -172.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.69 172.05 14.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.684 1.194 . . . . 0.0 112.292 168.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.78 116.13 8.52 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.603 -0.686 . . . . 0.0 112.758 167.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.5 p -87.16 125.78 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 109.648 165.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.0 m -131.18 145.33 51.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.598 1.159 . . . . 0.0 111.863 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.3 m -101.19 -20.65 15.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.358 1.863 . . . . 0.0 112.089 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.7 t -161.15 161.76 31.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.543 2.337 . . . . 0.0 109.573 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -112.26 3.49 17.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.054 1.342 . . . . 0.0 113.562 166.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.23 -171.07 3.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.604 1.961 . . . . 0.0 110.286 -168.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.3 ttm105 . . . . . 0 C--O 1.257 1.451 0 C-N-CA 125.638 1.575 . . . . 0.0 113.052 176.294 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 CA-C-O 118.519 -0.701 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -75.65 67.13 2.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.235 1.814 . . . . 0.0 112.317 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.89 167.01 5.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.85 2.46 . . . . 0.0 112.953 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -141.47 133.54 27.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.798 -1.189 . . . . 0.0 112.526 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD13 ' CE1' ' A' ' 44' ' ' PHE . 8.1 tt -122.18 129.08 51.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.401 2.28 . . . . 0.0 109.762 -176.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -125.99 133.13 51.87 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.557 0.743 . . . . 0.0 111.393 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.01 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.904 0.882 . . . . 0.0 109.262 167.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.93 -17.11 76.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.012 0.815 . . . . 0.0 113.863 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -148.99 88.62 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.123 1.369 . . . . 0.0 111.661 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.61 -58.0 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.338 162.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.67 85.75 1.58 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.419 2.079 . . . . 0.0 110.531 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.78 -33.84 27.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.901 0.88 . . . . 0.0 112.539 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -160.73 -24.63 0.06 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 172.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.12 61.68 1.44 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.316 1.446 . . . . 0.0 112.085 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.23 128.21 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 109.915 164.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 m -126.08 175.36 7.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.692 1.997 . . . . 0.0 110.693 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -45.45 -49.28 13.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.085 1.754 . . . . 0.0 113.883 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -79.45 -11.6 59.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.827 0.851 . . . . 0.0 113.073 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -83.48 -55.96 4.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.581 1.152 . . . . 0.0 109.803 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.34 -34.54 77.93 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.686 -0.634 . . . . 0.0 111.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -69.48 -45.34 69.23 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.073 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -67.2 -40.01 86.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.41 1.459 . . . . 0.0 112.246 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -27.92 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.831 0.741 . . . . 0.0 112.878 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -97.69 -10.67 24.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.63 -52.14 47.09 Favored Pre-proline 0 N--CA 1.478 0.965 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.94 10.35 2.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.291 1.994 . . . . 0.0 113.697 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -120.15 -29.32 4.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.476 1.51 . . . . 0.0 113.384 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.81 37.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -86.36 -20.44 28.27 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.309 1.444 . . . . 0.0 114.716 -165.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 61.88 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 127.037 2.135 . . . . 0.0 115.748 176.337 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.413 ' H ' HD13 ' A' ' 30' ' ' ILE . 7.8 mmt -141.93 -73.48 0.31 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.578 1.551 . . . . 0.0 113.386 169.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -138.78 171.83 13.76 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.675 1.59 . . . . 0.0 111.894 -169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -130.34 151.53 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -160.55 131.26 5.45 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.275 2.23 . . . . 0.0 109.712 163.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.3 mt -137.37 134.22 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.33 -1.481 . . . . 0.0 109.721 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.41 150.7 23.72 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 112.489 -173.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 59.34 -93.83 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.018 1.727 . . . . 0.0 113.321 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.81 9.2 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.076 1.75 . . . . 0.0 112.621 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.21 169.98 15.21 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 111.299 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.16 138.92 10.44 Favored Glycine 0 N--CA 1.466 0.637 0 C-N-CA 123.93 0.776 . . . . 0.0 112.345 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -122.37 100.53 6.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.858 1.663 . . . . 0.0 108.528 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.04 131.37 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -94.98 142.87 26.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.746 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CE1' HD13 ' A' ' 5' ' ' LEU . 6.6 m-85 -128.57 162.39 27.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.209 1.403 . . . . 0.0 110.981 -168.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -92.32 145.65 24.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.712 153.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.0 m120 62.61 126.02 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.55 2.34 . . . . 0.0 116.792 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 -34.76 14.72 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.447 2.764 . . . . 0.0 114.393 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.27 -35.98 80.66 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.576 -0.702 . . . . 0.0 110.873 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -35.15 79.78 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.871 2.068 . . . . 0.0 112.408 175.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.82 -59.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.619 -0.676 . . . . 0.0 111.432 168.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -34.35 77.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.404 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.75 -39.36 84.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.476 1.035 . . . . 0.0 111.977 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 112.706 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -68.51 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 120.958 -1.089 . . . . 0.0 109.914 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.59 -29.1 63.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.01 -25.02 16.09 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.69 -41.18 3.09 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 m -82.75 -19.77 37.24 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.26 -0.9 . . . . 0.0 112.962 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -120.42 145.99 46.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.562 1.945 . . . . 0.0 110.547 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -122.14 -11.13 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.7 ttt -144.23 154.3 42.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.575 1.55 . . . . 0.0 111.326 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -71.32 123.36 22.12 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.102 -0.999 . . . . 0.0 111.409 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 54.84 36.23 26.06 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.248 1.019 . . . . 0.0 112.277 -168.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.76 158.32 24.36 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.405 1.479 . . . . 0.0 113.901 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -96.56 157.76 15.75 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.318 -1.107 . . . . 0.0 113.072 -165.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt 57.72 14.6 2.51 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.152 2.181 . . . . 0.0 114.571 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.22 107.17 8.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.056 1.342 . . . . 0.0 109.925 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -113.66 150.2 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.688 1.195 . . . . 0.0 109.42 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.72 169.46 19.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.132 1.773 . . . . 0.0 112.468 -168.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -146.33 131.79 18.68 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 110.856 162.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.08 124.38 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 108.796 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -138.66 168.94 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.128 0.971 . . . . 0.0 112.702 -170.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -114.73 -172.51 2.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.446 1.099 . . . . 0.0 112.996 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 p -66.2 -3.85 6.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -66.68 165.61 14.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.42 1.088 . . . . 0.0 111.032 168.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.19 -1.39 23.04 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.26 1.424 . . . . 0.0 114.758 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 . . . . . 0 C--O 1.253 1.246 0 CA-C-O 116.379 -1.772 . . . . 0.0 111.446 -175.186 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 N-CA-C 111.717 -0.147 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.16 130.63 47.24 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.061 -1.024 . . . . 0.0 111.811 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.51 162.04 36.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 112.46 -172.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -128.96 139.47 52.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 111.181 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -127.81 111.1 13.26 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.169 2.588 . . . . 0.0 109.021 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -113.99 130.6 56.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.533 -0.729 . . . . 0.0 111.293 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.45 134.37 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 108.608 166.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.66 -141.12 0.4 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.7 0.667 . . . . 0.0 112.558 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.53 82.4 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.152 1.781 . . . . 0.0 112.532 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.22 -58.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.571 1.548 . . . . 0.0 111.253 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.49 101.65 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.972 2.448 . . . . 0.0 110.538 169.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.63 -18.27 13.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.397 1.079 . . . . 0.0 112.52 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.99 165.06 12.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.896 1.678 . . . . 0.0 110.425 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.04 144.31 55.16 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.742 -0.599 . . . . 0.0 111.723 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.81 137.95 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.671 1.188 . . . . 0.0 110.074 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 t -84.84 152.45 23.6 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.767 1.227 . . . . 0.0 112.721 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -51.04 -24.28 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.715 1.206 . . . . 0.0 113.291 163.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -86.86 -37.8 17.38 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.622 1.169 . . . . 0.0 111.772 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -61.92 -51.32 68.61 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 110.41 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.08 -35.49 78.27 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.428 -0.795 . . . . 0.0 112.414 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.837 0.744 . . . . 0.0 111.977 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -74.72 -34.61 62.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.175 0.898 . . . . 0.0 112.666 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.01 -35.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.728 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -91.27 -3.33 56.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 m -46.73 -49.97 44.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 120.729 1.604 . . . . 0.0 113.973 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.56 -9.94 18.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.8 1.667 . . . . 0.0 113.91 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.41 -28.57 18.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.183 1.393 . . . . 0.0 111.63 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.66 -176.24 47.06 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 118.966 2.346 . . . . 0.0 118.966 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -162.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 31' ' ' MET 0.261 0.3 OUTLIER 61.86 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 128.908 2.883 . . . . 0.0 116.227 178.298 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.431 ' H ' HD13 ' A' ' 30' ' ' ILE . 5.8 mmt -139.81 -61.96 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.762 1.625 . . . . 0.0 113.268 169.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -156.56 172.76 17.99 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.774 1.17 . . . . 0.0 111.604 -168.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.84 152.95 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.166 1.348 . . . . 0.0 114.198 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.72 125.08 8.81 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.381 2.272 . . . . 0.0 108.465 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -138.62 127.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 120.694 -1.254 . . . . 0.0 110.03 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -149.3 156.85 42.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.32 1.448 . . . . 0.0 111.715 178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 52.97 -109.73 0.49 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.601 1.56 . . . . 0.0 113.105 165.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.71 14.31 13.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.958 1.303 . . . . 0.0 113.684 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -127.12 167.73 15.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.535 1.134 . . . . 0.0 112.111 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.67 127.95 4.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.49 88.07 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.21 1.404 . . . . 0.0 109.241 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -87.41 151.72 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.132 0.968 . . . . 0.0 108.425 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.77 141.38 51.26 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 120.305 -1.497 . . . . 0.0 108.373 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 49' ' ' SER . 2.4 m-85 -131.96 165.05 24.79 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.891 1.277 . . . . 0.0 112.176 -165.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.42 140.25 36.95 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 156.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.322 2.1 p30 60.07 144.45 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.723 3.209 . . . . 0.0 115.981 -169.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.0 -23.09 8.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.669 2.246 . . . . 0.0 112.576 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -64.67 -35.79 82.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.903 0.881 . . . . 0.0 110.849 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.413 ' HB3' ' CD2' ' A' ' 44' ' ' PHE . 72.4 m -57.51 -47.05 82.98 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.599 1.56 . . . . 0.0 112.582 167.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.37 -55.61 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.335 0.654 . . . . 0.0 110.506 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -36.78 79.51 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.978 -1.01 . . . . 0.0 112.328 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.87 -41.25 83.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.614 1.552 . . . . 0.0 112.088 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -55.86 29.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.097 0.862 . . . . 0.0 111.222 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.3 mt -72.67 -48.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 O-C-N 121.81 -0.556 . . . . 0.0 111.357 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.61 -13.55 62.37 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.086 -0.959 . . . . 0.0 113.43 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.5 t -107.81 -24.76 11.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.094 1.357 . . . . 0.0 114.383 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -96.95 -62.56 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.875 1.67 . . . . 0.0 111.993 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -68.27 -33.99 75.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.637 -0.664 . . . . 0.0 111.182 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 55.07 -158.44 0.2 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 112.565 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -121.96 140.2 52.74 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.69 1.196 . . . . 0.0 109.425 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.97 159.51 15.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.381 1.472 . . . . 0.0 111.249 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -76.63 32.39 0.13 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.244 1.418 . . . . 0.0 114.085 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.28 136.77 31.95 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.153 1.781 . . . . 0.0 109.827 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.76 150.52 48.07 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm 48.53 42.24 18.48 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.678 1.239 . . . . 0.0 113.03 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -141.54 134.49 28.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.574 1.55 . . . . 0.0 110.021 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.93 40.98 30.42 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.832 1.253 . . . . 0.0 112.009 -175.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 42.8 pt -84.38 161.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.648 1.179 . . . . 0.0 113.142 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 166.34 26.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.791 1.637 . . . . 0.0 111.884 -168.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.15 126.9 29.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 110.49 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.79 140.25 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.608 1.563 . . . . 0.0 109.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m -140.53 131.93 26.81 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.723 0.809 . . . . 0.0 112.026 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -81.46 -2.66 50.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.942 2.097 . . . . 0.0 112.998 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 m -131.35 151.8 51.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.011 2.125 . . . . 0.0 110.603 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -120.88 145.49 47.59 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.97 . . . . 0.0 113.315 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.27 28.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 110.982 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.523 1.929 . . . . 0.0 113.614 -171.688 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.479 0.638 0 CA-C-O 119.174 -0.427 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 144.43 38.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 165.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 167.06 28.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.89 2.476 . . . . 0.0 109.877 -171.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -136.79 127.64 27.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.555 1.142 . . . . 0.0 112.142 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.4 tt -118.83 129.05 55.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.655 1.982 . . . . 0.0 109.755 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -111.89 139.58 47.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 110.944 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.62 139.88 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.823 1.249 . . . . 0.0 110.738 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.78 155.89 16.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.999 1.761 . . . . 0.0 111.877 163.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.8 -17.29 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -83.59 -47.57 0.76 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.36 1.464 . . . . 0.0 114.12 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.48 35.43 0.58 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.916 3.077 . . . . 0.0 114.088 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.22 -32.21 15.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.659 1.584 . . . . 0.0 111.544 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -65.12 148.73 51.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.248 1.019 . . . . 0.0 109.634 162.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -50.37 133.93 23.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.365 1.066 . . . . 0.0 112.782 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -145.39 140.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.128 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.4 m -135.78 172.71 12.62 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.973 1.709 . . . . 0.0 108.772 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.54 -39.54 61.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -69.12 -33.5 73.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.18 -53.66 49.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.822 0.737 . . . . 0.0 111.105 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.02 -33.01 74.62 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.71 0.404 . . . . 0.0 111.676 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.38 -48.08 81.3 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -75.94 -35.1 59.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.784 1.174 . . . . 0.0 113.209 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.13 -26.37 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.81 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -99.67 -16.28 18.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -46.07 -48.23 42.65 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 120.836 1.653 . . . . 0.0 115.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -17.71 18.19 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 121.874 1.705 . . . . 0.0 113.758 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -87.38 -34.33 18.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 112.666 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.99 173.1 36.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.443 1.024 . . . . 0.0 115.54 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -94.59 -13.55 25.84 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER 57.43 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 128.458 2.703 . . . . 0.0 116.912 165.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mmt -136.05 -71.08 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.944 -1.723 . . . . 0.0 113.716 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.97 158.4 40.58 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.05 0.94 . . . . 0.0 111.36 -168.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -107.48 153.99 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -155.81 93.03 1.42 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.526 1.13 . . . . 0.0 111.609 164.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.45 135.74 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 120.626 -1.296 . . . . 0.0 112.164 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.41 146.79 13.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.448 1.899 . . . . 0.0 110.844 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 63.73 -164.05 0.26 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.577 1.951 . . . . 0.0 112.458 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.39 30.13 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.843 1.657 . . . . 0.0 113.938 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.68 174.37 11.25 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.277 2.631 . . . . 0.0 109.68 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.01 143.01 8.14 Favored Glycine 0 CA--C 1.52 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 111.817 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.38 140.48 49.77 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.21 1.004 . . . . 0.0 108.801 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.4 123.83 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -81.83 143.38 31.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.41 1.1 . . . . 0.0 109.893 168.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.61 164.91 20.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.381 1.472 . . . . 0.0 111.59 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.5 137.65 32.57 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 157.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.85 124.71 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 128.041 2.536 . . . . 0.0 116.651 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.79 -24.31 13.41 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.378 2.718 . . . . 0.0 114.042 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -64.29 -38.42 90.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.682 1.128 . . . . 0.0 110.362 170.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -35.2 80.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.627 1.571 . . . . 0.0 112.071 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.64 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.316 -0.865 . . . . 0.0 112.162 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.296 6.4 ppt_? -69.24 -34.08 74.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.837 0.744 . . . . 0.0 112.924 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -68.31 -33.22 73.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.442 1.019 . . . . 0.0 112.741 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.67 -68.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 69' ' ' LEU 0.259 1.3 pp -72.58 -27.87 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.403 1.456 . . . . 0.0 114.682 -176.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -80.22 -19.34 47.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.3 1.864 . . . . 0.0 114.026 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.1 t -107.41 -30.13 8.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 119.662 1.119 . . . . 0.0 112.134 171.752 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.6 163.91 33.33 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 110.626 171.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -152.21 140.35 20.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.181 0.592 . . . . 0.0 111.848 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -93.07 137.74 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.857 1.263 . . . . 0.0 109.909 163.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.465 0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 111.977 178.431 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 CA-C-O 119.745 -0.19 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -87.77 147.92 24.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.85 163.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.18 154.91 30.03 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.175 1.39 . . . . 0.0 109.23 -172.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -142.03 123.75 15.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.542 1.064 . . . . 0.0 112.883 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 tt -113.87 105.79 13.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.854 2.462 . . . . 0.0 108.904 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -94.75 142.38 27.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.186 0.994 . . . . 0.0 111.162 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 mt -138.51 131.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.386 1.074 . . . . 0.0 110.839 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.38 150.91 18.61 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.904 0.764 . . . . 0.0 112.531 167.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 61.34 27.21 16.9 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.66 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -134.99 -45.97 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.04 1.736 . . . . 0.0 113.386 172.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.66 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 71.7 Cg_endo -73.14 21.27 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.654 2.236 . . . . 0.0 114.864 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.12 -21.92 49.63 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.063 2.145 . . . . 0.0 110.948 169.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.87 162.86 25.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.695 1.598 . . . . 0.0 111.194 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -84.98 106.33 16.4 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.967 0.907 . . . . 0.0 109.257 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.48 137.69 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.788 1.235 . . . . 0.0 111.63 -170.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -123.19 172.32 8.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.83 1.652 . . . . 0.0 111.736 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -48.49 -53.0 19.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.072 1.349 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -62.29 -31.16 71.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.77 -49.28 13.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.837 0.744 . . . . 0.0 112.263 -174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 33' ' ' ILE . 4.3 pp -65.91 -29.24 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -67.99 -53.2 27.85 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.42 0.688 . . . . 0.0 111.991 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -67.39 -32.34 73.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.138 1.336 . . . . 0.0 112.797 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.54 -45.64 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.51 -3.73 57.42 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -48.37 40.2 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.15 -14.35 16.73 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.874 1.716 . . . . 0.0 113.496 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -91.34 -24.12 19.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.553 . . . . 0.0 113.582 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.91 169.54 42.23 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.97 -18.26 56.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -166.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.33 148.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 128.271 2.628 . . . . 0.0 116.224 173.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.7 mmt -131.99 -96.88 0.32 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.196 1.799 . . . . 0.0 110.427 167.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' H ' ' HB2' ' A' ' 43' ' ' GLN . 81.9 mt-30 -120.78 173.07 7.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.972 2.109 . . . . 0.0 112.314 -168.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 20' ' ' LEU . 10.5 pt -124.92 145.32 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.315 -0.866 . . . . 0.0 112.798 -172.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -154.15 70.41 0.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.158 0.98 . . . . 0.0 113.121 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.73 117.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 108.434 170.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -150.51 150.34 31.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.793 2.437 . . . . 0.0 109.051 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 56.29 -170.37 0.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 113.218 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.82 1.79 3.06 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 120.267 -1.521 . . . . 0.0 113.623 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -144.04 59.62 1.36 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.768 2.427 . . . . 0.0 110.815 -159.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 173.89 42.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.948 1.261 . . . . 0.0 113.217 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -143.82 165.49 27.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.008 1.385 . . . . 0.0 113.966 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.9 mt -129.68 134.5 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 126.017 1.727 . . . . 0.0 107.16 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.466 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 71.8 mt-30 -85.54 141.46 29.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 169.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.86 164.08 21.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 111.59 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.85 141.14 31.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 160.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 62.26 148.84 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 127.706 2.403 . . . . 0.0 115.689 -166.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.48 -33.24 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.632 2.888 . . . . 0.0 112.496 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -60.45 -38.48 84.28 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.761 -0.587 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.0 m -53.59 -43.76 68.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.088 1.355 . . . . 0.0 113.645 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.3 -51.45 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.437 0.695 . . . . 0.0 109.8 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.94 -38.45 66.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.36 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 -31.59 72.82 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.923 1.238 . . . . 0.0 112.505 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.74 -64.05 1.03 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.498 0.719 . . . . 0.0 112.744 173.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.83 -24.15 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.69 -13.66 62.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.915 1.689 . . . . 0.0 111.579 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.5 t -105.12 -37.21 7.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.165 1.386 . . . . 0.0 112.906 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 N--CA 1.473 0.696 0 O-C-N 120.93 -1.106 . . . . 0.0 113.161 -179.512 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.6 pt . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.834 0.349 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.05 165.39 30.06 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.783 0.833 . . . . 0.0 112.566 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -141.17 135.74 31.13 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.11 -0.369 . . . . 0.0 111.299 160.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.06 135.51 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.885 1.274 . . . . 0.0 110.676 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.466 0.363 0 C-N-CA 124.505 1.122 . . . . 0.0 111.981 -175.448 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.478 0.568 0 N-CA-C 112.677 0.222 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -120.17 124.04 44.76 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.941 0.897 . . . . 0.0 111.181 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -138.44 161.69 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.054 1.742 . . . . 0.0 112.126 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -134.75 125.56 27.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.119 -0.988 . . . . 0.0 111.658 -172.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -111.37 125.12 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.205 2.602 . . . . 0.0 109.022 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.81 128.58 53.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.406 0.682 . . . . 0.0 110.568 165.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.84 134.69 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.25 -158.96 0.43 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.457 0.551 . . . . 0.0 112.787 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -70.65 73.64 0.55 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.293 1.037 . . . . 0.0 113.256 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.3 tp -129.02 -35.68 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.261 1.825 . . . . 0.0 112.772 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.23 42.7 0.14 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.621 3.547 . . . . 0.0 115.896 168.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -15.23 63.45 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.261 -1.524 . . . . 0.0 113.102 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -95.97 166.32 11.83 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.652 1.581 . . . . 0.0 111.423 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -60.8 126.27 26.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.884 0.874 . . . . 0.0 111.068 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.42 121.96 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.456 1.503 . . . . 0.0 107.972 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -101.19 170.25 8.37 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.867 0.867 . . . . 0.0 111.668 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -54.39 -39.59 67.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.635 . . . . 0.0 112.41 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -71.51 -30.39 65.89 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.87 -54.32 16.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.923 1.238 . . . . 0.0 111.086 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.36 -32.79 73.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.178 -0.326 . . . . 0.0 111.782 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.62 -50.83 61.72 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.522 -0.736 . . . . 0.0 111.447 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -66.88 -38.67 86.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.207 1.367 . . . . 0.0 112.643 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.38 -28.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.291 0.951 . . . . 0.0 112.774 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.33 -2.12 31.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -49.66 -51.95 55.12 Favored Pre-proline 0 N--CA 1.48 1.053 0 CA-C-N 120.107 1.321 . . . . 0.0 114.359 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.77 -19.72 16.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.424 1.544 . . . . 0.0 113.983 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -87.22 -19.94 27.64 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.293 -0.88 . . . . 0.0 112.379 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.32 39.21 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -108.35 -7.46 15.88 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.245 1.942 . . . . 0.0 116.245 -170.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.0 155.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 127.952 2.501 . . . . 0.0 117.278 164.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mmt -139.76 -65.09 0.47 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.296 1.438 . . . . 0.0 112.79 165.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -152.56 159.86 43.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.112 0.965 . . . . 0.0 112.293 -163.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.69 143.4 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.741 1.216 . . . . 0.0 111.327 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -156.26 97.57 1.78 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.994 0.917 . . . . 0.0 112.283 161.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.48 133.83 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.978 -1.076 . . . . 0.0 111.639 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -153.3 162.92 40.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.218 2.607 . . . . 0.0 109.478 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.12 -159.64 0.27 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.409 1.084 . . . . 0.0 112.623 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.14 60.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.962 1.305 . . . . 0.0 113.985 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -103.8 -172.05 2.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.27 1.828 . . . . 0.0 111.885 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.07 145.79 11.21 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 120.525 -1.359 . . . . 0.0 114.219 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.09 138.14 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.29 1.036 . . . . 0.0 110.693 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.5 mt -139.88 133.07 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.91 150.67 20.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.493 -1.379 . . . . 0.0 110.072 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.79 156.72 47.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.857 1.663 . . . . 0.0 112.414 -165.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -94.09 141.22 28.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 58.51 128.92 0.02 OUTLIER Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 128.86 2.864 . . . . 0.0 116.259 -167.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.58 -27.45 38.96 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.274 1.983 . . . . 0.0 114.349 172.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -68.44 -29.8 68.54 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.313 -1.492 . . . . 0.0 112.309 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -62.81 -33.98 76.34 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.71 -54.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.456 0.571 . . . . 0.0 110.897 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.422 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.5 -18.1 62.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.6 -61.41 1.78 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.102 0.865 . . . . 0.0 110.752 166.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.31 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.288 -0.882 . . . . 0.0 111.914 -171.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 -5.33 50.67 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.81 1.244 . . . . 0.0 112.91 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 t -115.03 -31.98 5.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.538 1.063 . . . . 0.0 113.327 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 178.15 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.454 0.645 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.05 174.94 12.59 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.077 1.751 . . . . 0.0 111.842 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -148.62 119.48 7.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.966 0.506 . . . . 0.0 111.53 171.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.08 126.84 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.264 1.425 . . . . 0.0 109.158 166.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 124.358 1.063 . . . . 0.0 112.403 -168.073 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 CA--C 1.539 0.766 0 N-CA-C 112.363 0.101 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -128.12 147.8 50.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.133 1.373 . . . . 0.0 111.304 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.63 155.53 34.85 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.355 2.262 . . . . 0.0 107.865 -171.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -117.07 135.2 53.91 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.044 -1.035 . . . . 0.0 112.218 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -121.69 100.9 7.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.493 2.717 . . . . 0.0 108.173 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -101.82 134.87 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.024 -0.423 . . . . 0.0 110.988 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.24 136.23 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.079 1.352 . . . . 0.0 107.566 165.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.91 -151.24 0.27 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.034 0.826 . . . . 0.0 113.556 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -73.82 87.2 1.74 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.25 1.02 . . . . 0.0 111.097 -170.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.428 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 3.2 tm? -146.97 -52.91 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.839 2.056 . . . . 0.0 111.99 -169.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 93.7 Cg_endo -74.36 72.66 4.16 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.859 2.373 . . . . 0.0 110.805 169.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.04 -37.63 54.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.923 1.289 . . . . 0.0 111.514 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -73.53 162.3 29.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.084 1.354 . . . . 0.0 112.611 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -63.11 131.73 49.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.794 0.838 . . . . 0.0 110.508 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.56 152.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.918 1.687 . . . . 0.0 109.266 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -133.53 166.96 21.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.509 1.123 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -51.46 -43.11 62.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.763 1.225 . . . . 0.0 112.496 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.09 -30.89 71.05 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -73.74 -49.61 24.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.784 1.174 . . . . 0.0 111.981 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.19 -33.0 74.97 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.315 -0.865 . . . . 0.0 111.645 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -66.75 -47.9 70.78 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.986 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -70.44 -28.4 65.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.721 1.146 . . . . 0.0 112.82 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.02 -39.2 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.237 0.926 . . . . 0.0 112.949 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -90.26 -7.3 53.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 m -49.12 -44.37 72.28 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 120.778 1.626 . . . . 0.0 115.34 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.33 -14.71 18.25 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 CA-C-N 122.341 1.872 . . . . 0.0 113.808 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -87.06 -37.01 17.83 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.555 -1.341 . . . . 0.0 112.957 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.28 -178.44 36.15 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.646 1.818 . . . . 0.0 117.646 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.408 ' CG ' HD22 ' A' ' 46' ' ' ASN . 76.1 m80 -92.75 -14.46 27.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -160.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 61.18 154.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 127.67 2.388 . . . . 0.0 116.71 173.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -145.43 -59.7 0.34 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.415 1.486 . . . . 0.0 113.098 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -162.04 171.81 16.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.006 1.722 . . . . 0.0 110.377 -170.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.5 152.81 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.171 -1.58 . . . . 0.0 113.037 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -152.15 136.19 16.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.114 1.765 . . . . 0.0 107.922 161.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.75 135.55 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.942 1.297 . . . . 0.0 108.561 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -145.79 143.13 29.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.877 0.871 . . . . 0.0 111.277 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 44.44 -124.04 0.96 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 124.803 1.241 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.59 2.84 46.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.132 1.773 . . . . 0.0 115.22 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -134.44 158.44 43.88 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.17 136.25 11.49 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.153 0.883 . . . . 0.0 112.355 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -131.31 64.72 1.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 0.0 110.04 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.25 157.88 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.513 1.525 . . . . 0.0 109.867 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -118.58 132.33 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.122 1.369 . . . . 0.0 109.169 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -123.7 156.25 36.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.891 1.276 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -77.64 149.12 34.76 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 157.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.408 HD22 ' CG ' ' A' ' 29' ' ' HIS . 69.0 m-20 56.38 124.27 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 127.987 2.515 . . . . 0.0 116.669 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.8 -28.45 30.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.745 2.297 . . . . 0.0 113.332 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.11 -32.41 69.8 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.609 0.64 . . . . 0.0 112.095 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -30.55 36.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.43 -59.78 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.746 0.818 . . . . 0.0 110.563 165.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -36.61 82.43 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.513 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.716 1.144 . . . . 0.0 112.181 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -55.31 23.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.757 1.162 . . . . 0.0 112.583 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 mt -68.86 -49.83 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.567 0.621 . . . . 0.0 110.946 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -75.52 -30.99 59.97 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.957 0.799 . . . . 0.0 113.074 -168.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -80.44 -38.76 29.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.835 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 N--CA 1.476 0.843 0 CA-C-N 120.284 1.402 . . . . 0.0 113.467 -179.516 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.1 pt . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 120.687 0.28 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 175.25 12.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.109 0.964 . . . . 0.0 113.222 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -145.22 123.36 12.16 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.178 161.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.5 129.21 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 109.61 166.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.327 172.564 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.482 0.841 0 CA-C-O 118.839 -0.567 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.78 137.32 58.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.364 0.529 . . . . 0.0 109.985 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -145.91 168.06 21.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.793 2.037 . . . . 0.0 109.331 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -147.2 124.62 11.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.942 1.247 . . . . 0.0 114.012 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tt -113.6 125.28 53.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.735 2.414 . . . . 0.0 110.156 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -118.77 142.05 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.258 0.623 . . . . 0.0 111.409 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.92 139.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.15 1.38 . . . . 0.0 108.788 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.46 143.24 14.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.461 0.553 . . . . 0.0 113.999 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 52.8 34.98 17.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.928 1.291 . . . . 0.0 112.972 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.542 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.7 tt -128.51 -51.56 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.664 2.385 . . . . 0.0 109.804 171.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 91.7 Cg_endo -78.75 88.94 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.449 2.1 . . . . 0.0 110.845 170.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.9 -12.7 17.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.416 1.886 . . . . 0.0 112.533 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -96.41 171.82 8.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.825 1.65 . . . . 0.0 111.684 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -68.47 139.66 55.71 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.34 138.15 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.183 1.793 . . . . 0.0 108.273 -175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -112.04 171.3 7.59 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.877 0.871 . . . . 0.0 111.992 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -55.07 -36.63 65.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.597 1.159 . . . . 0.0 112.772 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -69.28 -30.83 69.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.03 -56.95 7.05 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.996 0.817 . . . . 0.0 110.907 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.89 -35.02 79.28 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.905 -0.497 . . . . 0.0 111.623 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.75 -48.58 68.67 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.582 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -69.58 -35.3 75.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.632 1.56 . . . . 0.0 112.72 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.02 -31.72 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.13 -13.13 28.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.23 -47.56 66.59 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.509 1.504 . . . . 0.0 114.934 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -0.5 9.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 CA-C-N 121.673 1.633 . . . . 0.0 113.83 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -115.25 -20.09 10.5 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.125 1.77 . . . . 0.0 114.287 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.44 163.32 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -83.84 -21.04 32.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -161.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 64.27 154.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 126.582 1.953 . . . . 0.0 115.756 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.8 mmt -134.62 -65.7 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.73 -1.231 . . . . 0.0 113.179 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.38 160.51 41.71 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.489 1.116 . . . . 0.0 111.137 -165.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.11 153.01 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -149.41 136.95 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.9 2.08 . . . . 0.0 107.392 158.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt -140.49 121.75 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 108.291 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -149.29 153.41 37.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.972 1.309 . . . . 0.0 111.258 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 55.84 -140.19 0.91 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.996 0.918 . . . . 0.0 111.332 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 21.81 2.34 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.288 1.435 . . . . 0.0 113.418 170.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -131.02 169.95 15.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.127 1.371 . . . . 0.0 112.468 -163.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.39 140.73 10.5 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.445 1.497 . . . . 0.0 111.64 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -130.76 67.07 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.024 2.13 . . . . 0.0 109.834 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.5 120.91 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 120.834 -1.166 . . . . 0.0 110.058 -165.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -83.78 135.98 34.33 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.557 -0.714 . . . . 0.0 109.561 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -122.23 164.77 17.26 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.642 1.577 . . . . 0.0 112.106 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -98.14 139.51 33.82 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 156.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 67.47 145.17 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 128.439 2.696 . . . . 0.0 116.647 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.55 -43.44 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.353 2.702 . . . . 0.0 112.265 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -62.07 -30.1 70.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.907 0.883 . . . . 0.0 111.854 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -73.93 -19.92 60.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 114.923 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.28 -51.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.068 0.849 . . . . 0.0 110.266 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -43.37 98.98 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.559 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.36 -24.47 63.9 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.316 1.417 . . . . 0.0 112.961 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.45 -66.79 0.52 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.294 0.952 . . . . 0.0 111.44 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.19 -23.94 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.165 -1.584 . . . . 0.0 114.769 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -91.85 -0.19 57.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.665 1.575 . . . . 0.0 113.373 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 t -133.8 -29.43 1.32 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.127 1.331 . . . . 0.0 114.009 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 . . . . . 0 N--CA 1.471 0.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.64 169.483 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.77 165.82 24.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.915 0.886 . . . . 0.0 112.857 171.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -152.33 135.08 15.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.278 1.031 . . . . 0.0 110.769 170.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.44 133.29 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.075 1.35 . . . . 0.0 110.365 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 124.408 1.083 . . . . 0.0 111.524 -175.385 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 N--CA 1.482 0.847 0 CA-C-O 119.207 -0.414 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.0 153.59 43.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 112.885 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.71 163.77 36.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 108.152 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -136.84 126.4 25.26 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.152 1.342 . . . . 0.0 113.68 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.76 130.26 39.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.541 2.736 . . . . 0.0 108.501 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.65 134.9 49.63 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.288 0.635 . . . . 0.0 110.439 164.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.31 135.3 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.769 1.228 . . . . 0.0 108.347 169.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.88 -156.63 2.06 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.151 0.881 . . . . 0.0 112.315 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -63.92 90.46 0.06 Allowed 'General case' 0 CA--C 1.551 0.986 0 O-C-N 121.429 -1.042 . . . . 0.0 112.617 -173.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 66.0 tp -153.24 -48.69 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.23 1.812 . . . . 0.0 113.872 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 67.7 Cg_endo -77.07 56.7 5.52 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.362 2.708 . . . . 0.0 112.444 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.92 -4.06 35.82 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.275 1.43 . . . . 0.0 112.78 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -85.23 170.63 12.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.678 1.991 . . . . 0.0 111.602 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -69.48 129.09 38.75 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.654 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.03 127.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.729 0.776 . . . . 0.0 112.723 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -127.22 -179.92 5.12 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.597 1.559 . . . . 0.0 110.548 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -45.78 -48.93 15.48 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.541 1.936 . . . . 0.0 112.912 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -66.31 -36.3 82.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.44 0.564 . . . . 0.0 112.377 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.32 -56.6 7.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.6 -29.54 70.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.903 -0.498 . . . . 0.0 112.056 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.86 -52.08 27.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.06 -0.972 . . . . 0.0 111.586 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -64.29 -38.59 91.59 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.59 1.541 . . . . 0.0 111.799 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -74.67 -26.75 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.03 -11.31 20.69 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 m -45.4 -47.89 35.19 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.82 -7.47 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.255 1.841 . . . . 0.0 113.872 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -109.36 -41.15 4.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.939 1.295 . . . . 0.0 112.771 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.23 168.58 27.71 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -170.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -92.3 -15.54 27.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -163.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 0.2 OUTLIER 60.06 155.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 127.905 2.482 . . . . 0.0 115.704 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.5 mmt -137.86 -65.02 0.53 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.831 1.653 . . . . 0.0 112.077 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -158.64 165.51 34.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.004 1.322 . . . . 0.0 111.969 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 pt -128.74 147.51 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -165.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.33 92.03 1.3 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.382 1.473 . . . . 0.0 111.933 162.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.79 136.98 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.88 -1.137 . . . . 0.0 110.244 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -157.76 146.8 19.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.486 1.915 . . . . 0.0 109.052 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.09 -160.06 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.099 0.96 . . . . 0.0 111.786 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.17 -9.89 57.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.655 1.582 . . . . 0.0 114.456 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -111.95 -178.18 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.206 2.203 . . . . 0.0 111.029 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.66 146.43 10.63 Favored Glycine 0 N--CA 1.466 0.638 0 O-C-N 120.264 -1.523 . . . . 0.0 114.899 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.45 133.5 51.03 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 109.255 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.4 mt -138.0 119.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -73.1 137.0 44.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -121.91 163.91 18.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.309 1.843 . . . . 0.0 109.985 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.29 136.53 32.94 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 160.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.332 6.5 p30 54.24 139.22 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 130.158 3.383 . . . . 0.0 118.368 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.04 -27.63 13.8 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.368 2.712 . . . . 0.0 113.988 -170.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -65.67 -35.6 81.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.65 -0.656 . . . . 0.0 110.911 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -37.1 82.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.966 1.706 . . . . 0.0 112.182 172.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.25 -59.9 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.8 0.727 . . . . 0.0 111.245 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -36.2 79.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.612 -169.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.49 -37.68 88.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.47 80.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 111.8 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.7 mt -71.01 -51.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.348 -0.845 . . . . 0.0 111.023 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -66.18 -33.9 76.81 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.437 -0.79 . . . . 0.0 111.22 -171.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t -102.0 -15.19 16.87 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 N--CA 1.48 1.034 0 CA-C-N 120.823 1.647 . . . . 0.0 113.986 176.324 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.2 mt . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.57 172.53 18.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.116 0.966 . . . . 0.0 113.599 -175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -147.51 122.72 10.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 112.249 163.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.58 145.67 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 C--O 1.236 0.36 0 C-N-CA 123.914 0.885 . . . . 0.0 112.477 171.886 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 111.624 -0.183 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.64 148.52 34.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 122.24 1.019 . . . . 0.0 113.308 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -159.88 164.27 33.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 109.428 -172.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -143.17 127.14 17.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.849 1.66 . . . . 0.0 111.941 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.515 HD13 ' CE1' ' A' ' 44' ' ' PHE . 7.5 tt -117.98 120.7 38.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.421 2.688 . . . . 0.0 109.737 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.86 124.3 52.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.191 0.597 . . . . 0.0 110.856 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 mm -81.94 141.12 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.913 0.885 . . . . 0.0 108.777 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.26 -163.56 1.42 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.643 0.64 . . . . 0.0 113.076 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -74.38 41.02 0.14 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.0 mt -97.18 -46.72 0.24 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.365 1.866 . . . . 0.0 114.146 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.68 73.44 5.81 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.426 2.75 . . . . 0.0 111.748 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.56 -13.97 59.57 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.514 165.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -83.49 150.12 26.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.151 1.78 . . . . 0.0 112.107 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -59.0 152.09 20.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.804 0.842 . . . . 0.0 111.587 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.44 160.46 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.173 0.989 . . . . 0.0 111.65 -171.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -125.18 167.75 14.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.758 1.223 . . . . 0.0 112.574 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -52.67 -33.15 45.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.434 0.694 . . . . 0.0 112.704 166.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.68 -35.52 74.64 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -78.39 -51.12 10.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.63 -36.53 81.04 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.919 -0.488 . . . . 0.0 111.303 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -71.5 -42.57 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.286 -0.884 . . . . 0.0 111.75 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -64.27 -44.78 90.66 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.214 1.37 . . . . 0.0 111.592 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -78.14 -30.46 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 117.875 -1.059 . . . . 0.0 113.175 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -93.12 -14.32 27.38 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.1 m -45.68 -48.67 37.98 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-N 120.738 1.608 . . . . 0.0 115.305 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.5 -3.35 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.963 1.379 . . . . 0.0 114.068 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.71 -26.64 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.206 1.402 . . . . 0.0 113.119 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.31 176.3 39.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 122.553 1.085 . . . . 0.0 115.506 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -96.75 -17.95 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -166.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 44' ' ' PHE 0.309 0.1 OUTLIER 58.66 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 127.458 2.303 . . . . 0.0 115.634 175.686 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.7 mmt -139.94 -63.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.703 1.601 . . . . 0.0 112.069 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -153.22 169.59 22.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.368 1.467 . . . . 0.0 111.224 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.3 149.94 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 120.877 -1.139 . . . . 0.0 112.686 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -156.35 131.26 9.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.861 1.264 . . . . 0.0 108.73 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.7 mt -143.05 120.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.03 159.92 43.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.163 1.785 . . . . 0.0 110.319 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 52.36 -137.7 1.19 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.765 1.226 . . . . 0.0 112.598 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.77 12.08 22.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.839 1.655 . . . . 0.0 113.457 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.75 -172.59 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -162.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.43 135.65 5.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.311 0.958 . . . . 0.0 112.147 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.58 64.92 0.76 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.993 2.117 . . . . 0.0 109.93 -169.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.98 144.82 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.44 1.096 . . . . 0.0 110.078 -167.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -109.22 143.19 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.82 -1.175 . . . . 0.0 110.513 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 5' ' ' LEU . 11.4 m-85 -134.52 165.77 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.967 1.307 . . . . 0.0 112.586 -169.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -100.8 136.46 40.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.403 1.081 . . . . 0.0 109.186 164.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER 59.19 153.19 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 129.189 2.996 . . . . 0.0 116.487 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.75 -29.83 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.231 2.621 . . . . 0.0 113.893 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -66.84 -41.3 87.62 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.854 . . . . 0.0 110.548 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.29 -40.58 35.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.978 2.511 . . . . 0.0 113.595 167.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.56 -58.86 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.332 0.515 . . . . 0.0 111.467 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.81 91.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.011 -172.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.0 -39.37 87.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.615 1.098 . . . . 0.0 112.758 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.57 93.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.475 0.71 . . . . 0.0 111.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.46 -53.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.155 -0.966 . . . . 0.0 111.467 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -62.33 -25.81 68.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.49 1.116 . . . . 0.0 113.015 -169.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.4 t -105.71 -28.22 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.483 1.212 0 CA-C-N 120.81 1.641 . . . . 0.0 114.791 -172.873 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 mm . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.522 0.677 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.05 177.53 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.539 1.936 . . . . 0.0 110.939 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.03 145.34 32.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.597 0.759 . . . . 0.0 111.943 157.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 p -123.78 127.15 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.086 1.754 . . . . 0.0 109.722 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 124.501 1.121 . . . . 0.0 110.693 173.611 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -98.88 66.42 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.493 1.917 . . . . 0.0 110.222 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.08 157.29 38.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.544 1.138 . . . . 0.0 111.683 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -132.97 134.36 44.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.292 1.037 . . . . 0.0 112.895 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 tt -126.83 111.05 13.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.143 2.177 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -107.73 125.45 51.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.99 0.916 . . . . 0.0 110.136 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mt -114.97 138.78 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.022 0.929 . . . . 0.0 109.491 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.36 -146.38 0.32 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.878 1.228 . . . . 0.0 113.297 166.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -75.1 72.28 2.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.923 1.289 . . . . 0.0 112.48 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.434 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 64.0 tp -131.03 -53.16 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 116.893 -1.527 . . . . 0.0 114.65 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 45.7 Cg_endo -79.99 53.14 4.61 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.151 2.567 . . . . 0.0 111.923 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.24 -22.73 51.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.379 1.472 . . . . 0.0 111.972 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.15 165.92 15.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.989 1.715 . . . . 0.0 111.848 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -57.37 131.18 49.31 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.546 0.739 . . . . 0.0 111.253 165.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -144.27 129.18 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.517 1.127 . . . . 0.0 110.301 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.5 p -99.71 170.45 8.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.667 1.187 . . . . 0.0 111.779 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.67 -34.19 64.79 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.295 -0.878 . . . . 0.0 112.627 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.29 -32.47 66.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.47 -36.59 68.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 112.906 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.64 -32.83 58.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.841 0.456 . . . . 0.0 112.128 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -61.8 -46.2 90.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.558 0.743 . . . . 0.0 111.452 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -66.22 -46.01 78.67 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.148 0.885 . . . . 0.0 112.028 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.93 -26.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.416 1.007 . . . . 0.0 113.695 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -99.63 -0.5 40.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -46.49 -53.46 24.13 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.7 -7.76 11.43 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.668 1.579 . . . . 0.0 114.225 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -83.75 -23.57 31.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.133 1.373 . . . . 0.0 112.207 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.62 -173.59 44.86 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -106.32 -10.98 16.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -157.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 62.04 154.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 127.848 2.459 . . . . 0.0 116.504 170.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.446 ' H ' HD13 ' A' ' 30' ' ' ILE . 8.0 mmt -143.99 -64.78 0.37 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.474 1.509 . . . . 0.0 113.127 169.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -160.65 176.11 11.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.066 1.346 . . . . 0.0 111.994 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.37 157.4 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.553 1.07 . . . . 0.0 112.724 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -156.74 103.96 2.12 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.873 1.269 . . . . 0.0 110.792 166.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -118.21 116.75 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.581 -1.324 . . . . 0.0 110.518 -173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -148.74 149.5 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.385 1.874 . . . . 0.0 111.021 -168.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 t30 58.44 -163.03 0.21 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.149 1.38 . . . . 0.0 112.786 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.02 29.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 O-C-N 119.695 -1.878 . . . . 0.0 114.021 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -144.25 179.22 7.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.321 2.249 . . . . 0.0 109.872 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.8 144.91 9.27 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 121.191 -0.943 . . . . 0.0 112.597 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -131.5 144.85 51.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -138.42 152.82 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.5 141.89 48.12 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.365 1.066 . . . . 0.0 108.953 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -132.41 155.95 47.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.526 1.131 . . . . 0.0 111.287 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -84.17 135.33 34.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 158.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 60.94 139.41 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 128.477 2.711 . . . . 0.0 116.703 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.79 -25.02 24.31 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.307 2.672 . . . . 0.0 112.444 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.07 -34.54 76.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.213 1.005 . . . . 0.0 111.209 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -64.57 -43.56 93.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.418 1.087 . . . . 0.0 112.345 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.14 -49.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 123.554 0.741 . . . . 0.0 110.569 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -61.93 -53.52 54.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.851 0.751 . . . . 0.0 111.322 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -70.99 -24.01 62.3 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.19 5.65 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.319 0.963 . . . . 0.0 111.131 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -75.87 -43.28 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.572 -0.705 . . . . 0.0 111.438 -172.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 -17.41 63.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.972 1.309 . . . . 0.0 112.728 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 t -105.17 4.24 31.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.525 1.13 . . . . 0.0 112.701 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 . . . . . 0 N--CA 1.471 0.583 0 C-N-CA 124.171 0.988 . . . . 0.0 112.46 -175.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.8 35.54 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 112.943 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.59 130.97 25.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 166.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.57 125.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.795 1.638 . . . . 0.0 108.649 165.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t . . . . . 0 N--CA 1.468 0.473 0 C-N-CA 123.954 0.902 . . . . 0.0 111.973 -177.686 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 CA--C 1.545 1.043 0 N-CA-C 114.11 0.773 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -130.98 49.91 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.692 1.997 . . . . 0.0 112.119 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -59.42 161.18 5.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.689 1.595 . . . . 0.0 111.786 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -125.14 125.48 43.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.361 1.065 . . . . 0.0 111.449 -165.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -119.8 123.27 43.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.271 1.828 . . . . 0.0 108.949 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -117.13 146.42 43.18 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.591 1.157 . . . . 0.0 110.929 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.38 139.45 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.814 1.646 . . . . 0.0 110.165 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.98 149.05 18.38 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.746 1.165 . . . . 0.0 113.78 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.05 36.37 27.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.6 tt -134.93 -56.22 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.791 1.636 . . . . 0.0 112.179 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 72.0 Cg_endo -74.47 99.42 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.27 1.98 . . . . 0.0 111.593 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.37 23.37 3.46 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.986 2.515 . . . . 0.0 111.313 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -137.74 161.64 36.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.806 2.442 . . . . 0.0 108.9 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -56.43 131.92 49.77 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.03 0.832 . . . . 0.0 109.957 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.59 135.05 12.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.291 1.436 . . . . 0.0 109.269 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 167.2 11.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.448 1.499 . . . . 0.0 110.082 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -54.22 -32.0 54.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -65.81 -31.94 73.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.088 1.355 . . . . 0.0 113.93 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.45 -50.8 13.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.816 0.846 . . . . 0.0 110.81 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.43 -30.17 70.47 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.434 -0.791 . . . . 0.0 111.897 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -69.87 -45.29 68.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.871 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -64.66 -39.22 93.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.902 1.228 . . . . 0.0 112.234 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -76.49 -38.39 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.425 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -89.52 -4.39 57.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -48.13 -49.56 59.92 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.41 -19.83 16.65 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 121.84 1.693 . . . . 0.0 113.713 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -77.22 -31.19 55.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.656 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.9 -175.36 46.67 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -18.07 25.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -159.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 62.04 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.343 2.257 . . . . 0.0 115.474 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.427 ' H ' HD13 ' A' ' 30' ' ' ILE . 6.2 mmt -139.35 -72.46 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.529 1.531 . . . . 0.0 112.258 166.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -142.84 171.53 13.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.37 1.868 . . . . 0.0 112.217 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 pt -131.88 150.87 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.579 1.151 . . . . 0.0 113.459 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -151.84 96.46 2.23 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.01 1.724 . . . . 0.0 109.889 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.14 130.99 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.388 -1.445 . . . . 0.0 111.961 -171.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -163.79 141.02 7.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.184 1.394 . . . . 0.0 112.724 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 41.11 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.897 2.479 . . . . 0.0 114.995 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.78 -7.83 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.926 2.49 . . . . 0.0 117.494 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.31 164.88 21.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.838 1.655 . . . . 0.0 110.806 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.74 152.68 24.25 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.79 0.709 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.24 140.73 45.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.506 1.123 . . . . 0.0 109.667 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -134.76 117.57 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -75.97 140.29 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.35 153.94 44.22 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.758 1.623 . . . . 0.0 110.966 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.33 145.74 28.89 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 152.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 58.88 135.66 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.012 2.925 . . . . 0.0 116.883 -171.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.13 -31.93 11.44 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.259 1.973 . . . . 0.0 112.808 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.55 -29.31 69.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.719 0.69 . . . . 0.0 111.406 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 m -66.24 -46.76 76.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.796 1.238 . . . . 0.0 113.379 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.94 -51.69 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.78 0.832 . . . . 0.0 111.526 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -47.03 63.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.913 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.56 -13.81 61.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.647 1.112 . . . . 0.0 113.639 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.55 -77.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.405 1.482 . . . . 0.0 112.196 164.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.95 -32.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 O-C-N 120.444 -1.41 . . . . 0.0 114.39 -171.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.58 -12.18 60.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.644 1.111 . . . . 0.0 113.032 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -105.65 -25.03 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.504 1.521 . . . . 0.0 112.653 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.792 1.237 . . . . 0.0 113.55 -174.428 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.0 pt . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.71 162.71 34.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -171.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -143.68 128.71 18.57 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.673 -0.642 . . . . 0.0 112.298 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.61 126.67 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.076 2.15 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 174.074 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.989 -0.427 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -60.35 134.61 57.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.251 1.02 . . . . 0.0 112.137 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -145.79 166.07 26.99 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.187 2.195 . . . . 0.0 110.56 -164.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.7 ttp-105 -148.32 130.32 15.33 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.878 -1.139 . . . . 0.0 113.23 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.72 111.55 23.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.22 2.608 . . . . 0.0 109.123 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -109.98 133.57 53.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.816 1.246 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 mt -131.14 141.98 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.553 1.141 . . . . 0.0 110.541 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.07 -137.98 0.3 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.467 1.508 . . . . 0.0 113.626 164.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -78.7 78.82 5.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 0.0 111.667 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.506 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 58.4 tp -139.48 -55.34 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.377 165.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 60.6 Cg_endo -75.15 23.56 0.41 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.839 2.359 . . . . 0.0 114.184 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 tt -67.24 -41.83 85.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.722 1.209 . . . . 0.0 113.232 -163.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -144.3 -23.29 0.54 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.45 18.8 13.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.111 1.364 . . . . 0.0 113.614 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.45 125.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 111.067 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 m -111.79 175.85 5.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.043 1.337 . . . . 0.0 110.295 164.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -56.22 -37.82 70.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.91 -28.32 68.85 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.06 -52.14 7.72 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 111.798 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.49 -36.55 78.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.613 0.642 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.04 -48.38 63.02 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.264 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -65.14 -35.51 81.34 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.493 1.497 . . . . 0.0 112.617 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.82 -33.36 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -88.61 -18.33 28.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.048 1.294 . . . . 0.0 114.33 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -43.47 -47.23 17.89 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.63 -13.21 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 CA-C-N 121.948 1.731 . . . . 0.0 113.849 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -105.73 -25.65 12.13 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.766 1.226 . . . . 0.0 113.111 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . -149.71 159.0 27.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 118.511 2.165 . . . . 0.0 118.511 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -88.38 -22.12 23.95 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.754 1.622 . . . . 0.0 114.407 -165.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 62.9 156.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.641 2.776 . . . . 0.0 116.768 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.1 mmt -130.97 -71.15 0.58 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.939 1.696 . . . . 0.0 111.325 164.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.19 162.92 39.53 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.446 1.498 . . . . 0.0 111.609 -166.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.66 145.54 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 120.971 -1.081 . . . . 0.0 113.092 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -147.01 137.92 23.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.196 1.398 . . . . 0.0 109.007 159.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.9 mt -139.34 122.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.911 1.284 . . . . 0.0 108.207 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -158.38 155.09 28.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.797 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 58.29 -151.78 0.41 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 111.479 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.44 25.07 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 113.67 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -143.51 170.22 16.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.373 1.469 . . . . 0.0 112.266 -163.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.91 140.99 12.28 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.032 1.301 . . . . 0.0 112.007 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -131.25 72.27 1.5 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.046 1.338 . . . . 0.0 110.539 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.27 129.78 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 120.686 -1.259 . . . . 0.0 110.094 -167.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.98 137.17 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.612 1.165 . . . . 0.0 109.704 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -133.02 169.87 16.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.896 1.278 . . . . 0.0 112.51 -171.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -112.28 146.02 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.42 1.088 . . . . 0.0 109.139 162.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 60.86 122.56 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 127.586 2.354 . . . . 0.0 115.156 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.13 -34.46 16.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.775 2.316 . . . . 0.0 112.815 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -58.91 -24.94 62.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.817 0.847 . . . . 0.0 112.546 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -82.53 -38.65 23.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 111.949 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.53 -55.25 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.99 0.916 . . . . 0.0 111.62 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.75 99.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.82 -40.0 95.57 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.006 1.275 . . . . 0.0 112.237 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.35 85.06 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.719 0.69 . . . . 0.0 112.026 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.0 mt -71.46 -52.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.41 -19.43 61.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.266 -0.896 . . . . 0.0 113.08 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.6 t -115.27 -8.82 12.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.083 1.353 . . . . 0.0 114.311 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 176.038 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.7 mm . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 166.49 32.63 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.045 0.938 . . . . 0.0 113.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -148.44 133.89 18.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.39 0.676 . . . . 0.0 111.865 163.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.59 133.21 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.152 1.381 . . . . 0.0 109.941 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 CA--C 1.54 0.813 0 N-CA-C 112.937 0.322 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -124.41 133.55 53.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.951 1.7 . . . . 0.0 111.863 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.37 172.86 12.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.8 2.04 . . . . 0.0 109.817 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -144.74 137.75 26.71 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.811 -1.181 . . . . 0.0 111.048 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 5' ' ' LEU . 6.1 tt -136.15 126.32 26.31 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.5 1.92 . . . . 0.0 109.684 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -117.33 143.86 45.5 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.439 1.096 . . . . 0.0 111.817 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.63 113.92 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.579 1.152 . . . . 0.0 109.083 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.78 50.8 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.009 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -150.25 79.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.282 1.041 . . . . 0.0 111.639 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.562 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 1.2 tt -153.0 -48.04 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.669 1.187 . . . . 0.0 112.168 169.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 52.3 Cg_endo -82.35 43.91 1.59 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 113.572 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.84 -23.22 67.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.083 1.353 . . . . 0.0 112.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -72.49 0.24 10.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.29 1.836 . . . . 0.0 113.637 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 51.71 56.72 7.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.018 1.327 . . . . 0.0 112.176 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.07 141.47 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.983 1.313 . . . . 0.0 111.736 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -79.13 174.35 11.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.98 -46.54 61.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.559 1.544 . . . . 0.0 112.45 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -74.57 -24.14 58.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.781 0.832 . . . . 0.0 112.846 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.82 -39.88 29.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.698 1.136 . . . . 0.0 112.251 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.85 -34.75 69.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.801 -0.562 . . . . 0.0 111.083 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -74.69 -37.43 62.64 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.686 -1.259 . . . . 0.0 113.088 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -66.08 -26.67 67.59 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.087 1.767 . . . . 0.0 113.166 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.04 -37.65 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.081 0.952 . . . . 0.0 112.026 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -86.96 -14.88 40.48 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.529 1.513 . . . . 0.0 114.964 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 m -47.59 -50.41 50.8 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.93 6.14 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.945 1.764 . . . . 0.0 114.916 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.4 -22.06 5.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.917 1.287 . . . . 0.0 114.1 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.49 -169.13 21.62 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 119.265 0.939 . . . . 0.0 114.997 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -112.12 -17.22 12.87 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 59.39 156.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 127.277 2.231 . . . . 0.0 116.878 171.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.51 ' H ' HD13 ' A' ' 30' ' ' ILE . 9.3 mmt -138.53 -67.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.417 1.487 . . . . 0.0 112.66 167.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -155.37 172.59 17.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.391 1.476 . . . . 0.0 111.978 -163.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.35 160.42 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.555 -1.34 . . . . 0.0 112.983 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -158.04 114.78 2.87 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.108 1.363 . . . . 0.0 109.959 157.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -128.18 115.54 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.588 -1.32 . . . . 0.0 108.871 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -154.5 160.48 41.58 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.633 1.573 . . . . 0.0 110.927 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 50.33 -147.54 0.36 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.745 1.218 . . . . 0.0 110.912 -174.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.92 7.9 11.8 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 120.046 -1.659 . . . . 0.0 114.99 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.02 -175.02 3.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.882 1.273 . . . . 0.0 112.764 -171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.41 147.13 18.04 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.006 0.812 . . . . 0.0 112.543 166.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -132.9 144.12 49.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.287 1.435 . . . . 0.0 110.356 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 mt -142.68 124.18 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.406 1.082 . . . . 0.0 108.158 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -85.28 139.13 31.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.349 1.071 . . . . 0.0 108.692 168.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.12 169.48 12.15 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.828 -168.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -104.09 144.16 31.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 155.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.52 127.61 0.01 OUTLIER Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 129.115 2.966 . . . . 0.0 117.807 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -29.8 10.12 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.731 2.287 . . . . 0.0 114.82 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -65.52 -35.95 82.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.087 1.312 . . . . 0.0 110.84 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -40.52 89.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.564 1.946 . . . . 0.0 112.728 168.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.36 -51.68 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.387 0.994 . . . . 0.0 112.195 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -24.76 63.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -75.57 -39.03 58.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.436 -0.79 . . . . 0.0 111.706 169.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.0 -62.93 1.37 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.61 0.764 . . . . 0.0 111.996 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.266 1.1 pp -73.1 -44.65 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.91 1.232 . . . . 0.0 114.054 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.15 -30.75 69.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.369 1.895 . . . . 0.0 112.752 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -104.91 -29.14 10.68 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 . . . . . 0 N--CA 1.476 0.835 0 CA-C-N 120.169 1.35 . . . . 0.0 110.904 168.546 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.899 0.856 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.85 166.56 14.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 109.826 165.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -133.71 120.66 20.88 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.189 0.45 . . . . 0.0 111.377 163.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.05 135.22 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.381 1.072 . . . . 0.0 109.82 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 122.172 0.987 . . . . 0.0 112.797 178.553 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -92.96 142.99 26.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.144 0.883 . . . . 0.0 112.864 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.77 167.6 29.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.703 2.001 . . . . 0.0 110.984 -173.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -138.71 130.99 28.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.206 1.402 . . . . 0.0 111.419 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.73 135.01 51.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.343 2.657 . . . . 0.0 109.167 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -132.16 132.85 43.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.969 0.908 . . . . 0.0 111.025 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.61 112.35 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.235 1.014 . . . . 0.0 110.266 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 68' ' ' ILE . . . -91.18 0.36 75.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.886 172.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -64.72 5.98 0.26 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.895 1.678 . . . . 0.0 114.545 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 mt 51.44 54.94 15.5 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.819 2.048 . . . . 0.0 114.641 -172.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -60.72 115.66 2.83 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.876 1.717 . . . . 0.0 110.401 165.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.1 mt -136.44 -7.69 1.97 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.551 1.54 . . . . 0.0 113.879 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -88.1 164.48 15.7 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.658 1.183 . . . . 0.0 111.031 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -59.16 128.65 38.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.22 1.008 . . . . 0.0 112.294 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 m -150.38 151.3 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.647 1.979 . . . . 0.0 109.642 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 t -117.21 168.98 9.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.894 0.854 . . . . 0.0 112.576 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -53.91 -29.08 40.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.451 1.5 . . . . 0.0 114.268 173.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -75.37 -29.26 59.83 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.136 0.88 . . . . 0.0 113.344 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.37 -59.58 3.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.715 1.143 . . . . 0.0 110.996 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.96 -32.89 71.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.779 0.832 . . . . 0.0 111.885 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.36 -44.42 65.05 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.904 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -66.65 -40.91 88.87 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.989 1.722 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.06 -17.76 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -107.81 -8.32 16.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -47.38 -49.51 53.33 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-N 120.911 1.687 . . . . 0.0 114.692 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.1 -8.31 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.041 1.827 . . . . 0.0 114.066 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -97.62 -33.01 11.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.793 1.237 . . . . 0.0 112.765 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.56 -179.71 39.98 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 116.626 1.41 . . . . 0.0 116.626 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -93.27 -18.79 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.2 152.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 127.057 2.143 . . . . 0.0 116.174 174.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.2 mmt -134.05 -68.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.368 1.467 . . . . 0.0 112.202 166.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -151.54 170.58 19.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 111.049 -166.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.34 137.49 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.514 -1.366 . . . . 0.0 111.373 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -140.56 71.36 1.37 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.426 1.49 . . . . 0.0 110.986 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.43 107.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.445 -1.409 . . . . 0.0 108.675 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.2 138.2 50.46 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.738 2.015 . . . . 0.0 109.687 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 53.05 -149.57 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.85 1.26 . . . . 0.0 112.628 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.95 -36.08 28.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.254 0.934 . . . . 0.0 112.046 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -83.01 64.28 7.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.557 1.143 . . . . 0.0 111.559 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 144.98 47.61 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.345 0.497 . . . . 0.0 112.301 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -133.9 155.62 49.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.959 1.361 . . . . 0.0 112.426 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.28 126.71 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.374 1.47 . . . . 0.0 107.452 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -77.37 137.62 38.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.56 0.744 . . . . 0.0 109.457 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.58 164.84 24.03 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.823 0.849 . . . . 0.0 112.684 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -102.63 145.48 29.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.587 1.155 . . . . 0.0 109.131 162.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 53.32 124.21 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 128.905 2.882 . . . . 0.0 116.321 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.91 -29.81 17.85 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.217 . . . . 0.0 112.782 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.98 -30.65 71.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.607 0.763 . . . . 0.0 111.651 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -33.94 38.03 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.751 1.621 . . . . 0.0 112.403 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.35 -58.33 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.23 0.468 . . . . 0.0 110.332 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.278 6.6 ppt_? -64.44 -44.85 89.84 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.336 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -62.69 -29.2 70.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.085 1.766 . . . . 0.0 114.072 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.5 -60.92 2.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.361 0.982 . . . . 0.0 112.055 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.91 -17.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.08 -22.88 36.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.728 1.604 . . . . 0.0 112.953 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.8 t -96.7 -21.24 17.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.649 0.78 . . . . 0.0 112.506 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 N--CA 1.477 0.904 0 CA-C-N 120.042 1.292 . . . . 0.0 112.125 172.695 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.408 HG23 ' HA3' ' A' ' 8' ' ' GLY . 8.0 tp . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD13 ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.79 161.47 26.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.914 1.286 . . . . 0.0 112.322 175.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.29 143.01 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.885 161.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.48 137.46 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.075 2.15 . . . . 0.0 108.404 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.466 0.35 0 C-N-CA 124.597 1.159 . . . . 0.0 109.229 175.538 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 CA--C 1.539 0.768 0 CA-C-O 119.972 -0.095 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -136.06 145.15 45.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.429 1.492 . . . . 0.0 110.386 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.16 167.6 19.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.082 0.953 . . . . 0.0 111.891 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -150.82 125.63 9.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.149 -0.969 . . . . 0.0 112.59 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 6' ' ' PHE . 5.9 tt -106.56 142.71 35.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.572 2.749 . . . . 0.0 109.551 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.525 ' N ' HD23 ' A' ' 5' ' ' LEU . 26.5 t80 -136.51 144.05 44.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 167.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.97 119.87 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.923 1.289 . . . . 0.0 109.378 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.81 -8.78 66.95 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.309 0.884 . . . . 0.0 115.309 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -163.46 91.54 0.69 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.236 1.518 . . . . 0.0 111.029 167.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.555 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 29.1 tp -156.51 -48.08 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.16 -1.4 . . . . 0.0 112.82 165.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 54.5 Cg_endo -83.35 66.7 7.59 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.523 2.148 . . . . 0.0 112.225 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.6 mt -84.06 -6.04 59.34 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 0.0 113.805 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.64 11.58 19.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.632 1.573 . . . . 0.0 112.501 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 58.89 138.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.171 2.589 . . . . 0.0 113.694 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.94 136.07 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.33 1.052 . . . . 0.0 109.627 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -89.01 157.05 18.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.625 0.77 . . . . 0.0 112.35 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -47.59 -48.46 28.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.001 1.72 . . . . 0.0 112.891 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -70.11 -26.41 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.1 -44.78 16.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.612 1.165 . . . . 0.0 112.539 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.64 -34.55 77.18 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.553 -0.717 . . . . 0.0 110.988 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -63.97 -48.65 75.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.074 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -65.07 -42.86 93.79 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.452 1.478 . . . . 0.0 112.657 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -26.98 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.726 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -96.28 -5.4 40.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -48.52 -42.92 58.9 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.46 -16.64 4.68 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.124 1.883 . . . . 0.0 113.346 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -79.29 -24.2 43.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.448 1.099 . . . . 0.0 112.23 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.75 41.36 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.61 -17.15 22.59 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -163.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.56 154.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 127.098 2.159 . . . . 0.0 116.759 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -139.38 -65.81 0.47 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.022 1.329 . . . . 0.0 113.22 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -159.99 174.95 13.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.381 1.072 . . . . 0.0 112.086 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.09 155.01 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.469 -1.394 . . . . 0.0 114.559 -171.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.63 120.12 5.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.998 1.319 . . . . 0.0 110.779 162.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.6 mt -132.15 126.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 120.991 -1.068 . . . . 0.0 112.205 -168.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -156.2 147.65 22.62 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.422 1.489 . . . . 0.0 112.058 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 53.55 -152.21 0.31 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.535 1.534 . . . . 0.0 112.561 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.09 -4.21 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.037 1.335 . . . . 0.0 114.245 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.67 -175.61 2.76 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 110.681 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.29 149.66 15.33 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.365 -0.834 . . . . 0.0 113.017 165.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.87 135.87 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.364 1.465 . . . . 0.0 109.971 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.25 114.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -73.71 139.22 45.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.799 0.809 . . . . 0.0 108.844 170.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.52 157.48 42.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.097 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.25 146.17 23.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 60.89 138.09 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 129.156 2.983 . . . . 0.0 117.033 -172.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.57 -35.53 2.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.03 2.486 . . . . 0.0 112.754 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.48 -34.22 75.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.549 0.613 . . . . 0.0 111.269 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -64.14 -43.81 94.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.068 1.347 . . . . 0.0 112.751 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.6 -52.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.745 0.702 . . . . 0.0 111.344 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -40.44 79.59 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.779 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.48 -28.2 66.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.194 1.361 . . . . 0.0 112.655 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.94 -63.6 1.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.892 0.769 . . . . 0.0 111.814 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 pp -78.77 -27.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.89 -26.92 67.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.192 1.36 . . . . 0.0 112.182 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.27 -15.35 16.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.629 1.171 . . . . 0.0 113.624 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 . . . . . 0 N--CA 1.477 0.925 0 O-C-N 120.67 -1.269 . . . . 0.0 113.938 178.159 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.28 166.43 24.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.236 1.415 . . . . 0.0 111.327 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.9 140.07 31.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.63 0.772 . . . . 0.0 112.948 171.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.25 140.4 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.514 1.925 . . . . 0.0 110.103 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.268 1.427 . . . . 0.0 110.039 178.805 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -120.57 152.26 38.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.504 1.922 . . . . 0.0 110.641 168.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 t -163.52 165.21 23.89 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.066 1.746 . . . . 0.0 109.76 -173.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -136.91 121.98 19.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.283 1.433 . . . . 0.0 111.721 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 44' ' ' PHE . 8.3 tt -108.53 134.21 51.61 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.924 2.49 . . . . 0.0 110.048 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -127.22 137.59 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.257 0.623 . . . . 0.0 111.903 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.19 132.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.27 1.428 . . . . 0.0 108.174 167.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.16 -152.12 0.99 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.483 1.039 . . . . 0.0 113.492 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.35 85.72 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.868 1.667 . . . . 0.0 113.074 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.6 tm? -153.47 -58.56 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.412 1.485 . . . . 0.0 112.753 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 74.8 Cg_endo -71.36 -35.66 8.02 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.855 1.698 . . . . 0.0 112.195 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp 55.91 178.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.452 1.501 . . . . 0.0 112.884 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -70.24 17.66 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.078 1.351 . . . . 0.0 113.721 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.65 -11.52 27.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.08 1.752 . . . . 0.0 112.906 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.5 t -94.55 126.79 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -109.37 171.13 7.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.333 1.453 . . . . 0.0 110.964 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -61.7 -24.37 66.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -74.52 -33.38 62.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.514 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -80.08 -51.37 9.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.047 1.339 . . . . 0.0 111.947 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.17 -32.55 71.16 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.445 -0.784 . . . . 0.0 111.444 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -67.91 -53.64 24.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.494 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -65.0 -31.12 72.2 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.421 1.464 . . . . 0.0 113.925 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.2 -35.85 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.513 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 27.5 m-85 -89.28 -12.4 40.75 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.9 m -46.27 -46.55 44.96 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.13 -4.35 15.24 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 122.723 2.008 . . . . 0.0 113.541 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.05 -21.13 10.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.802 1.241 . . . . 0.0 113.587 -173.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.94 177.03 37.49 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.136 -0.977 . . . . 0.0 115.445 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.24 -16.77 23.32 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.87 157.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 126.523 1.929 . . . . 0.0 115.943 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.0 mmt -136.1 -79.61 0.41 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.206 1.403 . . . . 0.0 112.315 165.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -149.82 170.45 18.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.295 1.438 . . . . 0.0 112.064 -162.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.51 146.43 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -160.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -149.21 132.9 16.86 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.987 2.115 . . . . 0.0 108.524 164.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.91 135.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.41 1.484 . . . . 0.0 108.756 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -150.47 146.96 26.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.524 1.129 . . . . 0.0 110.929 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 51.89 -95.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.678 1.591 . . . . 0.0 113.396 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.54 3.13 6.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.606 1.563 . . . . 0.0 113.565 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -119.51 161.93 19.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.216 1.806 . . . . 0.0 112.557 -164.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.49 135.99 11.22 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.42 1.01 . . . . 0.0 113.027 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.76 95.1 4.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.211 1.804 . . . . 0.0 108.168 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.2 mt -115.52 129.24 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 120.641 -1.287 . . . . 0.0 109.467 -167.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -83.31 142.01 31.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.956 0.902 . . . . 0.0 109.906 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.411 ' CE1' HD13 ' A' ' 5' ' ' LEU . 1.9 m-85 -134.57 173.85 11.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.539 1.536 . . . . 0.0 112.704 -170.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -118.79 127.1 53.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.627 1.571 . . . . 0.0 108.845 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 67.65 151.13 0.12 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.306 2.642 . . . . 0.0 114.978 -166.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.19 -30.75 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.064 2.509 . . . . 0.0 112.208 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.16 -37.8 86.58 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.664 0.786 . . . . 0.0 110.456 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.0 m -59.04 -27.61 65.65 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.65 -51.65 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.669 0.788 . . . . 0.0 110.769 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -58.43 -51.75 68.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.399 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.17 -40.25 80.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.451 1.023 . . . . 0.0 112.315 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -58.22 -59.01 5.97 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.216 0.462 . . . . 0.0 111.784 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -41.82 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.957 0.798 . . . . 0.0 111.138 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.63 -33.87 74.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 112.426 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.3 t -101.55 -33.04 10.09 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 . . . . . 0 N--CA 1.474 0.739 0 CA-C-N 119.909 1.231 . . . . 0.0 112.357 173.566 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 171.67 13.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.316 1.046 . . . . 0.0 112.365 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -144.44 144.43 31.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.329 0.585 . . . . 0.0 111.273 164.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.42 131.45 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.818 1.647 . . . . 0.0 109.064 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.467 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 110.134 178.216 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.481 0.772 0 CA-C-O 119.631 -0.237 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -57.01 136.36 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.253 1.021 . . . . 0.0 110.668 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 157.03 43.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.279 1.432 . . . . 0.0 110.811 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -136.94 118.95 15.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.155 0.982 . . . . 0.0 111.488 -168.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.61 101.2 9.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.581 2.352 . . . . 0.0 109.204 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -102.43 137.72 40.31 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.52 121.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.609 1.164 . . . . 0.0 110.304 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.53 -22.81 35.75 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -149.47 26.57 0.84 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 116.272 1.952 . . . . 0.0 116.272 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.8 tp -125.29 -34.59 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-O 116.677 -1.63 . . . . 0.0 114.782 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -72.07 46.49 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.019 3.146 . . . . 0.0 115.015 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.06 -5.71 57.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.593 1.957 . . . . 0.0 113.032 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -123.35 171.1 9.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.878 2.071 . . . . 0.0 111.099 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -67.32 142.97 56.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -144.33 134.13 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.908 1.283 . . . . 0.0 110.684 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -102.16 165.19 11.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.586 1.955 . . . . 0.0 112.005 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -53.49 -38.48 63.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.421 1.088 . . . . 0.0 113.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -79.68 -31.52 41.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 -52.17 64.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.75 0.82 . . . . 0.0 111.74 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD11 ' CG2' ' A' ' 33' ' ' ILE . 3.9 pp -68.33 -34.86 76.87 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.801 -0.562 . . . . 0.0 111.534 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -67.32 -44.13 79.88 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.327 -0.858 . . . . 0.0 111.865 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -70.87 -40.11 72.46 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.778 1.172 . . . . 0.0 111.912 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.91 -27.02 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.584 1.084 . . . . 0.0 113.056 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.52 -5.59 39.05 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -44.26 86.97 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.54 1.6 9.16 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 121.965 1.777 . . . . 0.0 114.034 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.0 -27.57 8.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.59 174.75 42.67 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 116.82 1.488 . . . . 0.0 116.82 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -88.5 -17.45 30.28 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -162.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 62.14 152.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 126.943 2.097 . . . . 0.0 116.155 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.9 mmt -135.98 -72.25 0.46 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.473 1.509 . . . . 0.0 111.436 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -146.72 169.18 19.58 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 111.201 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.443 ' CG2' HD11 ' A' ' 20' ' ' LEU . 1.6 pp -133.43 142.13 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.828 -1.17 . . . . 0.0 112.705 -170.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -153.1 125.91 8.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.605 1.162 . . . . 0.0 109.261 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -143.36 132.1 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.335 1.454 . . . . 0.0 108.691 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -143.45 127.81 17.81 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.045 0.938 . . . . 0.0 111.56 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.2 t30 53.58 -71.13 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.047 2.539 . . . . 0.0 116.795 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.12 7.73 1.6 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.324 2.25 . . . . 0.0 113.12 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -135.91 140.35 43.99 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.05 -169.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.59 123.03 6.11 Favored Glycine 0 N--CA 1.466 0.666 0 CA-C-O 119.078 -0.845 . . . . 0.0 111.608 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.55 58.28 0.73 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.768 2.427 . . . . 0.0 108.936 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -83.0 139.81 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 120.129 -1.607 . . . . 0.0 109.456 -169.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.92 137.24 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.406 1.082 . . . . 0.0 110.874 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.59 164.15 23.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.466 1.107 . . . . 0.0 112.759 -168.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.63 146.79 26.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.542 156.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 63.38 144.35 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 129.455 3.102 . . . . 0.0 116.32 -172.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.38 -40.88 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.409 2.739 . . . . 0.0 111.612 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -62.75 -41.68 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.709 0.804 . . . . 0.0 111.148 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.7 m -54.23 -34.42 60.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 170.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -72.62 -58.74 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.898 0.772 . . . . 0.0 110.154 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.254 5.4 ppt_? -67.79 -25.98 65.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.423 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -74.46 -37.77 63.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.769 1.168 . . . . 0.0 112.006 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.28 90.83 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.02 -1.05 . . . . 0.0 112.617 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -74.1 -54.16 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.637 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.92 -11.69 60.01 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -168.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.3 t -109.85 -31.36 7.45 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 . . . . . 0 N--CA 1.481 1.107 0 CA-C-N 120.343 1.429 . . . . 0.0 113.733 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 165.83 28.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -143.03 126.03 16.28 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.377 0.671 . . . . 0.0 111.781 164.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -99.11 127.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 109.993 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 124.806 1.242 . . . . 0.0 111.426 171.497 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.537 0.658 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -99.56 64.73 1.32 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.356 2.262 . . . . 0.0 111.032 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 158.11 25.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.919 0.888 . . . . 0.0 112.273 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.85 119.02 10.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 -164.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tt -110.15 125.61 53.21 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.319 2.648 . . . . 0.0 108.892 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -117.87 141.22 48.67 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 111.94 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -132.55 139.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.317 1.447 . . . . 0.0 109.984 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.63 166.55 12.96 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.144 0.878 . . . . 0.0 112.541 163.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.0 t30 57.43 12.87 1.59 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.634 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 10.1 tt -131.8 -45.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.57 1.948 . . . . 0.0 113.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.634 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 75.9 Cg_endo -74.27 26.66 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.227 2.618 . . . . 0.0 113.849 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.8 mt -68.09 -20.97 64.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.452 1.501 . . . . 0.0 112.346 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -99.1 12.5 35.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.456 1.903 . . . . 0.0 112.906 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 54.51 163.65 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.208 2.603 . . . . 0.0 114.04 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 t -140.87 129.48 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.241 -1.537 . . . . 0.0 110.06 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -66.2 152.61 44.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.755 0.822 . . . . 0.0 112.386 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -43.43 -34.79 1.38 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 113.835 164.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -89.95 -37.96 13.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.152 0.981 . . . . 0.0 112.307 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -61.47 -50.58 72.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.457 0.571 . . . . 0.0 110.793 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.76 -39.5 87.9 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.694 -0.628 . . . . 0.0 111.938 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.49 -42.38 98.53 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.835 -0.541 . . . . 0.0 110.918 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -77.76 -45.79 23.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.939 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -67.55 -25.5 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 120.313 1.415 . . . . 0.0 112.412 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -100.27 8.74 43.54 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -56.12 -55.88 37.03 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 120.553 1.524 . . . . 0.0 112.655 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.89 -16.99 29.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.043 1.829 . . . . 0.0 113.98 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -80.63 -13.06 59.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.377 1.071 . . . . 0.0 113.35 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 49' ' ' SER . . . -179.81 -156.5 17.96 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 121.186 -0.946 . . . . 0.0 113.596 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -119.65 -11.65 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.32 0.0 OUTLIER 53.01 163.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 129.414 3.086 . . . . 0.0 116.46 172.401 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.8 mmt -143.04 -69.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.882 -1.761 . . . . 0.0 112.868 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.61 178.01 8.28 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.542 1.537 . . . . 0.0 111.549 -169.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.44 151.51 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.562 1.073 . . . . 0.0 112.714 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.31 111.26 1.88 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.365 158.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.83 123.54 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.861 -1.149 . . . . 0.0 110.325 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -162.18 150.15 14.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.103 1.761 . . . . 0.0 109.876 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.2 t30 60.01 -162.88 0.25 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.734 1.613 . . . . 0.0 112.426 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.3 17.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.343 1.857 . . . . 0.0 114.636 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -141.35 173.75 11.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.233 2.213 . . . . 0.0 110.912 -167.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.4 150.72 22.08 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 121.308 -0.87 . . . . 0.0 112.18 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -120.12 139.41 52.63 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.362 1.065 . . . . 0.0 110.513 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -130.39 131.2 65.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 170.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -94.4 146.36 24.12 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.064 -1.023 . . . . 0.0 108.881 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.82 153.48 47.09 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.566 1.146 . . . . 0.0 112.952 -162.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.96 138.34 34.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.349 0.66 . . . . 0.0 110.229 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 56.25 132.37 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 129.127 2.971 . . . . 0.0 115.683 -162.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.67 -27.22 38.65 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.911 2.407 . . . . 0.0 112.503 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -59.68 -35.72 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.631 -0.668 . . . . 0.0 111.803 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.42 ' HB3' ' HA3' ' A' ' 28' ' ' GLY . 49.5 m -61.82 -34.96 76.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 113.128 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 -56.07 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.589 0.756 . . . . 0.0 110.134 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.26 94.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.923 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.69 -26.31 66.12 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.39 -57.14 4.72 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.992 0.814 . . . . 0.0 112.01 168.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.93 -36.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.146 -0.971 . . . . 0.0 112.746 -169.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.05 -37.08 69.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.939 0.79 . . . . 0.0 110.323 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.4 t -86.03 -32.49 21.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.666 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 pt . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 121.661 0.743 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.51 176.13 12.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.621 1.168 . . . . 0.0 113.382 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.22 145.94 28.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.673 0.789 . . . . 0.0 110.984 159.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -112.63 119.31 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.98 1.712 . . . . 0.0 109.212 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.353 1.061 . . . . 0.0 112.206 -171.046 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 112.821 0.277 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.07 125.72 53.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.604 1.562 . . . . 0.0 111.162 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.45 155.0 45.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.187 1.395 . . . . 0.0 112.685 -178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -129.52 133.71 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.596 1.558 . . . . 0.0 111.274 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -115.32 104.23 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.137 2.975 . . . . 0.0 107.981 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -96.51 126.26 41.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.202 0.601 . . . . 0.0 110.095 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 mt -115.17 139.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.472 1.109 . . . . 0.0 108.754 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.22 -151.35 0.31 Allowed Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.88 1.267 . . . . 0.0 113.07 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.79 68.31 4.73 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 121.123 -1.222 . . . . 0.0 113.604 -167.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 58.4 tp -129.19 -53.67 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 116.798 -1.572 . . . . 0.0 114.461 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 96.0 Cg_endo -80.7 95.62 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.993 2.462 . . . . 0.0 110.85 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.68 -38.05 6.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.674 1.19 . . . . 0.0 113.3 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -148.03 168.41 22.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.582 1.153 . . . . 0.0 112.902 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t30 51.5 46.16 26.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.965 1.306 . . . . 0.0 112.637 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.16 139.12 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.85 1.26 . . . . 0.0 111.174 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 t -154.19 173.59 15.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.95 2.1 . . . . 0.0 108.196 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -55.58 -40.84 72.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.198 0.908 . . . . 0.0 113.086 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -73.19 -34.13 65.81 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.194 0.598 . . . . 0.0 112.576 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -71.17 -43.79 66.78 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.791 -0.568 . . . . 0.0 111.765 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.75 -34.17 73.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.705 0.684 . . . . 0.0 111.969 171.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.98 -48.48 81.52 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.654 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -72.62 -33.49 66.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.51 1.05 . . . . 0.0 113.189 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 24' ' ' PHE 0.258 1.8 pp -79.88 -26.0 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.642 1.11 . . . . 0.0 113.573 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' CD1' HD12 ' A' ' 23' ' ' ILE . 15.8 m-30 -101.29 -4.52 26.91 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.571 1.078 . . . . 0.0 113.899 171.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.98 -53.85 19.6 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 114.098 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.14 0.69 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.185 1.923 . . . . 0.0 114.218 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.42 -13.9 14.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.383 1.473 . . . . 0.0 113.429 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.93 -174.79 46.86 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -101.13 -10.45 20.43 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -162.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.89 152.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 168.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.4 mmt -138.11 -73.38 0.41 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 111.99 165.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -153.89 -175.8 5.54 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.811 1.644 . . . . 0.0 111.918 -170.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 pt -131.68 157.03 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.579 1.536 . . . . 0.0 113.45 -165.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -147.8 101.08 3.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.897 1.279 . . . . 0.0 110.0 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.39 110.62 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.29 -1.506 . . . . 0.0 110.737 -174.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -146.61 152.82 39.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.495 1.518 . . . . 0.0 111.319 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t30 55.14 -159.4 0.19 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.26 1.424 . . . . 0.0 112.466 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.56 30.82 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.995 2.118 . . . . 0.0 114.213 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.75 175.36 10.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.808 2.043 . . . . 0.0 111.059 -170.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.19 135.97 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.326 -0.859 . . . . 0.0 111.947 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.39 157.36 45.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 110.046 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.58 153.54 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.086 -1.009 . . . . 0.0 108.776 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.13 144.62 42.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.679 1.191 . . . . 0.0 109.953 168.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.96 155.5 50.63 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.847 1.259 . . . . 0.0 112.33 -163.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.77 140.11 31.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.045 155.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 60.35 139.17 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.188 2.595 . . . . 0.0 116.418 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.97 -30.33 7.33 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.52 2.147 . . . . 0.0 112.986 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.88 -34.22 77.46 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.56 -0.712 . . . . 0.0 111.494 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -60.47 -42.4 96.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.241 1.416 . . . . 0.0 113.216 167.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.9 -55.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.318 0.647 . . . . 0.0 110.921 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -45.53 94.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.493 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -63.8 -34.58 78.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.754 1.161 . . . . 0.0 112.507 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.5 -54.26 39.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.684 1.129 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mt -72.4 -36.18 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.094 -1.004 . . . . 0.0 111.708 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -83.73 -10.94 57.79 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.847 -1.158 . . . . 0.0 113.331 -173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.38 -40.71 2.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 112.576 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.472 0.666 0 CA-C-N 118.962 0.801 . . . . 0.0 110.955 177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.5 pt . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.15 0.5 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.86 167.54 21.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.939 1.296 . . . . 0.0 112.19 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -149.9 122.75 8.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -82.43 133.42 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.735 1.214 . . . . 0.0 109.834 166.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.468 0.431 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 177.905 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 CA-C-O 119.028 -0.488 . . . . 0.0 113.014 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -88.76 59.66 5.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 112.363 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 160.42 31.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.487 0.715 . . . . 0.0 111.091 173.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -140.47 145.37 36.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.72 125.37 37.81 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.801 2.44 . . . . 0.0 108.953 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -127.19 139.88 52.63 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.869 0.868 . . . . 0.0 110.18 173.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -121.18 141.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.046 1.338 . . . . 0.0 107.656 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.02 -151.94 0.03 OUTLIER Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.17 1.843 . . . . 0.0 113.81 171.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -76.18 41.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.759 -1.436 . . . . 0.0 114.718 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.34 -51.87 0.12 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.697 1.999 . . . . 0.0 114.256 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.41 -31.86 2.54 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.897 1.731 . . . . 0.0 112.539 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.43 177.56 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.134 1.774 . . . . 0.0 112.513 -168.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -75.06 2.03 11.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.417 -1.427 . . . . 0.0 112.312 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -79.21 38.32 0.35 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.923 2.089 . . . . 0.0 113.001 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.44 138.26 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.926 2.09 . . . . 0.0 108.139 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.3 t -122.85 179.97 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.572 1.549 . . . . 0.0 111.821 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -59.39 -35.61 74.26 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -79.68 -38.63 33.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.256 0.622 . . . . 0.0 111.291 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.8 -42.5 99.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.83 -38.74 57.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.222 0.609 . . . . 0.0 112.052 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -68.34 -43.66 77.03 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 121.386 -0.821 . . . . 0.0 110.97 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -66.04 -41.62 90.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.206 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.78 -34.21 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.849 0.749 . . . . 0.0 112.077 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.419 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 28.4 m-85 -87.52 -19.0 28.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 m -44.05 -51.96 16.93 Favored Pre-proline 0 N--CA 1.48 1.067 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.3 -6.19 18.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.683 1.588 . . . . 0.0 114.063 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -105.6 -24.17 12.62 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.439 1.496 . . . . 0.0 113.772 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.35 165.69 38.41 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -81.16 -19.06 44.23 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 63.58 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.337 1.855 . . . . 0.0 114.938 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -141.75 -68.02 0.39 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.563 -1.336 . . . . 0.0 112.717 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -146.27 179.99 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.574 1.95 . . . . 0.0 110.053 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 pt -134.62 155.57 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.834 -1.166 . . . . 0.0 113.296 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.05 146.03 17.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.242 1.817 . . . . 0.0 108.262 157.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.7 mt -142.53 138.61 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.064 1.746 . . . . 0.0 108.367 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -151.22 150.69 30.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.08 0.952 . . . . 0.0 110.836 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 58.74 -90.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.499 1.52 . . . . 0.0 114.212 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.82 10.41 2.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.133 2.173 . . . . 0.0 112.558 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.42 147.65 50.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.011 1.725 . . . . 0.0 111.948 -164.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 140.38 15.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.97 0.795 . . . . 0.0 112.6 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.2 55.3 1.91 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.529 1.931 . . . . 0.0 110.176 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.5 150.46 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.217 1.407 . . . . 0.0 109.85 -164.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -112.3 140.41 47.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.777 -1.202 . . . . 0.0 110.218 -176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -133.79 144.66 49.16 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 112.272 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.25 135.15 38.44 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 155.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 61.54 133.36 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 129.93 3.292 . . . . 0.0 117.561 -174.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.0 -26.54 15.06 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.092 2.528 . . . . 0.0 113.991 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.29 -32.75 72.11 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.736 -1.227 . . . . 0.0 111.542 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.1 m -68.89 -25.24 64.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.496 1.519 . . . . 0.0 113.185 168.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.7 t -71.21 -58.6 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.558 1.072 . . . . 0.0 110.945 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -46.72 88.36 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.822 -174.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.66 -27.62 69.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.809 1.186 . . . . 0.0 113.455 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -68.26 -50.74 51.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.647 0.658 . . . . 0.0 112.128 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 mt -70.77 -46.66 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.191 -0.943 . . . . 0.0 111.289 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.35 -22.14 61.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.121 0.968 . . . . 0.0 112.293 -169.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.9 t -118.38 -19.42 8.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.473 0.686 0 CA-C-N 120.201 1.364 . . . . 0.0 111.314 167.871 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 121.028 0.442 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.69 172.05 14.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.684 1.194 . . . . 0.0 112.292 168.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.78 116.13 8.52 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.603 -0.686 . . . . 0.0 112.758 167.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.5 p -87.16 125.78 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 109.648 165.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.0 m . . . . . 0 C--O 1.235 0.297 0 C-N-CA 124.598 1.159 . . . . 0.0 111.863 -179.014 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 CA-C-O 118.519 -0.701 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -75.65 67.13 2.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.235 1.814 . . . . 0.0 112.317 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.89 167.01 5.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.85 2.46 . . . . 0.0 112.953 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -141.47 133.54 27.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.798 -1.189 . . . . 0.0 112.526 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.446 HD13 ' CE1' ' A' ' 44' ' ' PHE . 8.1 tt -122.18 129.08 51.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.401 2.28 . . . . 0.0 109.762 -176.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -125.99 133.13 51.87 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.557 0.743 . . . . 0.0 111.393 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.01 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.904 0.882 . . . . 0.0 109.262 167.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.93 -17.11 76.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.012 0.815 . . . . 0.0 113.863 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -148.99 88.62 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.123 1.369 . . . . 0.0 111.661 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.61 -58.0 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.338 162.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.67 85.75 1.58 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.419 2.079 . . . . 0.0 110.531 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.78 -33.84 27.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.901 0.88 . . . . 0.0 112.539 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -160.73 -24.63 0.06 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 172.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.12 61.68 1.44 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.316 1.446 . . . . 0.0 112.085 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.23 128.21 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 109.915 164.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 m -126.08 175.36 7.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.692 1.997 . . . . 0.0 110.693 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -45.45 -49.28 13.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.085 1.754 . . . . 0.0 113.883 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -79.45 -11.6 59.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.827 0.851 . . . . 0.0 113.073 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -83.48 -55.96 4.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.581 1.152 . . . . 0.0 109.803 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.34 -34.54 77.93 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.686 -0.634 . . . . 0.0 111.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -69.48 -45.34 69.23 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.073 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -67.2 -40.01 86.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.41 1.459 . . . . 0.0 112.246 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -27.92 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.831 0.741 . . . . 0.0 112.878 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -97.69 -10.67 24.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.63 -52.14 47.09 Favored Pre-proline 0 N--CA 1.478 0.965 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.94 10.35 2.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.291 1.994 . . . . 0.0 113.697 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -120.15 -29.32 4.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.476 1.51 . . . . 0.0 113.384 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.81 37.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -86.36 -20.44 28.27 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.309 1.444 . . . . 0.0 114.716 -165.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 61.88 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 127.037 2.135 . . . . 0.0 115.748 176.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.413 ' H ' HD13 ' A' ' 30' ' ' ILE . 7.8 mmt -141.93 -73.48 0.31 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.578 1.551 . . . . 0.0 113.386 169.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -138.78 171.83 13.76 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.675 1.59 . . . . 0.0 111.894 -169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -130.34 151.53 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -160.55 131.26 5.45 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.275 2.23 . . . . 0.0 109.712 163.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.3 mt -137.37 134.22 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.33 -1.481 . . . . 0.0 109.721 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.41 150.7 23.72 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 112.489 -173.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 59.34 -93.83 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.018 1.727 . . . . 0.0 113.321 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.81 9.2 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.076 1.75 . . . . 0.0 112.621 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.21 169.98 15.21 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 111.299 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.16 138.92 10.44 Favored Glycine 0 N--CA 1.466 0.637 0 C-N-CA 123.93 0.776 . . . . 0.0 112.345 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -122.37 100.53 6.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.858 1.663 . . . . 0.0 108.528 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.04 131.37 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -94.98 142.87 26.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.746 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CE1' HD13 ' A' ' 5' ' ' LEU . 6.6 m-85 -128.57 162.39 27.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.209 1.403 . . . . 0.0 110.981 -168.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -92.32 145.65 24.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.712 153.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 62.61 126.02 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.55 2.34 . . . . 0.0 116.792 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 -34.76 14.72 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.447 2.764 . . . . 0.0 114.393 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.27 -35.98 80.66 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.576 -0.702 . . . . 0.0 110.873 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -35.15 79.78 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.871 2.068 . . . . 0.0 112.408 175.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.82 -59.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.619 -0.676 . . . . 0.0 111.432 168.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -34.35 77.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.404 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.75 -39.36 84.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.476 1.035 . . . . 0.0 111.977 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 112.706 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -68.51 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 120.958 -1.089 . . . . 0.0 109.914 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.59 -29.1 63.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.01 -25.02 16.09 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 121.595 0.712 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.72 169.46 19.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.132 1.773 . . . . 0.0 112.468 -168.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -146.33 131.79 18.68 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 110.856 162.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.08 124.38 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 108.796 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 124.128 0.971 . . . . 0.0 112.702 -170.482 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 N-CA-C 111.717 -0.147 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.16 130.63 47.24 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.061 -1.024 . . . . 0.0 111.811 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.51 162.04 36.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 112.46 -172.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -128.96 139.47 52.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 111.181 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -127.81 111.1 13.26 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.169 2.588 . . . . 0.0 109.021 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -113.99 130.6 56.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.533 -0.729 . . . . 0.0 111.293 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.45 134.37 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 108.608 166.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.66 -141.12 0.4 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.7 0.667 . . . . 0.0 112.558 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.53 82.4 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.152 1.781 . . . . 0.0 112.532 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.22 -58.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.571 1.548 . . . . 0.0 111.253 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.49 101.65 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.972 2.448 . . . . 0.0 110.538 169.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.63 -18.27 13.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.397 1.079 . . . . 0.0 112.52 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.99 165.06 12.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.896 1.678 . . . . 0.0 110.425 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.04 144.31 55.16 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.742 -0.599 . . . . 0.0 111.723 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.81 137.95 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.671 1.188 . . . . 0.0 110.074 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 t -84.84 152.45 23.6 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.767 1.227 . . . . 0.0 112.721 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -51.04 -24.28 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.715 1.206 . . . . 0.0 113.291 163.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -86.86 -37.8 17.38 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.622 1.169 . . . . 0.0 111.772 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -61.92 -51.32 68.61 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 110.41 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.08 -35.49 78.27 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.428 -0.795 . . . . 0.0 112.414 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.837 0.744 . . . . 0.0 111.977 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -74.72 -34.61 62.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.175 0.898 . . . . 0.0 112.666 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.01 -35.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.728 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -91.27 -3.33 56.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 m -46.73 -49.97 44.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 120.729 1.604 . . . . 0.0 113.973 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.56 -9.94 18.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.8 1.667 . . . . 0.0 113.91 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.41 -28.57 18.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.183 1.393 . . . . 0.0 111.63 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.66 -176.24 47.06 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 118.966 2.346 . . . . 0.0 118.966 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -162.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 31' ' ' MET 0.261 0.3 OUTLIER 61.86 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 128.908 2.883 . . . . 0.0 116.227 178.298 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.431 ' H ' HD13 ' A' ' 30' ' ' ILE . 5.8 mmt -139.81 -61.96 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.762 1.625 . . . . 0.0 113.268 169.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -156.56 172.76 17.99 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.774 1.17 . . . . 0.0 111.604 -168.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.84 152.95 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.166 1.348 . . . . 0.0 114.198 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.72 125.08 8.81 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.381 2.272 . . . . 0.0 108.465 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -138.62 127.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 120.694 -1.254 . . . . 0.0 110.03 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -149.3 156.85 42.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.32 1.448 . . . . 0.0 111.715 178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 52.97 -109.73 0.49 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.601 1.56 . . . . 0.0 113.105 165.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.71 14.31 13.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.958 1.303 . . . . 0.0 113.684 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -127.12 167.73 15.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.535 1.134 . . . . 0.0 112.111 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.67 127.95 4.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.49 88.07 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.21 1.404 . . . . 0.0 109.241 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -87.41 151.72 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.132 0.968 . . . . 0.0 108.425 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.77 141.38 51.26 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 120.305 -1.497 . . . . 0.0 108.373 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 49' ' ' SER . 2.4 m-85 -131.96 165.05 24.79 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.891 1.277 . . . . 0.0 112.176 -165.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.42 140.25 36.95 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 156.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.322 2.1 p30 60.07 144.45 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.723 3.209 . . . . 0.0 115.981 -169.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.0 -23.09 8.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.669 2.246 . . . . 0.0 112.576 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -64.67 -35.79 82.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.903 0.881 . . . . 0.0 110.849 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.413 ' HB3' ' CD2' ' A' ' 44' ' ' PHE . 72.4 m -57.51 -47.05 82.98 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.599 1.56 . . . . 0.0 112.582 167.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.37 -55.61 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.335 0.654 . . . . 0.0 110.506 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -36.78 79.51 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.978 -1.01 . . . . 0.0 112.328 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.87 -41.25 83.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.614 1.552 . . . . 0.0 112.088 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -55.86 29.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.097 0.862 . . . . 0.0 111.222 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.3 mt -72.67 -48.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 O-C-N 121.81 -0.556 . . . . 0.0 111.357 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.61 -13.55 62.37 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.086 -0.959 . . . . 0.0 113.43 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.5 t -107.81 -24.76 11.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.094 1.357 . . . . 0.0 114.383 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 . . . . . 0 N--CA 1.48 1.051 0 CA-C-N 120.875 1.67 . . . . 0.0 111.993 173.581 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 42.8 pt . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 122.516 1.15 . . . . 0.0 113.142 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 166.34 26.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.791 1.637 . . . . 0.0 111.884 -168.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.15 126.9 29.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 110.49 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.79 140.25 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.608 1.563 . . . . 0.0 109.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.238 0.492 0 C-N-CA 123.723 0.809 . . . . 0.0 112.026 179.42 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.479 0.638 0 CA-C-O 119.174 -0.427 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 144.43 38.61 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 165.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 167.06 28.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.89 2.476 . . . . 0.0 109.877 -171.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -136.79 127.64 27.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.555 1.142 . . . . 0.0 112.142 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.4 tt -118.83 129.05 55.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.655 1.982 . . . . 0.0 109.755 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -111.89 139.58 47.27 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.163 1.385 . . . . 0.0 110.944 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 mt -135.62 139.88 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.823 1.249 . . . . 0.0 110.738 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.78 155.89 16.64 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.999 1.761 . . . . 0.0 111.877 163.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.8 -17.29 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.6 tt -83.59 -47.57 0.76 Allowed Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.36 1.464 . . . . 0.0 114.12 171.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.48 35.43 0.58 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.916 3.077 . . . . 0.0 114.088 -170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.22 -32.21 15.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.659 1.584 . . . . 0.0 111.544 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -65.12 148.73 51.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.248 1.019 . . . . 0.0 109.634 162.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -50.37 133.93 23.81 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.365 1.066 . . . . 0.0 112.782 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 p -145.39 140.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.677 1.191 . . . . 0.0 111.128 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.4 m -135.78 172.71 12.62 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.973 1.709 . . . . 0.0 108.772 169.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.54 -39.54 61.54 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -69.12 -33.5 73.57 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -63.18 -53.66 49.81 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.822 0.737 . . . . 0.0 111.105 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.02 -33.01 74.62 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.71 0.404 . . . . 0.0 111.676 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -62.38 -48.08 81.3 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.332 -0.855 . . . . 0.0 111.226 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -75.94 -35.1 59.85 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.784 1.174 . . . . 0.0 113.209 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -73.13 -26.37 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.81 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -99.67 -16.28 18.24 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -46.07 -48.23 42.65 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-N 120.836 1.653 . . . . 0.0 115.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -17.71 18.19 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 121.874 1.705 . . . . 0.0 113.758 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -87.38 -34.33 18.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 112.666 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.99 173.1 36.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 122.443 1.024 . . . . 0.0 115.54 -176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -94.59 -13.55 25.84 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER 57.43 151.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 128.458 2.703 . . . . 0.0 116.912 165.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.4 mmt -136.05 -71.08 0.46 Allowed 'General case' 0 N--CA 1.476 0.85 0 O-C-N 119.944 -1.723 . . . . 0.0 113.716 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -153.97 158.4 40.58 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.05 0.94 . . . . 0.0 111.36 -168.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -107.48 153.99 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -155.81 93.03 1.42 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.526 1.13 . . . . 0.0 111.609 164.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.0 mt -115.45 135.74 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 120.626 -1.296 . . . . 0.0 112.164 -173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.41 146.79 13.8 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.448 1.899 . . . . 0.0 110.844 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 63.73 -164.05 0.26 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.577 1.951 . . . . 0.0 112.458 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.39 30.13 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.843 1.657 . . . . 0.0 113.938 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -145.68 174.37 11.25 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.277 2.631 . . . . 0.0 109.68 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.01 143.01 8.14 Favored Glycine 0 CA--C 1.52 0.359 0 O-C-N 121.331 -0.856 . . . . 0.0 111.817 174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -118.38 140.48 49.77 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.21 1.004 . . . . 0.0 108.801 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.4 123.83 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -81.83 143.38 31.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 122.41 1.1 . . . . 0.0 109.893 168.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.61 164.91 20.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.381 1.472 . . . . 0.0 111.59 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.5 137.65 32.57 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 157.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 58.85 124.71 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 128.041 2.536 . . . . 0.0 116.651 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.79 -24.31 13.41 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.378 2.718 . . . . 0.0 114.042 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -64.29 -38.42 90.99 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.682 1.128 . . . . 0.0 110.362 170.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -35.2 80.05 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.627 1.571 . . . . 0.0 112.071 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.64 -50.92 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.316 -0.865 . . . . 0.0 112.162 169.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.296 6.4 ppt_? -69.24 -34.08 74.26 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.837 0.744 . . . . 0.0 112.924 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -68.31 -33.22 73.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.442 1.019 . . . . 0.0 112.741 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.67 -68.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.184 0.594 . . . . 0.0 111.358 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.425 HD13 HD23 ' A' ' 69' ' ' LEU 0.259 1.3 pp -72.58 -27.87 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.403 1.456 . . . . 0.0 114.682 -176.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -80.22 -19.34 47.18 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.3 1.864 . . . . 0.0 114.026 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.1 t -107.41 -30.13 8.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -84.36 -46.45 11.73 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.662 1.119 . . . . 0.0 112.134 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 t -92.38 -83.2 0.3 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.413 1.006 . . . . 0.0 111.556 -174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -163.59 149.77 11.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.269 1.427 . . . . 0.0 110.033 168.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -78.85 2.11 21.11 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.0 ttt -147.24 144.44 28.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.018 1.327 . . . . 0.0 110.545 170.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -76.41 157.9 31.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.701 1.201 . . . . 0.0 113.04 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -142.0 125.8 17.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.26 1.424 . . . . 0.0 110.581 172.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -55.17 134.44 48.32 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.173 0.892 . . . . 0.0 113.027 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 46.4 28.45 0.73 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.671 1.588 . . . . 0.0 114.993 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -140.32 -47.72 0.43 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.982 -1.074 . . . . 0.0 113.307 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.8 tp -154.05 118.99 5.0 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.465 0.706 . . . . 0.0 110.463 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 mp -120.04 136.7 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.79 0.836 . . . . 0.0 108.918 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.425 HD23 HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -145.6 163.91 33.33 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.764 1.226 . . . . 0.0 110.626 171.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -152.21 140.35 20.3 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.181 0.592 . . . . 0.0 111.848 168.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 p -93.07 137.74 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.857 1.263 . . . . 0.0 109.909 163.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.3 m -148.18 139.01 23.08 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.186 -0.946 . . . . 0.0 111.977 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -115.39 177.56 4.62 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.314 1.446 . . . . 0.0 111.317 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.9 p -150.61 161.11 43.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.782 1.633 . . . . 0.0 110.154 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -67.13 139.64 57.5 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 122.304 -0.247 . . . . 0.0 111.37 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.66 156.33 39.12 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.463 0.705 . . . . 0.0 111.716 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.382 1.873 . . . . 0.0 113.392 -177.224 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 CA-C-O 119.745 -0.19 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -87.77 147.92 24.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.85 163.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.18 154.91 30.03 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.175 1.39 . . . . 0.0 109.23 -172.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -142.03 123.75 15.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.542 1.064 . . . . 0.0 112.883 -172.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 tt -113.87 105.79 13.68 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.854 2.462 . . . . 0.0 108.904 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -94.75 142.38 27.53 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.186 0.994 . . . . 0.0 111.162 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 mt -138.51 131.76 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.386 1.074 . . . . 0.0 110.839 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.38 150.91 18.61 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.904 0.764 . . . . 0.0 112.531 167.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 61.34 27.21 16.9 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.66 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -134.99 -45.97 0.02 OUTLIER Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.04 1.736 . . . . 0.0 113.386 172.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.66 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 71.7 Cg_endo -73.14 21.27 0.33 Allowed 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.654 2.236 . . . . 0.0 114.864 -177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -78.12 -21.92 49.63 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.063 2.145 . . . . 0.0 110.948 169.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.87 162.86 25.61 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.695 1.598 . . . . 0.0 111.194 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -84.98 106.33 16.4 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.967 0.907 . . . . 0.0 109.257 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.48 137.69 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.788 1.235 . . . . 0.0 111.63 -170.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -123.19 172.32 8.68 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.83 1.652 . . . . 0.0 111.736 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -48.49 -53.0 19.67 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.072 1.349 . . . . 0.0 111.779 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -62.29 -31.16 71.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -78.77 -49.28 13.29 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.837 0.744 . . . . 0.0 112.263 -174.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 33' ' ' ILE . 4.3 pp -65.91 -29.24 69.63 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.695 -0.628 . . . . 0.0 111.619 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -67.99 -53.2 27.85 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.42 0.688 . . . . 0.0 111.991 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -67.39 -32.34 73.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.138 1.336 . . . . 0.0 112.797 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.54 -45.64 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.276 0.943 . . . . 0.0 111.844 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -90.51 -3.73 57.42 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -48.37 40.2 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.15 -14.35 16.73 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.874 1.716 . . . . 0.0 113.496 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -91.34 -24.12 19.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.553 . . . . 0.0 113.582 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.91 169.54 42.23 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.97 -18.26 56.19 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 -166.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.33 148.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 128.271 2.628 . . . . 0.0 116.224 173.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.7 mmt -131.99 -96.88 0.32 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.196 1.799 . . . . 0.0 110.427 167.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' H ' ' HB2' ' A' ' 43' ' ' GLN . 81.9 mt-30 -120.78 173.07 7.44 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.972 2.109 . . . . 0.0 112.314 -168.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 20' ' ' LEU . 10.5 pt -124.92 145.32 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 121.315 -0.866 . . . . 0.0 112.798 -172.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -154.15 70.41 0.81 Allowed 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.158 0.98 . . . . 0.0 113.121 171.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.73 117.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 120.615 -1.303 . . . . 0.0 108.434 170.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -150.51 150.34 31.15 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.793 2.437 . . . . 0.0 109.051 174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 56.29 -170.37 0.08 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 113.218 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.82 1.79 3.06 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 120.267 -1.521 . . . . 0.0 113.623 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -144.04 59.62 1.36 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.768 2.427 . . . . 0.0 110.815 -159.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 173.89 42.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.948 1.261 . . . . 0.0 113.217 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -143.82 165.49 27.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.008 1.385 . . . . 0.0 113.966 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.9 mt -129.68 134.5 63.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 126.017 1.727 . . . . 0.0 107.16 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.466 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 71.8 mt-30 -85.54 141.46 29.85 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.803 169.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -125.86 164.08 21.52 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.097 1.359 . . . . 0.0 111.59 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -97.85 141.14 31.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 160.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 62.26 148.84 0.09 OUTLIER Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 127.706 2.403 . . . . 0.0 115.689 -166.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.48 -33.24 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.632 2.888 . . . . 0.0 112.496 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -60.45 -38.48 84.28 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.761 -0.587 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.0 m -53.59 -43.76 68.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.088 1.355 . . . . 0.0 113.645 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.3 -51.45 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.437 0.695 . . . . 0.0 109.8 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -72.94 -38.45 66.78 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 118.581 -0.723 . . . . 0.0 112.36 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 -31.59 72.82 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.923 1.238 . . . . 0.0 112.505 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.74 -64.05 1.03 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.498 0.719 . . . . 0.0 112.744 173.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.83 -24.15 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -69.69 -13.66 62.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.915 1.689 . . . . 0.0 111.579 169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.5 t -105.12 -37.21 7.0 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.165 1.386 . . . . 0.0 112.906 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -86.73 -42.52 13.29 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.93 -1.106 . . . . 0.0 113.161 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -102.23 34.48 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.585 1.954 . . . . 0.0 110.967 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -53.28 137.75 33.99 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.472 1.909 . . . . 0.0 113.778 -169.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -63.16 146.33 53.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.692 0.797 . . . . 0.0 111.702 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.8 mtm 59.23 23.34 11.69 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.854 1.262 . . . . 0.0 113.934 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -147.98 -46.75 0.16 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.781 1.232 . . . . 0.0 112.637 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.72 -15.85 1.55 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.215 2.206 . . . . 0.0 113.129 173.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -62.8 -15.83 55.46 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.663 -1.273 . . . . 0.0 115.206 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.27 -24.04 64.84 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.256 1.528 . . . . 0.0 113.214 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -125.78 -20.03 4.75 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.72 150.23 21.72 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.449 1.022 . . . . 0.0 110.846 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.6 pt -126.94 155.86 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.295 0.638 . . . . 0.0 110.963 168.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.05 165.39 30.06 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.783 0.833 . . . . 0.0 112.566 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -141.17 135.74 31.13 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.11 -0.369 . . . . 0.0 111.299 160.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -93.06 135.51 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.885 1.274 . . . . 0.0 110.676 169.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.8 t -160.39 166.94 28.41 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.505 1.122 . . . . 0.0 111.981 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -148.58 0.38 0.57 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 64.6 p -159.38 170.59 21.45 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.347 1.859 . . . . 0.0 110.502 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.26 150.4 28.57 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.723 -1.236 . . . . 0.0 110.439 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -100.2 -11.89 20.03 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.876 0 C-N-CA 125.257 1.423 . . . . 0.0 112.555 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.478 0.568 0 N-CA-C 112.677 0.222 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -120.17 124.04 44.76 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.941 0.897 . . . . 0.0 111.181 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -138.44 161.69 36.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.054 1.742 . . . . 0.0 112.126 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -134.75 125.56 27.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.119 -0.988 . . . . 0.0 111.658 -172.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tt -111.37 125.12 53.52 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.205 2.602 . . . . 0.0 109.022 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -120.81 128.58 53.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.406 0.682 . . . . 0.0 110.568 165.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 mp -98.84 134.69 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 163.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.25 -158.96 0.43 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 123.457 0.551 . . . . 0.0 112.787 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -70.65 73.64 0.55 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.293 1.037 . . . . 0.0 113.256 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.3 tp -129.02 -35.68 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 126.261 1.825 . . . . 0.0 112.772 172.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -65.23 42.7 0.14 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.621 3.547 . . . . 0.0 115.896 168.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -68.72 -15.23 63.45 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.261 -1.524 . . . . 0.0 113.102 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -95.97 166.32 11.83 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.652 1.581 . . . . 0.0 111.423 170.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -60.8 126.27 26.76 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.884 0.874 . . . . 0.0 111.068 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.42 121.96 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.456 1.503 . . . . 0.0 107.972 174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -101.19 170.25 8.37 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.867 0.867 . . . . 0.0 111.668 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -54.39 -39.59 67.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.635 . . . . 0.0 112.41 -176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -71.51 -30.39 65.89 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.87 -54.32 16.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.923 1.238 . . . . 0.0 111.086 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.36 -32.79 73.63 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 122.178 -0.326 . . . . 0.0 111.782 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.62 -50.83 61.72 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.522 -0.736 . . . . 0.0 111.447 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -66.88 -38.67 86.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 120.207 1.367 . . . . 0.0 112.643 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.38 -28.7 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.291 0.951 . . . . 0.0 112.774 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.33 -2.12 31.81 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 m -49.66 -51.95 55.12 Favored Pre-proline 0 N--CA 1.48 1.053 0 CA-C-N 120.107 1.321 . . . . 0.0 114.359 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.77 -19.72 16.03 Favored 'Trans proline' 0 C--N 1.35 0.652 0 CA-C-N 121.424 1.544 . . . . 0.0 113.983 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -87.22 -19.94 27.64 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.293 -0.88 . . . . 0.0 112.379 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.89 174.32 39.21 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -108.35 -7.46 15.88 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 116.245 1.942 . . . . 0.0 116.245 -170.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.0 155.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 127.952 2.501 . . . . 0.0 117.278 164.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.8 mmt -139.76 -65.09 0.47 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.296 1.438 . . . . 0.0 112.79 165.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -152.56 159.86 43.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.112 0.965 . . . . 0.0 112.293 -163.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.69 143.4 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.741 1.216 . . . . 0.0 111.327 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -156.26 97.57 1.78 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.994 0.917 . . . . 0.0 112.283 161.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.48 133.83 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.978 -1.076 . . . . 0.0 111.639 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -153.3 162.92 40.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 128.218 2.607 . . . . 0.0 109.478 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.12 -159.64 0.27 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.409 1.084 . . . . 0.0 112.623 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.14 60.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.962 1.305 . . . . 0.0 113.985 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -103.8 -172.05 2.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.27 1.828 . . . . 0.0 111.885 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.07 145.79 11.21 Favored Glycine 0 N--CA 1.467 0.747 0 O-C-N 120.525 -1.359 . . . . 0.0 114.219 172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -114.09 138.14 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.29 1.036 . . . . 0.0 110.693 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.5 mt -139.88 133.07 35.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -93.91 150.67 20.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.493 -1.379 . . . . 0.0 110.072 168.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -137.79 156.72 47.65 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.857 1.663 . . . . 0.0 112.414 -165.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -94.09 141.22 28.79 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 58.51 128.92 0.02 OUTLIER Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 128.86 2.864 . . . . 0.0 116.259 -167.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.58 -27.45 38.96 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.274 1.983 . . . . 0.0 114.349 172.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -68.44 -29.8 68.54 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.313 -1.492 . . . . 0.0 112.309 173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.4 m -62.81 -33.98 76.34 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.2 t -66.71 -54.95 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 118.456 0.571 . . . . 0.0 110.897 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.422 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.5 -18.1 62.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.6 -61.41 1.78 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 119.102 0.865 . . . . 0.0 110.752 166.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -36.31 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.288 -0.882 . . . . 0.0 111.914 -171.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 -5.33 50.67 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.81 1.244 . . . . 0.0 112.91 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.3 t -115.03 -31.98 5.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.538 1.063 . . . . 0.0 113.327 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -115.69 -25.07 7.96 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -110.55 21.16 16.93 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.123 -0.986 . . . . 0.0 112.687 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -75.09 158.49 33.03 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.768 0.794 . . . . 0.0 112.596 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -133.12 131.07 40.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.753 1.621 . . . . 0.0 109.33 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.9 tpt -145.09 4.76 1.09 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.059 0.944 . . . . 0.0 113.067 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -88.04 -29.12 20.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.855 1.262 . . . . 0.0 111.536 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -129.89 -17.6 3.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.396 1.878 . . . . 0.0 112.507 166.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.43 -5.76 49.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.444 1.974 . . . . 0.0 115.232 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -143.17 1.69 1.26 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.697 1.999 . . . . 0.0 114.391 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -78.64 -18.54 54.3 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.01 1.324 . . . . 0.0 112.705 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.52 160.41 23.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.522 1.529 . . . . 0.0 111.807 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.5 tp -142.41 165.78 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.319 1.448 . . . . 0.0 111.278 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.05 174.94 12.59 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.077 1.751 . . . . 0.0 111.842 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -148.62 119.48 7.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.966 0.506 . . . . 0.0 111.53 171.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.08 126.84 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.264 1.425 . . . . 0.0 109.158 166.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.4 t -152.01 -173.62 4.6 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.358 1.063 . . . . 0.0 112.403 -168.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -117.98 151.83 36.68 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.524 1.13 . . . . 0.0 112.279 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -64.06 -8.66 12.59 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.024 1.33 . . . . 0.0 114.525 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.48 -12.07 59.42 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.292 1.437 . . . . 0.0 113.157 172.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.2 144.65 27.42 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.687 1.195 . . . . 0.0 111.874 168.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? . . . . . 0 C--O 1.256 1.403 0 C-N-CA 126.314 1.846 . . . . 0.0 111.334 176.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 CA--C 1.539 0.766 0 N-CA-C 112.363 0.101 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -128.12 147.8 50.56 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.133 1.373 . . . . 0.0 111.304 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.63 155.53 34.85 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.355 2.262 . . . . 0.0 107.865 -171.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -117.07 135.2 53.91 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.044 -1.035 . . . . 0.0 112.218 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -121.69 100.9 7.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 128.493 2.717 . . . . 0.0 108.173 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -101.82 134.87 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.024 -0.423 . . . . 0.0 110.988 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.24 136.23 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.079 1.352 . . . . 0.0 107.566 165.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.91 -151.24 0.27 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.034 0.826 . . . . 0.0 113.556 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -73.82 87.2 1.74 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.25 1.02 . . . . 0.0 111.097 -170.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 3.2 tm? -146.97 -52.91 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 126.839 2.056 . . . . 0.0 111.99 -169.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 93.7 Cg_endo -74.36 72.66 4.16 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.859 2.373 . . . . 0.0 110.805 169.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.04 -37.63 54.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.923 1.289 . . . . 0.0 111.514 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -73.53 162.3 29.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.084 1.354 . . . . 0.0 112.611 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -63.11 131.73 49.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.794 0.838 . . . . 0.0 110.508 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.56 152.32 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.918 1.687 . . . . 0.0 109.266 -170.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -133.53 166.96 21.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.509 1.123 . . . . 0.0 111.465 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -51.46 -43.11 62.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.763 1.225 . . . . 0.0 112.496 177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.09 -30.89 71.05 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 176.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -73.74 -49.61 24.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.784 1.174 . . . . 0.0 111.981 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.19 -33.0 74.97 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.315 -0.865 . . . . 0.0 111.645 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -66.75 -47.9 70.78 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.396 -0.815 . . . . 0.0 111.986 173.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -70.44 -28.4 65.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.721 1.146 . . . . 0.0 112.82 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.02 -39.2 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.237 0.926 . . . . 0.0 112.949 175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -90.26 -7.3 53.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 m -49.12 -44.37 72.28 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 120.778 1.626 . . . . 0.0 115.34 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.33 -14.71 18.25 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 CA-C-N 122.341 1.872 . . . . 0.0 113.808 175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -87.06 -37.01 17.83 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.555 -1.341 . . . . 0.0 112.957 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.28 -178.44 36.15 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 117.646 1.818 . . . . 0.0 117.646 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.408 ' CG ' HD22 ' A' ' 46' ' ' ASN . 76.1 m80 -92.75 -14.46 27.89 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -160.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 61.18 154.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 127.67 2.388 . . . . 0.0 116.71 173.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.8 mmt -145.43 -59.7 0.34 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.415 1.486 . . . . 0.0 113.098 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -162.04 171.81 16.94 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.006 1.722 . . . . 0.0 110.377 -170.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pp -131.5 152.81 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.171 -1.58 . . . . 0.0 113.037 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -152.15 136.19 16.49 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.114 1.765 . . . . 0.0 107.922 161.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.75 135.55 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.942 1.297 . . . . 0.0 108.561 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -145.79 143.13 29.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.877 0.871 . . . . 0.0 111.277 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 44.44 -124.04 0.96 Allowed 'General case' 0 CA--C 1.554 1.135 0 C-N-CA 124.803 1.241 . . . . 0.0 110.905 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.59 2.84 46.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.132 1.773 . . . . 0.0 115.22 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -134.44 158.44 43.88 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.17 136.25 11.49 Favored Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.153 0.883 . . . . 0.0 112.355 -173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -131.31 64.72 1.58 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.294 1.438 . . . . 0.0 110.04 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.25 157.88 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.513 1.525 . . . . 0.0 109.867 -172.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -118.58 132.33 56.2 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.122 1.369 . . . . 0.0 109.169 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -123.7 156.25 36.31 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.891 1.276 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -77.64 149.12 34.76 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 157.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.408 HD22 ' CG ' ' A' ' 29' ' ' HIS . 69.0 m-20 56.38 124.27 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 127.987 2.515 . . . . 0.0 116.669 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -68.8 -28.45 30.14 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.745 2.297 . . . . 0.0 113.332 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.11 -32.41 69.8 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.609 0.64 . . . . 0.0 112.095 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.69 -30.55 36.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.246 1.018 . . . . 0.0 111.926 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.43 -59.78 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.746 0.818 . . . . 0.0 110.563 165.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -36.61 82.43 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.513 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.716 1.144 . . . . 0.0 112.181 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -55.31 23.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.757 1.162 . . . . 0.0 112.583 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.2 mt -68.86 -49.83 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 118.567 0.621 . . . . 0.0 110.946 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -75.52 -30.99 59.97 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.957 0.799 . . . . 0.0 113.074 -168.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.5 t -80.44 -38.76 29.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.835 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.63 -62.41 1.25 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.284 1.402 . . . . 0.0 113.467 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 m -78.88 -67.81 0.71 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.28 1.032 . . . . 0.0 113.209 -169.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -162.93 129.06 3.34 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.462 1.505 . . . . 0.0 112.645 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -75.81 137.67 40.66 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.781 1.232 . . . . 0.0 111.788 168.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -71.57 -46.94 57.94 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -168.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -76.8 -26.43 54.43 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -165.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -120.91 14.06 11.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.31 143.85 35.02 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.23 0.919 . . . . 0.0 113.108 167.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.3 mtpt -146.92 -4.38 0.56 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.097 1.759 . . . . 0.0 114.981 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -129.58 -1.57 4.89 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.817 2.047 . . . . 0.0 113.069 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.5 mt -148.54 157.89 43.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.28 2.232 . . . . 0.0 110.0 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.1 pt -132.71 158.92 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.353 1.461 . . . . 0.0 111.481 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 175.25 12.33 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.109 0.964 . . . . 0.0 113.222 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -145.22 123.36 12.16 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.178 161.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.5 129.21 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 109.61 166.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -134.72 137.41 43.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.099 0.56 . . . . 0.0 111.327 172.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.5 m -86.68 -165.2 1.21 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.869 1.667 . . . . 0.0 112.86 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.2 m -55.15 118.63 4.52 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.748 -0.595 . . . . 0.0 110.275 172.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -157.64 160.21 37.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.913 1.285 . . . . 0.0 110.528 177.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.34 154.83 15.83 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.4 0.545 . . . . 0.0 111.671 168.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--O 1.253 1.241 0 C-N-CA 127.03 2.132 . . . . 0.0 113.837 -178.368 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.482 0.841 0 CA-C-O 118.839 -0.567 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -60.78 137.32 58.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.364 0.529 . . . . 0.0 109.985 172.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -145.91 168.06 21.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.793 2.037 . . . . 0.0 109.331 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -147.2 124.62 11.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.942 1.247 . . . . 0.0 114.012 -172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tt -113.6 125.28 53.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.735 2.414 . . . . 0.0 110.156 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -118.77 142.05 48.06 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.258 0.623 . . . . 0.0 111.409 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.92 139.13 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.15 1.38 . . . . 0.0 108.788 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.46 143.24 14.89 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.461 0.553 . . . . 0.0 113.999 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 52.8 34.98 17.54 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.928 1.291 . . . . 0.0 112.972 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.7 tt -128.51 -51.56 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.664 2.385 . . . . 0.0 109.804 171.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 91.7 Cg_endo -78.75 88.94 1.4 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.449 2.1 . . . . 0.0 110.845 170.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.9 -12.7 17.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.416 1.886 . . . . 0.0 112.533 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -96.41 171.82 8.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.825 1.65 . . . . 0.0 111.684 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -68.47 139.66 55.71 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.198 0.523 . . . . 0.0 110.256 164.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -143.34 138.15 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.183 1.793 . . . . 0.0 108.273 -175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.2 t -112.04 171.3 7.59 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.877 0.871 . . . . 0.0 111.992 173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -55.07 -36.63 65.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.597 1.159 . . . . 0.0 112.772 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -69.28 -30.83 69.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -68.03 -56.95 7.05 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.996 0.817 . . . . 0.0 110.907 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -63.89 -35.02 79.28 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.905 -0.497 . . . . 0.0 111.623 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -66.75 -48.58 68.67 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.582 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -69.58 -35.3 75.23 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.632 1.56 . . . . 0.0 112.72 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -80.02 -31.72 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.068 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.13 -13.13 28.88 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.23 -47.56 66.59 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.509 1.504 . . . . 0.0 114.934 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.65 -0.5 9.43 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 CA-C-N 121.673 1.633 . . . . 0.0 113.83 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -115.25 -20.09 10.5 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.125 1.77 . . . . 0.0 114.287 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.44 163.32 33.15 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -83.84 -21.04 32.17 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -161.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 64.27 154.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 126.582 1.953 . . . . 0.0 115.756 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.8 mmt -134.62 -65.7 0.63 Allowed 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.73 -1.231 . . . . 0.0 113.179 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -154.38 160.51 41.71 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.489 1.116 . . . . 0.0 111.137 -165.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.4 pt -125.11 153.01 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -171.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -149.41 136.95 20.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.9 2.08 . . . . 0.0 107.392 158.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt -140.49 121.75 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.06 1.344 . . . . 0.0 108.291 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -149.29 153.41 37.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.972 1.309 . . . . 0.0 111.258 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 55.84 -140.19 0.91 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.996 0.918 . . . . 0.0 111.332 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.34 21.81 2.34 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.288 1.435 . . . . 0.0 113.418 170.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -131.02 169.95 15.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.127 1.371 . . . . 0.0 112.468 -163.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.39 140.73 10.5 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.445 1.497 . . . . 0.0 111.64 173.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -130.76 67.07 1.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.024 2.13 . . . . 0.0 109.834 -168.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.5 120.91 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 120.834 -1.166 . . . . 0.0 110.058 -165.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -83.78 135.98 34.33 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.557 -0.714 . . . . 0.0 109.561 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -122.23 164.77 17.26 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.642 1.577 . . . . 0.0 112.106 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -98.14 139.51 33.82 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 156.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 67.47 145.17 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 128.439 2.696 . . . . 0.0 116.647 -176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.55 -43.44 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.353 2.702 . . . . 0.0 112.265 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -62.07 -30.1 70.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.907 0.883 . . . . 0.0 111.854 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.3 m -73.93 -19.92 60.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 114.923 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.28 -51.9 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 119.068 0.849 . . . . 0.0 110.266 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -43.37 98.98 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.559 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.36 -24.47 63.9 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.316 1.417 . . . . 0.0 112.961 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.45 -66.79 0.52 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.294 0.952 . . . . 0.0 111.44 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.19 -23.94 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.165 -1.584 . . . . 0.0 114.769 -176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -91.85 -0.19 57.51 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.665 1.575 . . . . 0.0 113.373 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 t -133.8 -29.43 1.32 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 120.127 1.331 . . . . 0.0 114.009 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -84.78 -50.12 7.86 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.961 -1.087 . . . . 0.0 110.64 169.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.6 m -114.94 37.48 3.46 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.106 1.362 . . . . 0.0 113.503 -175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.3 139.92 56.54 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -167.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.38 125.21 26.81 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.125 0.97 . . . . 0.0 111.901 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.2 mmt -123.91 -18.43 5.99 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.949 1.7 . . . . 0.0 111.791 170.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -93.93 171.23 8.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.603 1.561 . . . . 0.0 111.017 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -133.29 0.51 3.39 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.65 -150.27 3.4 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 123.915 0.769 . . . . 0.0 112.898 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -91.8 -11.76 35.67 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -87.13 158.41 19.17 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.135 1.334 . . . . 0.0 112.316 175.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.5 mt 55.24 52.99 10.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.399 1.08 . . . . 0.0 112.801 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.22 143.63 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.521 1.529 . . . . 0.0 109.601 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.77 165.82 24.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.915 0.886 . . . . 0.0 112.857 171.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -152.33 135.08 15.45 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.278 1.031 . . . . 0.0 110.769 170.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.44 133.29 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.075 1.35 . . . . 0.0 110.365 170.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.5 t -146.65 159.89 42.88 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.408 1.083 . . . . 0.0 111.524 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.0 p -86.49 -155.69 0.27 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.688 1.995 . . . . 0.0 112.852 -169.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.2 m -68.07 38.81 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.659 1.984 . . . . 0.0 113.723 170.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -70.82 162.98 28.24 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.959 2.104 . . . . 0.0 113.126 -171.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.01 174.64 5.8 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.044 1.738 . . . . 0.0 113.92 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? . . . . . 0 C--O 1.252 1.214 0 C-N-CA 127.516 2.326 . . . . 0.0 110.932 -164.106 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 N--CA 1.482 0.847 0 CA-C-O 119.207 -0.414 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -68.0 153.59 43.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.925 0.89 . . . . 0.0 112.885 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.71 163.77 36.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 108.152 -176.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -136.84 126.4 25.26 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.152 1.342 . . . . 0.0 113.68 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.76 130.26 39.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.541 2.736 . . . . 0.0 108.501 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.65 134.9 49.63 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.288 0.635 . . . . 0.0 110.439 164.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.31 135.3 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.769 1.228 . . . . 0.0 108.347 169.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.88 -156.63 2.06 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.151 0.881 . . . . 0.0 112.315 166.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -63.92 90.46 0.06 Allowed 'General case' 0 CA--C 1.551 0.986 0 O-C-N 121.429 -1.042 . . . . 0.0 112.617 -173.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 66.0 tp -153.24 -48.69 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.23 1.812 . . . . 0.0 113.872 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 67.7 Cg_endo -77.07 56.7 5.52 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.362 2.708 . . . . 0.0 112.444 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.92 -4.06 35.82 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.275 1.43 . . . . 0.0 112.78 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -85.23 170.63 12.64 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.678 1.991 . . . . 0.0 111.602 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -69.48 129.09 38.75 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.654 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.03 127.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.729 0.776 . . . . 0.0 112.723 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -127.22 -179.92 5.12 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.597 1.559 . . . . 0.0 110.548 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -45.78 -48.93 15.48 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.541 1.936 . . . . 0.0 112.912 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -66.31 -36.3 82.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.44 0.564 . . . . 0.0 112.377 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -69.32 -56.6 7.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.856 0.863 . . . . 0.0 111.195 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.6 -29.54 70.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.903 -0.498 . . . . 0.0 112.056 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -69.86 -52.08 27.87 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 118.06 -0.972 . . . . 0.0 111.586 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.9 ptt-85 -64.29 -38.59 91.59 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 120.59 1.541 . . . . 0.0 111.799 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -74.67 -26.75 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -100.03 -11.31 20.69 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 m -45.4 -47.89 35.19 Favored Pre-proline 0 N--CA 1.479 1.025 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.82 -7.47 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 CA-C-N 122.255 1.841 . . . . 0.0 113.872 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -109.36 -41.15 4.7 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.939 1.295 . . . . 0.0 112.771 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -146.23 168.58 27.71 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 -170.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -92.3 -15.54 27.26 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -163.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 0.2 OUTLIER 60.06 155.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 127.905 2.482 . . . . 0.0 115.704 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.5 mmt -137.86 -65.02 0.53 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.831 1.653 . . . . 0.0 112.077 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.0 tp60 -158.64 165.51 34.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.004 1.322 . . . . 0.0 111.969 -168.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 pt -128.74 147.51 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -165.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -156.33 92.03 1.3 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.382 1.473 . . . . 0.0 111.933 162.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.79 136.98 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.88 -1.137 . . . . 0.0 110.244 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -157.76 146.8 19.58 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.486 1.915 . . . . 0.0 109.052 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 60.09 -160.06 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.099 0.96 . . . . 0.0 111.786 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.17 -9.89 57.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.655 1.582 . . . . 0.0 114.456 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -111.95 -178.18 3.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.206 2.203 . . . . 0.0 111.029 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.66 146.43 10.63 Favored Glycine 0 N--CA 1.466 0.638 0 O-C-N 120.264 -1.523 . . . . 0.0 114.899 175.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -106.45 133.5 51.03 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.088 1.355 . . . . 0.0 109.255 171.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.4 mt -138.0 119.82 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -73.1 137.0 44.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 167.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -121.91 163.91 18.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.309 1.843 . . . . 0.0 109.985 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.29 136.53 32.94 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 160.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.332 6.5 p30 54.24 139.22 0.02 OUTLIER Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 130.158 3.383 . . . . 0.0 118.368 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.04 -27.63 13.8 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.368 2.712 . . . . 0.0 113.988 -170.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -65.67 -35.6 81.23 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.65 -0.656 . . . . 0.0 110.911 175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.39 -37.1 82.61 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.966 1.706 . . . . 0.0 112.182 172.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.25 -59.9 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 118.8 0.727 . . . . 0.0 111.245 167.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -36.2 79.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 118.335 -0.841 . . . . 0.0 112.612 -169.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.49 -37.68 88.4 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 119.467 1.03 . . . . 0.0 111.831 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -48.47 80.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 111.8 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.7 mt -71.01 -51.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.348 -0.845 . . . . 0.0 111.023 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -66.18 -33.9 76.81 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.437 -0.79 . . . . 0.0 111.22 -171.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.8 t -102.0 -15.19 16.87 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -124.03 -41.03 2.24 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 120.823 1.647 . . . . 0.0 113.986 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.4 m -71.02 -28.86 64.7 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.732 -1.23 . . . . 0.0 112.195 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -113.87 -7.6 13.18 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 56.44 13.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.5 mtp -123.36 -29.82 3.76 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 120.425 -1.422 . . . . 0.0 114.178 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 54.95 23.68 5.26 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.605 1.562 . . . . 0.0 114.387 -167.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -160.97 153.13 20.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.783 1.633 . . . . 0.0 110.979 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.99 -175.52 38.5 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.338 0.971 . . . . 0.0 114.34 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HE3' ' CD1' ' A' ' 69' ' ' LEU . 18.1 tptm -136.95 122.3 19.4 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.322 1.449 . . . . 0.0 110.01 175.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -144.71 -39.24 0.27 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.61 1.564 . . . . 0.0 112.219 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.18 155.45 19.41 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.576 1.15 . . . . 0.0 110.614 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.76 130.12 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.923 0.889 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' CD1' ' HE3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -158.57 172.53 18.14 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.116 0.966 . . . . 0.0 113.599 -175.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -147.51 122.72 10.21 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.487 0.661 . . . . 0.0 112.249 163.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.58 145.67 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.716 1.607 . . . . 0.0 110.748 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -151.49 138.6 19.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.914 0.885 . . . . 0.0 112.477 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -92.89 -166.18 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.153 2.181 . . . . 0.0 112.399 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.4 m -69.72 6.22 1.22 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.614 1.566 . . . . 0.0 114.925 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.39 -1.98 55.21 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.671 1.588 . . . . 0.0 113.612 -176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -156.59 -176.46 5.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.716 1.606 . . . . 0.0 111.978 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 125.58 1.552 . . . . 0.0 111.013 163.573 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 CA--C 1.54 0.798 0 N-CA-C 111.624 -0.183 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -112.64 148.52 34.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 122.24 1.019 . . . . 0.0 113.308 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 t -159.88 164.27 33.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 109.428 -172.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -143.17 127.14 17.33 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.849 1.66 . . . . 0.0 111.941 -172.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.515 HD13 ' CE1' ' A' ' 44' ' ' PHE . 7.5 tt -117.98 120.7 38.62 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.421 2.688 . . . . 0.0 109.737 -177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -111.86 124.3 52.07 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.191 0.597 . . . . 0.0 110.856 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.2 mm -81.94 141.12 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.913 0.885 . . . . 0.0 108.777 171.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.26 -163.56 1.42 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.643 0.64 . . . . 0.0 113.076 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -74.38 41.02 0.14 Allowed 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.0 mt -97.18 -46.72 0.24 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.365 1.866 . . . . 0.0 114.146 -172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.68 73.44 5.81 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.426 2.75 . . . . 0.0 111.748 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.56 -13.97 59.57 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.03 1.332 . . . . 0.0 111.514 165.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -83.49 150.12 26.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.151 1.78 . . . . 0.0 112.107 173.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -59.0 152.09 20.58 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.804 0.842 . . . . 0.0 111.587 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.7 p -164.44 160.46 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.173 0.989 . . . . 0.0 111.65 -171.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -125.18 167.75 14.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.758 1.223 . . . . 0.0 112.574 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -52.67 -33.15 45.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.434 0.694 . . . . 0.0 112.704 166.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -59.68 -35.52 74.64 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -78.39 -51.12 10.54 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.74 0.816 . . . . 0.0 112.133 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.63 -36.53 81.04 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.919 -0.488 . . . . 0.0 111.303 173.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -71.5 -42.57 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.286 -0.884 . . . . 0.0 111.75 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -64.27 -44.78 90.66 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.214 1.37 . . . . 0.0 111.592 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 pp -78.14 -30.46 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 117.875 -1.059 . . . . 0.0 113.175 -174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -93.12 -14.32 27.38 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.1 m -45.68 -48.67 37.98 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-N 120.738 1.608 . . . . 0.0 115.305 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.5 -3.35 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.963 1.379 . . . . 0.0 114.068 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -106.71 -26.64 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.206 1.402 . . . . 0.0 113.119 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.31 176.3 39.51 Favored Glycine 0 CA--C 1.536 1.357 0 CA-C-O 122.553 1.085 . . . . 0.0 115.506 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.6 m170 -96.75 -17.95 19.94 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.138 1.532 . . . . 0.0 115.138 -166.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 44' ' ' PHE 0.309 0.1 OUTLIER 58.66 158.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 127.458 2.303 . . . . 0.0 115.634 175.686 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.7 mmt -139.94 -63.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.703 1.601 . . . . 0.0 112.069 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -153.22 169.59 22.65 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.368 1.467 . . . . 0.0 111.224 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -131.3 149.94 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 120.877 -1.139 . . . . 0.0 112.686 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -156.35 131.26 9.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.861 1.264 . . . . 0.0 108.73 166.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.7 mt -143.05 120.64 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -169.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -149.03 159.92 43.79 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.163 1.785 . . . . 0.0 110.319 -174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 52.36 -137.7 1.19 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.765 1.226 . . . . 0.0 112.598 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.77 12.08 22.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.839 1.655 . . . . 0.0 113.457 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -130.75 -172.59 2.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.519 1.528 . . . . 0.0 111.579 -162.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -152.43 135.65 5.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.311 0.958 . . . . 0.0 112.147 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.58 64.92 0.76 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.993 2.117 . . . . 0.0 109.93 -169.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.6 mt -88.98 144.82 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.44 1.096 . . . . 0.0 110.078 -167.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -109.22 143.19 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.82 -1.175 . . . . 0.0 110.513 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.515 ' CE1' HD13 ' A' ' 5' ' ' LEU . 11.4 m-85 -134.52 165.77 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.967 1.307 . . . . 0.0 112.586 -169.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -100.8 136.46 40.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.403 1.081 . . . . 0.0 109.186 164.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.351 0.0 OUTLIER 59.19 153.19 0.09 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 129.189 2.996 . . . . 0.0 116.487 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.75 -29.83 0.4 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.231 2.621 . . . . 0.0 113.893 -174.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -66.84 -41.3 87.62 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.854 . . . . 0.0 110.548 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.29 -40.58 35.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 127.978 2.511 . . . . 0.0 113.595 167.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.56 -58.86 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.332 0.515 . . . . 0.0 111.467 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -39.81 91.42 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.011 -172.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -67.0 -39.37 87.1 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.615 1.098 . . . . 0.0 112.758 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.57 93.0 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.475 0.71 . . . . 0.0 111.851 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.46 -53.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.155 -0.966 . . . . 0.0 111.467 177.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -62.33 -25.81 68.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.49 1.116 . . . . 0.0 113.015 -169.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.4 t -105.71 -28.22 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.04 -19.11 7.3 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 120.81 1.641 . . . . 0.0 114.791 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 56.9 m -124.42 30.18 6.1 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.204 1.401 . . . . 0.0 112.639 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -150.2 148.67 29.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.791 2.037 . . . . 0.0 109.486 170.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -77.0 52.13 0.85 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.805 1.242 . . . . 0.0 111.864 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.6 mmt 55.35 -167.78 0.09 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.863 1.665 . . . . 0.0 113.232 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.7 p-10 -62.04 -9.62 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 120.689 -1.257 . . . . 0.0 114.11 170.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -72.17 -16.24 61.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.0 141.33 47.25 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.256 0.931 . . . . 0.0 114.48 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -129.01 -16.68 4.04 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.51 1.924 . . . . 0.0 113.991 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -130.02 -12.18 4.18 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.78 152.46 42.65 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.169 0.895 . . . . 0.0 111.2 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 mm -122.82 154.3 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.461 1.504 . . . . 0.0 109.74 169.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.05 177.53 10.23 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.539 1.936 . . . . 0.0 110.939 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -144.03 145.34 32.13 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.597 0.759 . . . . 0.0 111.943 157.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.9 p -123.78 127.15 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.086 1.754 . . . . 0.0 109.722 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.2 m -142.35 147.59 36.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.501 1.121 . . . . 0.0 110.693 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.5 p -79.19 -167.46 1.18 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.105 0.962 . . . . 0.0 111.706 167.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.6 t -56.11 138.47 49.57 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.859 -1.15 . . . . 0.0 112.488 174.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -150.42 171.95 16.21 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.874 0.869 . . . . 0.0 111.266 164.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.4 168.64 9.47 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.807 1.643 . . . . 0.0 111.873 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 . . . . . 0 C--O 1.251 1.144 0 C-N-CA 125.732 1.613 . . . . 0.0 112.159 178.312 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.8 tttm -98.88 66.42 1.59 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.493 1.917 . . . . 0.0 110.222 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.08 157.29 38.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.544 1.138 . . . . 0.0 111.683 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -132.97 134.36 44.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.292 1.037 . . . . 0.0 112.895 -172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.4 tt -126.83 111.05 13.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.143 2.177 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -107.73 125.45 51.4 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.99 0.916 . . . . 0.0 110.136 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mt -114.97 138.78 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.022 0.929 . . . . 0.0 109.491 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.36 -146.38 0.32 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.878 1.228 . . . . 0.0 113.297 166.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -75.1 72.28 2.2 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.923 1.289 . . . . 0.0 112.48 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 64.0 tp -131.03 -53.16 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-O 116.893 -1.527 . . . . 0.0 114.65 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 45.7 Cg_endo -79.99 53.14 4.61 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.151 2.567 . . . . 0.0 111.923 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 mp -77.24 -22.73 51.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.379 1.472 . . . . 0.0 111.972 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -67.15 165.92 15.03 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.989 1.715 . . . . 0.0 111.848 171.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -57.37 131.18 49.31 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.546 0.739 . . . . 0.0 111.253 165.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.8 t -144.27 129.18 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.517 1.127 . . . . 0.0 110.301 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.5 p -99.71 170.45 8.56 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.667 1.187 . . . . 0.0 111.779 164.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -55.67 -34.19 64.79 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.295 -0.878 . . . . 0.0 112.627 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -72.29 -32.47 66.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -72.47 -36.59 68.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 112.906 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.64 -32.83 58.24 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.841 0.456 . . . . 0.0 112.128 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -61.8 -46.2 90.54 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.558 0.743 . . . . 0.0 111.452 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.6 ptt85 -66.22 -46.01 78.67 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.148 0.885 . . . . 0.0 112.028 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.93 -26.23 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.416 1.007 . . . . 0.0 113.695 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -99.63 -0.5 40.18 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 173.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -46.49 -53.46 24.13 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.7 -7.76 11.43 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 121.668 1.579 . . . . 0.0 114.225 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -83.75 -23.57 31.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.133 1.373 . . . . 0.0 112.207 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.62 -173.59 44.86 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -106.32 -10.98 16.14 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 -157.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 62.04 154.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 127.848 2.459 . . . . 0.0 116.504 170.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.446 ' H ' HD13 ' A' ' 30' ' ' ILE . 8.0 mmt -143.99 -64.78 0.37 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.474 1.509 . . . . 0.0 113.127 169.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -160.65 176.11 11.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.066 1.346 . . . . 0.0 111.994 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.37 157.4 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 119.553 1.07 . . . . 0.0 112.724 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -156.74 103.96 2.12 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.873 1.269 . . . . 0.0 110.792 166.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -118.21 116.75 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 120.581 -1.324 . . . . 0.0 110.518 -173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -148.74 149.5 31.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.385 1.874 . . . . 0.0 111.021 -168.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 t30 58.44 -163.03 0.21 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.149 1.38 . . . . 0.0 112.786 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.02 29.56 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 O-C-N 119.695 -1.878 . . . . 0.0 114.021 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -144.25 179.22 7.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.321 2.249 . . . . 0.0 109.872 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.8 144.91 9.27 Favored Glycine 0 CA--C 1.523 0.569 0 O-C-N 121.191 -0.943 . . . . 0.0 112.597 171.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -131.5 144.85 51.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -171.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt -138.42 152.82 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -118.5 141.89 48.12 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.365 1.066 . . . . 0.0 108.953 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -132.41 155.95 47.56 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.526 1.131 . . . . 0.0 111.287 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -84.17 135.33 34.41 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 158.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.6 m120 60.94 139.41 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 128.477 2.711 . . . . 0.0 116.703 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -70.79 -25.02 24.31 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.307 2.672 . . . . 0.0 112.444 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.07 -34.54 76.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.213 1.005 . . . . 0.0 111.209 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -64.57 -43.56 93.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.418 1.087 . . . . 0.0 112.345 168.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.14 -49.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 123.554 0.741 . . . . 0.0 110.569 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -61.93 -53.52 54.62 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.851 0.751 . . . . 0.0 111.322 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -70.99 -24.01 62.3 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -171.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.37 -59.19 5.65 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.319 0.963 . . . . 0.0 111.131 167.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mt -75.87 -43.28 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 121.572 -0.705 . . . . 0.0 111.438 -172.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 -17.41 63.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.972 1.309 . . . . 0.0 112.728 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.8 t -105.17 4.24 31.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.525 1.13 . . . . 0.0 112.701 175.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -130.82 -63.2 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.171 0.988 . . . . 0.0 112.46 -175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -66.49 -37.65 85.54 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.667 0.787 . . . . 0.0 111.78 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -90.55 -1.29 57.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.16 0.984 . . . . 0.0 112.907 170.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 54.05 -125.69 2.31 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.993 1.717 . . . . 0.0 112.494 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.2 mtt -105.87 14.13 28.51 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.452 -1.405 . . . . 0.0 112.655 -172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -132.4 173.64 11.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.065 1.346 . . . . 0.0 111.376 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -106.14 5.9 30.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.11 158.83 51.34 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 119.148 0.885 . . . . 0.0 113.177 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -81.2 132.44 35.35 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.444 0.698 . . . . 0.0 111.231 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -131.01 -27.94 2.0 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.495 2.318 . . . . 0.0 111.712 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.1 mt -147.06 177.03 9.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.775 2.43 . . . . 0.0 111.505 -170.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.42 141.95 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.946 1.298 . . . . 0.0 109.525 171.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.88 165.8 35.54 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 112.943 173.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -140.59 130.97 25.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 166.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.57 125.95 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.795 1.638 . . . . 0.0 108.649 165.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 t -146.23 171.58 14.74 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.954 0.902 . . . . 0.0 111.973 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.7 p -142.78 150.6 40.23 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.293 1.437 . . . . 0.0 110.984 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 71.8 p -148.45 171.03 16.71 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -121.87 -34.47 3.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.277 1.431 . . . . 0.0 112.714 174.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.58 -6.67 0.61 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.759 1.624 . . . . 0.0 114.306 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.699 -1.62 . . . . 0.0 113.378 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 CA--C 1.545 1.043 0 N-CA-C 114.11 0.773 . . . . 0.0 114.11 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -130.98 49.91 2.28 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.692 1.997 . . . . 0.0 112.119 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -59.42 161.18 5.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.689 1.595 . . . . 0.0 111.786 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -125.14 125.48 43.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.361 1.065 . . . . 0.0 111.449 -165.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -119.8 123.27 43.29 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.271 1.828 . . . . 0.0 108.949 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -117.13 146.42 43.18 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.591 1.157 . . . . 0.0 110.929 173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.38 139.45 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.814 1.646 . . . . 0.0 110.165 176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.98 149.05 18.38 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.746 1.165 . . . . 0.0 113.78 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.05 36.37 27.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 6.6 tt -134.93 -56.22 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.791 1.636 . . . . 0.0 112.179 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 72.0 Cg_endo -74.47 99.42 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.27 1.98 . . . . 0.0 111.593 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.37 23.37 3.46 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.986 2.515 . . . . 0.0 111.313 -176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -137.74 161.64 36.0 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.806 2.442 . . . . 0.0 108.9 178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -56.43 131.92 49.77 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.03 0.832 . . . . 0.0 109.957 168.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.59 135.05 12.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 125.291 1.436 . . . . 0.0 109.269 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -118.21 167.2 11.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.448 1.499 . . . . 0.0 110.082 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -54.22 -32.0 54.67 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 mp0 -65.81 -31.94 73.19 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.088 1.355 . . . . 0.0 113.93 178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.45 -50.8 13.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.816 0.846 . . . . 0.0 110.81 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.43 -30.17 70.47 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.434 -0.791 . . . . 0.0 111.897 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -69.87 -45.29 68.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.871 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -64.66 -39.22 93.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.902 1.228 . . . . 0.0 112.234 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 pp -76.49 -38.39 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 118.09 -0.957 . . . . 0.0 112.425 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -89.52 -4.39 57.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 m -48.13 -49.56 59.92 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.41 -19.83 16.65 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 121.84 1.693 . . . . 0.0 113.713 174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -77.22 -31.19 55.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.281 1.033 . . . . 0.0 111.656 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 179.9 -175.36 46.67 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -18.07 25.16 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 -159.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 62.04 155.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 127.343 2.257 . . . . 0.0 115.474 174.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.427 ' H ' HD13 ' A' ' 30' ' ' ILE . 6.2 mmt -139.35 -72.46 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.529 1.531 . . . . 0.0 112.258 166.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -142.84 171.53 13.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 126.37 1.868 . . . . 0.0 112.217 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.4 pt -131.88 150.87 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.579 1.151 . . . . 0.0 113.459 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -151.84 96.46 2.23 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.01 1.724 . . . . 0.0 109.889 168.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.14 130.99 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 120.388 -1.445 . . . . 0.0 111.961 -171.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -163.79 141.02 7.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.184 1.394 . . . . 0.0 112.724 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 41.11 84.84 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.897 2.479 . . . . 0.0 114.995 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.78 -7.83 0.1 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.926 2.49 . . . . 0.0 117.494 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -128.31 164.88 21.66 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.838 1.655 . . . . 0.0 110.806 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.74 152.68 24.25 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 123.79 0.709 . . . . 0.0 112.438 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -135.24 140.73 45.48 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.506 1.123 . . . . 0.0 109.667 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -134.76 117.57 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.752 1.621 . . . . 0.0 106.848 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -75.97 140.29 41.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.35 153.94 44.22 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.758 1.623 . . . . 0.0 110.966 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -83.33 145.74 28.89 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 152.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 58.88 135.66 0.03 OUTLIER Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 129.012 2.925 . . . . 0.0 116.883 -171.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.13 -31.93 11.44 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.259 1.973 . . . . 0.0 112.808 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.55 -29.31 69.92 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.719 0.69 . . . . 0.0 111.406 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 m -66.24 -46.76 76.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.796 1.238 . . . . 0.0 113.379 166.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.94 -51.69 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.78 0.832 . . . . 0.0 111.526 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -47.03 63.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.913 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -66.56 -13.81 61.51 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.647 1.112 . . . . 0.0 113.639 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.55 -77.41 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.405 1.482 . . . . 0.0 112.196 164.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 pp -69.95 -32.53 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 O-C-N 120.444 -1.41 . . . . 0.0 114.39 -171.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.58 -12.18 60.97 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.644 1.111 . . . . 0.0 113.032 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -105.65 -25.03 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.504 1.521 . . . . 0.0 112.653 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -98.94 -59.68 1.68 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.792 1.237 . . . . 0.0 113.55 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.5 m -67.84 -51.38 49.14 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 168.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 54.83 22.03 3.97 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.645 1.578 . . . . 0.0 112.899 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -100.72 162.53 12.86 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.969 2.108 . . . . 0.0 110.002 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.5 mtm -120.11 169.72 9.96 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.416 1.086 . . . . 0.0 111.962 -172.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -51.89 156.96 1.34 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.422 1.089 . . . . 0.0 113.053 178.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 57.75 18.05 4.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.742 1.217 . . . . 0.0 113.926 -171.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.4 149.82 39.33 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.67 1.129 . . . . 0.0 113.326 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -72.19 -35.78 69.05 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.233 0.613 . . . . 0.0 112.135 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -142.91 166.44 24.63 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.896 1.279 . . . . 0.0 113.442 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mt 57.36 20.84 6.24 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.715 2.006 . . . . 0.0 115.295 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.0 pt -63.07 156.77 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.806 1.243 . . . . 0.0 112.624 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.71 162.71 34.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -171.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -143.68 128.71 18.57 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.673 -0.642 . . . . 0.0 112.298 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.61 126.67 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.076 2.15 . . . . 0.0 110.158 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.8 t -141.04 132.43 26.75 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 95.9 p -85.07 18.6 2.46 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.5 m -55.36 155.52 5.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.966 1.307 . . . . 0.0 114.461 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -101.42 1.19 38.09 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.241 1.416 . . . . 0.0 113.354 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.24 163.24 37.01 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.436 1.094 . . . . 0.0 112.268 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.654 1.581 . . . . 0.0 113.055 177.702 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo . . . . . 0 N--CA 1.48 0.706 0 N-CA-C 110.989 -0.427 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -60.35 134.61 57.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.251 1.02 . . . . 0.0 112.137 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -145.79 166.07 26.99 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.187 2.195 . . . . 0.0 110.56 -164.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.7 ttp-105 -148.32 130.32 15.33 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.878 -1.139 . . . . 0.0 113.23 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 tt -108.72 111.55 23.38 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.22 2.608 . . . . 0.0 109.123 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -109.98 133.57 53.04 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.816 1.246 . . . . 0.0 110.136 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 mt -131.14 141.98 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.553 1.141 . . . . 0.0 110.541 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.07 -137.98 0.3 Allowed Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.467 1.508 . . . . 0.0 113.626 164.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -78.7 78.82 5.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.225 1.01 . . . . 0.0 111.667 -173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.506 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 58.4 tp -139.48 -55.34 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.377 165.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.506 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 60.6 Cg_endo -75.15 23.56 0.41 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.839 2.359 . . . . 0.0 114.184 178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 tt -67.24 -41.83 85.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.722 1.209 . . . . 0.0 113.232 -163.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HE3' ' HA ' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -144.3 -23.29 0.54 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -96.45 18.8 13.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.111 1.364 . . . . 0.0 113.614 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.45 125.19 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.289 -1.507 . . . . 0.0 111.067 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.2 m -111.79 175.85 5.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.043 1.337 . . . . 0.0 110.295 164.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -56.22 -37.82 70.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.91 -28.32 68.85 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.06 -52.14 7.72 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.933 0.893 . . . . 0.0 111.798 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.49 -36.55 78.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.613 0.642 . . . . 0.0 110.843 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -69.04 -48.38 63.02 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.249 -0.881 . . . . 0.0 112.264 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.6 ptt85 -65.14 -35.51 81.34 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.493 1.497 . . . . 0.0 112.617 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -81.82 -33.36 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -88.61 -18.33 28.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.048 1.294 . . . . 0.0 114.33 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 m -43.47 -47.23 17.89 Favored Pre-proline 0 N--CA 1.48 1.041 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.63 -13.21 29.78 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 CA-C-N 121.948 1.731 . . . . 0.0 113.849 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -105.73 -25.65 12.13 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.766 1.226 . . . . 0.0 113.111 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 49' ' ' SER . . . -149.71 159.0 27.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 118.511 2.165 . . . . 0.0 118.511 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -88.38 -22.12 23.95 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.754 1.622 . . . . 0.0 114.407 -165.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 62.9 156.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 128.641 2.776 . . . . 0.0 116.768 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.1 mmt -130.97 -71.15 0.58 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.939 1.696 . . . . 0.0 111.325 164.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -150.19 162.92 39.53 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.446 1.498 . . . . 0.0 111.609 -166.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.66 145.54 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 120.971 -1.081 . . . . 0.0 113.092 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -147.01 137.92 23.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.196 1.398 . . . . 0.0 109.007 159.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 88.9 mt -139.34 122.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.911 1.284 . . . . 0.0 108.207 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -158.38 155.09 28.06 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.853 1.661 . . . . 0.0 109.797 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 58.29 -151.78 0.41 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.935 0.894 . . . . 0.0 111.479 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.44 25.07 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 113.67 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -143.51 170.22 16.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.373 1.469 . . . . 0.0 112.266 -163.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.91 140.99 12.28 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.032 1.301 . . . . 0.0 112.007 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -131.25 72.27 1.5 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.046 1.338 . . . . 0.0 110.539 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.27 129.78 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 O-C-N 120.686 -1.259 . . . . 0.0 110.094 -167.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.98 137.17 32.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.612 1.165 . . . . 0.0 109.704 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -133.02 169.87 16.2 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.896 1.278 . . . . 0.0 112.51 -171.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -112.28 146.02 38.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.42 1.088 . . . . 0.0 109.139 162.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 60.86 122.56 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.388 0 C-N-CA 127.586 2.354 . . . . 0.0 115.156 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.13 -34.46 16.61 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.775 2.316 . . . . 0.0 112.815 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -58.91 -24.94 62.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.817 0.847 . . . . 0.0 112.546 171.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -82.53 -38.65 23.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 111.949 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.6 t -60.53 -55.25 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.99 0.916 . . . . 0.0 111.62 169.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -41.75 99.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -63.82 -40.0 95.57 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.006 1.275 . . . . 0.0 112.237 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.8 -47.35 85.06 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.719 0.69 . . . . 0.0 112.026 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.0 mt -71.46 -52.72 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.092 -1.005 . . . . 0.0 111.14 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -72.41 -19.43 61.6 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.266 -0.896 . . . . 0.0 113.08 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 2.6 t -115.27 -8.82 12.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.083 1.353 . . . . 0.0 114.311 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -139.11 -15.31 1.12 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.5 m -97.27 1.41 49.57 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.739 -1.851 . . . . 0.0 112.167 156.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 53.74 33.07 15.99 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.749 2.419 . . . . 0.0 115.332 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.05 125.48 26.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.577 -0.702 . . . . 0.0 111.345 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.5 mtm -94.7 11.93 29.56 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.995 1.718 . . . . 0.0 113.884 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 60.43 30.72 20.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.44 1.096 . . . . 0.0 112.337 -170.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -143.65 -12.95 0.67 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.994 2.118 . . . . 0.0 112.506 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.12 -172.01 32.57 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.813 1.673 . . . . 0.0 111.291 165.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.5 tttt -129.03 24.63 5.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.004 0.922 . . . . 0.0 113.263 -173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -93.59 -23.65 18.22 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.472 -0.767 . . . . 0.0 113.068 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 tp -150.31 169.84 20.44 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.122 0.569 . . . . 0.0 112.134 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.7 mm -113.27 140.65 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.435 1.894 . . . . 0.0 109.222 167.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 166.49 32.63 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.045 0.938 . . . . 0.0 113.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -148.44 133.89 18.61 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.39 0.676 . . . . 0.0 111.865 163.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.59 133.21 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.152 1.381 . . . . 0.0 109.941 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -150.08 167.4 26.91 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 m -123.86 151.43 43.47 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.829 1.651 . . . . 0.0 111.208 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.0 m -134.81 158.26 44.64 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -168.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -84.81 145.9 27.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.268 0.627 . . . . 0.0 112.021 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -110.33 1.56 18.57 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.965 1.706 . . . . 0.0 113.106 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.463 1.505 . . . . 0.0 112.717 171.047 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo . . . . . 0 CA--C 1.54 0.813 0 N-CA-C 112.937 0.322 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -124.41 133.55 53.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.951 1.7 . . . . 0.0 111.863 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.37 172.86 12.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.8 2.04 . . . . 0.0 109.817 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -144.74 137.75 26.71 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.811 -1.181 . . . . 0.0 111.048 -170.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 5' ' ' LEU . 6.1 tt -136.15 126.32 26.31 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.5 1.92 . . . . 0.0 109.684 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -117.33 143.86 45.5 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.439 1.096 . . . . 0.0 111.817 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.63 113.92 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.579 1.152 . . . . 0.0 109.083 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.78 50.8 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.009 -172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -150.25 79.7 1.35 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.282 1.041 . . . . 0.0 111.639 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.562 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 1.2 tt -153.0 -48.04 0.01 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.669 1.187 . . . . 0.0 112.168 169.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 52.3 Cg_endo -82.35 43.91 1.59 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.162 2.575 . . . . 0.0 113.572 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.84 -23.22 67.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.083 1.353 . . . . 0.0 112.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -72.49 0.24 10.86 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.29 1.836 . . . . 0.0 113.637 171.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 51.71 56.72 7.42 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.018 1.327 . . . . 0.0 112.176 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -58.07 141.47 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.983 1.313 . . . . 0.0 111.736 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.2 t -79.13 174.35 11.65 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.98 -46.54 61.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.559 1.544 . . . . 0.0 112.45 177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -74.57 -24.14 58.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.781 0.832 . . . . 0.0 112.846 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -79.82 -39.88 29.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.698 1.136 . . . . 0.0 112.251 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 pp -71.85 -34.75 69.52 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.801 -0.562 . . . . 0.0 111.083 167.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -74.69 -37.43 62.64 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 120.686 -1.259 . . . . 0.0 113.088 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -66.08 -26.67 67.59 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.087 1.767 . . . . 0.0 113.166 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -89.04 -37.65 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.081 0.952 . . . . 0.0 112.026 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -86.96 -14.88 40.48 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.529 1.513 . . . . 0.0 114.964 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 m -47.59 -50.41 50.8 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.93 6.14 3.53 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.945 1.764 . . . . 0.0 114.916 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.4 -22.06 5.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.917 1.287 . . . . 0.0 114.1 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.49 -169.13 21.62 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 119.265 0.939 . . . . 0.0 114.997 -175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -112.12 -17.22 12.87 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.51 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 59.39 156.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 127.277 2.231 . . . . 0.0 116.878 171.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.51 ' H ' HD13 ' A' ' 30' ' ' ILE . 9.3 mmt -138.53 -67.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.417 1.487 . . . . 0.0 112.66 167.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -155.37 172.59 17.95 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.391 1.476 . . . . 0.0 111.978 -163.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.35 160.42 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 O-C-N 120.555 -1.34 . . . . 0.0 112.983 -168.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -158.04 114.78 2.87 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.108 1.363 . . . . 0.0 109.959 157.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.4 mt -128.18 115.54 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 120.588 -1.32 . . . . 0.0 108.871 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -154.5 160.48 41.58 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.633 1.573 . . . . 0.0 110.927 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 50.33 -147.54 0.36 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.745 1.218 . . . . 0.0 110.912 -174.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.92 7.9 11.8 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 120.046 -1.659 . . . . 0.0 114.99 -175.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -125.02 -175.02 3.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.882 1.273 . . . . 0.0 112.764 -171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.41 147.13 18.04 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.006 0.812 . . . . 0.0 112.543 166.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -132.9 144.12 49.95 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.287 1.435 . . . . 0.0 110.356 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 mt -142.68 124.18 12.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.406 1.082 . . . . 0.0 108.158 -174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -85.28 139.13 31.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 122.349 1.071 . . . . 0.0 108.692 168.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -125.12 169.48 12.15 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.828 -168.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -104.09 144.16 31.94 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 155.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 56.52 127.61 0.01 OUTLIER Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 129.115 2.966 . . . . 0.0 117.807 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -29.8 10.12 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.731 2.287 . . . . 0.0 114.82 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -65.52 -35.95 82.39 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 120.087 1.312 . . . . 0.0 110.84 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -40.52 89.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.564 1.946 . . . . 0.0 112.728 168.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.36 -51.68 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 119.387 0.994 . . . . 0.0 112.195 172.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -24.76 63.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -75.57 -39.03 58.7 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.436 -0.79 . . . . 0.0 111.706 169.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.0 -62.93 1.37 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.61 0.764 . . . . 0.0 111.996 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . 0.266 1.1 pp -73.1 -44.65 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.91 1.232 . . . . 0.0 114.054 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.15 -30.75 69.06 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.369 1.895 . . . . 0.0 112.752 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -104.91 -29.14 10.68 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -85.72 -51.93 6.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.169 1.35 . . . . 0.0 110.904 168.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.6 m -100.05 -98.67 0.24 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.577 1.551 . . . . 0.0 112.116 -167.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -149.2 151.08 33.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.166 1.386 . . . . 0.0 111.972 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -78.93 176.88 9.21 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.067 1.347 . . . . 0.0 112.266 170.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.41 -26.63 66.83 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.413 -1.429 . . . . 0.0 113.312 178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.8 p30 46.71 -146.84 0.18 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.244 2.218 . . . . 0.0 113.72 170.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -85.47 -12.1 52.67 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.755 1.622 . . . . 0.0 113.339 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.93 13.61 69.63 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.3 1.428 . . . . 0.0 115.124 -177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -77.01 -33.13 57.56 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.791 1.636 . . . . 0.0 114.115 -171.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -110.07 -48.72 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.04 2.136 . . . . 0.0 111.361 170.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.22 152.04 36.52 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -171.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.52 166.36 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.972 1.309 . . . . 0.0 112.038 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.85 166.56 14.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.358 1.863 . . . . 0.0 109.826 165.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -133.71 120.66 20.88 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.189 0.45 . . . . 0.0 111.377 163.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.05 135.22 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.381 1.072 . . . . 0.0 109.82 171.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.4 t -154.36 166.42 33.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.172 0.987 . . . . 0.0 112.797 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 p -128.05 -160.1 0.99 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.95 1.7 . . . . 0.0 112.103 -170.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 68.2 m -70.4 10.81 0.41 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 171.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -51.79 150.64 3.9 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.647 -1.283 . . . . 0.0 112.509 174.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.16 -9.95 13.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.348 1.459 . . . . 0.0 114.892 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 125.968 1.707 . . . . 0.0 112.433 175.135 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.482 0.846 0 N-CA-C 110.722 -0.53 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -92.96 142.99 26.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.144 0.883 . . . . 0.0 112.864 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.77 167.6 29.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.703 2.001 . . . . 0.0 110.984 -173.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -138.71 130.99 28.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.206 1.402 . . . . 0.0 111.419 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.73 135.01 51.96 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.343 2.657 . . . . 0.0 109.167 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -132.16 132.85 43.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.969 0.908 . . . . 0.0 111.025 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.61 112.35 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.235 1.014 . . . . 0.0 110.266 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' HA3' HG23 ' A' ' 68' ' ' ILE . . . -91.18 0.36 75.3 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.235 -0.759 . . . . 0.0 114.886 172.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -64.72 5.98 0.26 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.895 1.678 . . . . 0.0 114.545 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.4 mt 51.44 54.94 15.5 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 126.819 2.048 . . . . 0.0 114.641 -172.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -60.72 115.66 2.83 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 121.876 1.717 . . . . 0.0 110.401 165.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.1 mt -136.44 -7.69 1.97 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.551 1.54 . . . . 0.0 113.879 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -88.1 164.48 15.7 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.658 1.183 . . . . 0.0 111.031 170.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -59.16 128.65 38.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.22 1.008 . . . . 0.0 112.294 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.6 m -150.38 151.3 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.647 1.979 . . . . 0.0 109.642 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.2 t -117.21 168.98 9.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.894 0.854 . . . . 0.0 112.576 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -53.91 -29.08 40.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.451 1.5 . . . . 0.0 114.268 173.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -75.37 -29.26 59.83 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 119.136 0.88 . . . . 0.0 113.344 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.37 -59.58 3.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.715 1.143 . . . . 0.0 110.996 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.96 -32.89 71.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.779 0.832 . . . . 0.0 111.885 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -71.36 -44.42 65.05 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.904 176.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -66.65 -40.91 88.87 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.989 1.722 . . . . 0.0 111.928 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.06 -17.76 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -107.81 -8.32 16.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 171.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.6 m -47.38 -49.51 53.33 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-N 120.911 1.687 . . . . 0.0 114.692 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.1 -8.31 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.041 1.827 . . . . 0.0 114.066 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -97.62 -33.01 11.49 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.793 1.237 . . . . 0.0 112.765 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.56 -179.71 39.98 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 116.626 1.41 . . . . 0.0 116.626 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -93.27 -18.79 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 -158.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.2 152.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 127.057 2.143 . . . . 0.0 116.174 174.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.2 mmt -134.05 -68.48 0.56 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.368 1.467 . . . . 0.0 112.202 166.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -151.54 170.58 19.3 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 111.049 -166.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.34 137.49 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.514 -1.366 . . . . 0.0 111.373 -170.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -140.56 71.36 1.37 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.426 1.49 . . . . 0.0 110.986 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.43 107.59 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.445 -1.409 . . . . 0.0 108.675 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.2 138.2 50.46 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.738 2.015 . . . . 0.0 109.687 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 53.05 -149.57 0.39 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.85 1.26 . . . . 0.0 112.628 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.95 -36.08 28.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.254 0.934 . . . . 0.0 112.046 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -83.01 64.28 7.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.557 1.143 . . . . 0.0 111.559 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -65.83 144.98 47.61 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.345 0.497 . . . . 0.0 112.301 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -133.9 155.62 49.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.959 1.361 . . . . 0.0 112.426 177.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.28 126.71 49.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 125.374 1.47 . . . . 0.0 107.452 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -77.37 137.62 38.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.56 0.744 . . . . 0.0 109.457 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.58 164.84 24.03 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.823 0.849 . . . . 0.0 112.684 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -102.63 145.48 29.59 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.587 1.155 . . . . 0.0 109.131 162.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 53.32 124.21 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 128.905 2.882 . . . . 0.0 116.321 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.91 -29.81 17.85 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.626 2.217 . . . . 0.0 112.782 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -61.98 -30.65 71.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.607 0.763 . . . . 0.0 111.651 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -33.94 38.03 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.751 1.621 . . . . 0.0 112.403 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.35 -58.33 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 118.23 0.468 . . . . 0.0 110.332 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.278 6.6 ppt_? -64.44 -44.85 89.84 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 117.46 -1.257 . . . . 0.0 111.336 -173.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -62.69 -29.2 70.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.085 1.766 . . . . 0.0 114.072 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.5 -60.92 2.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.361 0.982 . . . . 0.0 112.055 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.91 -17.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -82.08 -22.88 36.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.728 1.604 . . . . 0.0 112.953 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.8 t -96.7 -21.24 17.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.649 0.78 . . . . 0.0 112.506 170.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -87.75 -56.92 3.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 120.042 1.292 . . . . 0.0 112.125 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 68.1 m -84.61 39.33 0.73 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.101 1.36 . . . . 0.0 112.02 167.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -66.29 -43.79 85.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.312 1.445 . . . . 0.0 111.867 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -151.95 -54.83 0.13 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.341 1.456 . . . . 0.0 112.159 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 36.2 mtm 36.66 52.85 1.03 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.007 1.723 . . . . 0.0 114.46 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -56.36 101.99 0.07 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.904 1.282 . . . . 0.0 112.523 -166.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -162.43 -35.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.423 1.089 . . . . 0.0 112.325 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.31 167.18 37.63 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.66 1.6 . . . . 0.0 111.592 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -83.62 20.56 1.38 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.768 1.627 . . . . 0.0 113.0 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -65.84 -36.54 83.75 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.343 1.857 . . . . 0.0 112.863 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.42 144.93 55.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.408 HG23 ' HA3' ' A' ' 8' ' ' GLY . 8.0 tp -167.14 153.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.711 2.004 . . . . 0.0 108.302 164.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD13 ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -124.79 161.47 26.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.914 1.286 . . . . 0.0 112.322 175.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.29 143.01 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.908 0.861 . . . . 0.0 110.885 161.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.48 137.46 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 127.075 2.15 . . . . 0.0 108.404 174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.6 m -138.29 113.64 9.5 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.597 1.159 . . . . 0.0 109.229 175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -77.33 25.8 0.17 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -172.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.3 t -159.04 177.71 10.83 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.359 1.464 . . . . 0.0 111.366 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -148.64 156.96 43.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.03 1.332 . . . . 0.0 111.805 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.87 172.31 0.12 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.639 1.976 . . . . 0.0 114.729 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.358 1.463 . . . . 0.0 112.574 -178.191 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo . . . . . 0 CA--C 1.539 0.768 0 CA-C-O 119.972 -0.095 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -136.06 145.15 45.67 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.429 1.492 . . . . 0.0 110.386 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.16 167.6 19.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.082 0.953 . . . . 0.0 111.891 -172.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -150.82 125.63 9.74 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.149 -0.969 . . . . 0.0 112.59 -174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 6' ' ' PHE . 5.9 tt -106.56 142.71 35.78 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.572 2.749 . . . . 0.0 109.551 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.525 ' N ' HD23 ' A' ' 5' ' ' LEU . 26.5 t80 -136.51 144.05 44.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 167.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -121.97 119.87 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.923 1.289 . . . . 0.0 109.378 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.81 -8.78 66.95 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 115.309 0.884 . . . . 0.0 115.309 -176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -163.46 91.54 0.69 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.236 1.518 . . . . 0.0 111.029 167.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.555 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 29.1 tp -156.51 -48.08 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.16 -1.4 . . . . 0.0 112.82 165.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 54.5 Cg_endo -83.35 66.7 7.59 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.523 2.148 . . . . 0.0 112.225 -173.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.6 mt -84.06 -6.04 59.34 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.803 -1.186 . . . . 0.0 113.805 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -112.64 11.58 19.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.632 1.573 . . . . 0.0 112.501 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 58.89 138.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.171 2.589 . . . . 0.0 113.694 -173.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.94 136.07 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.33 1.052 . . . . 0.0 109.627 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.7 m -89.01 157.05 18.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.625 0.77 . . . . 0.0 112.35 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -47.59 -48.46 28.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.001 1.72 . . . . 0.0 112.891 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -70.11 -26.41 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -82.1 -44.78 16.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.612 1.165 . . . . 0.0 112.539 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -67.64 -34.55 77.18 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.553 -0.717 . . . . 0.0 110.988 170.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -63.97 -48.65 75.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.074 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -65.07 -42.86 93.79 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.452 1.478 . . . . 0.0 112.657 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -26.98 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 118.014 -0.993 . . . . 0.0 112.726 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -96.28 -5.4 40.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 173.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.8 m -48.52 -42.92 58.9 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.46 -16.64 4.68 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.124 1.883 . . . . 0.0 113.346 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -79.29 -24.2 43.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.448 1.099 . . . . 0.0 112.23 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.56 -171.75 41.36 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -94.61 -17.15 22.59 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -163.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.56 154.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 127.098 2.159 . . . . 0.0 116.759 169.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.0 mmt -139.38 -65.81 0.47 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.022 1.329 . . . . 0.0 113.22 168.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -159.99 174.95 13.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.381 1.072 . . . . 0.0 112.086 -166.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.1 pt -133.09 155.01 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.469 -1.394 . . . . 0.0 114.559 -171.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -153.63 120.12 5.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.998 1.319 . . . . 0.0 110.779 162.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.6 mt -132.15 126.99 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 O-C-N 120.991 -1.068 . . . . 0.0 112.205 -168.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -156.2 147.65 22.62 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.422 1.489 . . . . 0.0 112.058 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 53.55 -152.21 0.31 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.535 1.534 . . . . 0.0 112.561 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.09 -4.21 20.14 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.037 1.335 . . . . 0.0 114.245 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.67 -175.61 2.76 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.377 . . . . 0.0 110.681 -169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.29 149.66 15.33 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.365 -0.834 . . . . 0.0 113.017 165.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -111.87 135.87 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.364 1.465 . . . . 0.0 109.971 172.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -130.25 114.24 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -73.71 139.22 45.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.799 0.809 . . . . 0.0 108.844 170.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.52 157.48 42.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.321 1.448 . . . . 0.0 111.097 -170.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.25 146.17 23.92 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 60.89 138.09 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 129.156 2.983 . . . . 0.0 117.033 -172.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.57 -35.53 2.71 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.03 2.486 . . . . 0.0 112.754 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.48 -34.22 75.11 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.549 0.613 . . . . 0.0 111.269 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.6 m -64.14 -43.81 94.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.068 1.347 . . . . 0.0 112.751 172.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.6 -52.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 118.745 0.702 . . . . 0.0 111.344 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -40.44 79.59 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 118.642 -0.694 . . . . 0.0 111.779 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.48 -28.2 66.82 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.194 1.361 . . . . 0.0 112.655 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.94 -63.6 1.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.892 0.769 . . . . 0.0 111.814 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 pp -78.77 -27.49 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -66.89 -26.92 67.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.192 1.36 . . . . 0.0 112.182 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.27 -15.35 16.0 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.629 1.171 . . . . 0.0 113.624 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -107.39 -46.12 3.93 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 120.67 -1.269 . . . . 0.0 113.938 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.4 m -83.82 -39.9 19.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.792 0.724 . . . . 0.0 111.003 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 56.23 -173.34 0.07 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.854 1.661 . . . . 0.0 114.267 171.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 57.93 16.23 3.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.021 1.729 . . . . 0.0 114.91 165.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -58.54 -33.9 70.4 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.318 -1.489 . . . . 0.0 110.79 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.97 6.61 41.41 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.194 1.797 . . . . 0.0 113.363 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -130.09 -11.87 4.17 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.424 1.49 . . . . 0.0 114.621 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.13 -177.78 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 120.777 -1.202 . . . . 0.0 112.926 -175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -144.91 23.27 1.55 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.0 1.32 . . . . 0.0 114.096 -177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.8 -30.57 63.82 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.115 0.966 . . . . 0.0 111.317 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.16 167.81 18.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.895 1.278 . . . . 0.0 112.84 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.99 153.32 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.052 1.741 . . . . 0.0 109.378 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.28 166.43 24.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.236 1.415 . . . . 0.0 111.327 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.9 140.07 31.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.63 0.772 . . . . 0.0 112.948 171.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.4 p -103.25 140.4 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.514 1.925 . . . . 0.0 110.103 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m -153.69 146.35 24.22 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.268 1.427 . . . . 0.0 110.039 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.0 p -99.37 0.03 41.98 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.3 t -146.19 167.34 23.7 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.123 1.769 . . . . 0.0 111.12 -173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -97.29 -12.63 22.67 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.464 1.106 . . . . 0.0 112.876 175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.94 -38.82 0.26 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.5 ttm-85 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 123.809 0.844 . . . . 0.0 112.923 -175.014 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 113.254 0.444 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -120.57 152.26 38.34 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.504 1.922 . . . . 0.0 110.641 168.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 t -163.52 165.21 23.89 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.066 1.746 . . . . 0.0 109.76 -173.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -136.91 121.98 19.03 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.283 1.433 . . . . 0.0 111.721 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 44' ' ' PHE . 8.3 tt -108.53 134.21 51.61 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.924 2.49 . . . . 0.0 110.048 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -127.22 137.59 52.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.257 0.623 . . . . 0.0 111.903 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.19 132.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.27 1.428 . . . . 0.0 108.174 167.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.16 -152.12 0.99 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.483 1.039 . . . . 0.0 113.492 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -60.35 85.72 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.868 1.667 . . . . 0.0 113.074 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 2.6 tm? -153.47 -58.56 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.412 1.485 . . . . 0.0 112.753 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.472 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 74.8 Cg_endo -71.36 -35.66 8.02 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.855 1.698 . . . . 0.0 112.195 -171.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp 55.91 178.21 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.452 1.501 . . . . 0.0 112.884 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -70.24 17.66 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.078 1.351 . . . . 0.0 113.721 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -95.65 -11.52 27.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.08 1.752 . . . . 0.0 112.906 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.5 t -94.55 126.79 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -109.37 171.13 7.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.333 1.453 . . . . 0.0 110.964 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -61.7 -24.37 66.72 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 mp0 -74.52 -33.38 62.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.807 1.243 . . . . 0.0 111.514 173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -80.08 -51.37 9.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.047 1.339 . . . . 0.0 111.947 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.17 -32.55 71.16 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.445 -0.784 . . . . 0.0 111.444 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -67.91 -53.64 24.91 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.444 -0.789 . . . . 0.0 111.494 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 -65.0 -31.12 72.2 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.421 1.464 . . . . 0.0 113.925 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.2 -35.85 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 118.74 -0.647 . . . . 0.0 112.513 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 27.5 m-85 -89.28 -12.4 40.75 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.9 m -46.27 -46.55 44.96 Favored Pre-proline 0 N--CA 1.478 0.974 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.13 -4.35 15.24 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 CA-C-N 122.723 2.008 . . . . 0.0 113.541 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.05 -21.13 10.71 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.802 1.241 . . . . 0.0 113.587 -173.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -160.94 177.03 37.49 Favored Glycine 0 CA--C 1.528 0.847 0 O-C-N 121.136 -0.977 . . . . 0.0 115.445 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -94.24 -16.77 23.32 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -172.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 61.87 157.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 126.523 1.929 . . . . 0.0 115.943 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.0 mmt -136.1 -79.61 0.41 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.206 1.403 . . . . 0.0 112.315 165.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -149.82 170.45 18.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.295 1.438 . . . . 0.0 112.064 -162.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.7 pp -127.51 146.43 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -160.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -149.21 132.9 16.86 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.987 2.115 . . . . 0.0 108.524 164.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.91 135.54 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.41 1.484 . . . . 0.0 108.756 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -150.47 146.96 26.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.524 1.129 . . . . 0.0 110.929 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 51.89 -95.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.678 1.591 . . . . 0.0 113.396 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.54 3.13 6.88 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.606 1.563 . . . . 0.0 113.565 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -119.51 161.93 19.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.216 1.806 . . . . 0.0 112.557 -164.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.49 135.99 11.22 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.42 1.01 . . . . 0.0 113.027 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.76 95.1 4.01 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.211 1.804 . . . . 0.0 108.168 177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 57.2 mt -115.52 129.24 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 120.641 -1.287 . . . . 0.0 109.467 -167.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -83.31 142.01 31.39 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.956 0.902 . . . . 0.0 109.906 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.411 ' CE1' HD13 ' A' ' 5' ' ' LEU . 1.9 m-85 -134.57 173.85 11.21 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.539 1.536 . . . . 0.0 112.704 -170.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -118.79 127.1 53.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.627 1.571 . . . . 0.0 108.845 169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 67.65 151.13 0.12 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 128.306 2.642 . . . . 0.0 114.978 -166.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.19 -30.75 1.49 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 123.064 2.509 . . . . 0.0 112.208 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -62.16 -37.8 86.58 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.664 0.786 . . . . 0.0 110.456 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.0 m -59.04 -27.61 65.65 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 79.5 t -84.65 -51.65 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 123.669 0.788 . . . . 0.0 110.769 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -58.43 -51.75 68.53 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.399 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -58.17 -40.25 80.97 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.451 1.023 . . . . 0.0 112.315 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -58.22 -59.01 5.97 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.216 0.462 . . . . 0.0 111.784 176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -72.97 -41.82 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.957 0.798 . . . . 0.0 111.138 -175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.63 -33.87 74.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 112.426 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.3 t -101.55 -33.04 10.09 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -87.66 -50.64 6.36 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.909 1.231 . . . . 0.0 112.357 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -88.91 -49.45 6.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.246 0.93 . . . . 0.0 112.385 -173.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 51.68 -144.79 0.57 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.823 1.649 . . . . 0.0 111.485 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 54.57 16.67 1.4 Allowed 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 116.668 2.099 . . . . 0.0 116.668 170.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.0 ttt -75.97 -29.96 58.43 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.041 -1.037 . . . . 0.0 110.869 165.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -110.21 167.42 10.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.019 1.728 . . . . 0.0 111.231 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 t80 50.6 35.46 11.59 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.708 1.603 . . . . 0.0 113.998 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.12 -10.88 0.33 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.309 0.956 . . . . 0.0 115.467 178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 pttp 42.61 34.47 0.56 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.109 2.164 . . . . 0.0 116.322 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -62.01 -34.42 76.16 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.285 1.034 . . . . 0.0 111.756 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.97 166.71 23.97 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.453 1.101 . . . . 0.0 112.476 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.3 mt -114.55 151.0 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.884 1.674 . . . . 0.0 108.486 166.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.77 171.67 13.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.316 1.046 . . . . 0.0 112.365 174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -144.44 144.43 31.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.329 0.585 . . . . 0.0 111.273 164.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.42 131.45 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.818 1.647 . . . . 0.0 109.064 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.4 t -142.96 131.1 21.89 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.968 0.907 . . . . 0.0 110.134 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 m -75.61 12.36 1.05 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.0 m 48.84 29.99 2.51 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.183 1.393 . . . . 0.0 113.483 -166.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -103.39 26.91 7.81 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.422 1.889 . . . . 0.0 111.761 -170.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.08 172.1 13.24 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.778 2.031 . . . . 0.0 110.389 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.899 -170.137 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.481 0.772 0 CA-C-O 119.631 -0.237 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -57.01 136.36 56.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.253 1.021 . . . . 0.0 110.668 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.83 157.03 43.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.279 1.432 . . . . 0.0 110.811 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -136.94 118.95 15.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.155 0.982 . . . . 0.0 111.488 -168.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.6 tt -110.61 101.2 9.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.581 2.352 . . . . 0.0 109.204 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -102.43 137.72 40.31 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.52 121.7 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.609 1.164 . . . . 0.0 110.304 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.53 -22.81 35.75 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 116.423 1.329 . . . . 0.0 116.423 -170.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -149.47 26.57 0.84 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 116.272 1.952 . . . . 0.0 116.272 -169.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.8 tp -125.29 -34.59 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 CA-C-O 116.677 -1.63 . . . . 0.0 114.782 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -72.07 46.49 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.019 3.146 . . . . 0.0 115.015 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.06 -5.71 57.94 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.593 1.957 . . . . 0.0 113.032 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -123.35 171.1 9.67 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.878 2.071 . . . . 0.0 111.099 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -67.32 142.97 56.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.3 t -144.33 134.13 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.908 1.283 . . . . 0.0 110.684 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.0 t -102.16 165.19 11.28 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.586 1.955 . . . . 0.0 112.005 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -53.49 -38.48 63.72 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.421 1.088 . . . . 0.0 113.19 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -79.68 -31.52 41.34 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 -52.17 64.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.75 0.82 . . . . 0.0 111.74 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD11 ' CG2' ' A' ' 33' ' ' ILE . 3.9 pp -68.33 -34.86 76.87 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.801 -0.562 . . . . 0.0 111.534 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -67.32 -44.13 79.88 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.327 -0.858 . . . . 0.0 111.865 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -70.87 -40.11 72.46 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.778 1.172 . . . . 0.0 111.912 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -72.91 -27.02 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 119.584 1.084 . . . . 0.0 113.056 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.52 -5.59 39.05 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -44.26 86.97 Favored Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.54 1.6 9.16 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 121.965 1.777 . . . . 0.0 114.034 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -112.0 -27.57 8.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.59 174.75 42.67 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 116.82 1.488 . . . . 0.0 116.82 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -88.5 -17.45 30.28 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -162.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 62.14 152.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 126.943 2.097 . . . . 0.0 116.155 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.9 mmt -135.98 -72.25 0.46 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.473 1.509 . . . . 0.0 111.436 169.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -146.72 169.18 19.58 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.479 1.512 . . . . 0.0 111.201 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.443 ' CG2' HD11 ' A' ' 20' ' ' LEU . 1.6 pp -133.43 142.13 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.828 -1.17 . . . . 0.0 112.705 -170.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -153.1 125.91 8.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.605 1.162 . . . . 0.0 109.261 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -143.36 132.1 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.335 1.454 . . . . 0.0 108.691 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -143.45 127.81 17.81 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.045 0.938 . . . . 0.0 111.56 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.2 t30 53.58 -71.13 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.047 2.539 . . . . 0.0 116.795 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.12 7.73 1.6 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.324 2.25 . . . . 0.0 113.12 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -135.91 140.35 43.99 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.555 1.542 . . . . 0.0 111.05 -169.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.59 123.03 6.11 Favored Glycine 0 N--CA 1.466 0.666 0 CA-C-O 119.078 -0.845 . . . . 0.0 111.608 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -115.55 58.28 0.73 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.768 2.427 . . . . 0.0 108.936 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 67.5 mt -83.0 139.81 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 120.129 -1.607 . . . . 0.0 109.456 -169.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.92 137.24 47.15 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.406 1.082 . . . . 0.0 110.874 -175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.59 164.15 23.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.466 1.107 . . . . 0.0 112.759 -168.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.63 146.79 26.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.542 156.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 63.38 144.35 0.07 OUTLIER Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 129.455 3.102 . . . . 0.0 116.32 -172.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.38 -40.88 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.409 2.739 . . . . 0.0 111.612 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -62.75 -41.68 99.32 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.709 0.804 . . . . 0.0 111.148 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.7 m -54.23 -34.42 60.64 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 170.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 77.4 t -72.62 -58.74 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 118.898 0.772 . . . . 0.0 110.154 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.254 5.4 ppt_? -67.79 -25.98 65.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.423 -174.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -74.46 -37.77 63.15 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.769 1.168 . . . . 0.0 112.006 171.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.68 -45.28 90.83 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.02 -1.05 . . . . 0.0 112.617 173.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.9 mt -74.1 -54.16 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.367 -0.833 . . . . 0.0 110.637 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -75.92 -11.69 60.01 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -168.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.3 t -109.85 -31.36 7.45 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -108.86 -32.41 7.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.343 1.429 . . . . 0.0 113.733 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -87.37 59.15 5.37 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.521 -1.362 . . . . 0.0 111.868 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 54.79 5.16 0.08 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -88.79 -4.69 58.44 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.697 1.599 . . . . 0.0 113.304 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 tpt -78.6 39.19 0.34 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.889 2.076 . . . . 0.0 112.352 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -138.14 153.34 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.371 1.869 . . . . 0.0 110.257 -170.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -72.43 -32.03 65.97 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.692 0.797 . . . . 0.0 111.322 169.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.04 178.17 34.02 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.113 0.863 . . . . 0.0 113.027 169.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 143.99 49.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.988 1.315 . . . . 0.0 111.604 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -155.87 -39.48 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.222 1.409 . . . . 0.0 112.345 167.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.88 134.35 34.52 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -173.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 mp -104.3 135.83 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.691 1.596 . . . . 0.0 109.193 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 165.83 28.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -174.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -143.03 126.03 16.28 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.377 0.671 . . . . 0.0 111.781 164.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 p -99.11 127.05 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 109.993 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 60.8 p -142.62 161.74 37.29 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.806 1.242 . . . . 0.0 111.426 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -116.34 -162.86 0.87 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.166 0.987 . . . . 0.0 112.236 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 90.9 p -61.17 -0.12 0.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -62.47 -23.7 67.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.978 1.311 . . . . 0.0 112.934 167.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.8 176.29 8.82 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 112.613 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 127.234 2.214 . . . . 0.0 111.179 173.547 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo . . . . . 0 CA--C 1.537 0.658 0 N-CA-C 114.161 0.793 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -99.56 64.73 1.32 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.356 2.262 . . . . 0.0 111.032 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.15 158.11 25.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.919 0.888 . . . . 0.0 112.273 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -142.85 119.02 10.76 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.407 1.483 . . . . 0.0 110.716 -164.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tt -110.15 125.61 53.21 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.319 2.648 . . . . 0.0 108.892 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -117.87 141.22 48.67 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.047 0.939 . . . . 0.0 111.94 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -132.55 139.0 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.317 1.447 . . . . 0.0 109.984 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.63 166.55 12.96 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.144 0.878 . . . . 0.0 112.541 163.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.0 t30 57.43 12.87 1.59 Allowed 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 171.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.634 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 10.1 tt -131.8 -45.21 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 126.57 1.948 . . . . 0.0 113.775 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.634 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 75.9 Cg_endo -74.27 26.66 0.34 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.227 2.618 . . . . 0.0 113.849 173.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.8 mt -68.09 -20.97 64.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.452 1.501 . . . . 0.0 112.346 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -99.1 12.5 35.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.456 1.903 . . . . 0.0 112.906 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 54.51 163.65 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.208 2.603 . . . . 0.0 114.04 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.4 t -140.87 129.48 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.241 -1.537 . . . . 0.0 110.06 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -66.2 152.61 44.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.755 0.822 . . . . 0.0 112.386 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -43.43 -34.79 1.38 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.941 1.296 . . . . 0.0 113.835 164.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -89.95 -37.96 13.99 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.152 0.981 . . . . 0.0 112.307 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -61.47 -50.58 72.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.457 0.571 . . . . 0.0 110.793 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.76 -39.5 87.9 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 121.694 -0.628 . . . . 0.0 111.938 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -63.49 -42.38 98.53 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 121.835 -0.541 . . . . 0.0 110.918 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -77.76 -45.79 23.58 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.939 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.6 pp -67.55 -25.5 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 120.313 1.415 . . . . 0.0 112.412 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -100.27 8.74 43.54 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 169.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 m -56.12 -55.88 37.03 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-N 120.553 1.524 . . . . 0.0 112.655 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.89 -16.99 29.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.043 1.829 . . . . 0.0 113.98 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -80.63 -13.06 59.37 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.377 1.071 . . . . 0.0 113.35 -175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 49' ' ' SER . . . -179.81 -156.5 17.96 Favored Glycine 0 CA--C 1.526 0.749 0 O-C-N 121.186 -0.946 . . . . 0.0 113.596 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -119.65 -11.65 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 116.449 2.018 . . . . 0.0 116.449 -176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.32 0.0 OUTLIER 53.01 163.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 129.414 3.086 . . . . 0.0 116.46 172.401 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.8 mmt -143.04 -69.13 0.34 Allowed 'General case' 0 N--CA 1.478 0.964 0 O-C-N 119.882 -1.761 . . . . 0.0 112.868 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.61 178.01 8.28 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.542 1.537 . . . . 0.0 111.549 -169.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.44 151.51 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.562 1.073 . . . . 0.0 112.714 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -160.31 111.26 1.88 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.365 158.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.83 123.54 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.861 -1.149 . . . . 0.0 110.325 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -162.18 150.15 14.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.103 1.761 . . . . 0.0 109.876 -171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.2 t30 60.01 -162.88 0.25 Allowed 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.734 1.613 . . . . 0.0 112.426 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.3 17.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.343 1.857 . . . . 0.0 114.636 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -141.35 173.75 11.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.233 2.213 . . . . 0.0 110.912 -167.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.4 150.72 22.08 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 121.308 -0.87 . . . . 0.0 112.18 170.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -120.12 139.41 52.63 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.362 1.065 . . . . 0.0 110.513 171.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.9 mt -130.39 131.2 65.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 170.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -94.4 146.36 24.12 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.064 -1.023 . . . . 0.0 108.881 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -139.82 153.48 47.09 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.566 1.146 . . . . 0.0 112.952 -162.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.96 138.34 34.65 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.349 0.66 . . . . 0.0 110.229 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 56.25 132.37 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 129.127 2.971 . . . . 0.0 115.683 -162.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.67 -27.22 38.65 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.911 2.407 . . . . 0.0 112.503 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -59.68 -35.72 75.03 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.631 -0.668 . . . . 0.0 111.803 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.42 ' HB3' ' HA3' ' A' ' 28' ' ' GLY . 49.5 m -61.82 -34.96 76.87 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 113.128 174.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.25 -56.07 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.589 0.756 . . . . 0.0 110.134 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -39.26 94.19 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.923 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.69 -26.31 66.12 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.39 -57.14 4.72 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.992 0.814 . . . . 0.0 112.01 168.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.93 -36.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.146 -0.971 . . . . 0.0 112.746 -169.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -72.05 -37.08 69.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.939 0.79 . . . . 0.0 110.323 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.4 t -86.03 -32.49 21.42 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -113.39 -46.18 3.09 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 m -79.44 -8.57 59.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -139.06 168.3 20.14 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.404 2.281 . . . . 0.0 110.104 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.47 -26.2 7.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.612 1.165 . . . . 0.0 113.483 -172.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.424 ' HG3' ' H ' ' A' ' 63' ' ' PHE . 45.1 tpp -150.92 133.28 15.46 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.954 0.902 . . . . 0.0 112.749 -175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -63.8 -3.31 2.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.764 1.626 . . . . 0.0 114.882 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.424 ' H ' ' HG3' ' A' ' 61' ' ' MET . 78.2 m-85 -132.22 11.05 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.687 1.995 . . . . 0.0 112.904 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.03 134.55 7.69 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.721 1.153 . . . . 0.0 113.327 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -76.92 128.63 34.89 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.532 1.133 . . . . 0.0 111.052 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -140.43 -34.16 0.54 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.919 1.687 . . . . 0.0 112.111 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 tp -150.42 156.11 40.85 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.978 1.311 . . . . 0.0 113.334 -177.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 34.2 pt -90.8 143.93 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.623 1.169 . . . . 0.0 112.548 167.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.51 176.13 12.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.621 1.168 . . . . 0.0 113.382 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.22 145.94 28.46 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.673 0.789 . . . . 0.0 110.984 159.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 p -112.63 119.31 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 125.98 1.712 . . . . 0.0 109.212 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 t -142.22 163.43 32.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.353 1.061 . . . . 0.0 112.206 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.6 p -132.49 15.07 4.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.925 1.29 . . . . 0.0 113.05 162.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 95.6 p -148.78 -6.76 0.39 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 116.253 1.946 . . . . 0.0 116.253 -173.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -66.04 164.32 15.56 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 120.334 1.425 . . . . 0.0 112.033 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.88 158.18 22.78 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.278 1.031 . . . . 0.0 112.902 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 124.515 1.126 . . . . 0.0 111.698 175.432 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 112.821 0.277 . . . . 0.0 112.821 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -110.07 125.72 53.26 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.604 1.562 . . . . 0.0 111.162 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -141.45 155.0 45.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.187 1.395 . . . . 0.0 112.685 -178.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -129.52 133.71 47.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.596 1.558 . . . . 0.0 111.274 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -115.32 104.23 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 129.137 2.975 . . . . 0.0 107.981 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -96.51 126.26 41.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.202 0.601 . . . . 0.0 110.095 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 mt -115.17 139.03 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.472 1.109 . . . . 0.0 108.754 169.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.22 -151.35 0.31 Allowed Glycine 0 CA--C 1.536 1.363 0 CA-C-O 122.88 1.267 . . . . 0.0 113.07 166.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -78.79 68.31 4.73 Favored 'General case' 0 CA--C 1.55 0.942 0 O-C-N 121.123 -1.222 . . . . 0.0 113.604 -167.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' H ' ' HD2' ' A' ' 11' ' ' PRO . 58.4 tp -129.19 -53.67 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 116.798 -1.572 . . . . 0.0 114.461 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' A' ' 10' ' ' LEU . 96.0 Cg_endo -80.7 95.62 0.98 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.993 2.462 . . . . 0.0 110.85 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.68 -38.05 6.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.674 1.19 . . . . 0.0 113.3 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -148.03 168.41 22.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.582 1.153 . . . . 0.0 112.902 -171.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t30 51.5 46.16 26.92 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.965 1.306 . . . . 0.0 112.637 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -129.16 139.12 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.85 1.26 . . . . 0.0 111.174 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.6 t -154.19 173.59 15.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.95 2.1 . . . . 0.0 108.196 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -55.58 -40.84 72.51 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.198 0.908 . . . . 0.0 113.086 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -73.19 -34.13 65.81 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.194 0.598 . . . . 0.0 112.576 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -71.17 -43.79 66.78 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.791 -0.568 . . . . 0.0 111.765 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.75 -34.17 73.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.705 0.684 . . . . 0.0 111.969 171.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -59.98 -48.48 81.52 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.654 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -72.62 -33.49 66.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.51 1.05 . . . . 0.0 113.189 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 24' ' ' PHE 0.258 1.8 pp -79.88 -26.0 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 119.642 1.11 . . . . 0.0 113.573 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' CD1' HD12 ' A' ' 23' ' ' ILE . 15.8 m-30 -101.29 -4.52 26.91 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.571 1.078 . . . . 0.0 113.899 171.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.98 -53.85 19.6 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 114.098 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.14 0.69 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.185 1.923 . . . . 0.0 114.218 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -109.42 -13.9 14.51 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.383 1.473 . . . . 0.0 113.429 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 178.93 -174.79 46.86 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 118.224 2.049 . . . . 0.0 118.224 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -101.13 -10.45 20.43 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -162.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 62.89 152.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 168.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.4 mmt -138.11 -73.38 0.41 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 111.99 165.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -153.89 -175.8 5.54 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.811 1.644 . . . . 0.0 111.918 -170.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.7 pt -131.68 157.03 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.579 1.536 . . . . 0.0 113.45 -165.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -147.8 101.08 3.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.897 1.279 . . . . 0.0 110.0 172.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.4 mt -126.39 110.62 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 120.29 -1.506 . . . . 0.0 110.737 -174.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -146.61 152.82 39.53 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.495 1.518 . . . . 0.0 111.319 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.3 t30 55.14 -159.4 0.19 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.26 1.424 . . . . 0.0 112.466 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.56 30.82 0.05 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.995 2.118 . . . . 0.0 114.213 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.75 175.36 10.24 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.808 2.043 . . . . 0.0 111.059 -170.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.19 135.97 4.02 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.326 -0.859 . . . . 0.0 111.947 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.39 157.36 45.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.214 1.406 . . . . 0.0 110.046 -171.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.58 153.54 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 121.086 -1.009 . . . . 0.0 108.776 -175.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.13 144.62 42.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.679 1.191 . . . . 0.0 109.953 168.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.96 155.5 50.63 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.847 1.259 . . . . 0.0 112.33 -163.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.77 140.11 31.47 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.045 155.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 60.35 139.17 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 128.188 2.595 . . . . 0.0 116.418 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.97 -30.33 7.33 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.52 2.147 . . . . 0.0 112.986 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.88 -34.22 77.46 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.56 -0.712 . . . . 0.0 111.494 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.6 m -60.47 -42.4 96.18 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.241 1.416 . . . . 0.0 113.216 167.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 68.8 t -63.9 -55.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.318 0.647 . . . . 0.0 110.921 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -45.53 94.16 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.305 -0.855 . . . . 0.0 111.493 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -63.8 -34.58 78.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.754 1.161 . . . . 0.0 112.507 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.5 -54.26 39.17 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.684 1.129 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mt -72.4 -36.18 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.094 -1.004 . . . . 0.0 111.708 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -83.73 -10.94 57.79 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.847 -1.158 . . . . 0.0 113.331 -173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 t -120.38 -40.71 2.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 112.576 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.56 -50.16 6.09 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.962 0.801 . . . . 0.0 110.955 177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 m -85.36 18.72 2.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.249 1.02 . . . . 0.0 113.669 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' HG2' ' H ' ' A' ' 61' ' ' MET . 52.1 tt0 -54.88 139.04 41.52 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.446 1.498 . . . . 0.0 111.771 -177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -98.39 -0.3 43.94 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.503 1.521 . . . . 0.0 114.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.459 ' H ' ' HG2' ' A' ' 59' ' ' GLN . 19.1 ttt 70.92 148.95 0.08 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.03 2.532 . . . . 0.0 113.823 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -75.24 35.32 0.11 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.666 1.586 . . . . 0.0 114.249 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -142.03 -11.11 0.87 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.428 1.491 . . . . 0.0 114.275 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.1 165.36 38.69 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 119.824 1.193 . . . . 0.0 113.283 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -155.54 128.5 8.09 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.659 1.184 . . . . 0.0 110.157 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -127.67 -0.72 6.11 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 pp -133.1 172.53 12.53 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.574 1.95 . . . . 0.0 110.866 173.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 44.5 pt -120.34 166.39 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.367 1.067 . . . . 0.0 112.154 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.86 167.54 21.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.939 1.296 . . . . 0.0 112.19 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -149.9 122.75 8.71 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 165.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.1 p -82.43 133.42 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.735 1.214 . . . . 0.0 109.834 166.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.9 t -147.58 160.87 42.16 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 66.7 p -157.77 -176.05 5.72 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.2 t -55.6 -25.26 37.62 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.833 0.853 . . . . 0.0 113.267 166.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.84 -20.68 56.05 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.5 1.045 . . . . 0.0 113.604 171.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -84.45 -1.85 56.31 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.071 0.948 . . . . 0.0 113.066 169.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.344 0 CA-C-O 117.686 -1.149 . . . . 0.0 110.333 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.482 0.813 0 CA-C-O 119.028 -0.488 . . . . 0.0 113.014 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -88.76 59.66 5.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 112.363 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.53 160.42 31.5 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.487 0.715 . . . . 0.0 111.091 173.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 -140.47 145.37 36.84 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.612 1.165 . . . . 0.0 112.053 -177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.72 125.37 37.81 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 127.801 2.44 . . . . 0.0 108.953 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -127.19 139.88 52.63 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.869 0.868 . . . . 0.0 110.18 173.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 mp -121.18 141.22 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.046 1.338 . . . . 0.0 107.656 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.02 -151.94 0.03 OUTLIER Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.17 1.843 . . . . 0.0 113.81 171.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.6 p30 -76.18 41.4 0.23 Allowed 'General case' 0 CA--C 1.552 1.05 0 O-C-N 120.759 -1.436 . . . . 0.0 114.718 -173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -104.34 -51.87 0.12 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.697 1.999 . . . . 0.0 114.256 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.41 -31.86 2.54 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.897 1.731 . . . . 0.0 112.539 -172.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.43 177.56 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.134 1.774 . . . . 0.0 112.513 -168.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -75.06 2.03 11.62 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.417 -1.427 . . . . 0.0 112.312 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -79.21 38.32 0.35 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.923 2.089 . . . . 0.0 113.001 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -143.44 138.26 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.926 2.09 . . . . 0.0 108.139 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.3 t -122.85 179.97 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.572 1.549 . . . . 0.0 111.821 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -59.39 -35.61 74.26 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -170.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -79.68 -38.63 33.16 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.256 0.622 . . . . 0.0 111.291 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.8 -42.5 99.09 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.815 0.846 . . . . 0.0 112.248 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.83 -38.74 57.8 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.222 0.609 . . . . 0.0 112.052 174.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -68.34 -43.66 77.03 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 121.386 -0.821 . . . . 0.0 110.97 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -66.04 -41.62 90.64 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.206 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.78 -34.21 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.849 0.749 . . . . 0.0 112.077 -176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.419 ' CD1' ' HB1' ' A' ' 53' ' ' ALA . 28.4 m-85 -87.52 -19.0 28.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 176.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.4 m -44.05 -51.96 16.93 Favored Pre-proline 0 N--CA 1.48 1.067 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.3 -6.19 18.43 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.683 1.588 . . . . 0.0 114.063 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -105.6 -24.17 12.62 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.439 1.496 . . . . 0.0 113.772 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -166.35 165.69 38.41 Favored Glycine 0 CA--C 1.531 1.094 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -81.16 -19.06 44.23 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -165.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 63.58 160.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 126.337 1.855 . . . . 0.0 114.938 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mmt -141.75 -68.02 0.39 Allowed 'General case' 0 N--CA 1.476 0.845 0 O-C-N 120.563 -1.336 . . . . 0.0 112.717 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -146.27 179.99 7.13 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.574 1.95 . . . . 0.0 110.053 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 pt -134.62 155.57 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 120.834 -1.166 . . . . 0.0 113.296 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -159.05 146.03 17.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.242 1.817 . . . . 0.0 108.262 157.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.7 mt -142.53 138.61 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.064 1.746 . . . . 0.0 108.367 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -151.22 150.69 30.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.08 0.952 . . . . 0.0 110.836 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 58.74 -90.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.499 1.52 . . . . 0.0 114.212 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.82 10.41 2.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 127.133 2.173 . . . . 0.0 112.558 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -127.42 147.65 50.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.011 1.725 . . . . 0.0 111.948 -164.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.93 140.38 15.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.97 0.795 . . . . 0.0 112.6 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -133.2 55.3 1.91 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.529 1.931 . . . . 0.0 110.176 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.5 150.46 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.217 1.407 . . . . 0.0 109.85 -164.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -112.3 140.41 47.04 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.777 -1.202 . . . . 0.0 110.218 -176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -133.79 144.66 49.16 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 112.272 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -77.25 135.15 38.44 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 155.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 61.54 133.36 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 129.93 3.292 . . . . 0.0 117.561 -174.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.0 -26.54 15.06 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.092 2.528 . . . . 0.0 113.991 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.29 -32.75 72.11 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.736 -1.227 . . . . 0.0 111.542 173.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.1 m -68.89 -25.24 64.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.496 1.519 . . . . 0.0 113.185 168.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 66.7 t -71.21 -58.6 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.558 1.072 . . . . 0.0 110.945 168.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -46.72 88.36 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.408 -0.806 . . . . 0.0 111.822 -174.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.66 -27.62 69.05 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.809 1.186 . . . . 0.0 113.455 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 24' ' ' PHE . . . -68.26 -50.74 51.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.647 0.658 . . . . 0.0 112.128 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 mt -70.77 -46.66 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.191 -0.943 . . . . 0.0 111.289 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -72.35 -22.14 61.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.121 0.968 . . . . 0.0 112.293 -169.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.9 t -118.38 -19.42 8.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -175.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -100.85 -54.05 2.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 120.201 1.364 . . . . 0.0 111.314 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 m -77.0 -56.18 4.81 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -162.08 133.4 5.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.918 0.887 . . . . 0.0 112.735 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -100.14 154.11 18.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.363 1.065 . . . . 0.0 112.659 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.7 tpt 55.74 49.29 16.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.534 1.533 . . . . 0.0 113.017 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -55.36 -17.28 4.57 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 175.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -55.76 -12.38 1.27 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 173.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.11 34.56 Favored Glycine 0 CA--C 1.541 1.66 0 N-CA-C 115.942 1.137 . . . . 0.0 115.942 170.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 53.2 36.77 23.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.535 1.934 . . . . 0.0 114.961 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -126.42 -11.42 6.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.695 1.998 . . . . 0.0 113.659 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -138.04 148.09 44.76 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 128.26 2.624 . . . . 0.0 110.053 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt -124.48 148.31 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.898 0.879 . . . . 0.0 111.22 -172.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.69 172.05 14.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.684 1.194 . . . . 0.0 112.292 168.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -143.78 116.13 8.52 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.603 -0.686 . . . . 0.0 112.758 167.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.5 p -87.16 125.78 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.388 1.075 . . . . 0.0 109.648 165.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.0 m -131.18 145.33 51.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.598 1.159 . . . . 0.0 111.863 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.3 m -101.19 -20.65 15.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.358 1.863 . . . . 0.0 112.089 174.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.7 t -161.15 161.76 31.15 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.543 2.337 . . . . 0.0 109.573 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -112.26 3.49 17.15 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.054 1.342 . . . . 0.0 113.562 166.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -141.23 -171.07 3.2 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.604 1.961 . . . . 0.0 110.286 -168.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.3 ttm105 . . . . . 0 C--O 1.257 1.451 0 C-N-CA 125.638 1.575 . . . . 0.0 113.052 176.294 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 N--CA 1.481 0.776 0 CA-C-O 118.519 -0.701 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -75.65 67.13 2.08 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.235 1.814 . . . . 0.0 112.317 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.89 167.01 5.03 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.85 2.46 . . . . 0.0 112.953 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -141.47 133.54 27.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.798 -1.189 . . . . 0.0 112.526 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD13 ' CE1' ' A' ' 44' ' ' PHE . 8.1 tt -122.18 129.08 51.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.401 2.28 . . . . 0.0 109.762 -176.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -125.99 133.13 51.87 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.557 0.743 . . . . 0.0 111.393 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.01 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.904 0.882 . . . . 0.0 109.262 167.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.93 -17.11 76.75 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 124.012 0.815 . . . . 0.0 113.863 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -148.99 88.62 1.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.123 1.369 . . . . 0.0 111.661 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.0 tp -153.61 -58.0 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 117.758 -1.115 . . . . 0.0 112.338 162.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -82.67 85.75 1.58 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.419 2.079 . . . . 0.0 110.531 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.78 -33.84 27.21 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.901 0.88 . . . . 0.0 112.539 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -160.73 -24.63 0.06 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 172.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.12 61.68 1.44 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.316 1.446 . . . . 0.0 112.085 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.7 t -132.23 128.21 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.532 1.133 . . . . 0.0 109.915 164.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.0 m -126.08 175.36 7.8 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.692 1.997 . . . . 0.0 110.693 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -45.45 -49.28 13.53 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.085 1.754 . . . . 0.0 113.883 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -79.45 -11.6 59.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.827 0.851 . . . . 0.0 113.073 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -83.48 -55.96 4.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.581 1.152 . . . . 0.0 109.803 170.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.34 -34.54 77.93 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.686 -0.634 . . . . 0.0 111.821 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -69.48 -45.34 69.23 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.163 -0.922 . . . . 0.0 112.073 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -67.2 -40.01 86.4 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.41 1.459 . . . . 0.0 112.246 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pp -74.28 -27.92 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.831 0.741 . . . . 0.0 112.878 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -97.69 -10.67 24.57 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.2 m -48.63 -52.14 47.09 Favored Pre-proline 0 N--CA 1.478 0.965 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -76.94 10.35 2.37 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 122.291 1.994 . . . . 0.0 113.697 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -120.15 -29.32 4.9 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.476 1.51 . . . . 0.0 113.384 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -161.68 172.81 37.95 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -86.36 -20.44 28.27 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.309 1.444 . . . . 0.0 114.716 -165.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 31' ' ' MET . 0.4 OUTLIER 61.88 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 127.037 2.135 . . . . 0.0 115.748 176.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.413 ' H ' HD13 ' A' ' 30' ' ' ILE . 7.8 mmt -141.93 -73.48 0.31 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.578 1.551 . . . . 0.0 113.386 169.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -138.78 171.83 13.76 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.675 1.59 . . . . 0.0 111.894 -169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -130.34 151.53 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -168.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -160.55 131.26 5.45 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.275 2.23 . . . . 0.0 109.712 163.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.3 mt -137.37 134.22 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.33 -1.481 . . . . 0.0 109.721 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.41 150.7 23.72 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.003 0.921 . . . . 0.0 112.489 -173.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 59.34 -93.83 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.018 1.727 . . . . 0.0 113.321 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.81 9.2 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.076 1.75 . . . . 0.0 112.621 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -131.21 169.98 15.21 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.207 1.803 . . . . 0.0 111.299 -171.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.16 138.92 10.44 Favored Glycine 0 N--CA 1.466 0.637 0 C-N-CA 123.93 0.776 . . . . 0.0 112.345 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -122.37 100.53 6.99 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.858 1.663 . . . . 0.0 108.528 173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 55.3 mt -114.04 131.37 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -94.98 142.87 26.97 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.746 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CE1' HD13 ' A' ' 5' ' ' LEU . 6.6 m-85 -128.57 162.39 27.37 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.209 1.403 . . . . 0.0 110.981 -168.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -92.32 145.65 24.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.712 153.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 62.61 126.02 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 127.55 2.34 . . . . 0.0 116.792 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 -34.76 14.72 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.447 2.764 . . . . 0.0 114.393 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -62.27 -35.98 80.66 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.576 -0.702 . . . . 0.0 110.873 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -35.15 79.78 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.871 2.068 . . . . 0.0 112.408 175.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -63.82 -59.76 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 121.619 -0.676 . . . . 0.0 111.432 168.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -34.35 77.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.197 -0.906 . . . . 0.0 112.404 -172.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.75 -39.36 84.19 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.476 1.035 . . . . 0.0 111.977 174.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.63 -39.99 94.68 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.185 -0.947 . . . . 0.0 112.706 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.7 mt -68.51 -62.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 120.958 -1.089 . . . . 0.0 109.914 172.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -72.59 -29.1 63.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -162.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.9 t -96.01 -25.02 16.09 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.69 -41.18 3.09 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 m -82.75 -19.77 37.24 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.26 -0.9 . . . . 0.0 112.962 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -120.42 145.99 46.66 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.562 1.945 . . . . 0.0 110.547 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -122.14 -11.13 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -176.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.7 ttt -144.23 154.3 42.96 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.575 1.55 . . . . 0.0 111.326 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -71.32 123.36 22.12 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.102 -0.999 . . . . 0.0 111.409 174.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 54.84 36.23 26.06 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.248 1.019 . . . . 0.0 112.277 -168.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -59.76 158.32 24.36 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.405 1.479 . . . . 0.0 113.901 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -96.56 157.76 15.75 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.318 -1.107 . . . . 0.0 113.072 -165.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt 57.72 14.6 2.51 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.152 2.181 . . . . 0.0 114.571 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.22 107.17 8.81 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.056 1.342 . . . . 0.0 109.925 -172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.0 mt -113.66 150.2 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.688 1.195 . . . . 0.0 109.42 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.72 169.46 19.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.132 1.773 . . . . 0.0 112.468 -168.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -146.33 131.79 18.68 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 110.856 162.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -104.08 124.38 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.63 1.172 . . . . 0.0 108.796 167.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -138.66 168.94 18.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.128 0.971 . . . . 0.0 112.702 -170.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 83.9 p -114.73 -172.51 2.13 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.446 1.099 . . . . 0.0 112.996 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.4 p -66.2 -3.85 6.51 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 169.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -66.68 165.61 14.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.42 1.088 . . . . 0.0 111.032 168.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.19 -1.39 23.04 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.26 1.424 . . . . 0.0 114.758 175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 . . . . . 0 C--O 1.253 1.246 0 CA-C-O 116.379 -1.772 . . . . 0.0 111.446 -175.186 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.54 0.808 0 N-CA-C 111.717 -0.147 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.16 130.63 47.24 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.061 -1.024 . . . . 0.0 111.811 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.51 162.04 36.31 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.244 1.418 . . . . 0.0 112.46 -172.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 -128.96 139.47 52.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.931 1.293 . . . . 0.0 111.181 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -127.81 111.1 13.26 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 128.169 2.588 . . . . 0.0 109.021 -177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -113.99 130.6 56.52 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.533 -0.729 . . . . 0.0 111.293 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.45 134.37 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.502 1.121 . . . . 0.0 108.608 166.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.66 -141.12 0.4 Allowed Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.7 0.667 . . . . 0.0 112.558 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.53 82.4 0.06 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.152 1.781 . . . . 0.0 112.532 -172.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.3 tp -142.22 -58.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.571 1.548 . . . . 0.0 111.253 170.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.49 101.65 1.52 Allowed 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.972 2.448 . . . . 0.0 110.538 169.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.3 mp -108.63 -18.27 13.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.397 1.079 . . . . 0.0 112.52 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -93.99 165.06 12.83 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.896 1.678 . . . . 0.0 110.425 173.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -68.04 144.31 55.16 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.742 -0.599 . . . . 0.0 111.723 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.2 t -141.81 137.95 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.671 1.188 . . . . 0.0 110.074 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.9 t -84.84 152.45 23.6 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.767 1.227 . . . . 0.0 112.721 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -51.04 -24.28 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.715 1.206 . . . . 0.0 113.291 163.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -86.86 -37.8 17.38 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.622 1.169 . . . . 0.0 111.772 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -61.92 -51.32 68.61 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 110.41 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.08 -35.49 78.27 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.428 -0.795 . . . . 0.0 112.414 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -70.05 -39.47 75.69 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.837 0.744 . . . . 0.0 111.977 177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -74.72 -34.61 62.61 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.175 0.898 . . . . 0.0 112.666 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.01 -35.66 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.728 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -91.27 -3.33 56.98 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.4 m -46.73 -49.97 44.97 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 120.729 1.604 . . . . 0.0 113.973 175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.56 -9.94 18.67 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 121.8 1.667 . . . . 0.0 113.91 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -90.41 -28.57 18.56 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.183 1.393 . . . . 0.0 111.63 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -179.66 -176.24 47.06 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 118.966 2.346 . . . . 0.0 118.966 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -86.02 -21.93 27.53 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -162.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 31' ' ' MET 0.261 0.3 OUTLIER 61.86 156.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 128.908 2.883 . . . . 0.0 116.227 178.298 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.431 ' H ' HD13 ' A' ' 30' ' ' ILE . 5.8 mmt -139.81 -61.96 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.762 1.625 . . . . 0.0 113.268 169.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -156.56 172.76 17.99 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.774 1.17 . . . . 0.0 111.604 -168.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.84 152.95 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 120.166 1.348 . . . . 0.0 114.198 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -151.72 125.08 8.81 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.381 2.272 . . . . 0.0 108.465 164.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -138.62 127.93 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 120.694 -1.254 . . . . 0.0 110.03 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -149.3 156.85 42.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.32 1.448 . . . . 0.0 111.715 178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 52.97 -109.73 0.49 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.601 1.56 . . . . 0.0 113.105 165.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.71 14.31 13.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.958 1.303 . . . . 0.0 113.684 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -127.12 167.73 15.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.535 1.134 . . . . 0.0 112.111 -176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -135.67 127.95 4.46 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.49 88.07 2.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.21 1.404 . . . . 0.0 109.241 173.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.9 mt -87.41 151.72 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.132 0.968 . . . . 0.0 108.425 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -121.77 141.38 51.26 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 120.305 -1.497 . . . . 0.0 108.373 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.413 ' CD2' ' HB3' ' A' ' 49' ' ' SER . 2.4 m-85 -131.96 165.05 24.79 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.891 1.277 . . . . 0.0 112.176 -165.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.42 140.25 36.95 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 156.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . 0.322 2.1 p30 60.07 144.45 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 129.723 3.209 . . . . 0.0 115.981 -169.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.0 -23.09 8.14 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.669 2.246 . . . . 0.0 112.576 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -64.67 -35.79 82.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.903 0.881 . . . . 0.0 110.849 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.413 ' HB3' ' CD2' ' A' ' 44' ' ' PHE . 72.4 m -57.51 -47.05 82.98 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 125.599 1.56 . . . . 0.0 112.582 167.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.37 -55.61 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 123.335 0.654 . . . . 0.0 110.506 -178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -36.78 79.51 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 117.978 -1.01 . . . . 0.0 112.328 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -67.87 -41.25 83.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.614 1.552 . . . . 0.0 112.088 173.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.81 -55.86 29.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.097 0.862 . . . . 0.0 111.222 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.3 mt -72.67 -48.84 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 O-C-N 121.81 -0.556 . . . . 0.0 111.357 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -69.61 -13.55 62.37 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.086 -0.959 . . . . 0.0 113.43 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 29.5 t -107.81 -24.76 11.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.094 1.357 . . . . 0.0 114.383 176.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -96.95 -62.56 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 120.875 1.67 . . . . 0.0 111.993 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -68.27 -33.99 75.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.637 -0.664 . . . . 0.0 111.182 175.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 55.07 -158.44 0.2 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 112.565 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -121.96 140.2 52.74 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.69 1.196 . . . . 0.0 109.425 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.97 159.51 15.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.381 1.472 . . . . 0.0 111.249 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -76.63 32.39 0.13 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.244 1.418 . . . . 0.0 114.085 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.28 136.77 31.95 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.153 1.781 . . . . 0.0 109.827 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.76 150.52 48.07 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 173.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm 48.53 42.24 18.48 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 118.678 1.239 . . . . 0.0 113.03 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -141.54 134.49 28.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.574 1.55 . . . . 0.0 110.021 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.93 40.98 30.42 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.832 1.253 . . . . 0.0 112.009 -175.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 42.8 pt -84.38 161.24 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.648 1.179 . . . . 0.0 113.142 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 166.34 26.94 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.791 1.637 . . . . 0.0 111.884 -168.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.15 126.9 29.18 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.155 0.502 . . . . 0.0 110.49 167.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -108.79 140.25 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.608 1.563 . . . . 0.0 109.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.3 m -140.53 131.93 26.81 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.723 0.809 . . . . 0.0 112.026 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -81.46 -2.66 50.46 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.942 2.097 . . . . 0.0 112.998 171.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.1 m -131.35 151.8 51.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.011 2.125 . . . . 0.0 110.603 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -120.88 145.49 47.59 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.149 -0.97 . . . . 0.0 113.315 -175.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.42 148.27 28.56 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 110.982 172.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.523 1.929 . . . . 0.0 113.614 -171.688 . . . . . . . . 0 0 . 1 stop_ save_